-DOCSTART- -X- -X- O

Clustering NN B-NP O
of IN B-PP O
missense JJ B-NP O
mutations NNS I-NP O
in IN B-PP O
the DT B-NP O
ataxia NN I-NP B-Disease
- HYPH B-NP I-Disease
telangiectasia NN I-NP I-Disease
gene NN I-NP O
in IN B-PP O
a DT B-NP O
sporadic JJ I-NP B-Disease
T NN I-NP I-Disease
- HYPH I-NP I-Disease
cell NN I-NP I-Disease
leukaemia NN I-NP I-Disease
. . O O

Ataxia NN B-NP B-Disease
- HYPH O I-Disease
telangiectasia NN B-NP I-Disease
( ( O O
A NN B-NP B-Disease
- HYPH I-NP I-Disease
T NN I-NP I-Disease
) ) O O
is VBZ B-VP O
a DT B-NP O
recessive JJ I-NP B-Disease
multi AFX I-NP I-Disease
- HYPH I-NP I-Disease
system NN I-NP I-Disease
disorder NN I-NP I-Disease
caused VBN B-VP O
by IN B-PP O
mutations NNS B-NP O
in IN B-PP O
the DT B-NP O
ATM NN I-NP O
gene NN I-NP O
at IN B-PP O
11q22 NN B-NP O
- HYPH O O
q23 NN B-NP O
( ( O O
ref NN B-NP O
. . I-NP O

3 CD I-NP O
) ) O O
. . O O

The DT B-NP O
risk NN I-NP O
of IN B-PP O
cancer NN B-NP B-Disease
, , O O
especially RB B-NP O
lymphoid JJ I-NP B-Disease
neoplasias NNS I-NP I-Disease
, , O O
is VBZ B-VP O
substantially RB I-VP O
elevated VBN I-VP O
in IN B-PP O
A NN B-NP B-Disease
- HYPH I-NP I-Disease
T NN I-NP I-Disease
patients NNS I-NP O
and CC O O
has VBZ B-VP O
long RB I-VP O
been VBN I-VP O
associated VBN I-VP O
with IN B-PP O
chromosomal JJ B-NP O
instability NN I-NP O
. . O O

By IN B-PP O
analysing VBG B-VP O
tumour NN B-NP B-Disease
DNA NN I-NP O
from IN B-PP O
patients NNS B-NP O
with IN B-PP O
sporadic JJ B-NP B-Disease
T NN I-NP I-Disease
- HYPH B-NP I-Disease
cell NN I-NP I-Disease
prolymphocytic JJ I-NP I-Disease
leukaemia NN I-NP I-Disease
( ( O O
T NN B-NP B-Disease
- HYPH B-NP I-Disease
PLL NN I-NP I-Disease
) ) O O
, , O O
a DT B-NP O
rare JJ I-NP O
clonal JJ I-NP B-Disease
malignancy NN I-NP I-Disease
with IN B-PP O
similarities NNS B-NP O
to TO B-PP O
a DT B-NP O
mature JJ I-NP B-Disease
T NN I-NP I-Disease
- HYPH B-NP I-Disease
cell NN I-NP I-Disease
leukaemia NN I-NP I-Disease
seen VBN B-VP O
in IN B-PP O
A NN B-NP B-Disease
- HYPH I-NP I-Disease
T NN B-NP I-Disease
, , O O
we PRP B-NP O
demonstrate VBP B-VP O
a DT B-NP O
high JJ I-NP O
frequency NN I-NP O
of IN B-PP O
ATM NN B-NP O
mutations NNS I-NP O
in IN B-PP O
T NN B-NP B-Disease
- HYPH I-NP I-Disease
PLL NN I-NP I-Disease
. . O O

In IN B-PP O
marked JJ B-NP O
contrast NN I-NP O
to TO B-PP O
the DT B-NP O
ATM NN I-NP O
mutation NN I-NP O
pattern NN I-NP O
in IN B-PP O
A NN B-NP B-Disease
- HYPH O I-Disease
T NN B-NP I-Disease
, , O O
the DT B-NP O
most RBS I-NP O
frequent JJ I-NP O
nucleotide NN I-NP O
changes NNS I-NP O
in IN B-PP O
this DT B-NP O
leukaemia NN I-NP B-Disease
were VBD B-VP O
missense JJ B-NP O
mutations NNS I-NP O
. . O O

These DT B-NP O
clustered VBD B-VP O
in IN B-PP O
the DT B-NP O
region NN I-NP O
corresponding VBG B-VP O
to TO B-PP O
the DT B-NP O
kinase NN I-NP O
domain NN I-NP O
, , O O
which WDT B-NP O
is VBZ B-VP O
highly RB I-VP O
conserved VBN I-VP O
in IN B-PP O
ATM NN B-NP O
- HYPH B-NP O
related VBN I-NP O
proteins NNS I-NP O
in IN B-PP O
mouse NN B-NP O
, , O O
yeast NN B-NP O
and CC O O
Drosophila NN B-NP O
. . O O

The DT B-NP O
resulting VBG I-NP O
amino JJ I-NP O
- HYPH I-NP O
acid NN I-NP O
substitutions NNS I-NP O
are VBP B-VP O
predicted VBN I-VP O
to TO I-VP O
interfere VB I-VP O
with IN B-PP O
ATP NN B-NP O
binding NN I-NP O
or CC O O
substrate NN B-NP O
recognition NN I-NP O
. . O O

Two CD B-NP O
of IN B-PP O
seventeen CD B-NP O
mutated VBN I-NP O
T NN I-NP B-Disease
- HYPH I-NP I-Disease
PLL NN I-NP I-Disease
samples NNS I-NP O
had VBD B-VP O
a DT B-NP O
previously RB I-NP O
reported VBN I-NP O
A NN I-NP B-Disease
- HYPH I-NP I-Disease
T NN I-NP I-Disease
allele NN I-NP O
. . O O

In IN B-PP O
contrast NN B-NP O
, , O O
no DT B-NP O
mutations NNS I-NP O
were VBD B-VP O
detected VBN I-VP O
in IN B-PP O
the DT B-NP O
p53 NN I-NP O
gene NN I-NP O
, , O O
suggesting VBG B-VP O
that IN B-SBAR O
this DT B-NP O
tumour NN I-NP B-Disease
suppressor NN I-NP O
is VBZ B-VP O
not RB I-VP O
frequently RB I-VP O
altered VBN I-VP O
in IN B-PP O
this DT B-NP O
leukaemia NN I-NP B-Disease
. . O O

Occasional JJ B-NP O
missense JJ I-NP O
mutations NNS I-NP O
in IN B-PP O
ATM NN B-NP O
were VBD B-VP O
also RB I-VP O
found VBN I-VP O
in IN B-PP O
tumour NN B-NP B-Disease
DNA NN I-NP O
from IN B-PP O
patients NNS B-NP O
with IN B-PP O
B NN B-NP B-Disease
- HYPH B-NP I-Disease
cell NN I-NP I-Disease
non AFX B-NP I-Disease
- HYPH I-NP I-Disease
Hodgkins NNP I-NP I-Disease
lymphomas NNS I-NP I-Disease
( ( O O
B NN B-NP B-Disease
- HYPH O I-Disease
NHL NN B-NP I-Disease
) ) O O
and CC O O
a DT B-NP O
B NN I-NP B-Disease
- HYPH I-NP I-Disease
NHL NN I-NP I-Disease
cell NN I-NP O
line NN I-NP O
. . O O

The DT B-NP O
evidence NN I-NP O
of IN B-PP O
a DT B-NP O
significant JJ I-NP O
proportion NN I-NP O
of IN B-PP O
loss NN B-NP O
- HYPH B-NP O
of IN B-PP O
- HYPH B-NP O
function NN I-NP O
mutations NNS I-NP O
and CC O O
a DT B-NP O
complete JJ I-NP O
absence NN I-NP O
of IN B-PP O
the DT B-NP O
normal JJ I-NP O
copy NN I-NP O
of IN B-PP O
ATM NN B-NP O
in IN B-PP O
the DT B-NP O
majority NN I-NP O
of IN B-PP O
mutated VBN B-NP O
tumours NNS I-NP B-Disease
establishes VBZ B-VP O
somatic JJ B-NP O
inactivation NN I-NP O
of IN B-PP O
this DT B-NP O
gene NN I-NP O
in IN B-PP O
the DT B-NP O
pathogenesis NN I-NP O
of IN B-PP O
sporadic JJ B-NP B-Disease
T NN I-NP I-Disease
- HYPH I-NP I-Disease
PLL NN I-NP I-Disease
and CC O O
suggests VBZ B-VP O
that IN B-SBAR O
ATM NN B-NP O
acts VBZ B-VP O
as IN B-PP O
a DT B-NP O
tumour NN I-NP B-Disease
suppressor NN I-NP O
. . O O

As IN B-SBAR O
constitutional JJ B-NP O
DNA NN I-NP O
was VBD B-VP O
not RB O O
available JJ B-ADJP O
, , O O
a DT B-NP O
putative JJ I-NP O
hereditary JJ I-NP O
predisposition NN I-NP O
to TO B-PP O
T NN B-NP B-Disease
- HYPH B-NP I-Disease
PLL NN I-NP I-Disease
will MD B-VP O
require VB I-VP O
further JJR B-NP O
investigation NN I-NP O
. . O O

. . O O

Myotonic JJ B-NP B-Disease
dystrophy NN I-NP I-Disease
protein NN I-NP O
kinase NN I-NP O
is VBZ B-VP O
involved VBN I-VP O
in IN B-PP O
the DT B-NP O
modulation NN I-NP O
of IN B-PP O
the DT B-NP O
Ca2 NN I-NP O
+ SYM B-NP O
homeostasis NN I-NP O
in IN B-PP O
skeletal JJ B-NP O
muscle NN I-NP O
cells NNS I-NP O
. . O O

Myotonic JJ B-NP B-Disease
dystrophy NN I-NP I-Disease
( ( O O
DM NN B-NP B-Disease
) ) O O
, , O O
the DT B-NP O
most RBS I-NP O
prevalent JJ I-NP O
muscular JJ I-NP B-Disease
disorder NN I-NP I-Disease
in IN B-PP O
adults NNS B-NP O
, , O O
is VBZ B-VP O
caused VBN I-VP O
by IN B-PP O
( ( O O
CTG NN B-NP O
) ) O O
n NN B-NP O
- HYPH B-NP O
repeat NN I-NP O
expansion NN I-NP O
in IN B-PP O
a DT B-NP O
gene NN I-NP O
encoding VBG B-VP O
a DT B-NP O
protein NN I-NP O
kinase NN I-NP O
( ( O O
DM NN B-NP B-Disease
protein NN I-NP O
kinase NN I-NP O
; : O O
DMPK NN B-NP O
) ) O O
and CC O O
involves VBZ B-VP O
changes NNS B-NP O
in IN B-PP O
cytoarchitecture NN B-NP O
and CC I-NP O
ion NN I-NP O
homeostasis NN I-NP O
. . O O

To TO B-VP O
obtain VB I-VP O
clues NNS B-NP O
to TO B-PP O
the DT B-NP O
normal JJ I-NP O
biological JJ I-NP O
role NN I-NP O
of IN B-PP O
DMPK NN B-NP O
in IN B-PP O
cellular JJ B-NP O
ion NN I-NP O
homeostasis NN I-NP O
, , O O
we PRP B-NP O
have VBP B-VP O
compared VBN I-VP O
the DT B-NP O
resting NN I-NP O
[ ( O O
Ca2 NN B-NP O
+ SYM O O
] ) O O
i NN B-NP O
, , O O
the DT B-NP O
amplitude NN I-NP O
and CC I-NP O
shape NN I-NP O
of IN B-PP O
depolarization NN B-NP O
- HYPH B-NP O
induced VBN I-NP O
Ca2 NN I-NP O
+ SYM B-NP O
transients NNS I-NP O
, , O O
and CC O O
the DT B-NP O
content NN I-NP O
of IN B-PP O
ATP NN B-NP O
- HYPH O O
driven VBN B-NP O
ion NN I-NP O
pumps NNS I-NP O
in IN B-PP O
cultured VBN B-NP O
skeletal JJ I-NP O
muscle NN I-NP O
cells NNS I-NP O
of IN B-PP O
wild JJ B-NP O
- HYPH I-NP O
type NN I-NP O
and CC I-NP O
DMPK NN I-NP O
[ ( O O
- HYPH B-NP O
/ SYM I-NP O
- HYPH I-NP O
] ) I-NP O
knockout NN I-NP O
mice NNS I-NP O
. . O O

In FW B-NP O
vitro FW I-NP O
- HYPH B-VP O
differentiated VBN B-NP O
DMPK NN I-NP O
[ ( O O
- HYPH O O
/ SYM O O
- HYPH O O
] ) O O
myotubes NNS B-NP O
exhibit VBP B-VP O
a DT B-NP O
higher JJR I-NP O
resting VBG I-NP O
[ ( O O
Ca2 NN O O
+ SYM O O
] ) O O
i NN B-NP O
than IN B-SBAR O
do VBP B-VP O
wild JJ B-NP O
- HYPH I-NP O
type NN I-NP O
myotubes NNS I-NP O
because IN B-PP O
of IN I-PP O
an DT B-NP O
altered JJ I-NP O
open JJ I-NP O
probability NN I-NP O
of IN B-PP O
voltage NN B-NP O
- HYPH B-NP O
dependent JJ I-NP O
l NN I-NP O
- HYPH I-NP O
type NN I-NP O
Ca2 NN I-NP O
+ SYM B-NP O
and CC O O
Na NN B-NP O
+ SYM I-NP O
channels NNS I-NP O
. . O O

The DT B-NP O
mutant JJ I-NP O
myotubes NNS I-NP O
exhibit VBP B-VP O
smaller JJR B-NP O
and CC I-NP O
slower JJR I-NP O
Ca2 NN I-NP O
+ SYM I-NP O
responses NNS I-NP O
upon IN B-PP O
triggering NN B-NP O
by IN B-PP O
acetylcholine NN B-NP O
or CC O O
high JJ B-NP O
external JJ I-NP O
K NN I-NP O
+ SYM B-NP O
. . O O

In IN B-PP O
addition NN B-NP O
, , O O
we PRP B-NP O
observed VBD B-VP O
that IN B-SBAR O
these DT B-NP O
Ca2 NN I-NP O
+ SYM O O
transients NNS B-NP O
partially RB B-ADVP O
result VBP B-VP O
from IN B-PP O
an DT B-NP O
influx NN I-NP O
of IN B-PP O
extracellular JJ B-NP O
Ca2 NN I-NP O
+ SYM B-ADVP O
through IN B-PP O
the DT B-NP O
l NN I-NP O
- HYPH I-NP O
type NN I-NP O
Ca2 NN I-NP O
+ SYM B-NP O
channel NN I-NP O
. . O O

Neither CC O O
the DT B-NP O
content NN I-NP O
nor CC O O
the DT B-NP O
activity NN I-NP O
of IN B-PP O
Na NN B-NP O
+ SYM O O
/ SYM O O
K NN B-NP O
+ SYM I-NP O
ATPase NN I-NP O
and CC O O
sarcoplasmic JJ B-NP O
reticulum NN I-NP O
Ca2 NN I-NP O
+ SYM O O
- HYPH O O
ATPase NN B-NP O
are VBP B-VP O
affected VBN I-VP O
by IN B-PP O
DMPK NN B-NP O
absence NN I-NP O
. . O O

In IN B-PP O
conclusion NN B-NP O
, , O O
our PRP$ B-NP O
data NNS I-NP O
suggest VBP B-VP O
that IN B-SBAR O
DMPK NN B-NP O
is VBZ B-VP O
involved VBN I-VP O
in IN B-PP O
modulating VBG B-VP O
the DT B-NP O
initial JJ I-NP O
events NNS I-NP O
of IN B-PP O
excitation NN B-NP O
- HYPH I-NP O
contraction NN I-NP O
coupling NN I-NP O
in IN B-PP O
skeletal JJ B-NP O
muscle NN I-NP O
. . O O

. . O O

Constitutional JJ B-NP O
RB1 NN I-NP O
- HYPH I-NP O
gene NN I-NP O
mutations NNS I-NP O
in IN B-PP O
patients NNS B-NP O
with IN B-PP O
isolated VBN B-NP O
unilateral JJ I-NP B-Disease
retinoblastoma NN I-NP I-Disease
. . O O

In IN B-PP O
most JJS B-NP O
patients NNS I-NP O
with IN B-PP O
isolated VBN B-NP O
unilateral JJ I-NP B-Disease
retinoblastoma NN I-NP I-Disease
, , O O
tumor NN B-NP B-Disease
development NN I-NP O
is VBZ B-VP O
initiated VBN I-VP O
by IN B-PP O
somatic JJ B-NP O
inactivation NN I-NP O
of IN B-PP O
both DT B-NP O
alleles NNS I-NP O
of IN B-PP O
the DT B-NP O
RB1 NN I-NP O
gene NN I-NP O
. . O O

However RB B-ADVP O
, , O O
some DT B-NP O
of IN B-PP O
these DT B-NP O
patients NNS I-NP O
can MD B-VP O
transmit VB I-VP O
retinoblastoma NN B-NP B-Disease
predisposition NN I-NP O
to TO B-PP O
their PRP$ B-NP O
offspring NN I-NP O
. . O O

To TO B-VP O
determine VB I-VP O
the DT B-NP O
frequency NN I-NP O
and CC I-NP O
nature NN I-NP O
of IN B-PP O
constitutional JJ B-NP O
RB1 NN I-NP O
- HYPH B-NP O
gene NN I-NP O
mutations NNS I-NP O
in IN B-PP O
patients NNS B-NP O
with IN B-PP O
isolated VBN B-NP O
unilateral JJ I-NP B-Disease
retinoblastoma NN I-NP I-Disease
, , O O
we PRP B-NP O
analyzed VBD B-VP O
DNA NN B-NP O
from IN B-PP O
peripheral JJ B-NP O
blood NN I-NP O
and CC B-PP O
from IN B-PP O
tumor NN B-NP B-Disease
tissue NN I-NP O
. . O O

The DT B-NP O
analysis NN I-NP O
of IN B-PP O
tumors NNS B-NP B-Disease
from IN B-PP O
54 CD B-NP O
( ( O O
71 CD B-NP O
% NN I-NP O
) ) O O
of IN B-PP O
76 CD B-NP O
informative JJ I-NP O
patients NNS I-NP O
showed VBD B-VP O
loss NN B-NP O
of IN B-PP O
constitutional JJ B-NP O
heterozygosity NN I-NP O
( ( O O
LOH NN B-NP O
) ) O O
at IN B-PP O
intragenic JJ B-NP O
loci NNS I-NP O
. . O O

Three CD B-NP O
of IN B-PP O
13 CD B-NP O
uninformative JJ I-NP O
patients NNS I-NP O
had VBD B-VP O
constitutional JJ B-NP O
deletions NNS I-NP O
. . O O

For IN B-PP O
39 CD B-NP O
randomly RB I-NP O
selected VBN I-NP O
tumors NNS I-NP B-Disease
, , O O
SSCP NN B-NP O
, , O O
hetero AFX B-NP O
- HYPH I-NP O
duplex NN I-NP O
analysis NN I-NP O
, , O O
sequencing NN B-NP O
, , O O
and CC O O
Southern JJ B-NP O
blot NN I-NP O
analysis NN I-NP O
were VBD B-VP O
used VBN I-VP O
to TO B-VP O
identify VB I-VP O
mutations NNS B-NP O
. . O O

Mutations NNS B-NP O
were VBD B-VP O
detected VBN I-VP O
in IN B-PP O
21 CD B-NP O
( ( O O
91 CD B-NP O
% NN I-NP O
) ) O O
of IN B-PP O
23 CD B-NP O
tumors NNS I-NP B-Disease
with IN B-PP O
LOH NN B-NP O
. . O O

In IN B-PP O
6 CD B-NP O
( ( O O
38 CD B-NP O
% NN I-NP O
) ) O O
of IN B-PP O
16 CD B-NP O
tumors NNS I-NP B-Disease
without IN B-PP O
LOH NN B-NP O
, , O O
one CD B-NP O
mutation NN I-NP O
was VBD B-VP O
detected VBN I-VP O
, , O O
and CC O O
in IN B-PP O
9 CD B-NP O
( ( O O
56 CD B-NP O
% NN I-NP O
) ) O O
of IN B-PP O
the DT B-NP O
tumors NNS I-NP B-Disease
without IN B-PP O
LOH NN B-NP O
, , O O
both DT B-NP O
mutations NNS I-NP O
were VBD B-VP O
found VBN I-VP O
. . O O

Thus RB B-ADVP O
, , O O
a DT B-NP O
total NN I-NP O
of IN B-PP O
45 CD B-NP O
mutations NNS I-NP O
were VBD B-VP O
identified VBN I-VP O
in IN B-PP O
tumors NNS B-NP B-Disease
of IN B-PP O
36 CD B-NP O
patients NNS I-NP O
. . O O

Thirty CD B-NP O
- HYPH I-NP O
nine CD I-NP O
of IN B-PP O
the DT B-NP O
mutations NNS I-NP O
- HYPH B-PP O
including VBG B-PP O
34 CD B-NP O
small JJ I-NP O
mutations NNS I-NP O
, , O O
2 CD B-NP O
large JJ I-NP O
structural JJ I-NP O
alterations NNS I-NP O
, , O O
and CC O O
hypermethylation NN B-NP O
in IN B-PP O
3 CD B-NP O
tumors NNS I-NP O
- HYPH B-NP O
were VBD B-VP O
not RB I-VP O
detected VBN I-VP O
in IN B-PP O
the DT B-NP O
corresponding VBG I-NP O
peripheral JJ I-NP O
blood NN I-NP O
DNA NN I-NP O
. . O O

In IN B-PP O
6 CD B-NP O
( ( O O
17 CD B-NP O
% NN I-NP O
) ) O O
of IN B-PP O
the DT B-NP O
36 CD I-NP O
patients NNS I-NP O
, , O O
a DT B-NP O
mutation NN I-NP O
was VBD B-VP O
detected VBN I-VP O
in IN B-PP O
constitutional JJ B-NP O
DNA NN I-NP O
, , O O
and CC O O
1 CD B-NP O
of IN B-PP O
these DT B-NP O
mutations NNS I-NP O
is VBZ B-VP O
known VBN I-VP O
to TO I-VP O
be VB I-VP O
associated VBN I-VP O
with IN B-PP O
reduced VBN B-NP O
expressivity NN I-NP O
. . O O

The DT B-NP O
presence NN I-NP O
of IN B-PP O
a DT B-NP O
constitutional JJ I-NP O
mutation NN I-NP O
was VBD B-VP O
not RB I-VP O
associated VBN I-VP O
with IN B-PP O
an DT B-NP O
early JJ I-NP O
age NN I-NP O
at IN B-PP O
treatment NN B-NP O
. . O O

In IN B-PP O
1 CD B-NP O
patient NN I-NP O
, , O O
somatic JJ B-NP O
mosaicism NN I-NP O
was VBD B-VP O
demonstrated VBN I-VP O
by IN B-PP O
molecular JJ B-NP O
analysis NN I-NP O
of IN B-PP O
DNA NN B-NP O
and CC I-NP O
RNA NN I-NP O
from IN B-PP O
peripheral JJ B-NP O
blood NN I-NP O
. . O O

In IN B-PP O
2 CD B-NP O
patients NNS I-NP O
without IN B-PP O
a DT B-NP O
detectable JJ I-NP O
mutation NN I-NP O
in IN B-PP O
peripheral JJ B-NP O
blood NN I-NP O
, , O O
mosaicism NN B-NP O
was VBD B-VP O
suggested VBN I-VP O
because IN B-SBAR O
1 CD B-NP O
of IN B-PP O
the DT B-NP O
patients NNS I-NP O
showed VBD B-VP O
multifocal JJ B-NP O
tumors NNS I-NP B-Disease
and CC O O
the DT B-NP O
other JJ I-NP O
later RB B-ADVP O
developed VBD B-VP O
bilateral JJ B-NP B-Disease
retinoblastoma NN I-NP I-Disease
. . O O

In IN B-PP O
conclusion NN B-NP O
, , O O
our PRP$ B-NP O
results NNS I-NP O
emphasize VBP B-VP O
that IN B-SBAR O
the DT B-NP O
manifestation NN I-NP O
and CC I-NP O
transmissibility NN I-NP O
of IN B-PP O
retinoblastoma NN B-NP B-Disease
depend VBP B-VP O
on IN B-PP O
the DT B-NP O
nature NN I-NP O
of IN B-PP O
the DT B-NP O
first JJ I-NP O
mutation NN I-NP O
, , O O
its PRP$ B-NP O
time NN I-NP O
in IN B-PP O
development NN B-NP O
, , O O
and CC O O
the DT B-NP O
number NN I-NP O
and CC O O
types NNS B-NP O
of IN B-PP O
cells NNS B-NP O
that WDT B-NP O
are VBP B-VP O
affected VBN I-VP O
. . O O

. . O O

Hereditary JJ B-NP B-Disease
deficiency NN I-NP I-Disease
of IN B-PP I-Disease
the DT B-NP I-Disease
fifth JJ I-NP I-Disease
component NN I-NP I-Disease
of IN B-PP I-Disease
complement NN B-NP I-Disease
in IN B-PP O
man NN B-NP O
. . O O

I PRP B-NP O
. . O O

Clinical JJ B-NP O
, , I-NP O
immunochemical JJ I-NP O
, , O O
and CC O O
family NN B-NP O
studies NNS I-NP O
. . O O

The DT B-NP O
first JJ I-NP O
recognized VBN I-NP O
human JJ I-NP O
kindred NN I-NP O
with IN B-PP O
hereditary JJ B-NP B-Disease
deficiency NN I-NP I-Disease
of IN B-PP I-Disease
the DT B-NP I-Disease
fifth JJ I-NP I-Disease
component NN I-NP I-Disease
of IN B-PP I-Disease
complement NN B-NP I-Disease
( ( O O
C5 NN B-NP O
) ) O O
is VBZ B-VP O
described VBN I-VP O
. . O O

The DT B-NP O
proband NN I-NP O
, , O O
a DT B-NP O
20 CD I-NP O
- HYPH I-NP O
year NN I-NP O
- HYPH B-NP O
old JJ I-NP O
black JJ I-NP O
female NN I-NP O
with IN B-PP O
systemic JJ B-NP B-Disease
lupus NN I-NP I-Disease
erythematosus NN I-NP I-Disease
since IN B-PP O
age NN B-NP O
11 CD I-NP O
, , O O
lacked VBD B-VP O
serum NN B-NP O
hemolytic JJ I-NP O
complement NN I-NP O
activity NN I-NP O
, , O O
even RB B-ADVP O
during IN B-PP O
remission NN B-NP O
. . O O

C5 NN B-NP O
was VBD B-VP O
undetectable JJ B-ADJP O
in IN B-PP O
her PRP$ B-NP O
serum NN I-NP O
by IN B-PP O
both CC O O
immunodiffusion NN B-NP O
and CC O O
hemolytic JJ B-NP O
assays NNS I-NP O
. . O O

Other JJ B-NP O
complement NN I-NP O
components NNS I-NP O
were VBD B-VP O
normal JJ B-ADJP O
during IN B-PP O
remission NN B-NP O
of IN B-PP O
lupus NN B-NP O
, , O O
but CC O O
C1 NN B-NP O
, , O O
C4 NN B-NP O
, , O O
C2 NN B-NP O
, , O O
and CC O O
C3 NN B-NP O
levels NNS I-NP O
fell VBD B-VP O
during IN B-PP O
exacerbations NNS B-NP O
. . O O

A DT B-NP O
younger JJR I-NP O
half NN I-NP O
- HYPH I-NP O
sister NN I-NP O
, , O O
who WP B-NP O
had VBD B-VP O
no DT B-NP O
underlying VBG I-NP O
disease NN I-NP O
, , O O
was VBD B-VP O
also RB I-VP O
found VBN I-VP O
to TO I-VP O
lack VB I-VP O
immunochemically RB B-NP O
detectable JJ I-NP O
C5 NN I-NP O
. . O O

By IN B-PP O
hemolytic JJ B-NP O
assay NN I-NP O
, , O O
she PRP B-NP O
exhibited VBD B-VP O
1 CD B-NP O
- HYPH I-NP O
2 CD I-NP O
% NN I-NP O
of IN B-PP O
the DT B-NP O
normal JJ I-NP O
serum NN I-NP O
C5 NN I-NP O
level NN I-NP O
and CC O O
normal JJ B-NP O
concentrations NNS I-NP O
of IN B-PP O
other JJ B-NP O
complement NN I-NP O
components NNS I-NP O
. . O O

C5 NN B-NP O
levels NNS I-NP O
of IN B-PP O
other JJ B-NP O
family NN I-NP O
members NNS I-NP O
were VBD B-VP O
either CC O O
normal JJ B-ADJP O
or CC O O
approximately RB B-ADVP O
half RB B-ADJP O
- HYPH I-ADJP O
normal JJ B-ADJP O
, , O O
consistent JJ B-ADJP O
with IN B-PP O
autosomal JJ B-NP O
codominant JJ I-NP O
inheritance NN I-NP O
of IN B-PP O
the DT B-NP O
gene NN I-NP O
determining VBG B-VP O
C5 NN B-NP B-Disease
deficiency NN I-NP I-Disease
. . O O

Normal JJ B-NP O
hemolytic JJ I-NP O
titers NNS I-NP O
were VBD B-VP O
restored VBN I-VP O
to TO B-PP O
both CC O O
homozygous JJ B-NP O
C5 NN I-NP B-Disease
- HYPH B-NP I-Disease
deficient JJ I-NP I-Disease
( ( O O
C5D NN B-NP B-Disease
) ) O O
sera NNS B-NP O
by IN B-PP O
addition NN B-NP O
of IN B-PP O
highly RB B-NP O
purified VBN I-NP O
human JJ I-NP O
C5 NN I-NP O
. . O O

In IN B-PP O
specific JJ B-NP O
C5 NN I-NP O
titrations NNS I-NP O
, , O O
however RB B-ADVP O
, , O O
it PRP B-NP O
was VBD B-VP O
noted VBN I-VP O
that IN B-SBAR O
when WRB B-ADVP O
limited JJ B-NP O
amounts NNS I-NP O
of IN B-PP O
C5 NN B-NP O
were VBD B-VP O
assayed VBN I-VP O
in IN B-PP O
the DT B-NP O
presence NN I-NP O
of IN B-PP O
low JJ B-NP O
dilutions NNS I-NP O
of IN B-PP O
either CC O O
C5D NN B-NP B-Disease
serum NN I-NP O
, , O O
curving VBG B-VP O
rather RB B-PP O
than IN I-PP O
linear JJ B-NP O
dose NN I-NP O
- HYPH B-NP O
response NN I-NP O
plots NNS I-NP O
were VBD B-VP O
consistently RB I-VP O
obtained VBN I-VP O
, , O O
suggesting VBG B-VP O
some DT B-NP O
inhibitory JJ I-NP O
effect NN I-NP O
. . O O

Further JJ B-NP O
studies NNS I-NP O
suggested VBD B-VP O
that IN B-SBAR O
low JJ B-NP O
dilutions NNS I-NP O
of IN B-PP O
C5D NN B-NP B-Disease
serum NN I-NP O
contain VBP B-VP O
a DT B-NP O
factor NN I-NP O
( ( O O
or CC O O
factors NNS B-NP O
) ) O O
interfering VBG B-VP O
at IN B-PP O
some DT B-NP O
step NN I-NP O
in IN B-PP O
the DT B-NP O
hemolytic JJ I-NP O
assay NN I-NP O
of IN B-PP O
C5 NN B-NP O
, , O O
rather RB B-CONJP O
than IN I-CONJP O
a DT B-NP O
true JJ I-NP O
C5 NN I-NP O
inhibitor NN I-NP O
or CC I-NP O
inactivator NN I-NP O
. . O O

Of IN B-PP O
clinical JJ B-NP O
interest NN I-NP O
are VBP B-VP O
( ( B-LST O
a LS I-LST O
) ) O O
the DT B-NP O
documentation NN I-NP O
of IN B-PP O
membranous JJ B-NP O
glomerulonephritis NN I-NP B-Disease
, , O O
vasculitis NN B-NP B-Disease
, , O O
and CC O O
arthritis NN B-NP B-Disease
in IN B-PP O
an DT B-NP O
individual JJ I-NP O
lacking VBG I-NP O
C5 NN I-NP O
( ( O O
and CC O O
its PRP$ B-NP O
biologic JJ I-NP O
functions NNS I-NP O
) ) O O
, , O O
and CC O O
( ( B-LST O
b LS I-LST O
) ) O O
a DT B-NP O
remarkable JJ I-NP O
propensity NN I-NP O
to TO B-PP O
bacterial JJ B-NP B-Disease
infections NNS I-NP I-Disease
in IN B-PP O
the DT B-NP O
proband NN I-NP O
, , O O
even RB B-ADVP O
during IN B-PP O
periods NNS B-NP O
of IN B-PP O
low JJ B-NP O
- HYPH I-NP O
dose NN I-NP O
or CC I-NP O
alternate JJ I-NP O
- HYPH I-NP O
day NN I-NP O
corticosteroid NN I-NP O
therapy NN I-NP O
. . O O

Other JJ B-NP O
observations NNS I-NP O
indicate VBP B-VP O
that IN B-SBAR O
the DT B-NP O
C5D NN I-NP B-Disease
state NN I-NP O
is VBZ B-VP O
compatible JJ B-ADJP O
with IN B-PP O
normal JJ B-NP O
coagulation NN I-NP O
function NN I-NP O
and CC O O
the DT B-NP O
capacity NN I-NP O
to TO B-VP O
mount VB I-VP O
a DT B-NP O
neutrophilic JJ I-NP O
leukocytosis NN I-NP O
during IN B-PP O
pyogenic JJ B-NP B-Disease
infection NN I-NP I-Disease
. . O O

. . O O

Susceptibility NN B-NP O
to TO B-PP O
ankylosing VBG B-VP B-Disease
spondylitis NN B-NP I-Disease
in IN B-PP O
twins NNS B-NP O
: : O O
the DT B-NP O
role NN I-NP O
of IN B-PP O
genes NNS B-NP O
, , O O
HLA NN B-NP O
, , O O
and CC O O
the DT B-NP O
environment NN I-NP O
. . O O

OBJECTIVE NN B-NP O
To TO B-VP O
determine VB I-VP O
the DT B-NP O
relative JJ I-NP O
effects NNS I-NP O
of IN B-PP O
genetic JJ B-NP O
and CC I-NP O
environmental JJ I-NP O
factors NNS I-NP O
in IN B-PP O
susceptibility NN B-NP O
to TO B-PP O
ankylosing VBG B-VP B-Disease
spondylitis NN B-NP I-Disease
( ( O O
AS NN B-NP B-Disease
) ) O O
. . O O

METHODS NNS B-NP O
Twins NNS I-NP O
with IN B-PP O
AS NN B-NP B-Disease
were VBD B-VP O
identified VBN I-VP O
from IN B-PP O
the DT B-NP O
Royal NNP I-NP O
National NNP I-NP O
Hospital NNP I-NP O
for IN B-PP O
Rheumatic NNP B-NP B-Disease
Diseases NNP I-NP I-Disease
database NN I-NP O
. . O O

Clinical JJ B-NP O
and CC I-NP O
radiographic JJ I-NP O
examinations NNS I-NP O
were VBD B-VP O
performed VBN I-VP O
to TO I-VP O
establish VB I-VP O
diagnoses NNS B-NP O
, , O O
and CC O O
disease NN B-NP O
severity NN I-NP O
was VBD B-VP O
assessed VBN I-VP O
using VBG B-VP O
a DT B-NP O
combination NN I-NP O
of IN B-PP O
validated VBN B-NP O
scoring NN I-NP O
systems NNS I-NP O
. . O O

HLA NN B-NP O
typing NN I-NP O
for IN B-PP O
HLA NN B-NP O
- HYPH I-NP O
B27 NN I-NP O
, , O O
HLA NN B-NP O
- HYPH I-NP O
B60 NN I-NP O
, , O O
and CC O O
HLA NN B-NP O
- HYPH B-NP O
DR1 NN I-NP O
was VBD B-VP O
performed VBN I-VP O
by IN B-PP O
polymerase NN B-NP O
chain NN I-NP O
reaction NN I-NP O
with IN B-PP O
sequence NN B-NP O
- HYPH B-NP O
specific JJ I-NP O
primers NNS I-NP O
, , O O
and CC O O
zygosity NN B-NP O
was VBD B-VP O
assessed VBN I-VP O
using VBG B-VP O
microsatellite NN B-NP O
markers NNS I-NP O
. . O O

Genetic JJ B-NP O
and CC I-NP O
environmental JJ I-NP O
variance NN I-NP O
components NNS I-NP O
were VBD B-VP O
assessed VBN I-VP O
with IN B-PP O
the DT B-NP O
program NN I-NP O
Mx NN I-NP O
, , O O
using VBG B-VP O
data NNS B-NP O
from IN B-PP O
this DT B-NP O
and CC I-NP O
previous JJ I-NP O
studies NNS I-NP O
of IN B-PP O
twins NNS B-NP O
with IN B-PP O
AS NN B-NP B-Disease
. . O O

RESULTS NNS B-NP O
Six CD B-NP O
of IN B-PP O
8 CD B-NP O
monozygotic JJ I-NP O
( ( O O
MZ JJ B-ADJP O
) ) O O
twin NN B-NP O
pairs NNS I-NP O
were VBD B-VP O
disease NN B-ADJP O
concordant JJ I-ADJP O
, , O O
compared VBN B-PP O
with IN B-PP O
4 CD B-NP O
of IN B-PP O
15 CD B-NP O
B27 NN I-NP O
- HYPH B-NP O
positive JJ I-NP O
dizygotic JJ I-NP O
( ( O O
DZ NN B-NP O
) ) O O
twin NN B-NP O
pairs NNS I-NP O
( ( O O
27 CD B-NP O
% NN I-NP O
) ) O O
and CC O O
4 CD B-NP O
of IN B-PP O
32 CD B-NP O
DZ NN I-NP O
twin NN I-NP O
pairs NNS I-NP O
overall JJ B-ADVP O
( ( O O
12 CD B-NP O
. . O O

5 CD B-NP O
% NN I-NP O
) ) O O
. . O O

Nonsignificant JJ B-NP O
increases NNS I-NP O
in IN B-PP O
similarity NN B-NP O
with IN B-PP O
regard NN B-NP O
to TO B-PP O
age NN B-NP O
at IN B-PP O
disease NN B-NP O
onset NN I-NP O
and CC O O
all DT B-NP O
of IN B-PP O
the DT B-NP O
disease NN I-NP O
severity NN I-NP O
scores NNS I-NP O
assessed VBN B-VP O
were VBD B-VP O
noted VBN I-VP O
in IN B-PP O
disease NN B-NP O
- HYPH B-NP O
concordant JJ I-NP O
MZ NN I-NP O
twins NNS I-NP O
compared VBN B-PP O
with IN B-PP O
concordant JJ B-NP O
DZ NN I-NP O
twins NNS I-NP O
. . O O

HLA NN B-NP O
- HYPH I-NP O
B27 NN I-NP O
and CC I-NP O
B60 NN I-NP O
were VBD B-VP O
associated VBN I-VP O
with IN B-PP O
the DT B-NP O
disease NN I-NP O
in IN B-PP O
probands NNS B-NP O
, , O O
and CC O O
the DT B-NP O
rate NN I-NP O
of IN B-PP O
disease NN B-NP O
concordance NN I-NP O
was VBD B-VP O
significantly RB I-VP O
increased VBN I-VP O
among IN B-PP O
DZ NN B-NP O
twin NN I-NP O
pairs NNS I-NP O
in IN B-PP O
which WDT B-NP O
the DT B-NP O
co AFX I-NP O
- HYPH I-NP O
twin NN I-NP O
was VBD B-VP O
positive JJ B-ADJP O
for IN B-PP O
both CC O O
B27 NN B-NP O
and CC I-NP O
DR1 NN I-NP O
. . O O

Additive JJ B-NP O
genetic JJ I-NP O
effects NNS I-NP O
were VBD B-VP O
estimated VBN I-VP O
to TO I-VP O
contribute VB I-VP O
97 CD B-NP O
% NN I-NP O
of IN B-PP O
the DT B-NP O
population NN I-NP O
variance NN I-NP O
. . O O

CONCLUSION NN B-NP O
Susceptibility NN I-NP O
to TO B-PP O
AS NN B-NP B-Disease
is VBZ B-VP O
largely RB I-VP O
genetically RB I-VP O
determined VBN I-VP O
, , O O
and CC O O
the DT B-NP O
environmental JJ I-NP O
trigger NN I-NP O
for IN B-PP O
the DT B-NP O
disease NN I-NP O
is VBZ B-VP O
probably RB B-ADVP O
ubiquitous JJ B-ADJP O
. . O O

HLA NN B-NP O
- HYPH I-NP O
B27 NN I-NP O
accounts VBZ B-VP O
for IN B-PP O
a DT B-NP O
minority NN I-NP O
of IN B-PP O
the DT B-NP O
overall JJ I-NP O
genetic JJ I-NP O
susceptibility NN I-NP O
to TO B-PP O
AS NN B-NP B-Disease
. . O O

Cell NN B-NP O
cycle NN I-NP O
- HYPH B-NP O
dependent JJ I-NP O
colocalization NN I-NP O
of IN B-PP O
BARD1 NN B-NP O
and CC I-NP O
BRCA1 NN I-NP O
proteins NNS I-NP O
in IN B-PP O
discrete JJ B-NP O
nuclear JJ I-NP O
domains NNS I-NP O
. . O O

Germ NN B-NP O
- HYPH I-NP O
line NN I-NP O
mutations NNS I-NP O
of IN B-PP O
the DT B-NP O
BRCA1 NN I-NP O
gene NN I-NP O
predispose NN I-NP O
women NNS I-NP O
to TO B-PP O
early JJ B-NP O
- HYPH I-NP O
onset NN I-NP O
breast NN I-NP B-Disease
and CC O I-Disease
ovarian JJ B-NP I-Disease
cancer NN I-NP I-Disease
by IN B-PP O
compromising VBG B-VP O
the DT B-NP O
genes NNS I-NP O
presumptive JJ B-NP O
function NN I-NP O
as IN B-PP O
a DT B-NP O
tumor NN I-NP B-Disease
suppressor NN I-NP O
. . O O

Although IN B-SBAR O
the DT B-NP O
biochemical JJ I-NP O
properties NNS I-NP O
of IN B-PP O
BRCA1 NN B-NP O
polypeptides NNS I-NP O
are VBP B-VP O
not RB I-VP O
understood VBN I-VP O
, , O O
their PRP$ B-NP O
expression NN I-NP O
pattern NN I-NP O
and CC O O
subcellular JJ B-NP O
localization NN I-NP O
suggest VBP B-VP O
a DT B-NP O
role NN I-NP O
in IN B-PP O
cell NN B-NP O
- HYPH B-NP O
cycle NN I-NP O
regulation NN I-NP O
. . O O

When WRB B-ADVP O
resting VBG B-NP O
cells NNS I-NP O
are VBP B-VP O
induced VBN I-VP O
to TO I-VP O
proliferate VB I-VP O
, , O O
the DT B-NP O
steady JJ I-NP O
- HYPH I-NP O
state NN I-NP O
levels NNS I-NP O
of IN B-PP O
BRCA1 NN B-NP O
increase NN I-NP O
in IN B-PP O
late JJ B-NP O
G1 NN I-NP O
and CC O O
reach VB B-VP O
a DT B-NP O
maximum NN I-NP O
during IN B-PP O
S NN B-NP O
phase NN I-NP O
. . O O

Moreover RB B-ADVP O
, , O O
in IN B-PP O
S NN B-NP O
phase NN I-NP O
cells NNS I-NP O
, , O O
BRCA1 NN B-NP O
polypeptides NNS I-NP O
are VBP B-VP O
hyperphosphorylated VBN I-VP O
and CC O O
accumulate VBP B-VP O
into IN B-PP O
discrete JJ B-NP O
subnuclear JJ I-NP O
foci NNS I-NP O
termed VBN B-VP O
BRCA1 NN I-NP O
nuclear JJ I-NP O
dots NNS I-NP O
. . O O

BRCA1 NN B-NP O
associates VBZ B-VP O
in FW B-ADVP O
vivo FW I-ADVP O
with IN B-PP O
a DT B-NP O
structurally RB I-NP O
related VBN I-NP O
protein NN I-NP O
termed VBN I-NP O
BARD1 NN I-NP O
. . O O

Here RB B-ADVP O
we PRP B-NP O
show VBP B-VP O
that IN B-SBAR O
the DT B-NP O
steady JJ I-NP O
- HYPH I-NP O
state NN I-NP O
levels NNS I-NP O
of IN B-PP O
BARD1 NN B-NP O
, , O O
unlike IN B-PP O
those DT B-NP O
of IN B-PP O
BRCA1 NN B-NP O
, , O O
remain VBP B-VP O
relatively RB B-ADJP O
constant JJ I-ADJP O
during IN B-PP O
cell NN B-NP O
cycle NN I-NP O
progression NN I-NP O
. . O O

However RB B-ADVP O
, , O O
immunostaining NN B-NP O
revealed VBD B-VP O
that IN B-SBAR O
BARD1 NN B-NP O
resides VBZ B-VP O
within IN B-PP O
BRCA1 NN B-NP O
nuclear JJ I-NP O
dots NNS I-NP O
during IN B-PP O
S NN B-NP O
phase NN I-NP O
of IN B-PP O
the DT B-NP O
cell NN I-NP O
cycle NN I-NP O
, , B-PP O
but CC I-PP O
not RB B-PP O
during IN I-PP O
the DT B-NP O
G1 NN I-NP O
phase NN I-NP O
. . O O

Nevertheless RB B-ADVP O
, , O O
BARD1 NN B-NP O
polypeptides NNS I-NP O
are VBP B-VP O
found VBN I-VP O
exclusively RB B-ADVP O
in IN B-PP O
the DT B-NP O
nuclear JJ I-NP O
fractions NNS I-NP O
of IN B-PP O
both CC O O
G1 NN B-NP O
- HYPH I-NP O
and CC I-NP O
S NN I-NP O
- HYPH I-NP O
phase NN I-NP O
cells NNS I-NP O
. . O O

Therefore RB B-ADVP O
, , O O
progression NN B-NP O
to TO B-PP O
S NN B-NP O
phase NN I-NP O
is VBZ B-VP O
accompanied VBN I-VP O
by IN B-PP O
the DT B-NP O
aggregation NN I-NP O
of IN B-PP O
nuclear JJ B-NP O
BARD1 NN I-NP O
polypeptides NNS I-NP O
into IN B-PP O
BRCA1 NN B-NP O
nuclear JJ I-NP O
dots NNS I-NP O
. . O O

This DT B-NP O
cell NN I-NP O
cycle NN I-NP O
- HYPH B-NP O
dependent JJ I-NP O
colocalization NN I-NP O
of IN B-PP O
BARD1 NN B-NP O
and CC I-NP O
BRCA1 NN I-NP O
indicates VBZ B-VP O
a DT B-NP O
role NN I-NP O
for IN B-PP O
BARD1 NN B-NP O
in IN B-PP O
BRCA1 NN B-NP O
- HYPH B-NP O
mediated VBN I-NP O
tumor NN I-NP B-Disease
suppression NN I-NP O
. . O O

Ethnic JJ B-NP O
differences NNS I-NP O
in IN B-PP O
the DT B-NP O
HFE NN I-NP O
codon NN I-NP O
282 CD I-NP O
( ( O O
Cys NN B-NP O
/ SYM B-NP O
Tyr NN I-NP O
) ) O O
polymorphism NN B-NP O
. . O O

Recent JJ B-NP O
studies NNS I-NP O
have VBP B-VP O
shown VBN I-VP O
that IN B-SBAR O
hereditary JJ B-NP B-Disease
hemochromatosis NN I-NP I-Disease
( ( O O
HH NN B-NP B-Disease
) ) O O
is VBZ B-VP O
likely JJ B-ADJP O
to TO B-VP O
be VB I-VP O
caused VBN I-VP O
by IN B-PP O
homozygosity NN B-NP O
for IN B-PP O
a DT B-NP O
Cys282Tyr NN I-NP O
mutation NN I-NP O
in IN B-PP O
the DT B-NP O
HFE NN I-NP O
gene NN I-NP O
located JJ B-NP O
4 CD I-NP O
. . O O

5 CD B-NP O
Mb NN I-NP O
telomeric JJ B-ADJP O
to TO B-PP O
HLA NN B-NP O
- HYPH I-NP O
A NN I-NP O
. . O O

Population NN B-NP O
studies NNS I-NP O
of IN B-PP O
this DT B-NP O
polymorphism NN I-NP O
are VBP B-VP O
facilitated VBN I-VP O
by IN B-PP O
the DT B-NP O
fact NN I-NP O
that IN B-SBAR O
the DT B-NP O
Cys282Tyr NN I-NP O
mutation NN I-NP O
creates VBZ B-VP O
a DT B-NP O
Rsal JJ I-NP O
restriction NN I-NP O
site NN I-NP O
. . O O

We PRP B-NP O
have VBP B-VP O
studied VBN I-VP O
the DT B-NP O
codon NN I-NP O
282 CD I-NP O
( ( O O
Cys NN B-NP O
/ SYM B-NP O
Tyr NN I-NP O
) ) O O
polymorphism NN B-NP O
in IN B-PP O
different JJ B-NP O
ethnic JJ I-NP O
groups NNS I-NP O
. . O O

In IN B-PP O
agreement NN I-PP O
with IN I-PP O
previous JJ B-NP O
observations NNS I-NP O
the DT B-NP O
Tyr NN I-NP O
allele NN I-NP O
appeared VBD B-VP O
to TO I-VP O
be VB I-VP O
rare JJ B-ADJP O
or CC I-ADJP O
absent JJ I-ADJP O
in IN B-PP O
Asiatic JJ O O
( ( O O
Indian JJ B-ADJP O
, , O O
Chinese JJ B-ADJP O
) ) O O
populations NNS B-NP O
. . O O

The DT B-NP O
highest JJS I-NP O
allele NN I-NP O
frequency NN I-NP O
( ( O O
7 CD B-NP O
. . O O

5 CD B-NP O
% NN I-NP O
) ) O O
was VBD B-VP O
found VBN I-VP O
in IN B-PP O
Swedes NNP B-NP O
. . O O

Saamis NNP B-NP O
( ( O O
2 CD B-NP O
% NN I-NP O
) ) O O
and CC O O
Mordvinians NNPS B-NP O
( ( O O
1 CD B-NP O
. . O O

8 CD B-NP O
% NN I-NP O
) ) O O
had VBD B-VP O
significantly RB B-NP O
lower JJR I-NP O
frequencies NNS I-NP O
of IN B-PP O
the DT B-NP O
Tyr NN I-NP O
allele NN I-NP O
. . O O

Comparisons NNS B-NP O
with IN B-PP O
allele NN B-NP O
frequencies NNS I-NP O
based VBN B-VP O
on IN B-PP O
prevalence NN B-NP O
estimates NNS I-NP O
of IN B-PP O
HH NN B-NP B-Disease
showed VBD B-VP O
some DT B-NP O
disagreements NNS I-NP O
with IN B-PP O
the DT B-NP O
RFLP NN I-NP O
data NNS I-NP O
, , O O
particularly RB B-ADVP O
in IN B-PP O
Finns NNS B-NP O
. . O O

The DT B-NP O
newly RB I-NP O
described VBN I-NP O
HFE NN I-NP O
marker NN I-NP O
provides VBZ B-VP O
a DT B-NP O
new JJ I-NP O
approach NN I-NP O
to TO B-PP O
the DT B-NP O
screening NN I-NP O
of IN B-PP O
HH NN B-NP B-Disease
as RB B-CONJP O
well RB I-CONJP O
as IN I-CONJP O
studies NNS B-NP O
of IN B-PP O
the DT B-NP O
relationship NN I-NP O
between IN B-PP O
the DT B-NP O
HFE NN I-NP O
Tyr NN I-NP O
allele NN I-NP O
and CC O O
different JJ B-NP O
disorders NNS I-NP O
including VBG B-PP O
cancer NN B-NP B-Disease
Autosomal JJ B-NP B-Disease
dominant JJ I-NP I-Disease
neurohypophyseal JJ I-NP I-Disease
diabetes NN I-NP I-Disease
insipidus NN I-NP I-Disease
associated VBN B-VP O
with IN B-PP O
a DT B-NP O
missense JJ I-NP O
mutation NN I-NP O
encoding VBG B-VP O
Gly23 NN B-NP O
- HYPH O O
- SYM B-NP O
> SYM B-VP O
Val NN B-NP O
in IN B-PP O
neurophysin NN B-NP O
II CD I-NP O
. . O O

Autosomal JJ B-NP B-Disease
dominant JJ I-NP I-Disease
neurohypophyseal JJ I-NP I-Disease
diabetes NN I-NP I-Disease
insipidus NN I-NP I-Disease
( ( O O
ADNDI NN B-NP B-Disease
) ) O O
is VBZ B-VP O
an DT B-NP O
inherited VBN I-NP B-Disease
disease NN I-NP I-Disease
caused VBN B-VP O
by IN B-PP O
progressive JJ B-NP O
degeneration NN I-NP O
of IN B-PP O
the DT B-NP O
magnocellular JJ I-NP O
neurons NNS I-NP O
of IN B-PP O
the DT B-NP O
hypothalamus NN I-NP O
leading VBG B-VP O
to TO B-PP O
decreased VBN B-NP O
ability NN I-NP O
to TO B-VP O
produce VB I-VP O
the DT B-NP O
hormone NN I-NP O
arginine NN I-NP O
vasopressin NN I-NP O
( ( O O
AVP NN B-NP O
) ) O O
. . O O

Affected JJ B-NP O
individuals NNS I-NP O
are VBP B-VP O
not RB O O
symptomatic JJ B-ADJP O
at IN B-PP O
birth NN B-NP O
, , O O
but CC O O
usually RB B-VP O
develop VBP I-VP O
diabetes NN B-NP B-Disease
insipidus NN I-NP I-Disease
at IN B-PP O
1 CD B-NP O
- HYPH I-NP O
6 CD I-NP O
yr NN I-NP O
of IN B-PP O
age NN B-NP O
. . O O

The DT B-NP O
genetic JJ I-NP O
locus NN I-NP O
of IN B-PP O
the DT B-NP O
disease NN I-NP O
is VBZ B-VP O
the DT B-NP O
AVP NN I-NP O
- HYPH O O
neurophysin NN B-NP O
II CD I-NP O
( ( O O
NPII NN B-NP O
) ) O O
gene NN B-NP O
, , O O
and CC O O
mutations NNS B-NP O
that WDT B-NP O
cause VBP B-VP O
ADNDI NNP B-NP B-Disease
have VBP B-VP O
been VBN I-VP O
found VBN I-VP O
in IN B-PP O
both CC O O
the DT B-NP O
signal NN I-NP O
peptide NN I-NP O
of IN B-PP O
the DT B-NP O
prepro AFX I-NP O
- HYPH I-NP O
AVP NN I-NP O
- HYPH I-NP O
NPII NN I-NP O
precursor NN I-NP O
and CC B-PP O
within IN B-PP O
NPII NN B-NP O
itself PRP B-NP O
. . O O

An DT B-NP O
affected VBN I-NP O
girl NN I-NP O
who WP B-NP O
presented VBD B-VP O
at IN B-PP O
9 CD B-NP O
months NNS I-NP O
of IN B-PP O
age NN B-NP O
and CC O O
her PRP B-NP O
similarly RB B-VP O
affected VBD I-VP O
younger JJR B-NP O
brother NN I-NP O
and CC I-NP O
father NN I-NP O
were VBD B-VP O
all DT O O
found VBN B-VP O
to TO I-VP O
have VB I-VP O
a DT B-NP O
novel JJ I-NP O
missense JJ I-NP O
mutation NN I-NP O
( ( O O
G1758 NN B-NP O
- SYM O O
- HYPH O O
> SYM O O
T NN B-NP O
) ) O O
encoding VBG B-VP O
the DT B-NP O
amino JJ I-NP O
acid NN I-NP O
substitution NN I-NP O
Gly23 NN I-NP O
- SYM B-NP O
- HYPH B-NP O
> SYM I-NP O
Val NN I-NP O
within IN B-PP O
NPII NN B-NP O
. . O O

The DT B-NP O
mutation NN I-NP O
was VBD B-VP O
confirmed VBN I-VP O
by IN B-PP O
restriction NN B-NP O
endonuclease NN I-NP O
analysis NN I-NP O
. . O O

A DT B-NP O
T1 NN I-NP O
- HYPH B-VP O
weighted VBN I-VP O
magnetic JJ B-NP O
resonance NN I-NP O
imaging NN I-NP O
of IN B-PP O
the DT B-NP O
fathers NNS I-NP O
pituitary JJ B-NP O
gland NN I-NP O
demonstrates VBZ B-VP O
an DT B-NP O
attenuated VBN I-NP O
posterior JJ I-NP O
pituitary JJ I-NP O
bright JJ I-NP O
spot NN I-NP O
. . O O

This DT B-NP O
mutation NN I-NP O
may MD B-VP O
be VB I-VP O
valuable JJ B-ADJP O
for IN B-PP O
developing VBG B-VP O
models NNS B-NP O
of IN B-PP O
dominantly RB B-NP B-Disease
inherited VBN I-NP I-Disease
neurodegeneration NN I-NP I-Disease
, , O O
as IN B-PP O
the DT B-NP O
early JJ I-NP O
age NN I-NP O
of IN B-PP O
onset NN B-NP O
of IN B-PP O
symptoms NNS B-NP O
suggests VBZ B-VP O
that IN B-SBAR O
this DT B-NP O
mutation NN I-NP O
may MD B-VP O
be VB I-VP O
particularly RB B-ADJP O
deleterious JJ I-ADJP O
to TO B-PP O
the DT B-NP O
magnocellular JJ I-NP O
neuron NN I-NP O
. . O O

. . O O

Frequent JJ B-NP O
inactivation NN I-NP O
of IN B-PP O
PTEN NN B-NP O
/ SYM B-VP O
MMAC1 NN B-NP O
in IN B-PP O
primary JJ B-NP O
prostate NN I-NP B-Disease
cancer NN I-NP I-Disease
. . O O

Sporadic JJ B-NP B-Disease
prostate NN I-NP I-Disease
carcinoma NN I-NP I-Disease
is VBZ B-VP O
the DT B-NP O
most RBS I-NP O
common JJ I-NP O
male JJ I-NP B-Disease
cancer NN I-NP I-Disease
in IN B-PP O
the DT B-NP O
Western JJ I-NP O
world NN I-NP O
, , O O
yet RB O O
many JJ B-NP O
of IN B-PP O
the DT B-NP O
major JJ I-NP O
genetic JJ I-NP O
events NNS I-NP O
involved VBN B-VP O
in IN B-PP O
the DT B-NP O
progression NN I-NP O
of IN B-PP O
this DT B-NP O
often RB I-NP O
fatal JJ I-NP O
cancer NN I-NP B-Disease
remain VBP B-VP O
to TO I-VP O
be VB I-VP O
elucidated VBN I-VP O
. . O O

Numerous JJ B-NP O
cytogenetic JJ I-NP O
and CC I-NP O
allelotype NN I-NP O
studies NNS I-NP O
have VBP B-VP O
reported VBN I-VP O
frequent JJ B-NP O
loss NN I-NP O
of IN B-PP O
heterozygosity NN B-NP O
on IN B-PP O
chromosomal JJ B-NP O
arm NN I-NP O
10q NN I-NP O
in IN B-PP O
sporadic JJ B-NP B-Disease
prostate NN I-NP I-Disease
cancer NN I-NP I-Disease
. . O O

Deletion NN B-NP O
mapping NN I-NP O
studies NNS I-NP O
have VBP B-VP O
unambiguously RB I-VP O
identified VBN I-VP O
a DT B-NP O
region NN I-NP O
of IN B-PP O
chromosome NN B-NP O
10q23 CD I-NP O
to TO B-VP O
be VB I-VP O
the DT B-NP O
minimal JJ I-NP O
area NN I-NP O
of IN B-PP O
loss NN B-NP O
. . O O

A DT B-NP O
new JJ I-NP O
tumor NN I-NP B-Disease
suppressor NN I-NP O
gene NN I-NP O
, , O O
PTEN NN B-NP O
/ SYM B-NP O
MMAC1 NN I-NP O
, , O O
was VBD B-VP O
isolated VBN I-VP O
recently RB B-ADVP O
at IN B-PP O
this DT B-NP O
region NN I-NP O
of IN B-PP O
chromosome NN B-NP O
10q23 CD I-NP O
and CC O O
found VBN B-VP O
to TO I-VP O
be VB I-VP O
inactivated VBN I-VP O
by IN B-PP O
mutation NN B-NP O
in IN B-PP O
three CD B-NP O
prostate NN I-NP B-Disease
cancer NN I-NP I-Disease
cell NN I-NP O
lines NNS I-NP O
. . O O

We PRP B-NP O
screened VBD B-VP O
80 CD B-NP O
prostate NN I-NP B-Disease
tumors NNS I-NP I-Disease
by IN B-PP O
microsatellite NN B-NP O
analysis NN I-NP O
and CC O O
found VBN B-VP O
chromosome NN B-NP O
10q23 CD I-NP O
to TO B-VP O
be VB I-VP O
deleted VBN I-VP O
in IN B-PP O
23 CD B-NP O
cases NNS I-NP O
. . O O

We PRP B-NP O
then RB B-ADVP O
proceeded VBD B-VP O
with IN B-PP O
sequence NN B-NP O
analysis NN I-NP O
of IN B-PP O
the DT B-NP O
entire JJ I-NP O
PTEN NN I-NP O
/ SYM B-NP O
MMAC1 NN I-NP O
coding NN I-NP O
region NN I-NP O
and CC O O
tested VBN B-VP O
for IN B-PP O
homozygous JJ B-NP O
deletion NN I-NP O
with IN B-PP O
new JJ B-NP O
intragenic JJ I-NP O
markers NNS I-NP O
in IN B-PP O
these DT B-NP O
23 CD I-NP O
cases NNS I-NP O
with IN B-PP O
10q23 CD B-NP O
loss NN I-NP O
of IN B-PP O
heterozygosity NN B-NP O
. . O O

The DT B-NP O
identification NN I-NP O
of IN B-PP O
the DT B-NP O
second JJ I-NP O
mutational JJ I-NP O
event NN I-NP O
in IN B-PP O
10 CD B-NP O
( ( O O
43 CD B-NP O
% NN I-NP O
) ) O O
tumors NNS B-NP B-Disease
establishes VBZ B-VP O
PTEN NN B-NP O
/ SYM B-NP O
MMAC1 NN I-NP O
as IN B-PP O
a DT B-NP O
main JJ I-NP O
inactivation NN I-NP O
target NN I-NP O
of IN B-PP O
10q NN B-NP O
loss NN I-NP O
in IN B-PP O
sporadic JJ B-NP B-Disease
prostate NN I-NP I-Disease
cancer NN I-NP I-Disease
. . O O

. . O O

Risk NN B-NP O
reversals NNS I-NP O
in IN B-PP O
predictive JJ B-NP O
testing NN I-NP O
for IN B-PP O
Huntington NNP B-NP B-Disease
disease NN I-NP I-Disease
. . O O

The DT B-NP O
first JJ I-NP O
predictive JJ I-NP O
testing NN I-NP O
for IN B-PP O
Huntington NNP B-NP B-Disease
disease NN I-NP I-Disease
( ( O O
HD NN B-NP B-Disease
) ) O O
was VBD B-VP O
based VBN I-VP O
on IN B-PP O
analysis NN B-NP O
of IN B-PP O
linked VBN B-NP O
polymorphic JJ I-NP O
DNA NN I-NP O
markers NNS I-NP O
to TO B-VP O
estimate VB I-VP O
the DT B-NP O
likelihood NN I-NP O
of IN B-PP O
inheriting VBG B-VP O
the DT B-NP O
mutation NN I-NP O
for IN B-PP O
HD NN B-NP B-Disease
. . O O

Limits NNS B-NP O
to TO B-PP O
accuracy NN B-NP O
included VBD B-VP O
recombination NN B-NP O
between IN B-PP O
the DT B-NP O
DNA NN I-NP O
markers NNS I-NP O
and CC O O
the DT B-NP O
mutation NN I-NP O
, , O O
pedigree NN B-NP O
structure NN I-NP O
, , O O
and CC O O
whether IN B-SBAR O
DNA NN B-NP O
samples NNS I-NP O
were VBD B-VP O
available JJ B-ADJP O
from IN B-PP O
family NN B-NP O
members NNS I-NP O
. . O O

With IN B-PP O
direct JJ B-NP O
tests NNS I-NP O
for IN B-PP O
the DT B-NP O
HD NN I-NP B-Disease
mutation NN I-NP O
, , O O
we PRP B-NP O
have VBP B-VP O
assessed VBN I-VP O
the DT B-NP O
accuracy NN I-NP O
of IN B-PP O
results NNS B-NP O
obtained VBN B-VP O
by IN B-PP O
linkage NN B-NP O
approaches NNS I-NP O
when WRB B-ADVP O
requested VBN B-VP O
to TO B-VP O
do VB I-VP O
so RB B-ADVP O
by IN B-PP O
the DT B-NP O
test NN I-NP O
individuals NNS I-NP O
. . O O

For IN B-PP O
six CD B-NP O
such JJ I-NP O
individuals NNS I-NP O
, , O O
there EX B-NP O
was VBD B-VP O
significant JJ B-NP O
disparity NN I-NP O
between IN B-PP O
the DT B-NP O
tests NNS I-NP O
. . O O

Three CD B-NP O
went VBD B-VP O
from IN B-PP O
a DT B-NP O
decreased VBN I-NP O
risk NN I-NP O
to TO B-PP O
an DT B-NP O
increased VBN I-NP O
risk NN I-NP O
, , O O
while IN B-SBAR O
in IN B-PP O
another DT B-NP O
three CD I-NP O
the DT B-NP O
risk NN I-NP O
was VBD B-VP O
decreased VBN I-VP O
. . O O

Knowledge NN B-NP O
of IN B-PP O
the DT B-NP O
potential JJ I-NP O
reasons NNS I-NP O
for IN B-PP O
these DT B-NP O
changes NNS I-NP O
in IN B-PP O
results NNS B-NP O
and CC I-NP O
impact NN I-NP O
of IN B-PP O
these DT B-NP O
risk NN I-NP O
reversals NNS I-NP O
on IN B-PP O
both DT B-NP O
patients NNS I-NP O
and CC O O
the DT B-NP O
counseling NN I-NP O
team NN I-NP O
can MD B-VP O
assist VB I-VP O
in IN B-PP O
the DT B-NP O
development NN I-NP O
of IN B-PP O
strategies NNS B-NP O
for IN B-PP O
the DT B-NP O
prevention NN I-NP O
and CC O O
, , O O
where WRB B-ADVP O
necessary JJ B-ADJP O
, , O O
management NN B-NP O
of IN B-PP O
a DT B-NP O
risk NN I-NP O
reversal NN I-NP O
in IN B-PP O
any DT B-NP O
predictive JJ I-NP O
testing NN I-NP O
program NN I-NP O
. . O O

. . O O

A DT B-NP O
novel JJ I-NP O
common JJ I-NP O
missense JJ I-NP O
mutation NN I-NP O
G301C NN I-NP O
in IN B-PP O
the DT B-NP O
N NN I-NP O
- HYPH B-NP O
acetylgalactosamine NN I-NP O
- HYPH B-NP O
6 CD I-NP O
- HYPH I-NP O
sulfate NN I-NP O
sulfatase NN I-NP O
gene NN I-NP O
in IN B-PP O
mucopolysaccharidosis NN B-NP B-Disease
IVA NN I-NP I-Disease
. . O O

Mucopolysaccharidosis NN B-NP B-Disease
IVA NN I-NP I-Disease
( ( O O
MPS NN B-NP B-Disease
IVA NN I-NP I-Disease
) ) O O
is VBZ B-VP O
an DT B-NP O
autosomal JJ I-NP B-Disease
recessive JJ I-NP I-Disease
lysosomal JJ I-NP I-Disease
storage NN I-NP I-Disease
disorder NN I-NP I-Disease
caused VBN B-VP O
by IN B-PP O
a DT B-NP O
genetic JJ I-NP B-Disease
defect NN I-NP I-Disease
in IN B-PP O
N NN B-NP O
- HYPH B-NP O
acetylgalactosamine NN I-NP O
- HYPH B-NP O
6 CD I-NP O
- HYPH I-NP O
sulfate NN I-NP O
sulfatase NN I-NP O
( ( O O
GALNS NN B-NP O
) ) O O
. . O O

In IN B-PP O
previous JJ B-NP O
studies NNS I-NP O
, , O O
we PRP B-NP O
have VBP B-VP O
found VBN I-VP O
two CD B-NP O
common JJ I-NP O
mutations NNS I-NP O
in IN B-PP O
Caucasians NNPS B-NP O
and CC I-NP O
Japanese NNPS I-NP O
, , O O
respectively RB B-ADVP O
. . O O

To TO B-VP O
characterize VB I-VP O
the DT B-NP O
mutational JJ I-NP O
spectrum NN I-NP O
in IN B-PP O
various JJ B-NP O
ethnic JJ I-NP O
groups NNS I-NP O
, , O O
mutations NNS B-NP O
in IN B-PP O
the DT B-NP O
GALNS NN I-NP O
gene NN I-NP O
in IN B-PP O
Colombian JJ B-NP O
MPS NN I-NP B-Disease
IVA NN I-NP I-Disease
patients NNS I-NP O
were VBD B-VP O
investigated VBN I-VP O
, , O O
and CC O O
genetic JJ B-NP O
backgrounds NNS I-NP O
were VBD B-VP O
extensively RB I-VP O
analyzed VBN I-VP O
to TO I-VP O
identify VB I-VP O
racial JJ B-NP O
origin NN I-NP O
, , O O
based VBN B-PP O
on IN B-PP O
mitochondrial JJ B-NP O
DNA NN I-NP O
( ( O O
mtDNA NN B-NP O
) ) O O
lineages NNS B-NP O
. . O O

Three CD B-NP O
novel JJ I-NP O
missense JJ I-NP O
mutations NNS I-NP O
never RB B-VP O
identified VBN I-VP O
previously RB B-ADVP O
in IN B-PP O
other JJ B-NP O
populations NNS I-NP O
and CC O O
found VBN B-VP O
in IN B-PP O
16 CD B-NP O
out IN B-PP O
of IN B-PP O
19 CD B-NP O
Colombian JJ I-NP O
MPS NN I-NP B-Disease
IVA NN I-NP I-Disease
unrelated JJ I-NP O
alleles NNS I-NP O
account VBP B-VP O
for IN B-PP O
84 CD B-NP O
. . O O

2 CD B-NP O
% NN I-NP O
of IN B-PP O
the DT B-NP O
alleles NNS I-NP O
in IN B-PP O
this DT B-NP O
study NN I-NP O
. . O O

The DT B-NP O
G301C NN I-NP O
and CC I-NP O
S162F NN I-NP O
mutations NNS I-NP O
account VBP B-VP O
for IN B-PP O
68 CD B-NP O
. . O O

4 CD B-NP O
% NN I-NP O
and CC O O
10 CD B-NP O
. . O O

5 CD B-NP O
% NN I-NP O
of IN B-PP O
mutations NNS B-NP O
, , O O
respectively RB B-ADVP O
, , O O
whereas IN O O
the DT B-NP O
remaining VBG I-NP O
F69V NN I-NP O
is VBZ B-VP O
limited VBN I-VP O
to TO B-PP O
a DT B-NP O
single JJ I-NP O
allele NN I-NP O
. . O O

The DT B-NP O
skewed JJ I-NP O
prevalence NN I-NP O
of IN B-PP O
G301C NN B-NP O
in IN B-PP O
only JJ B-NP O
Colombian JJ I-NP O
patients NNS I-NP O
and CC O O
haplotype NN B-NP O
analysis NN I-NP O
by IN B-PP O
restriction NN B-NP O
fragment NN I-NP O
length NN I-NP O
polymorphisms NNS I-NP O
in IN B-PP O
the DT B-NP O
GALNS NN I-NP O
gene NN I-NP O
suggest VBP B-VP O
that IN B-SBAR O
G301C NN B-NP O
originated VBN B-VP O
from IN B-PP O
a DT B-NP O
common JJ I-NP O
ancestor NN I-NP O
. . O O

Investigation NN B-NP O
of IN B-PP O
the DT B-NP O
genetic JJ I-NP O
background NN I-NP O
by IN B-PP O
means NNS B-NP O
of IN B-PP O
mtDNA NN B-NP O
lineages NNS I-NP O
indicate VBP B-VP O
that IN B-SBAR O
all PDT B-NP O
our PRP$ I-NP O
patients NNS I-NP O
are VBP B-VP O
probably RB B-ADVP O
of IN B-PP O
native JJ B-NP O
American JJ I-NP O
descent NN I-NP O
Low JJ B-NP O
frequency NN I-NP O
of IN B-PP O
BRCA1 NN B-NP O
germline NN I-NP O
mutations NNS I-NP O
in IN B-PP O
45 CD B-NP O
German JJ I-NP O
breast NN I-NP B-Disease
/ SYM B-NP I-Disease
ovarian JJ I-NP I-Disease
cancer NN I-NP I-Disease
families NNS I-NP O
. . O O

In IN B-PP O
this DT B-NP O
study NN I-NP O
we PRP B-NP O
investigated VBD B-VP O
45 CD B-NP O
German JJ I-NP O
breast NN I-NP B-Disease
/ SYM B-NP I-Disease
ovarian JJ I-NP I-Disease
cancer NN I-NP I-Disease
families NNS I-NP O
for IN B-PP O
germline NN B-NP O
mutations NNS I-NP O
in IN B-PP O
the DT B-NP O
BRCA1 NN I-NP O
gene NN I-NP O
. . O O

We PRP B-NP O
identified VBD B-VP O
four CD B-NP O
germline NN I-NP O
mutations NNS I-NP O
in IN B-PP O
three CD B-NP O
breast NN I-NP B-Disease
cancer NN I-NP I-Disease
families NNS I-NP O
and CC O O
in IN B-PP O
one CD B-NP O
breast NN I-NP B-Disease
- HYPH B-NP I-Disease
ovarian JJ I-NP I-Disease
cancer NN I-NP I-Disease
family NN I-NP O
. . O O

among IN B-PP O
these DT B-NP O
were VBD B-VP O
one CD B-NP O
frameshift NN I-NP O
mutation NN I-NP O
, , O O
one CD B-NP O
nonsense JJ I-NP O
mutation NN I-NP O
, , O O
one CD B-NP O
novel JJ I-NP O
splice NN I-NP O
site NN I-NP O
mutation NN I-NP O
, , O O
and CC O O
one CD B-NP O
missense JJ I-NP O
mutation NN I-NP O
. . O O

The DT B-NP O
missense JJ I-NP O
mutation NN I-NP O
was VBD B-VP O
also RB I-VP O
found VBN I-VP O
in IN B-PP O
2 CD B-NP O
. . O O

8 CD B-NP O
% NN I-NP O
of IN B-PP O
the DT B-NP O
general JJ I-NP O
population NN I-NP O
, , O O
suggesting VBG B-VP O
that IN B-SBAR O
it PRP B-NP O
is VBZ B-VP O
not RB O O
disease NN B-NP O
associated VBN B-VP O
. . O O

The DT B-NP O
average JJ I-NP O
age NN I-NP O
of IN B-PP O
disease NN B-NP O
onset NN I-NP O
in IN B-PP O
those DT B-NP O
families NNS I-NP O
harbouring VBG B-VP O
causative JJ B-NP O
mutations NNS I-NP O
was VBD B-VP O
between IN B-PP O
32 CD B-NP O
. . O O

3 CD B-NP O
and CC I-NP O
37 CD I-NP O
. . O O

4 CD B-NP O
years NNS I-NP O
, , O O
whereas IN O O
the DT B-NP O
family NN I-NP O
harbouring VBG B-VP O
the DT B-NP O
missense JJ I-NP O
mutation NN I-NP O
had VBD B-VP O
an DT B-NP O
average JJ I-NP O
age NN I-NP O
of IN B-PP O
onset NN B-NP O
of IN B-PP O
51 CD B-NP O
. . O O

2 CD B-NP O
years NNS I-NP O
. . O O

These DT B-NP O
findings NNS I-NP O
show VBP B-VP O
that IN B-SBAR O
BRCA1 NN B-NP O
is VBZ B-VP O
implicated VBN I-VP O
in IN B-PP O
a DT B-NP O
small JJ I-NP O
fraction NN I-NP O
of IN B-PP O
breast NN B-NP B-Disease
/ SYM B-NP I-Disease
ovarian JJ I-NP I-Disease
cancer NN I-NP I-Disease
families NNS I-NP O
suggesting VBG B-VP O
the DT B-NP O
involvement NN I-NP O
of IN B-PP O
another DT B-NP O
susceptibility NN I-NP O
gene NN I-NP O
( ( I-NP O
s NNS I-NP O
) ) O O
Paternal JJ B-NP O
transmission NN I-NP O
of IN B-PP O
congenital JJ B-NP B-Disease
myotonic JJ I-NP I-Disease
dystrophy NN I-NP I-Disease
. . O O

We PRP B-NP O
report VBP B-VP O
a DT B-NP O
rare JJ I-NP O
case NN I-NP O
of IN B-PP O
paternally RB B-NP O
transmitted VBN I-NP O
congenital JJ I-NP B-Disease
myotonic JJ I-NP I-Disease
dystrophy NN I-NP I-Disease
( ( O O
DM NN B-NP B-Disease
) ) O O
. . O O

The DT B-NP O
proband NN I-NP O
is VBZ B-VP O
a DT B-NP O
23 CD I-NP O
year NN I-NP O
old JJ B-ADJP O
, , O O
mentally RB B-NP B-Disease
retarded JJ I-NP I-Disease
male NN I-NP O
who WP B-NP O
suffers VBZ B-VP O
severe JJ B-NP O
muscular JJ I-NP B-Disease
weakness NN I-NP I-Disease
. . O O

He PRP B-NP O
presented VBD B-VP O
with IN B-PP O
respiratory JJ B-NP O
and CC I-NP O
feeding NN I-NP O
difficulties NNS I-NP O
at IN B-PP O
birth NN B-NP O
. . O O

His PRP$ B-NP O
two CD I-NP O
sibs NNS I-NP O
suffer VBP B-VP O
from IN B-PP O
childhood NN B-NP O
onset NN I-NP O
DM NN I-NP B-Disease
. . O O

Their PRP$ B-NP O
late JJ I-NP O
father NN I-NP O
had VBD B-VP O
the DT B-NP O
adult JJ I-NP O
type NN I-NP O
of IN B-PP O
DM NN B-NP B-Disease
, , O O
with IN B-PP O
onset NN B-NP O
around IN B-PP O
30 CD B-NP O
years NNS I-NP O
. . O O

Only RB B-NP O
six CD I-NP O
other JJ I-NP O
cases NNS I-NP O
of IN B-PP O
paternal JJ B-NP O
transmission NN I-NP O
of IN B-PP O
congenital JJ B-NP B-Disease
DM NN I-NP I-Disease
have VBP B-VP O
been VBN I-VP O
reported VBN I-VP O
recently RB B-ADVP O
. . O O

We PRP B-NP O
review VBP B-VP O
the DT B-NP O
sex NN I-NP O
related VBN B-VP O
effects NNS B-NP O
on IN B-PP O
transmission NN B-NP O
of IN B-PP O
congenital JJ B-NP B-Disease
DM NN I-NP I-Disease
. . O O

Decreased VBN B-NP O
fertility NN I-NP O
of IN B-PP O
males NNS B-NP O
with IN B-PP O
adult JJ B-NP O
onset NN I-NP O
DM NN I-NP B-Disease
and CC I-NP O
contraction NN I-NP O
of IN B-PP O
the DT B-NP O
repeat NN I-NP O
upon IN B-PP O
male JJ B-NP O
transmission NN I-NP O
contribute VBP B-VP O
to TO B-PP O
the DT B-NP O
almost RB I-NP O
absent JJ I-NP O
occurrence NN I-NP O
of IN B-PP O
paternal JJ B-NP O
transmission NN I-NP O
of IN B-PP O
congenital JJ B-NP B-Disease
DM NN I-NP I-Disease
. . O O

Also RB B-ADVP O
the DT B-NP O
fathers NNS I-NP O
of IN B-PP O
the DT B-NP O
reported VBN I-NP O
congenitally RB I-NP O
affected VBN I-NP O
children NNS I-NP O
showed VBD B-VP O
, , O O
on IN B-PP O
average NN B-NP O
, , O O
shorter JJR B-NP O
CTG NN I-NP O
repeat NN I-NP O
lengths NNS I-NP O
and CC O O
hence RB B-NP O
less RBR I-NP O
severe JJ I-NP O
clinical JJ I-NP O
symptoms NNS I-NP O
than IN B-PP O
the DT B-NP O
mothers NNS I-NP O
of IN B-PP O
children NNS B-NP O
with IN B-PP O
congenital JJ B-NP B-Disease
DM NN I-NP I-Disease
. . O O

We PRP B-NP O
conclude VBP B-VP O
that IN B-SBAR O
paternal JJ B-NP O
transmission NN I-NP O
of IN B-PP O
congenital JJ B-NP B-Disease
DM NN I-NP I-Disease
is VBZ B-VP O
rare JJ B-ADJP O
and CC O O
preferentially RB B-VP O
occurs VBZ I-VP O
with IN B-PP O
onset NN B-NP O
of IN B-PP O
DM NN B-NP B-Disease
past JJ B-NP O
30 CD I-NP O
years NNS I-NP O
in IN B-PP O
the DT B-NP O
father NN I-NP O
. . O O

. . O O

The DT B-NP O
RB1 NN I-NP O
gene NN I-NP O
mutation NN I-NP O
in IN B-PP O
a DT B-NP O
child NN I-NP O
with IN B-PP O
ectopic JJ B-NP B-Disease
intracranial JJ I-NP I-Disease
retinoblastoma NN I-NP I-Disease
. . O O

The DT B-NP O
RB1 NN I-NP O
gene NN I-NP O
mutation NN I-NP O
was VBD B-VP O
investigated VBN I-VP O
in IN B-PP O
a DT B-NP O
child NN I-NP O
with IN B-PP O
ectopic JJ B-NP B-Disease
intracranial JJ I-NP I-Disease
retinoblastoma NN I-NP I-Disease
using VBG B-VP O
DNA NN B-NP O
obtained VBN B-VP O
from IN B-PP O
both CC O O
the DT B-NP O
pineal JJ I-NP B-Disease
and CC I-NP I-Disease
retinal JJ I-NP I-Disease
tumours NNS I-NP I-Disease
of IN B-PP O
the DT B-NP O
patient NN I-NP O
. . O O

A DT B-NP O
nonsense JJ I-NP O
mutation NN I-NP O
in IN B-PP O
exon NN B-NP O
17 CD I-NP O
( ( O O
codon NN B-NP O
556 CD I-NP O
) ) O O
of IN B-PP O
the DT B-NP O
RB1 NN I-NP O
gene NN I-NP O
was VBD B-VP O
found VBN I-VP O
to TO I-VP O
be VB I-VP O
present JJ B-ADJP O
homozygously RB B-ADVP O
in IN B-PP O
both CC O O
the DT B-NP O
retinal NN I-NP B-Disease
and CC O I-Disease
the DT B-NP I-Disease
pineal JJ I-NP I-Disease
tumours NNS I-NP I-Disease
. . O O

The DT B-NP O
same JJ I-NP O
mutation NN I-NP O
was VBD B-VP O
present JJ B-ADJP O
heterozygously RB B-ADVP O
in IN B-PP O
the DT B-NP O
DNA NN I-NP O
from IN B-PP O
the DT B-NP O
constitutional JJ I-NP O
cells NNS I-NP O
of IN B-PP O
the DT B-NP O
patient NN I-NP O
, , O O
proving VBG B-VP O
it PRP B-NP O
to TO B-VP O
be VB I-VP O
of IN B-PP O
germline NN B-NP O
origin NN I-NP O
. . O O

The DT B-NP O
initial JJ I-NP O
mutation NN I-NP O
was VBD B-VP O
shown VBN I-VP O
to TO I-VP O
have VB I-VP O
occurred VBN I-VP O
in IN B-PP O
the DT B-NP O
paternally RB I-NP O
derived VBN I-NP O
RB1 NN I-NP O
allele NN I-NP O
. . O O

The DT B-NP O
mutation NN I-NP O
is VBZ B-VP O
in IN B-PP O
an DT B-NP O
area NN I-NP O
of IN B-PP O
the DT B-NP O
gene NN I-NP O
that WDT B-NP O
encodes VBZ B-VP O
the DT B-NP O
protein NN I-NP O
- HYPH B-PP O
binding VBG B-NP O
region NN I-NP O
known VBN B-VP O
as IN B-PP O
the DT B-NP O
pocket NN I-NP O
region NN I-NP O
and CC O O
has VBZ B-VP O
been VBN I-VP O
detected VBN I-VP O
in IN B-PP O
other JJ B-NP O
cases NNS I-NP O
of IN B-PP O
retinoblastoma NN B-NP B-Disease
. . O O

. . O O

Low JJ B-NP O
levels NNS I-NP O
of IN B-PP O
beta NN B-NP O
hexosaminidase NN I-NP O
A NN I-NP O
in IN B-PP O
healthy JJ B-NP O
individuals NNS I-NP O
with IN B-PP O
apparent JJ B-NP O
deficiency NN I-NP O
of IN B-PP O
this DT B-NP O
enzyme NN I-NP O
. . O O

Appreciable JJ B-NP O
beta NN I-NP O
hexosaminidase NN I-NP O
A NN I-NP O
( ( O O
hex NN B-NP O
A NN I-NP O
) ) O O
activity NN B-NP O
has VBZ B-VP O
been VBN I-VP O
detected VBN I-VP O
in IN B-PP O
cultured VBN B-NP O
skin NN I-NP O
fibroblasts NNS I-NP O
and CC O O
melanoma NN B-NP B-Disease
tissue NN I-NP O
from IN B-PP O
healthy JJ B-NP O
individuals NNS I-NP O
previously RB B-VP O
reported VBN I-VP O
as IN B-PP O
having VBG B-VP O
deficiency NN B-NP B-Disease
of IN B-PP I-Disease
hex NN B-NP I-Disease
A NN I-NP I-Disease
activity NN I-NP O
indistinguishable JJ B-ADJP O
from IN B-PP O
that DT B-NP O
of IN B-PP O
patients NNS B-NP O
with IN B-PP O
Tay NNP B-NP B-Disease
- HYPH B-NP I-Disease
Sachs NNP I-NP I-Disease
disease NN I-NP I-Disease
( ( O O
TSD NN B-NP B-Disease
) ) O O
. . O O

Identification NN B-NP O
and CC I-NP O
quantitation NN I-NP O
of IN B-PP O
hex NN B-NP O
A NN I-NP O
, , O O
amounting VBG B-VP O
to TO B-PP O
3 CD B-NP O
. . O O

5 CD B-NP O
% NN I-NP O
- HYPH B-NP O
6 CD I-NP O
. . O O

9 CD B-NP O
% NN I-NP O
of IN B-PP O
total JJ B-NP O
beta SYM I-NP O
hexosaminidase NN I-NP O
activity NN I-NP O
, , O O
has VBZ B-VP O
been VBN I-VP O
obtained VBN I-VP O
by IN B-PP O
cellulose NN B-NP O
acetate NN I-NP O
gel NN I-NP O
electrophoresis NN I-NP O
, , O O
DEAE NN B-NP O
- HYPH O O
cellulose NN B-NP O
ion NN I-NP O
- HYPH B-NP O
exchange NN I-NP O
chromatography NN I-NP O
, , O O
radial JJ B-NP O
immunodiffusion NN I-NP O
, , O O
and CC O O
radioimmunoassay NN B-NP O
. . O O

Previous JJ B-NP O
family NN I-NP O
studies NNS I-NP O
suggested VBD B-VP O
that IN B-SBAR O
these DT B-NP O
individuals NNS I-NP O
may MD B-VP O
be VB I-VP O
compound JJ B-NP O
heterozygotes NNS I-NP O
for IN B-PP O
the DT B-NP O
common JJ I-NP O
mutant JJ I-NP O
TSD NN I-NP B-Disease
gene NN I-NP O
and CC O O
a DT B-NP O
rare JJ I-NP O
( ( O O
allelic JJ B-ADJP O
) ) O O
mutant JJ B-NP O
gene NN I-NP O
. . O O

Thus RB B-ADVP O
, , O O
the DT B-NP O
postulated VBN I-NP O
rate NN I-NP O
mutant JJ I-NP O
gene NN I-NP O
appears VBZ B-VP O
to TO I-VP O
code VB I-VP O
for IN B-PP O
the DT B-NP O
expression NN I-NP O
of IN B-PP O
low JJ B-NP O
amounts NNS I-NP O
of IN B-PP O
hex NN B-NP O
A NN I-NP O
. . O O

Heterozygotes NNS B-NP O
for IN B-PP O
the DT B-NP O
rare JJ I-NP O
mutant NN I-NP O
may MD B-VP O
be VB I-VP O
indistinguishable JJ B-ADJP O
from IN B-PP O
heterozygotes NNS B-NP O
for IN B-PP O
the DT B-NP O
common JJ I-NP O
TSD NN I-NP B-Disease
mutant NN I-NP O
. . O O

However RB B-ADVP O
, , O O
direct JJ B-NP O
visualization NN I-NP O
and CC I-NP O
quantitation NN I-NP O
of IN B-PP O
hex NN B-NP O
A NN I-NP O
by IN B-PP O
the DT B-NP O
methods NNS I-NP O
described VBN B-VP O
may MD B-VP O
prevent VB I-VP O
false JJ B-NP O
- HYPH I-NP O
positive JJ I-NP O
prenatal JJ I-NP O
diagnosis NN I-NP O
of IN B-PP O
TSD NN B-NP B-Disease
in IN B-PP O
fetuses NNS B-NP O
having VBG B-VP O
the DT B-NP O
incomplete JJ I-NP O
hex NN I-NP B-Disease
A NN I-NP I-Disease
deficiency NN I-NP I-Disease
of IN B-PP O
the DT B-NP O
type NN I-NP O
described VBN B-VP O
in IN B-PP O
the DT B-NP O
four CD I-NP O
healthy JJ I-NP O
individuals NNS I-NP O
The DT B-NP O
tumor NN I-NP B-Disease
suppressor NN I-NP O
gene NN I-NP O
Smad4 NN I-NP O
/ SYM B-NP O
Dpc4 NN I-NP O
is VBZ B-VP O
required VBN I-VP O
for IN B-PP O
gastrulation NN B-NP O
and CC B-PP O
later RB B-ADVP O
for IN B-PP O
anterior JJ B-NP O
development NN I-NP O
of IN B-PP O
the DT B-NP O
mouse NN I-NP O
embryo NN I-NP O
. . O O

Mutations NNS B-NP O
in IN B-PP O
the DT B-NP O
SMAD4 NN I-NP O
/ SYM B-NP O
DPC4 NN I-NP O
tumor NN I-NP B-Disease
suppressor NN I-NP O
gene NN I-NP O
, , O O
a DT B-NP O
key JJ I-NP O
signal NN I-NP O
transducer NN I-NP O
in IN B-PP O
most JJS B-NP O
TGFbeta NN I-NP O
- HYPH B-NP O
related VBN I-NP O
pathways NNS I-NP O
, , O O
are VBP B-VP O
involved VBN I-VP O
in IN B-PP O
50 CD B-NP O
% NN I-NP O
of IN B-PP O
pancreatic JJ B-NP B-Disease
cancers NNS I-NP I-Disease
. . O O

Homozygous JJ B-NP O
Smad4 NN I-NP O
mutant JJ I-NP O
mice NNS I-NP O
die VBP B-VP O
before IN B-SBAR O
day NN B-NP O
7 CD I-NP O
. . O O

5 CD B-NP O
of IN B-PP O
embryogenesis NN B-NP O
. . O O

Mutant JJ B-NP O
embryos NNS I-NP O
have VBP B-VP O
reduced VBN I-VP O
size NN B-NP O
, , O O
fail VBP B-VP O
to TO I-VP O
gastrulate VB I-VP O
or CC I-VP O
express VB I-VP O
a DT B-NP O
mesodermal JJ I-NP O
marker NN I-NP O
, , O O
and CC O O
show VBP B-VP O
abnormal JJ B-NP O
visceral JJ I-NP O
endoderm NN I-NP O
development NN I-NP O
. . O O

Growth NN B-NP B-Disease
retardation NN I-NP I-Disease
of IN B-PP O
the DT B-NP O
Smad4 NN I-NP O
- HYPH B-NP O
deficient JJ I-NP O
embryos NNS I-NP O
results VBZ B-VP O
from IN B-PP O
reduced VBN B-NP O
cell NN I-NP O
proliferation NN I-NP O
rather RB B-CONJP O
than IN I-CONJP O
increased VBN B-NP O
apoptosis NN I-NP O
. . O O

Aggregation NN B-NP O
of IN B-PP O
mutant JJ B-NP O
Smad4 NN I-NP O
ES NN I-NP O
cells NNS I-NP O
with IN B-PP O
wild JJ B-NP O
- HYPH I-NP O
type NN I-NP O
tetraploid JJ I-NP O
morulae NNS I-NP O
rescues VBZ B-VP O
the DT B-NP O
gastrulation NN I-NP B-Disease
defect NN I-NP I-Disease
. . O O

These DT B-NP O
results NNS I-NP O
indicate VBP B-VP O
that IN B-SBAR O
Smad4 NN B-NP O
is VBZ B-VP O
initially RB I-VP O
required VBN I-VP O
for IN B-PP O
the DT B-NP O
differentiation NN I-NP O
of IN B-PP O
the DT B-NP O
visceral JJ I-NP O
endoderm NN I-NP O
and CC O O
that IN B-SBAR O
the DT B-NP O
gastrulation NN I-NP B-Disease
defect NN I-NP I-Disease
in IN B-PP O
the DT B-NP O
epiblast NN I-NP O
is VBZ B-VP O
secondary JJ B-ADJP O
and CC O O
non AFX O O
- HYPH O O
cell NN B-NP O
autonomous JJ B-ADJP O
. . O O

Rescued VBN B-NP O
embryos NNS I-NP O
show VBP B-VP O
severe JJ B-NP O
anterior JJ I-NP O
truncations NNS I-NP O
, , O O
indicating VBG B-VP O
a DT B-NP O
second JJ I-NP O
important JJ I-NP O
role NN I-NP O
for IN B-PP O
Smad4 NN B-NP O
in IN B-PP O
anterior JJ B-NP O
patterning NN I-NP O
during IN B-PP O
embryogenesis NN B-NP O
. . O O

Prevalence NN B-NP O
of IN B-PP O
p16 NN B-NP O
and CC I-NP O
CDK4 NN I-NP O
germline NN I-NP O
mutations NNS I-NP O
in IN B-PP O
48 CD B-NP O
melanoma NN I-NP B-Disease
- HYPH B-NP O
prone JJ I-NP O
families NNS I-NP O
in IN B-PP O
France NNP B-NP O
. . O O

The DT B-NP O
French NNP I-NP O
Familial NNP I-NP B-Disease
Melanoma NNP I-NP I-Disease
Study NNP I-NP O
Group NNP I-NP O
. . O O

Germline NN B-NP O
mutations NNS I-NP O
in IN B-PP O
the DT B-NP O
p16 NN I-NP O
and CC I-NP O
CDK4 NN I-NP O
genes NNS I-NP O
have VBP B-VP O
been VBN I-VP O
reported VBN I-VP O
in IN B-PP O
a DT B-NP O
subset NN I-NP O
of IN B-PP O
melanoma NN B-NP B-Disease
pedigrees NNS I-NP O
, , O O
but CC O O
their PRP$ B-NP O
prevalence NN I-NP O
is VBZ B-VP O
not RB I-VP O
well RB I-VP O
known VBN I-VP O
. . O O

We PRP B-NP O
searched VBD B-VP O
for IN B-PP O
such JJ B-NP O
germline NN I-NP O
mutations NNS I-NP O
in IN B-PP O
48 CD B-NP O
French JJ I-NP O
melanoma NN I-NP B-Disease
- HYPH I-NP O
prone JJ I-NP O
families NNS I-NP O
selected VBN B-VP O
according VBG B-PP O
to TO B-PP O
two CD B-NP O
major JJ I-NP O
criteria NNS I-NP O
families NNS I-NP O
with IN B-PP O
at IN B-NP O
least JJS I-NP O
three CD I-NP O
affected VBN I-NP O
members NNS I-NP O
( ( O O
n NN B-NP O
= SYM B-VP O
20 CD B-NP O
) ) O O
or CC O O
families NNS B-NP O
with IN B-PP O
two CD B-NP O
affected VBN I-NP O
members NNS I-NP O
, , O O
one CD B-NP O
of IN B-PP O
them PRP B-NP O
affected VBD B-VP O
before IN B-PP O
the DT B-NP O
age NN I-NP O
of IN B-PP O
50 CD B-NP O
( ( O O
n NN B-NP O
= SYM B-VP O
28 CD B-NP O
) ) O O
, , O O
and CC O O
one CD B-NP O
additional JJ I-NP O
minor JJ I-NP O
criterion NN I-NP O
. . O O

Sixteen CD B-NP O
different JJ I-NP O
p16 NN I-NP O
germline NN I-NP O
mutations NNS I-NP O
were VBD B-VP O
found VBN I-VP O
in IN B-PP O
21 CD B-NP O
families NNS I-NP O
, , O O
while IN B-SBAR O
one CD B-NP O
germline NN I-NP O
mutation NN I-NP O
, , O O
Arg24His NN B-NP O
, , O O
was VBD B-VP O
detected VBN I-VP O
in IN B-PP O
the DT B-NP O
CDK4 NN I-NP O
gene NN I-NP O
. . O O

The DT B-NP O
frequency NN I-NP O
of IN B-PP O
p16 NN B-NP O
gene NN I-NP O
mutation NN I-NP O
in IN B-PP O
our PRP$ B-NP O
sample NN I-NP O
( ( O O
44 CD B-NP O
% NN I-NP O
) ) O O
is VBZ B-VP O
among IN B-PP O
the DT B-NP O
highest JJS I-NP O
rates NNS I-NP O
yet RB B-VP O
reported VBN I-VP O
and CC O O
the DT B-NP O
CDK4 NN I-NP O
mutation NN I-NP O
is VBZ B-VP O
the DT B-NP O
second JJ I-NP O
mutation NN I-NP O
detected VBN B-VP O
in IN B-PP O
this DT B-NP O
gene NN I-NP O
worldwide RB B-ADVP O
. . O O

In IN B-PP O
summary NN B-NP O
, , O O
our PRP$ B-NP O
results NNS I-NP O
show VBP B-VP O
frequent JJ B-NP O
involvement NN I-NP O
of IN B-PP O
the DT B-NP O
p16 NN I-NP O
gene NN I-NP O
in IN B-PP O
familial JJ B-NP B-Disease
melanoma NN I-NP I-Disease
and CC O O
confirm VBP B-VP O
the DT B-NP O
role NN I-NP O
of IN B-PP O
the DT B-NP O
CDK4 NN I-NP O
gene NN I-NP O
as IN B-PP O
a DT B-NP O
melanoma NN I-NP B-Disease
- HYPH O O
predisposing VBG B-VP O
gene NN B-NP O
. . O O

. . O O

Progression NN B-NP O
of IN B-PP O
somatic JJ B-NP O
CTG NN I-NP O
repeat NN I-NP O
length NN I-NP O
heterogeneity NN I-NP O
in IN B-PP O
the DT B-NP O
blood NN I-NP O
cells NNS I-NP O
of IN B-PP O
myotonic JJ B-NP B-Disease
dystrophy NN I-NP I-Disease
patients NNS I-NP O
. . O O

The DT B-NP O
genetic JJ I-NP O
basis NN I-NP O
of IN B-PP O
myotonic JJ B-NP B-Disease
dystrophy NN I-NP I-Disease
( ( O O
DM NN B-NP B-Disease
) ) O O
is VBZ B-VP O
the DT B-NP O
expansion NN I-NP O
of IN B-PP O
an DT B-NP O
unstable JJ I-NP O
CTG NN I-NP O
repeat NN I-NP O
in IN B-PP O
the DT B-NP O
34 CD I-NP O
UTR NN I-NP O
of IN B-PP O
the DT B-NP O
DM NN I-NP B-Disease
protein NN I-NP O
kinase NN I-NP O
gene NN I-NP O
on IN B-PP O
chromosome NN B-NP O
19 CD I-NP O
. . O O

One CD B-NP O
of IN B-PP O
the DT B-NP O
principal JJ I-NP O
features NNS I-NP O
of IN B-PP O
the DT B-NP O
DM NN I-NP B-Disease
mutation NN I-NP O
is VBZ B-VP O
an DT B-NP O
extraordinarily RB I-NP O
high JJ I-NP O
level NN I-NP O
of IN B-PP O
somatic JJ B-NP O
mosaicism NN I-NP O
, , O O
due IN B-PP O
to TO B-PP O
an DT B-NP O
extremely RB I-NP O
high JJ I-NP O
degree NN I-NP O
of IN B-PP O
somatic JJ B-NP O
instability NN I-NP O
both CC B-PP O
within IN B-PP O
and CC I-PP O
between IN I-PP O
different JJ B-NP O
tissues NNS I-NP O
. . O O

This DT B-NP O
instability NN I-NP O
appears VBZ B-VP O
to TO I-VP O
be VB I-VP O
biased VBN I-VP O
towards IN B-PP O
further JJ B-NP O
expansion NN I-NP O
and CC O O
continuous JJ B-ADJP O
throughout IN B-PP O
the DT B-NP O
life NN I-NP O
of IN B-PP O
an DT B-NP O
individual NN I-NP O
, , O O
features NNS B-NP O
that WDT B-NP O
could MD B-VP O
be VB I-VP O
associated VBN I-VP O
with IN B-PP O
the DT B-NP O
progressive JJ I-NP O
nature NN I-NP O
of IN B-PP O
the DT B-NP O
disease NN I-NP O
. . O O

Although IN B-SBAR O
increasing VBG B-VP O
measured VBN B-NP O
allele NN I-NP O
size NN I-NP O
between IN B-PP O
patients NNS B-NP O
clearly RB B-ADVP O
correlates VBZ B-VP O
with IN B-PP O
an DT B-NP O
increased VBN I-NP O
severity NN I-NP O
of IN B-PP O
symptoms NNS B-NP O
and CC O O
an DT B-NP O
earlier JJR I-NP O
age NN I-NP O
of IN B-PP O
onset NN B-NP O
, , O O
this DT B-NP O
correlation NN I-NP O
is VBZ B-VP O
not RB O O
precise JJ B-NP O
and CC I-NP O
measured VBN I-NP O
allele NN I-NP O
length NN I-NP O
cannot MD B-VP O
be VB I-VP O
used VBN I-VP O
as IN B-PP O
an DT B-NP O
accurate JJ I-NP O
predictor NN I-NP O
of IN B-PP O
age NN B-NP O
of IN B-PP O
onset NN B-NP O
. . O O

In IN B-SBAR O
order NN O O
to TO B-VP O
further RB I-VP O
characterize VB I-VP O
the DT B-NP O
dynamics NNS I-NP O
of IN B-PP O
DM NN B-NP B-Disease
CTG NN I-NP O
repeat NN I-NP O
somatic JJ I-NP O
instability NN I-NP O
, , O O
we PRP B-NP O
have VBP B-VP O
studied VBN I-VP O
repeat NN B-NP O
length NN I-NP O
changes VBZ B-VP O
over IN B-PP O
time NN B-NP O
in IN B-PP O
111 CD B-NP O
myotonic JJ I-NP B-Disease
dystrophy NN I-NP I-Disease
patients NNS I-NP O
with IN B-PP O
varying VBG B-VP O
clinical JJ B-NP O
severity NN I-NP O
and CC I-NP O
CTG NN I-NP O
repeat NN I-NP O
size NN I-NP O
over IN B-PP O
time NN B-NP O
intervals NNS I-NP O
of IN B-PP O
1 CD B-NP O
- HYPH I-NP O
7 CD I-NP O
years NNS I-NP O
. . O O

We PRP B-NP O
have VBP B-VP O
found VBN I-VP O
a DT B-NP O
direct JJ I-NP O
progression NN I-NP O
of IN B-PP O
the DT B-NP O
size NN I-NP O
heterogeneity NN I-NP O
over IN B-PP O
time NN B-NP O
related VBN B-VP O
to TO B-PP O
initial JJ B-NP O
CTG NN I-NP O
repeat NN I-NP O
size NN I-NP O
and CC O O
the DT B-NP O
time NN I-NP O
interval NN I-NP O
and CC O O
always RB B-VP O
biased VBN I-VP O
towards IN B-PP O
further JJ B-NP O
expansion NN I-NP O
. . O O

Attempts NNS B-NP O
to TO B-VP O
mathematically RB I-VP O
model VB I-VP O
the DT B-NP O
dynamics NNS I-NP O
have VBP B-VP O
proved VBN I-VP O
only RB B-ADJP O
partially RB I-ADJP O
successful JJ I-ADJP O
suggesting VBG B-VP O
that IN B-SBAR O
individual JJ B-NP O
specific JJ I-NP O
genetic JJ I-NP O
and CC I-NP O
/ SYM I-NP O
or CC O O
environmental JJ B-NP O
factors NNS I-NP O
also RB B-ADVP O
play VBP B-VP O
a DT B-NP O
role NN I-NP O
in IN B-PP O
somatic JJ B-NP O
mosaicism NN I-NP O
. . O O

. . O O

Aspartylglucosaminuria NN B-NP B-Disease
among IN B-PP O
Palestinian JJ B-NP O
Arabs NNS I-NP O
. . O O

Aspartylglucosaminuria NN B-NP B-Disease
( ( O O
AGU NN B-NP B-Disease
) ) O O
is VBZ B-VP O
a DT B-NP O
rare JJ I-NP O
disorder NN I-NP B-Disease
of IN B-PP I-Disease
glycoprotein NN B-NP I-Disease
metabolism NN I-NP I-Disease
caused VBN B-VP O
by IN B-PP O
the DT B-NP O
deficiency NN I-NP B-Disease
of IN B-PP I-Disease
the DT B-NP I-Disease
lysosomal JJ I-NP I-Disease
enzyme NN I-NP I-Disease
aspartylglucosaminidase NN I-NP I-Disease
( ( O O
AGA NN B-NP O
) ) O O
. . O O

AGU NN B-NP B-Disease
is VBZ B-VP O
inherited VBN I-VP O
as IN B-PP O
an DT B-NP O
autosomal JJ I-NP O
recessive JJ I-NP O
trait NN I-NP O
and CC O O
occurs VBZ B-VP O
with IN B-PP O
a DT B-NP O
high JJ I-NP O
frequency NN I-NP O
in IN B-PP O
Finland NNP B-NP O
because IN B-PP O
of IN I-PP O
a DT B-NP O
founder NN I-NP O
effect NN I-NP O
. . O O

While IN B-SBAR O
very RB B-NP O
few JJ I-NP O
patients NNS I-NP O
with IN B-PP O
AGU NN B-NP B-Disease
have VBP B-VP O
been VBN I-VP O
reported VBN I-VP O
from IN B-PP O
non AFX B-NP O
- HYPH I-NP O
Finnish JJ I-NP O
origin NN I-NP O
, , O O
we PRP B-NP O
diagnosed VBD B-VP O
the DT B-NP O
disorder NN I-NP O
in IN B-PP O
8 CD B-NP O
patients NNS I-NP O
originating VBG B-VP O
from IN B-PP O
3 CD B-NP O
unrelated JJ I-NP O
families NNS I-NP O
, , O O
all DT B-NP O
Palestinian JJ I-NP O
Arabs NNS I-NP O
from IN B-PP O
the DT B-NP O
region NN I-NP O
of IN B-PP O
Jerusalem NNP B-NP O
. . O O

The DT B-NP O
clinical JJ I-NP O
diagnosis NN I-NP O
of IN B-PP O
AGU NN B-NP B-Disease
is VBZ B-VP O
often RB B-ADVP O
difficult JJ B-ADJP O
, , O O
in IN B-PP O
particular JJ B-NP O
early JJ I-NP O
in IN B-PP O
the DT B-NP O
course NN I-NP O
of IN B-PP O
the DT B-NP O
disease NN I-NP O
, , O O
and CC O O
most JJS B-NP O
of IN B-PP O
the DT B-NP O
patients NNS I-NP O
are VBP B-VP O
diagnosed VBN I-VP O
after IN B-PP O
the DT B-NP O
age NN I-NP O
of IN B-PP O
5 CD B-NP O
years NNS I-NP O
. . O O

However RB B-ADVP O
, , O O
since IN B-SBAR O
these DT B-NP O
patients NNS I-NP O
excrete VBP B-VP O
early JJ B-NP O
large JJ I-NP O
amounts NNS I-NP O
of IN B-PP O
aspartylglucosamine NN B-NP O
in IN B-PP O
urine NN B-NP O
, , O O
biochemical JJ B-NP O
screening NN I-NP O
is VBZ B-VP O
easy JJ B-ADJP O
by IN B-PP O
urine NN B-NP O
chromatography NN I-NP O
. . O O

. . O O

Detection NN B-NP O
of IN B-PP O
heterozygous JJ B-NP O
carriers NNS I-NP O
of IN B-PP O
the DT B-NP O
ataxia NN I-NP B-Disease
- HYPH O I-Disease
telangiectasia NN B-NP I-Disease
( ( O O
ATM NN B-NP O
) ) O O
gene NN B-NP O
by IN B-PP O
G2 NN B-NP O
phase NN I-NP O
chromosomal JJ I-NP O
radiosensitivity NN I-NP O
of IN B-PP O
peripheral JJ B-NP O
blood NN I-NP O
lymphocytes NNS I-NP O
. . O O

In IN B-PP O
ataxia NN B-NP B-Disease
- HYPH O I-Disease
telangiectasia NN B-NP I-Disease
( ( O O
A NN B-NP B-Disease
- HYPH I-NP I-Disease
T NN I-NP I-Disease
) ) O O
patients NNS B-NP O
, , O O
mutations NNS B-NP O
in IN B-PP O
a DT B-NP O
single JJ I-NP O
gene NN I-NP O
, , O O
ATM NN B-NP O
, , O O
result VBP B-VP O
in IN B-PP O
an DT B-NP O
autosomal JJ I-NP B-Disease
recessive JJ I-NP I-Disease
syndrome NN I-NP I-Disease
that WDT B-NP O
embraces VBZ B-VP O
a DT B-NP O
variety NN I-NP O
of IN B-PP O
clinical JJ B-NP O
features NNS I-NP O
and CC O O
manifests VBZ B-VP O
extreme JJ B-NP O
radiosensitivity NN I-NP O
and CC O O
a DT B-NP O
strong JJ I-NP O
pre AFX I-NP O
- HYPH I-NP O
disposition NN I-NP O
to TO B-PP O
malignancy NN B-NP B-Disease
. . O O

Heterozygotes NNS B-NP O
for IN B-PP O
the DT B-NP O
ATM NN I-NP O
gene NN I-NP O
have VBP B-VP O
no DT B-NP O
clinical JJ I-NP O
expression NN I-NP O
of IN B-PP O
A NN B-NP B-Disease
- HYPH I-NP I-Disease
T NN I-NP I-Disease
but CC O O
may MD B-VP O
be VB I-VP O
cancer NN B-NP B-Disease
prone NN I-NP O
with IN B-PP O
a DT B-NP O
moderate JJ I-NP O
increase NN I-NP O
in IN B-PP O
in FW B-NP O
vitro FW I-NP O
radiosensitivity NN I-NP O
. . O O

We PRP B-NP O
performed VBD B-VP O
a DT B-NP O
blind JJ I-NP O
chromosomal JJ I-NP O
analysis NN I-NP O
on IN B-PP O
G2 NN B-NP O
- HYPH B-NP O
phase NN I-NP O
lymphocytes NNS I-NP O
from IN B-PP O
7 CD B-NP O
unrelated JJ I-NP O
A NN I-NP B-Disease
- HYPH I-NP I-Disease
T NN I-NP I-Disease
patients NNS I-NP O
, , O O
13 CD B-NP O
obligate NN I-NP O
A NN I-NP B-Disease
- HYPH I-NP I-Disease
T NN I-NP I-Disease
heterozygotes NNS I-NP O
( ( O O
parents NNS B-NP O
of IN B-PP O
the DT B-NP O
patients NNS I-NP O
) ) O O
, , O O
and CC O O
14 CD B-NP O
normal JJ I-NP O
controls NNS I-NP O
following VBG B-VP O
X NN B-NP O
- HYPH O O
irradiation NN B-NP O
with IN B-PP O
1 CD B-NP O
Gy NN I-NP O
in IN B-SBAR O
order NN O O
to TO B-VP O
evaluate VB I-VP O
this DT B-NP O
cytogenetic JJ I-NP O
method NN I-NP O
as IN B-PP O
a DT B-NP O
tool NN I-NP O
for IN B-PP O
detection NN B-NP O
of IN B-PP O
ATM NN B-NP O
carriers NNS I-NP O
. . O O

Both CC O O
A NN B-NP B-Disease
- HYPH I-NP I-Disease
T NN I-NP I-Disease
homozygotes NNS I-NP O
and CC I-NP O
heterozygotes NNS I-NP O
showed VBD B-VP O
significantly RB B-NP O
increased VBN I-NP O
levels NNS I-NP O
of IN B-PP O
radiation NN B-NP O
- HYPH B-NP O
induced VBN I-NP O
chromatid NN I-NP O
damage NN I-NP O
relative JJ B-ADVP O
to TO B-PP O
that DT B-NP O
of IN B-PP O
normal JJ B-NP O
controls NNS I-NP O
. . O O

These DT B-NP O
results NNS I-NP O
show VBP B-VP O
that IN B-SBAR O
the DT B-NP O
G2 NN I-NP O
- HYPH B-NP O
phase NN I-NP O
chromosomal JJ I-NP O
radiosensitivity NN I-NP O
assay NN I-NP O
can MD B-VP O
be VB I-VP O
used VBN I-VP O
for IN B-PP O
the DT B-NP O
detection NN I-NP O
of IN B-PP O
A NN B-NP B-Disease
- HYPH I-NP I-Disease
T NN I-NP I-Disease
heterozygotes NNS I-NP O
. . O O

In IN B-PP O
combination NN B-NP O
with IN B-PP O
molecular JJ B-NP O
genetic JJ I-NP O
analyses NNS I-NP O
, , O O
this DT B-NP O
test NN I-NP O
may MD B-VP O
be VB I-VP O
of IN B-PP O
value NN B-NP O
in IN B-PP O
studies NNS B-NP O
of IN B-PP O
familial JJ B-NP B-Disease
and CC I-NP I-Disease
sporadic JJ I-NP I-Disease
cancers NNS I-NP I-Disease
aimed VBN B-VP O
at IN B-PP O
determination NN B-NP O
of IN B-PP O
the DT B-NP O
potential JJ I-NP O
involvement NN I-NP O
of IN B-PP O
ATM NN B-NP O
mutations NNS I-NP O
in IN B-PP O
tumor NN B-NP B-Disease
risk NN I-NP O
or CC I-NP O
development NN I-NP O
. . O O

. . O O

Ataxia NN B-NP B-Disease
- HYPH I-NP I-Disease
telangiectasia NN I-NP I-Disease
: : O O
identification NN B-NP O
and CC I-NP O
detection NN I-NP O
of IN B-PP O
founder NN B-NP O
- HYPH I-NP O
effect NN I-NP O
mutations NNS I-NP O
in IN B-PP O
the DT B-NP O
ATM NN I-NP O
gene NN I-NP O
in IN B-PP O
ethnic JJ B-NP O
populations NNS I-NP O
. . O O

To TO B-VP O
facilitate VB I-VP O
the DT B-NP O
evaluation NN I-NP O
of IN B-PP O
ATM NN B-NP O
heterozygotes NNS I-NP O
for IN B-PP O
susceptibility NN B-NP O
to TO B-PP O
other JJ B-NP O
diseases NNS I-NP O
, , O O
such JJ B-PP O
as IN I-PP O
breast NN B-NP B-Disease
cancer NN I-NP I-Disease
, , O O
we PRP B-NP O
have VBP B-VP O
attempted VBN I-VP O
to TO I-VP O
define VB I-VP O
the DT B-NP O
most RBS I-NP O
common JJ I-NP O
mutations NNS I-NP O
and CC O O
their PRP$ B-NP O
frequencies NNS I-NP O
in IN B-PP O
ataxia NN B-NP B-Disease
- HYPH B-NP I-Disease
telangiectasia NN I-NP I-Disease
( ( O O
A NN B-NP B-Disease
- HYPH I-NP I-Disease
T NN I-NP I-Disease
) ) O O
homozygotes NNS B-NP O
from IN B-PP O
10 CD B-NP O
ethnic JJ I-NP O
populations NNS I-NP O
. . O O

Both DT B-NP O
genomic JJ I-NP O
mutations NNS I-NP O
and CC O O
their PRP$ B-NP O
effects NNS I-NP O
on IN B-PP O
cDNA NN B-NP O
were VBD B-VP O
characterized VBN I-VP O
. . O O

Protein NN B-NP O
- HYPH I-NP O
truncation NN I-NP O
testing NN I-NP O
of IN B-PP O
the DT B-NP O
entire JJ I-NP O
ATM NN I-NP O
cDNA NN I-NP O
detected VBN B-VP O
92 CD B-NP O
( ( O O
66 CD B-NP O
% NN I-NP O
) ) O O
truncating NN B-NP O
mutations NNS I-NP O
in IN B-PP O
140 CD B-NP O
mutant JJ I-NP O
alleles NNS I-NP O
screened VBN B-VP O
. . O O

The DT B-NP O
haplotyping NN I-NP O
of IN B-PP O
patients NNS B-NP O
with IN B-PP O
identical JJ B-NP O
mutations NNS I-NP O
indicates VBZ B-VP O
that IN B-SBAR O
almost RB B-NP O
all DT I-NP O
of IN B-PP O
these DT B-NP O
represent JJ I-NP O
common JJ I-NP O
ancestry NN I-NP O
and CC O O
that IN B-SBAR O
very RB B-NP O
few JJ I-NP O
spontaneously RB B-VP O
recurring VBG I-VP O
ATM NN B-NP O
mutations NNS I-NP O
exist VBP B-VP O
. . O O

Assays NNS B-NP O
requiring VBG B-VP O
minimal JJ B-NP O
amounts NNS I-NP O
of IN B-PP O
genomic JJ B-NP O
DNA NN I-NP O
were VBD B-VP O
designed VBN I-VP O
to TO B-VP O
allow VB I-VP O
rapid JJ B-NP O
screening NN I-NP O
for IN B-PP O
common JJ B-NP O
ethnic JJ I-NP O
mutations NNS I-NP O
. . O O

These DT B-NP O
rapid JJ I-NP O
assays NNS I-NP O
detected VBD B-VP O
mutations NNS B-NP O
in IN B-PP O
76 CD B-NP O
% NN I-NP O
of IN B-PP O
Costa JJ B-NP O
Rican JJ I-NP O
patients NNS I-NP O
( ( O O
3 CD B-NP O
) ) O O
, , O O
50 CD B-NP O
% NN I-NP O
of IN B-PP O
Norwegian JJ B-NP O
patients NNS I-NP O
( ( O O
1 CD B-NP O
) ) O O
, , O O
25 CD B-NP O
% NN I-NP O
of IN B-PP O
Polish JJ B-NP O
patients NNS I-NP O
( ( O O
4 CD B-NP O
) ) O O
, , O O
and CC O O
14 CD B-NP O
% NN I-NP O
of IN B-PP O
Italian JJ B-NP O
patients NNS I-NP O
( ( O O
1 CD B-NP O
) ) O O
, , O O
as RB B-CONJP O
well RB I-CONJP O
as IN I-CONJP O
in IN B-PP O
patients NNS B-NP O
of IN B-PP O
Amish NN B-NP O
/ SYM B-NP O
Mennonite NN I-NP O
and CC O O
Irish JJ B-NP O
English JJ I-NP O
backgrounds NNS I-NP O
. . O O

Additional JJ B-NP O
mutations NNS I-NP O
were VBD B-VP O
observed VBN I-VP O
in IN B-PP O
Japanese NNP B-NP O
, , O O
Utah NNP B-NP O
Mormon NNP I-NP O
, , O O
and CC O O
African JJ B-NP O
American JJ I-NP O
patients NNS I-NP O
. . O O

These DT B-NP O
assays NNS I-NP O
should MD B-VP O
facilitate VB I-VP O
screening NN B-NP O
for IN B-PP O
A NN B-NP B-Disease
- HYPH I-NP I-Disease
T NN I-NP I-Disease
heterozygotes NNS I-NP O
in IN B-PP O
the DT B-NP O
populations NNS I-NP O
studied VBN B-VP O
. . O O

. . O O

The DT B-NP O
von NNP I-NP B-Disease
Hippel NNP I-NP I-Disease
- HYPH I-NP I-Disease
Lindau NNP I-NP I-Disease
tumor NN I-NP I-Disease
suppressor NN I-NP O
gene NN I-NP O
is VBZ B-VP O
required VBN I-VP O
for IN B-PP O
cell NN B-NP O
cycle NN I-NP O
exit NN I-NP O
upon IN B-PP O
serum NN B-NP O
withdrawal NN I-NP O
. . O O

The DT B-NP O
inactivation NN I-NP O
of IN B-PP O
the DT B-NP O
von NNP I-NP B-Disease
Hippel NNP I-NP I-Disease
- HYPH I-NP I-Disease
Lindau NNP I-NP I-Disease
( ( O I-Disease
VHL NNP O I-Disease
) ) O I-Disease
tumor NN B-NP I-Disease
suppressor NN I-NP O
gene NN I-NP O
predisposes VBZ B-VP O
affected VBN I-VP O
individuals NNS B-NP O
to TO B-PP O
the DT B-NP O
human JJ I-NP O
VHL NN I-NP B-Disease
cancer NN I-NP I-Disease
syndrome NN I-NP I-Disease
and CC O O
is VBZ B-VP O
associated VBN I-VP O
with IN B-PP O
sporadic JJ B-NP B-Disease
renal JJ I-NP I-Disease
cell NN I-NP I-Disease
carcinomas NNS I-NP I-Disease
( ( O O
RCC NN B-NP B-Disease
) ) O O
and CC O O
brain NN B-NP B-Disease
hemangioblastomas NNS I-NP I-Disease
. . O O

VHL NN B-NP O
- HYPH I-NP O
negative JJ I-NP O
786 CD I-NP O
- HYPH I-NP O
0 CD I-NP O
RCC NN I-NP B-Disease
cells NNS I-NP O
are VBP B-VP O
tumorigenic JJ B-ADJP O
in IN B-PP O
nude JJ B-NP O
mice NNS I-NP O
which WDT B-NP O
is VBZ B-VP O
suppressed VBN I-VP O
by IN B-PP O
the DT B-NP O
reintroduction NN I-NP O
of IN B-PP O
VHL NN B-NP B-Disease
. . O O

Remarkably RB B-ADVP O
, , O O
this DT B-NP O
occurs VBZ B-VP O
without IN B-PP O
affecting VBG B-VP O
the DT B-NP O
growth NN I-NP O
rate NN I-NP O
and CC O O
cell NN B-NP O
cycle NN I-NP O
profile NN I-NP O
of IN B-PP O
these DT B-NP O
cells NNS I-NP O
in IN B-PP O
culture NN B-NP O
. . O O

The DT B-NP O
786 CD I-NP O
- HYPH I-NP O
0 CD I-NP O
cell NN I-NP O
line NN I-NP O
, , O O
like IN B-PP O
many JJ B-NP O
cancer NN I-NP B-Disease
cells NNS I-NP O
, , O O
fails VBZ B-VP O
to TO I-VP O
exit VB I-VP O
the DT B-NP O
cell NN I-NP O
cycle NN I-NP O
upon IN B-PP O
serum NN B-NP O
withdrawal NN I-NP O
. . O O

Here RB B-ADVP O
, , O O
it PRP B-NP O
is VBZ B-VP O
shown VBN I-VP O
that IN B-SBAR O
reintroduction NN B-NP O
of IN B-PP O
the DT B-NP O
wild JJ I-NP O
- HYPH I-NP O
type NN I-NP O
VHL NN I-NP B-Disease
gene NN I-NP O
restores VBZ B-VP O
the DT B-NP O
ability NN I-NP O
of IN B-PP O
VHL NN B-NP O
- HYPH B-NP O
negative JJ I-NP O
RCC NN I-NP B-Disease
cancer NN I-NP I-Disease
cells NNS I-NP O
to TO B-VP O
exit VB I-VP O
the DT B-NP O
cell NN I-NP O
cycle NN I-NP O
and CC O O
enter NN B-NP O
G0 NN I-NP O
/ SYM B-NP O
quiescence NN I-NP O
in IN B-PP O
low JJ B-NP O
serum NN I-NP O
. . O O

Both CC O O
VHL NN B-NP O
- HYPH B-NP O
positive JJ I-NP O
and CC I-NP O
VHL NN I-NP O
- HYPH B-NP O
negative JJ I-NP O
RCC NN I-NP B-Disease
cells NNS I-NP O
exit VBP B-VP O
the DT B-NP O
cell NN I-NP O
cycle NN I-NP O
by IN B-PP O
contact NN B-NP O
inhibition NN I-NP O
. . O O

The DT B-NP O
cyclin NN I-NP O
- HYPH B-NP O
dependent JJ I-NP O
kinase NN I-NP O
inhibitor NN I-NP O
, , O O
p27 NN B-NP O
, , O O
accumulates VBZ B-VP O
upon IN B-PP O
serum NN B-NP O
withdrawal NN I-NP O
, , O O
only RB B-PP O
in IN I-PP O
the DT B-NP O
presence NN I-NP O
of IN B-PP O
VHL NN B-NP B-Disease
, , O O
as IN B-PP O
a DT B-NP O
result NN I-NP O
of IN B-PP O
the DT B-NP O
stabilization NN I-NP O
of IN B-PP O
the DT B-NP O
protein NN I-NP O
. . O O

We PRP B-NP O
propose VBP B-VP O
that IN B-SBAR O
the DT B-NP O
loss NN I-NP O
of IN B-PP O
wild JJ B-NP O
- HYPH I-NP O
type NN I-NP O
VHL NN I-NP B-Disease
gene NN I-NP O
results VBZ B-VP O
in IN B-PP O
a DT B-NP O
specific JJ I-NP O
cellular JJ I-NP O
defect NN I-NP O
in IN B-PP O
serum NN B-NP O
- HYPH B-NP O
dependent JJ I-NP O
growth NN I-NP O
control NN I-NP O
, , O O
which WDT B-NP O
may MD B-VP O
initiate VB I-VP O
tumor NN B-NP B-Disease
formation NN I-NP O
. . O O

This DT B-NP O
is VBZ B-VP O
corrected VBN I-VP O
by IN B-PP O
the DT B-NP O
reintroduction NN I-NP O
of IN B-PP O
wild JJ B-NP O
- HYPH I-NP O
type NN I-NP O
VHL NN I-NP B-Disease
, , O O
implicating VBG B-VP O
VHL NN B-NP B-Disease
as IN B-PP O
the DT B-NP O
first JJ I-NP O
tumor NN I-NP B-Disease
suppressor NN I-NP O
involved VBN B-VP O
in IN B-PP O
the DT B-NP O
regulation NN I-NP O
of IN B-PP O
cell NN B-NP O
cycle NN I-NP O
exit NN I-NP O
, , O O
which WDT B-NP O
is VBZ B-VP O
consistent JJ B-ADJP O
with IN B-PP O
its PRP$ B-NP O
gatekeeper NN I-NP O
function NN I-NP O
in IN B-PP O
the DT B-NP O
kidney NN I-NP O
. . O O

. . O O

Piebaldism NN B-NP B-Disease
with IN B-PP O
deafness NN B-NP B-Disease
: : O O
molecular JJ B-NP O
evidence NN I-NP O
for IN B-PP O
an DT B-NP O
expanded VBN I-NP O
syndrome NN I-NP O
. . O O

In IN B-PP O
a DT B-NP O
South JJ I-NP O
African JJ I-NP O
girl NN I-NP O
of IN B-PP O
Xhosa NNP B-NP O
stock NN I-NP O
with IN B-PP O
severe JJ B-NP O
piebaldism NN I-NP B-Disease
and CC O O
profound JJ B-NP O
congenital JJ I-NP O
sensorineural JJ I-NP B-Disease
deafness NN I-NP I-Disease
we PRP B-NP O
identified VBD B-VP O
a DT B-NP O
novel JJ I-NP O
missense JJ I-NP O
substitution NN I-NP O
at IN B-PP O
a DT B-NP O
highly RB I-NP O
conserved VBN I-NP O
residue NN I-NP O
in IN B-PP O
the DT B-NP O
intracellular JJ I-NP O
kinase NN I-NP O
domain NN I-NP O
of IN B-PP O
the DT B-NP O
KIT NN I-NP O
proto AFX O O
- HYPH O O
oncogene NN B-NP O
, , O O
R796G NN B-NP O
. . O O

Though IN B-SBAR O
auditory JJ B-NP B-Disease
anomalies NNS I-NP I-Disease
have VBP B-VP O
been VBN I-VP O
observed VBN I-VP O
in IN B-PP O
mice NNS B-NP O
with IN B-PP O
dominant JJ B-NP O
white JJ I-NP O
spotting NN I-NP O
( ( O O
W NN B-NP O
) ) O O
due IN B-PP O
to TO B-PP O
KIT NN B-NP O
mutations NNS I-NP O
, , O O
deafness NN B-NP B-Disease
is VBZ B-VP O
not RB O O
typical JJ B-ADJP O
in IN B-PP O
human JJ B-NP O
piebaldism NN I-NP B-Disease
. . O O

Thus RB B-ADVP O
, , O O
the DT B-NP O
occurrence NN I-NP O
of IN B-PP O
sensorineural JJ B-NP B-Disease
deafness NN I-NP I-Disease
in IN B-PP O
this DT B-NP O
patient NN I-NP O
extends VBZ B-VP O
considerably RB B-ADVP O
the DT B-NP O
phenotypic JJ I-NP O
range NN I-NP O
of IN B-PP O
piebaldism NN B-NP B-Disease
due JJ B-ADJP O
to TO B-PP O
KIT NN B-NP O
gene NN I-NP O
mutation NN I-NP O
in IN B-PP O
humans NNS B-NP O
and CC O O
tightens VBZ B-VP O
the DT B-NP O
clinical JJ I-NP O
similarity NN I-NP O
between IN B-PP O
piebaldism NN B-NP B-Disease
and CC O O
the DT B-NP O
various JJ I-NP O
forms NNS I-NP O
of IN B-PP O
Waardenburg NNP B-NP B-Disease
syndrome NN I-NP I-Disease
. . O O

. . O O

Cycloheximide NN B-NP O
facilitates VBZ B-VP O
the DT B-NP O
identification NN I-NP O
of IN B-PP O
aberrant JJ B-NP O
transcripts NNS I-NP O
resulting VBG B-VP O
from IN B-PP O
a DT B-NP O
novel JJ I-NP O
splice NN I-NP O
- HYPH B-NP O
site NN I-NP O
mutation NN I-NP O
in IN B-PP O
COL17A1 NN B-NP O
in IN B-PP O
a DT B-NP O
patient NN I-NP O
with IN B-PP O
generalized VBN B-NP O
atrophic JJ I-NP B-Disease
benign JJ I-NP I-Disease
epidermolysis NN I-NP I-Disease
bullosa NN I-NP I-Disease
. . O O

Patients NNS B-NP O
with IN B-PP O
generalized VBN B-NP O
atrophic JJ I-NP B-Disease
benign JJ I-NP I-Disease
epidermolysis NN I-NP I-Disease
bullosa NN I-NP I-Disease
often RB B-ADVP O
show VBP B-VP O
decreased VBN B-NP O
expression NN I-NP O
of IN B-PP O
type NN B-NP O
XVII CD I-NP O
collagen NN I-NP O
, , O O
a DT B-NP O
transmembrane NN I-NP O
hemidesmosomal JJ I-NP O
protein NN I-NP O
encoded VBN B-VP O
by IN B-PP O
COL17A1 NN B-NP O
. . O O

This DT B-NP O
report NN I-NP O
documents VBZ B-VP O
a DT B-NP O
novel JJ I-NP O
splice NN I-NP O
- HYPH B-NP O
site NN I-NP O
mutation NN I-NP O
in IN B-PP O
COL17A1 NN B-NP O
in IN B-PP O
a DT B-NP O
patient NN I-NP O
with IN B-PP O
generalized VBN B-NP O
atrophic JJ I-NP B-Disease
benign JJ I-NP I-Disease
epidermolysis NN I-NP I-Disease
bullosa NN I-NP I-Disease
, , O O
and CC O O
applies VBZ B-VP O
a DT B-NP O
new JJ I-NP O
methodology NN I-NP O
to TO B-VP O
define VB I-VP O
and CC I-VP O
characterize VB I-VP O
the DT B-NP O
resulting VBG I-NP O
mRNA NN I-NP O
splice NN I-NP O
variants NNS I-NP O
. . O O

Mutational JJ B-NP O
analysis NN I-NP O
of IN B-PP O
COL17A1 NN B-NP O
identified VBD B-VP O
a DT B-NP O
maternally RB I-NP O
inherited VBN I-NP O
G NN I-NP O
- HYPH B-ADVP O
to TO B-PP O
- HYPH B-NP O
T NN I-NP O
transversion NN I-NP O
at IN B-PP O
the DT B-NP O
- HYPH I-NP O
1 CD I-NP O
position NN I-NP O
of IN B-PP O
exon NN B-NP O
32 CD I-NP O
. . O O

This DT B-NP O
acceptor NN I-NP O
splice NN I-NP O
- HYPH B-NP O
site NN I-NP O
mutation NN I-NP O
led VBD B-VP O
to TO B-PP O
the DT B-NP O
formation NN I-NP O
of IN B-PP O
aberrant JJ B-NP O
transcripts NNS I-NP O
present VBP B-VP O
at IN B-PP O
extremely RB B-NP O
low JJ I-NP O
levels NNS I-NP O
. . O O

Based VBN B-PP O
on IN B-PP O
our PRP$ B-NP O
recent JJ I-NP O
finding NN I-NP O
that IN B-SBAR O
cycloheximide NN B-NP O
stabilized VBD B-VP O
mutant JJ B-NP O
COL17A1 NN I-NP O
transcripts NNS I-NP O
in IN B-PP O
keratinocytes NNS B-NP O
homozygous JJ B-ADJP O
for IN B-PP O
a DT B-NP O
frameshift NN I-NP O
mutation NN I-NP O
, , O O
the DT B-NP O
effects NNS I-NP O
of IN B-PP O
the DT B-NP O
splice NN I-NP O
- HYPH B-NP O
site NN I-NP O
mutation NN I-NP O
on IN B-PP O
splicing NN B-NP O
of IN B-PP O
COL17A1 NN B-NP O
transcripts NNS I-NP O
were VBD B-VP O
determined VBN I-VP O
using VBG B-VP O
reverse JJ B-NP O
transcriptase NN I-NP O
polymerase NN I-NP O
chain NN I-NP O
reaction NN I-NP O
of IN B-PP O
total JJ B-NP O
RNA NN I-NP O
from IN B-PP O
keratinocytes NNS B-NP O
incubated VBN B-VP O
for IN B-PP O
2 CD B-NP O
. . O O

5 CD B-NP O
h NN I-NP O
in IN B-PP O
the DT B-NP O
presence NN I-NP O
or CC I-NP O
absence NN I-NP O
of IN B-PP O
10 CD B-NP O
microg NN I-NP O
cycloheximide NN I-NP O
per IN B-PP O
ml NN B-NP O
. . O O

Using VBG B-VP O
this DT B-NP O
approach NN I-NP O
, , O O
an DT B-NP O
abnormally RB I-NP O
spliced VBN I-NP O
transcript NN I-NP O
was VBD B-VP O
identified VBN I-VP O
that WDT B-NP O
contains VBZ B-VP O
an DT B-NP O
extra JJ I-NP O
264 CD I-NP O
bases NNS I-NP O
upstream JJ B-ADJP O
from IN B-PP O
exon NN B-NP O
32 CD I-NP O
, , O O
resulting VBG B-VP O
in IN B-PP O
a DT B-NP O
premature JJ I-NP O
termination NN I-NP O
codon NN I-NP O
27 CD I-NP O
bp NN I-NP O
downstream RB B-ADVP O
from IN B-PP O
the DT B-NP O
cryptic JJ I-NP O
splice NN I-NP O
site NN I-NP O
. . O O

Three CD B-NP O
other JJ I-NP O
splice NN I-NP O
variants NNS I-NP O
, , O O
including VBG B-PP O
one CD B-NP O
derived VBN B-VP O
from IN B-PP O
the DT B-NP O
skipping NN I-NP O
of IN B-PP O
exon NN B-NP O
32 CD I-NP O
, , O O
were VBD B-VP O
also RB I-VP O
identified VBN I-VP O
. . O O

These DT B-NP O
results NNS I-NP O
indicate VBP B-VP O
the DT B-NP O
usefulness NN I-NP O
of IN B-PP O
cycloheximide NN B-NP O
treatment NN I-NP O
in IN B-PP O
evaluating VBG B-VP O
the DT B-NP O
abnormal JJ I-NP O
processing NN I-NP O
of IN B-PP O
mRNA NN B-NP O
due JJ B-ADJP O
to TO B-PP O
splice NN B-NP O
- HYPH I-NP O
site NN I-NP O
mutations NNS I-NP O
, , O O
because IN B-SBAR O
( ( B-LST O
i LS I-LST O
) ) O O
aberrant JJ B-NP O
splicing NN I-NP O
often RB B-ADVP O
generates VBZ B-VP O
a DT B-NP O
premature JJ I-NP O
termination NN I-NP O
codon NN I-NP O
, , O O
( ( B-LST O
ii LS I-LST O
) ) O O
transcripts NNS B-NP O
with IN B-PP O
premature JJ B-NP O
termination NN I-NP O
codons NNS I-NP O
can MD B-VP O
occur VB I-VP O
at IN B-PP O
low JJ B-NP O
or CC I-NP O
undetectable JJ I-NP O
levels NNS I-NP O
due JJ B-ADJP O
to TO B-PP O
nonsense NN B-NP O
- HYPH O O
mediated VBN B-NP O
mRNA NN I-NP O
decay NN I-NP O
, , O O
and CC O O
( ( B-LST O
iii LS I-LST O
) ) O O
the DT B-NP O
levels NNS I-NP O
of IN B-PP O
these DT B-NP O
transcripts NNS I-NP O
can MD B-VP O
be VB I-VP O
increased VBN I-VP O
by IN B-PP O
cycloheximide NN B-NP O
. . O O

A DT B-NP O
deletion NN I-NP O
mutation NN I-NP O
in IN B-PP O
COL17A1 NN B-NP O
in IN B-PP O
five CD B-NP O
Austrian JJ I-NP O
families NNS I-NP O
with IN B-PP O
generalized VBN B-NP O
atrophic JJ I-NP B-Disease
benign JJ I-NP I-Disease
epidermolysis NN I-NP I-Disease
bullosa NN I-NP I-Disease
represents VBZ B-VP O
propagation NN B-NP O
of IN B-PP O
an DT B-NP O
ancestral JJ I-NP O
allele NN I-NP O
. . O O

Patients NNS B-NP O
with IN B-PP O
generalized VBN B-NP O
atrophic JJ I-NP B-Disease
benign JJ I-NP I-Disease
epidermolysis NN I-NP I-Disease
bullosa NN I-NP I-Disease
, , O O
a DT B-NP O
usually RB I-NP O
nonlethal JJ I-NP O
form NN I-NP O
of IN B-PP O
junctional JJ B-NP B-Disease
epidermolysis NN I-NP I-Disease
bullosa NN I-NP I-Disease
, , O O
have VBP B-VP O
generalized VBN I-VP O
blistering NN B-NP B-Disease
, , O O
nail NN B-NP B-Disease
dystrophy NN I-NP I-Disease
, , O O
patchy NN B-NP B-Disease
alopecia NN I-NP I-Disease
, , O O
and CC O O
dental JJ B-NP B-Disease
abnormalities NNS I-NP I-Disease
. . O O

Skin NN B-NP B-Disease
fragility NN I-NP I-Disease
in IN B-PP O
most JJS B-NP O
cases NNS I-NP O
is VBZ B-VP O
due IN B-PP O
to TO B-PP O
mutations NNS B-NP O
in IN B-PP O
the DT B-NP O
gene NN I-NP O
encoding VBG B-VP O
type NN B-NP O
XVII NN I-NP O
collagen NN I-NP O
( ( O O
COL17A1 NN B-NP O
) ) O O
. . O O

Recently RB B-ADVP O
, , O O
we PRP B-NP O
reported VBD B-VP O
five CD B-NP O
Austrian JJ I-NP O
families NNS I-NP O
with IN B-PP O
generalized VBN B-NP O
atrophic JJ I-NP B-Disease
benign JJ I-NP I-Disease
epidermolysis NN I-NP I-Disease
bullosa NN I-NP I-Disease
who WP B-NP O
share VBP B-VP O
the DT B-NP O
same JJ I-NP O
COL17A1 NN I-NP O
mutation NN I-NP O
. . O O

Affected VBN B-NP O
individuals NNS I-NP O
in IN B-PP O
three CD B-NP O
families NNS I-NP O
are VBP B-VP O
homozygous JJ B-ADJP O
for IN B-PP O
4003delTC NN B-NP O
, , O O
whereas IN O O
those DT B-NP O
in IN B-PP O
two CD B-NP O
others NNS I-NP O
are VBP B-VP O
compound NN B-NP O
heterozygotes NNS I-NP O
. . O O

To TO B-VP O
determine VB I-VP O
if IN B-SBAR O
the DT B-NP O
occurrence NN I-NP O
of IN B-PP O
4003delTC NN B-NP O
in IN B-PP O
these DT B-NP O
unrelated JJ I-NP O
families NNS I-NP O
signifies VBZ B-VP O
propagation NN B-NP O
of IN B-PP O
an DT B-NP O
ancestral JJ I-NP O
allele NN I-NP O
or CC O O
a DT B-NP O
mutational JJ I-NP O
hot JJ I-NP O
spot NN I-NP O
, , O O
haplotypes NNS B-NP O
were VBD B-VP O
determined VBN I-VP O
for IN B-PP O
polymorphisms NNS B-NP O
both CC B-PP O
within IN B-PP O
and CC O O
flanking VBG B-VP O
COL17A1 NN B-NP O
. . O O

Five CD B-NP O
intragenic JJ I-NP O
polymorphisms NNS I-NP O
were VBD B-VP O
chosen VBN I-VP O
based VBN B-PP O
on IN B-PP O
their PRP$ B-NP O
informativeness NN I-NP O
. . O O

One CD B-NP O
of IN B-PP O
these DT B-NP O
, , O O
not RB O O
previously RB B-VP O
reported VBN I-VP O
, , O O
was VBD B-VP O
2988 CD B-NP O
A NN I-NP O
or CC I-NP O
C NN I-NP O
that WDT B-NP O
introduces VBZ B-VP O
a DT B-NP O
new JJ I-NP O
restriction NN I-NP O
site NN I-NP O
for IN B-PP O
Eco0109 NN B-NP O
I CD I-NP O
. . O O

All PDT B-NP O
the DT I-NP O
4003delTC NN I-NP O
alleles NNS I-NP O
showed VBD B-VP O
the DT B-NP O
same JJ I-NP O
haplotype NN I-NP O
for IN B-PP O
these DT B-NP O
five CD I-NP O
polymorphic JJ I-NP O
markers NNS I-NP O
. . O O

Fourteen CD B-NP O
microsatellite NN I-NP O
polymorphisms NNS I-NP O
were VBD B-VP O
selected VBN I-VP O
based VBN B-PP O
on IN B-PP O
their PRP$ B-NP O
high JJ I-NP O
heterozygosity NN I-NP O
and CC O O
their PRP$ B-NP O
location NN I-NP O
within IN B-PP O
10q23 CD B-NP O
- HYPH I-NP O
q25 NN I-NP O
near IN B-PP O
COL17A1 NN B-NP O
. . O O

Three CD B-NP O
families NNS I-NP O
shared VBD B-VP O
microsatellite NN B-NP O
polymorphisms NNS I-NP O
covering VBG B-VP O
at IN B-PP O
most JJS B-NP O
19 CD I-NP O
cM NN I-NP O
, , O O
whereas IN O O
the DT B-NP O
others NNS I-NP O
shared VBD B-VP O
smaller JJR B-NP O
regions NNS I-NP O
consistent JJ B-ADJP O
with IN B-PP O
cross AFX B-NP O
- HYPH I-NP O
over IN B-PP O
events NNS B-NP O
during IN B-PP O
passage NN B-NP O
of IN B-PP O
this DT B-NP O
mutation NN I-NP O
through IN B-PP O
several JJ B-NP O
generations NNS I-NP O
. . O O

These DT B-NP O
results NNS I-NP O
indicate VBP B-VP O
that IN B-SBAR O
4003delTC NN B-NP O
occurs VBZ B-VP O
on IN B-PP O
a DT B-NP O
single JJ I-NP O
ancestral JJ I-NP O
allele NN I-NP O
. . O O

. . O O

The DT B-NP O
haptoglobin NN I-NP O
- HYPH I-NP O
gene NN I-NP O
deletion NN I-NP O
responsible JJ B-ADJP O
for IN B-PP O
anhaptoglobinemia NN B-NP B-Disease
. . O O

We PRP B-NP O
have VBP B-VP O
found VBN I-VP O
an DT B-NP O
allelic JJ I-NP O
deletion NN I-NP O
of IN B-PP O
the DT B-NP O
haptoglobin NN I-NP O
( ( O O
Hp NN B-NP O
) ) O O
gene NN B-NP O
from IN B-PP O
an DT B-NP O
individual NN I-NP O
with IN B-PP O
anhaptoglobinemia NN B-NP B-Disease
. . O O

The DT B-NP O
Hp NN I-NP O
gene NN I-NP O
cluster NN I-NP O
consists VBZ B-VP O
of IN B-PP O
coding VBG B-VP O
regions NNS B-NP O
of IN B-PP O
the DT B-NP O
alpha NN I-NP O
chain NN I-NP O
and CC O O
beta NN B-NP O
chain NN I-NP O
of IN B-PP O
the DT B-NP O
haptoglobin NN I-NP O
gene NN I-NP O
( ( O O
Hp NN B-NP O
) ) O O
and CC O O
of IN B-PP O
the DT B-NP O
alpha NN I-NP O
chain NN I-NP O
and CC O O
beta NN B-NP O
chain NN I-NP O
of IN B-PP O
the DT B-NP O
haptoglobin NN I-NP O
- HYPH B-NP O
related VBN I-NP O
gene NN B-NP O
( ( O O
Hpr NN B-NP O
) ) O O
, , O O
in IN B-PP O
tandem NN B-NP O
from IN B-PP O
the DT B-NP O
5 CD I-NP O
side NN I-NP O
. . O O

Southern NN B-NP O
blot NN I-NP O
and CC I-NP O
PCR NN I-NP O
analyses NNS I-NP O
have VBP B-VP O
indicated VBN I-VP O
that IN B-SBAR O
the DT B-NP O
individual NN I-NP O
with IN B-PP O
anhaptoglobinemia NN B-NP B-Disease
was VBD B-VP O
homozygous JJ B-ADJP O
for IN B-PP O
the DT B-NP O
gene NN I-NP O
deletion NN I-NP O
and CC O O
that IN B-SBAR O
the DT B-NP O
gene NN I-NP O
deletion NN I-NP O
was VBD B-VP O
included VBN I-VP O
at IN B-ADVP O
least JJS I-ADVP O
from IN B-PP O
the DT B-NP O
promoter NN I-NP O
region NN I-NP O
of IN B-PP O
Hp NN B-NP O
to TO B-PP O
Hpr NN B-NP O
alpha NN I-NP O
but CC B-PP O
not RB B-PP O
to TO I-PP O
Hpr NN B-NP O
beta NN I-NP O
( ( O O
Hpdel NN B-NP O
) ) O O
. . O O

In IN B-PP O
addition NN B-NP O
, , O O
we PRP B-NP O
found VBD B-VP O
seven CD B-NP O
individuals NNS I-NP O
with IN B-PP O
hypohaptoglobinemia NN B-NP B-Disease
in IN B-PP O
three CD B-NP O
families NNS I-NP O
, , O O
and CC O O
the DT B-NP O
genotypes NNS I-NP O
of IN B-PP O
six CD B-NP O
of IN B-PP O
the DT B-NP O
seven CD I-NP O
individuals NNS I-NP O
were VBD B-VP O
found VBN I-VP O
to TO I-VP O
be VB I-VP O
Hp2 NN B-NP O
/ SYM B-NP O
Hpdel NN I-NP O
. . O O

The DT B-NP O
phenotypes NNS I-NP O
and CC I-NP O
genotypes NNS I-NP O
in IN B-PP O
one CD B-NP O
of IN B-PP O
these DT B-NP O
three CD I-NP O
families NNS I-NP O
showed VBD B-VP O
the DT B-NP O
father NN I-NP O
to TO B-VP O
be VB I-VP O
hypohaptoglobinemic JJ B-ADJP B-Disease
( ( O O
Hp2 NN B-NP O
) ) O O
and CC O O
Hp2 NN B-NP O
/ SYM B-NP O
Hpdel NN I-NP O
, , O O
the DT B-NP O
mother NN I-NP O
to TO B-VP O
be VB I-VP O
Hp2 NN B-NP O
- HYPH B-NP O
1 CD I-NP O
and CC I-NP O
Hp1 NN I-NP O
/ SYM I-NP O
Hp2 NN I-NP O
, , O O
one CD B-NP O
of IN B-PP O
the DT B-NP O
two CD I-NP O
children NNS I-NP O
to TO B-VP O
be VB I-VP O
hypohaptoglobinemic JJ B-ADJP B-Disease
( ( O O
Hp2 NN B-NP O
) ) O O
and CC O O
Hp2 NN B-NP O
/ SYM O O
Hpdel NN B-NP O
, , O O
and CC O O
the DT B-NP O
other JJ I-NP O
child NN I-NP O
to TO B-VP O
be VB I-VP O
Hp1 NN B-NP O
and CC I-NP O
Hp1 NN I-NP O
/ SYM B-NP O
Hpdel NN I-NP O
, , O O
showing VBG B-VP O
an DT B-NP O
anomalous JJ I-NP O
inheritance NN I-NP O
of IN B-PP O
Hp NN B-NP O
phenotypes NNS I-NP O
in IN B-PP O
the DT B-NP O
child NN I-NP O
with IN B-PP O
Hp1 NN B-NP O
. . O O

The DT B-NP O
Hp2 NN I-NP O
/ SYM B-VP O
Hpdel NN B-NP O
individuals NNS I-NP O
had VBD B-VP O
an DT B-NP O
extremely RB I-NP O
low JJ I-NP O
level NN I-NP O
of IN B-PP O
Hp NN B-NP O
( ( O O
mean NN B-NP O
+ SYM O O
/ SYM O O
- SYM O O
SD NN B-NP O
= SYM B-VP O
0 CD B-NP O
. SYM I-NP O

049 CD I-NP O
+ SYM O O
/ SYM O O
- SYM B-NP O
0 CD B-NP O
. SYM I-NP O

043 CD I-NP O
mg NN I-NP O
/ SYM B-NP O
ml NN I-NP O
; : O O
n NN B-NP O
= JJ B-VP O
6 CD B-NP O
) ) O O
, , O O
compared VBN B-PP O
with IN B-PP O
the DT B-NP O
level NN I-NP O
( ( O O
1 CD B-NP O
. . O O

64 CD B-NP O
+ SYM O O
/ SYM B-NP O
- SYM B-NP O
1 CD I-NP O
. SYM I-NP O

07 CD I-NP O
mg NN I-NP O
/ SYM B-NP O
ml NN I-NP O
) ) O O
obtained VBN B-VP O
from IN B-PP O
52 CD B-NP O
healthy JJ I-NP O
volunteers NNS I-NP O
having VBG B-VP O
phenotype NN B-NP O
Hp2 NN I-NP O
, , O O
whereas IN O O
the DT B-NP O
serum NN I-NP O
Hp NN I-NP O
level NN I-NP O
of IN B-PP O
an DT B-NP O
individual NN I-NP O
with IN B-PP O
Hp1 NN B-NP O
/ SYM B-NP O
Hpdel NN I-NP O
was VBD B-VP O
0 CD B-NP O
. . O O

50 CD B-NP O
mg NN I-NP O
/ SYM B-NP O
ml NN I-NP O
, , O O
which WDT B-NP O
was VBD B-VP O
approximately RB B-NP O
half PDT I-NP O
the DT I-NP O
level NN I-NP O
of IN B-PP O
Hp NN B-NP O
in IN B-PP O
control NN B-NP O
sera NNS I-NP O
from IN B-PP O
the DT B-NP O
Hp1 NN I-NP O
phenotype NN I-NP O
( ( O O
1 CD B-NP O
. . O O

26 CD B-NP O
+ SYM O O
/ SYM O O
- SYM B-NP O
0 CD B-NP O
. SYM I-NP O

33 CD I-NP O
mg NN I-NP O
/ SYM B-NP O
ml NN I-NP O
; : O O
n NN B-NP O
= SYM B-VP O
9 CD B-NP O
) ) O O
, , O O
showing VBG B-VP O
a DT B-NP O
gene NN I-NP O
- HYPH B-NP O
dosage NN I-NP O
effect NN I-NP O
. . O O

The DT B-NP O
other JJ I-NP O
allele NN I-NP O
( ( O O
Hp2 NN B-NP O
) ) O O
of IN B-PP O
individuals NNS B-NP O
with IN B-PP O
Hp2 NN B-NP O
/ SYM B-NP O
Hpdel NN I-NP O
was VBD B-VP O
found VBN I-VP O
to TO I-VP O
have VB I-VP O
, , O O
in IN B-PP O
all DT B-NP O
exons NNS I-NP O
, , O O
no DT B-NP O
mutation NN I-NP O
, , O O
by IN B-PP O
DNA NN B-NP O
sequencing NN I-NP O
. . O O

On IN B-PP O
the DT B-NP O
basis NN I-NP O
of IN B-PP O
the DT B-NP O
present JJ I-NP O
study NN I-NP O
, , O O
the DT B-NP O
mechanism NN I-NP O
of IN B-PP O
anhaptoglobinemia NN B-NP B-Disease
and CC O O
the DT B-NP O
mechanism NN I-NP O
of IN B-PP O
anomalous JJ B-NP O
inheritance NN I-NP O
of IN B-PP O
Hp NN B-NP O
phenotypes NNS I-NP O
were VBD B-VP O
well RB I-VP O
explained VBN I-VP O
. . O O

However RB B-ADVP O
, , O O
the DT B-NP O
mechanism NN I-NP O
of IN B-PP O
hypohaptoglobinemia NN B-NP B-Disease
remains VBZ B-VP O
unknown JJ B-ADJP O
ATM NN B-NP O
mutations NNS I-NP O
and CC I-NP O
phenotypes NNS I-NP O
in IN B-PP O
ataxia NN B-NP B-Disease
- HYPH B-NP I-Disease
telangiectasia NN I-NP I-Disease
families NNS I-NP O
in IN B-PP O
the DT B-NP O
British JJ I-NP O
Isles NNPS I-NP O
: : O O
expression NN B-NP O
of IN B-PP O
mutant JJ B-NP O
ATM NN I-NP O
and CC O O
the DT B-NP O
risk NN I-NP O
of IN B-PP O
leukemia NN B-NP B-Disease
, , O O
lymphoma NN B-NP B-Disease
, , O O
and CC O O
breast NN B-NP B-Disease
cancer NN I-NP I-Disease
. . O O

We PRP B-NP O
report VBP B-VP O
the DT B-NP O
spectrum NN I-NP O
of IN B-PP O
59 CD B-NP O
ATM NN I-NP O
mutations NNS I-NP O
observed VBN B-VP O
in IN B-PP O
ataxia NN B-NP B-Disease
- HYPH B-NP I-Disease
telangiectasia NN I-NP I-Disease
( ( O O
A NN B-NP B-Disease
- HYPH I-NP I-Disease
T NN I-NP I-Disease
) ) O O
patients NNS B-NP O
in IN B-PP O
the DT B-NP O
British JJ I-NP O
Isles NNPS I-NP O
. . O O

Of IN B-PP O
51 CD B-NP O
ATM NN I-NP O
mutations NNS I-NP O
identified VBN B-VP O
in IN B-PP O
families NNS B-NP O
native JJ B-ADJP O
to TO B-PP O
the DT B-NP O
British JJ I-NP O
Isles NNPS I-NP O
, , O O
11 CD B-NP O
were VBD B-VP O
founder NN B-NP O
mutations NNS I-NP O
, , O O
and CC O O
2 CD B-NP O
of IN B-PP O
these DT B-NP O
11 CD I-NP O
conferred VBD B-VP O
a DT B-NP O
milder JJR I-NP O
clinical JJ I-NP O
phenotype NN I-NP O
with IN B-PP O
respect NN B-NP O
to TO B-PP O
both CC O O
cerebellar JJ B-NP B-Disease
degeneration NN I-NP I-Disease
and CC O O
cellular JJ B-NP O
features NNS I-NP O
. . O O

We PRP B-NP O
report VBP B-VP O
, , O O
in IN B-PP O
two CD B-NP O
A NN I-NP B-Disease
- HYPH I-NP I-Disease
T NN I-NP I-Disease
families NNS I-NP O
, , O O
an DT B-NP O
ATM NN I-NP O
mutation NN I-NP O
( ( O O
7271T NN B-NP O
- SYM O O
- HYPH B-NP O
> SYM I-NP O
G NN I-NP O
) ) O O
that WDT B-NP O
may MD B-VP O
be VB I-VP O
associated VBN I-VP O
with IN B-PP O
an DT B-NP O
increased VBN I-NP O
risk NN I-NP O
of IN B-PP O
breast NN B-NP B-Disease
cancer NN I-NP I-Disease
in IN B-PP O
both CC B-NP O
homozygotes NNS I-NP O
and CC I-NP O
heterozygotes NNS I-NP O
( ( O O
relative JJ B-NP O
risk NN I-NP O
12 CD I-NP O
. . I-NP O

7 CD I-NP O
; : O O
P NN B-NP O
= JJ I-NP O
. . I-NP O

0025 CD I-NP O
) ) O O
, , O O
although IN B-SBAR O
there EX B-NP O
is VBZ B-VP O
a DT B-NP O
less RBR I-NP O
severe JJ I-NP O
A NN I-NP B-Disease
- HYPH I-NP I-Disease
T NN I-NP I-Disease
phenotype NN I-NP O
in IN B-PP O
terms NNS B-NP O
of IN B-PP O
the DT B-NP O
degree NN I-NP O
of IN B-PP O
cerebellar JJ B-NP B-Disease
degeneration NN I-NP I-Disease
. . O O

This DT B-NP O
mutation NN I-NP O
( ( O O
7271T NN B-NP O
- SYM O O
- HYPH B-NP O
> SYM I-NP O
G NN I-NP O
) ) O O
also RB B-ADVP O
allows VBZ B-VP O
expression NN B-NP O
of IN B-PP O
full JJ B-NP O
- HYPH I-NP O
length NN I-NP O
ATM NN I-NP O
protein NN I-NP O
at IN B-PP O
a DT B-NP O
level NN I-NP O
comparable JJ B-ADJP O
with IN B-PP O
that DT B-NP O
in IN B-PP O
unaffected JJ B-NP O
individuals NNS I-NP O
. . O O

In IN B-PP O
addition NN B-NP O
, , O O
we PRP B-NP O
have VBP B-VP O
studied VBN I-VP O
18 CD B-NP O
A NN I-NP B-Disease
- HYPH B-NP I-Disease
T NN I-NP I-Disease
patients NNS I-NP O
, , O O
in IN B-PP O
15 CD B-NP O
families NNS I-NP O
, , O O
who WP B-NP O
developed VBD B-VP O
leukemia NN B-NP B-Disease
, , O O
lymphoma NN B-NP B-Disease
, , O O
preleukemic JJ B-NP O
T NN I-NP O
- HYPH B-NP O
cell NN I-NP O
proliferation NN I-NP O
, , O O
or CC O O
Hodgkin NN B-NP B-Disease
lymphoma NN I-NP I-Disease
, , O O
mostly RB B-ADVP O
in IN B-PP O
childhood NN B-NP O
. . O O

A DT B-NP O
wide JJ I-NP O
variety NN I-NP O
of IN B-PP O
ATM NN B-NP O
mutation NN I-NP O
types NNS I-NP O
, , O O
including VBG B-PP O
missense JJ B-NP O
mutations NNS I-NP O
and CC B-PP O
in IN B-PP O
- HYPH B-NP O
frame NN I-NP O
deletions NNS I-NP O
, , O O
were VBD B-VP O
seen VBN I-VP O
in IN B-PP O
these DT B-NP O
patients NNS I-NP O
. . O O

We PRP B-NP O
also RB B-ADVP O
show VBP B-VP O
that IN B-SBAR O
25 CD B-NP O
% NN I-NP O
of IN B-PP O
all DT B-NP O
A NN I-NP B-Disease
- HYPH I-NP I-Disease
T NN I-NP I-Disease
patients NNS I-NP O
carried VBD B-VP O
in IN B-PP O
- HYPH B-NP O
frame NN I-NP O
deletions NNS I-NP O
or CC O O
missense JJ B-NP O
mutations NNS I-NP O
, , O O
many JJ B-NP O
of IN B-PP O
which WDT B-NP O
were VBD B-VP O
also RB I-VP O
associated VBN I-VP O
with IN B-PP O
expression NN B-NP O
of IN B-PP O
mutant JJ B-NP O
ATM NN I-NP O
protein NN I-NP O
. . O O

The DT B-NP O
DMPK NN I-NP O
gene NN I-NP O
of IN B-PP O
severely RB B-NP O
affected VBN I-NP O
myotonic JJ I-NP B-Disease
dystrophy NN I-NP I-Disease
patients NNS I-NP O
is VBZ B-VP O
hypermethylated VBN I-VP O
proximal JJ B-ADJP O
to TO B-PP O
the DT B-NP O
largely RB I-NP O
expanded VBN I-NP O
CTG NN I-NP O
repeat NN I-NP O
. . O O

Using VBG B-VP O
methylation NN B-NP O
- HYPH B-NP O
sensitive JJ I-NP O
restriction NN I-NP O
enzymes NNS I-NP O
, , O O
we PRP B-NP O
characterized VBD B-VP O
the DT B-NP O
methylation NN I-NP O
pattern NN I-NP O
on IN B-PP O
the DT B-NP O
5 CD I-NP O
side NN I-NP O
of IN B-PP O
the DT B-NP O
CTG NN I-NP O
repeat NN I-NP O
in IN B-PP O
the DT B-NP O
DMPK NN I-NP O
gene NN I-NP O
of IN B-PP O
normal JJ B-NP O
individuals NNS I-NP O
and CC B-PP O
of IN B-PP O
patients NNS B-NP O
affected VBN B-VP O
with IN B-PP O
myotonic JJ B-NP B-Disease
dystrophy NN I-NP I-Disease
, , O O
showing VBG B-VP O
expansions NNS B-NP O
of IN B-PP O
the DT B-NP O
repetitive JJ I-NP O
sequence NN I-NP O
. . O O

The DT B-NP O
gene NN I-NP O
segment NN I-NP O
analyzed VBN B-VP O
corresponds VBZ B-VP O
to TO B-PP O
the DT B-NP O
genomic JJ I-NP O
SacI NN I-NP O
- HYPH B-NP O
HindIII NN I-NP O
fragment NN I-NP O
carrying VBG B-VP O
exons NNS B-NP O
11 CD B-NP O
- : O O
15 CD B-NP O
. . O O

There EX B-NP O
is VBZ B-VP O
constitutive JJ B-NP O
methylation NN I-NP O
in IN B-PP O
intron NN B-NP O
12 CD I-NP O
at IN B-PP O
restriction NN B-NP O
sites NNS I-NP O
of IN B-PP O
SacII NN B-NP O
and CC I-NP O
HhaI NN I-NP O
, , O O
localized VBD B-VP O
1 CD B-NP O
, , I-NP O
159 CD I-NP O
- HYPH B-NP O
1 CD I-NP O
, , I-NP O
232 CD I-NP O
bp NN I-NP O
upstream RB B-ADVP O
of IN B-PP O
the DT B-NP O
CTG NN I-NP O
repeat NN I-NP O
, , O O
whereas IN O O
most JJS O O
, , O O
if IN B-SBAR O
not RB B-NP O
all DT I-NP O
, , O O
of IN B-PP O
the DT B-NP O
other JJ I-NP O
sites NNS I-NP O
of IN B-PP O
SacII NN B-NP O
, , O O
HhaI NN B-NP O
, , O O
and CC O O
HpaII NN B-NP O
in IN B-PP O
this DT B-NP O
region NN I-NP O
are VBP B-VP O
unmethylated VBN I-VP O
, , O O
in IN B-PP O
normal JJ B-NP O
individuals NNS I-NP O
and CC O O
most JJS B-NP O
of IN B-PP O
the DT B-NP O
patients NNS I-NP O
. . O O

In IN B-PP O
a DT B-NP O
number NN I-NP O
of IN B-PP O
young JJ O O
and CC O O
severely RB B-VP O
affected VBN I-VP O
patients NNS B-NP O
, , O O
however RB B-ADVP O
, , O O
complete JJ B-NP O
methylation NN I-NP O
of IN B-PP O
these DT B-NP O
restriction NN I-NP O
sites NNS I-NP O
was VBD B-VP O
found VBN I-VP O
in IN B-PP O
the DT B-NP O
mutated VBN I-NP O
allele NN I-NP O
. . O O

In IN B-PP O
most JJS B-NP O
of IN B-PP O
these DT B-NP O
patients NNS I-NP O
, , O O
the DT B-NP O
onset NN I-NP O
of IN B-PP O
the DT B-NP O
disease NN I-NP O
was VBD B-VP O
congenital JJ B-ADJP O
. . O O

Preliminary JJ B-NP O
in FW I-NP O
vivo FW I-NP O
footprinting NN I-NP O
data NNS I-NP O
gave VBD B-VP O
evidence NN B-NP O
for IN B-PP O
protein NN B-NP O
- HYPH B-NP O
DNA NN I-NP O
contact NN I-NP O
in IN B-PP O
normal JJ B-NP O
genes NNS I-NP O
at IN B-PP O
an DT B-NP O
Sp1 NN I-NP O
consensus NN I-NP O
binding NN I-NP O
site NN I-NP O
upstream JJ B-ADJP O
of IN B-PP O
the DT B-NP O
CTG NN I-NP O
repeat NN I-NP O
and CC B-PP O
for IN B-PP O
a DT B-NP O
significant JJ I-NP O
reduction NN I-NP O
of IN B-PP O
this DT B-NP O
interaction NN I-NP O
in IN B-PP O
cells NNS B-NP O
with IN B-PP O
a DT B-NP O
hypermethylated VBN I-NP O
DMPK NN I-NP O
gene NN I-NP O
. . O O

. . O O

The DT B-NP O
hemochromatosis NN I-NP B-Disease
gene NN I-NP O
product NN I-NP O
complexes NNS I-NP O
with IN B-PP O
the DT B-NP O
transferrin NN I-NP O
receptor NN I-NP O
and CC O O
lowers VBZ B-VP O
its PRP$ B-NP O
affinity NN I-NP O
for IN B-PP O
ligand NN B-NP O
binding NN I-NP O
. . O O

We PRP B-NP O
recently RB B-ADVP O
reported VBD B-VP O
the DT B-NP O
positional JJ I-NP O
cloning NN I-NP O
of IN B-PP O
a DT B-NP O
candidate NN I-NP O
gene NN I-NP O
for IN B-PP O
hereditary JJ B-NP B-Disease
hemochromatosis NN I-NP I-Disease
called VBN B-VP O
HFE NN B-NP O
. . O O

The DT B-NP O
gene NN I-NP O
product NN I-NP O
, , O O
a DT B-NP O
member NN I-NP O
of IN B-PP O
the DT B-NP O
major JJ I-NP O
histocompatibility NN I-NP O
complex NN I-NP O
class NN I-NP O
I CD I-NP O
- HYPH B-NP O
like JJ I-NP O
family NN I-NP O
, , O O
was VBD B-VP O
found VBN I-VP O
to TO I-VP O
have VB I-VP O
a DT B-NP O
mutation NN I-NP O
, , O O
Cys NN B-NP O
- HYPH B-NP O
282 CD I-NP O
- HYPH O O
- HYPH O O
> SYM O O
Tyr NN B-NP O
( ( O O
C282Y NN B-NP O
) ) O O
, , O O
in IN B-PP O
85 CD B-NP O
% NN I-NP O
of IN B-PP O
patient NN B-NP O
chromosomes NNS I-NP O
. . O O

This DT B-NP O
mutation NN I-NP O
eliminates VBZ B-VP O
the DT B-NP O
ability NN I-NP O
of IN B-PP O
HFE NN B-NP O
to TO B-VP O
associate VB I-VP O
with IN B-PP O
beta2 NN B-NP O
- HYPH O O
microglobulin NN B-NP O
( ( O O
beta2m NN B-NP O
) ) O O
and CC O O
prevents VBZ B-VP O
cell NN B-NP O
- HYPH B-NP O
surface NN I-NP O
expression NN I-NP O
. . O O

A DT B-NP O
second JJ I-NP O
mutation NN I-NP O
that WDT B-NP O
has VBZ B-VP O
no DT B-NP O
effect NN I-NP O
on IN B-PP O
beta2m NN B-NP O
association NN I-NP O
, , O O
H63D NN B-NP O
, , O O
was VBD B-VP O
found VBN I-VP O
in IN B-PP O
eight CD B-NP O
out IN B-PP O
of IN B-PP O
nine CD B-NP O
patients NNS I-NP O
heterozygous JJ B-ADJP O
for IN B-PP O
the DT B-NP O
C282Y NN I-NP O
mutant NN I-NP O
. . O O

In IN B-PP O
this DT B-NP O
report NN I-NP O
, , O O
we PRP B-NP O
demonstrate VBP B-VP O
in IN B-PP O
cultured VBN B-NP O
293 CD I-NP O
cells NNS I-NP O
overexpressing VBG B-VP O
wild JJ B-NP O
- HYPH I-NP O
type NN I-NP O
or CC I-NP O
mutant JJ I-NP O
HFE NN I-NP O
proteins NNS I-NP O
that WDT B-NP O
both CC O O
the DT B-NP O
wild JJ I-NP O
- HYPH I-NP O
type NN I-NP O
and CC I-NP O
H63D NN I-NP O
HFE NN I-NP O
proteins NNS I-NP O
form VBP B-VP O
stable JJ B-NP O
complexes NNS I-NP O
with IN B-PP O
the DT B-NP O
transferrin NN I-NP O
receptor NN I-NP O
( ( O O
TfR NN B-NP O
) ) O O
. . O O

The DT B-NP O
C282Y NN I-NP O
mutation NN I-NP O
nearly RB B-ADVP O
completely RB I-ADVP O
prevents VBZ B-VP O
the DT B-NP O
association NN I-NP O
of IN B-PP O
the DT B-NP O
mutant JJ I-NP O
HFE NN I-NP O
protein NN I-NP O
with IN B-PP O
the DT B-NP O
TfR NN I-NP O
. . O O

Studies NNS B-NP O
on IN B-PP O
cell NN B-NP O
- HYPH B-NP O
associated VBN I-NP O
transferrin NN I-NP O
at IN B-PP O
37 CD B-NP O
degrees NNS I-NP O
C NN I-NP O
suggest VBP B-VP O
that IN B-SBAR O
the DT B-NP O
overexpressed VBN I-NP O
wild JJ I-NP O
- HYPH I-NP O
type NN I-NP O
HFE NN I-NP O
protein NN I-NP O
decreases VBZ B-VP O
the DT B-NP O
affinity NN I-NP O
of IN B-PP O
the DT B-NP O
TfR NN I-NP O
for IN B-PP O
transferrin NN B-NP O
. . O O

The DT B-NP O
overexpressed VBN I-NP O
H63D NN I-NP O
protein NN I-NP O
does VBZ B-VP O
not RB I-VP O
have VB I-VP O
this DT B-NP O
effect NN I-NP O
, , O O
providing VBG B-VP O
the DT B-NP O
first JJ I-NP O
direct JJ I-NP O
evidence NN I-NP O
for IN B-PP O
a DT B-NP O
functional JJ I-NP O
consequence NN I-NP O
of IN B-PP O
the DT B-NP O
H63D NN I-NP O
mutation NN I-NP O
. . O O

Addition NN B-NP O
of IN B-PP O
soluble JJ B-NP O
wild JJ I-NP O
- HYPH I-NP O
type NN I-NP O
HFE NN I-NP O
/ SYM B-NP O
beta2m NN I-NP O
heterodimers NNS I-NP O
to TO B-PP O
cultured VBN B-NP O
cells NNS I-NP O
also RB B-ADVP O
decreased VBD B-VP O
the DT B-NP O
apparent JJ I-NP O
affinity NN I-NP O
of IN B-PP O
the DT B-NP O
TfR NN I-NP O
for IN B-PP O
its PRP$ B-NP O
ligand NN I-NP O
under IN B-PP O
steady JJ B-NP O
- HYPH I-NP O
state NN I-NP O
conditions NNS I-NP O
, , O O
both CC O O
in IN B-PP O
293 CD B-NP O
cells NNS I-NP O
and CC B-PP O
in IN B-PP O
HeLa NN B-NP O
cells NNS I-NP O
. . O O

Furthermore RB B-ADVP O
, , O O
at IN B-PP O
4 CD B-NP O
degrees NNS I-NP O
C JJ B-ADJP O
, , O O
the DT B-NP O
added VBN I-NP O
soluble JJ I-NP O
complex NN I-NP O
of IN B-PP O
HFE NN B-NP O
/ SYM B-NP O
beta2m NN I-NP O
inhibited VBD B-VP O
binding NN B-NP O
of IN B-PP O
transferrin NN B-NP O
to TO B-PP O
HeLa NN B-NP O
cell NN I-NP O
TfR NN I-NP O
in IN B-PP O
a DT B-NP O
concentration NN I-NP O
- HYPH B-NP O
dependent JJ I-NP O
manner NN I-NP O
. . O O

Scatchard NNP B-NP O
plots NNS I-NP O
of IN B-PP O
these DT B-NP O
data NNS I-NP O
indicate VBP B-VP O
that IN B-SBAR O
the DT B-NP O
added VBN I-NP O
heterodimer NN I-NP O
substantially RB B-VP O
reduced VBD I-VP O
the DT B-NP O
affinity NN I-NP O
of IN B-PP O
TfR NN B-NP O
for IN B-PP O
transferrin NN B-NP O
. . O O

These DT B-NP O
results NNS I-NP O
establish VBP B-VP O
a DT B-NP O
molecular JJ I-NP O
link NN I-NP O
between IN B-PP O
HFE NN B-NP O
and CC O O
a DT B-NP O
key JJ I-NP O
protein NN I-NP O
involved VBN B-VP O
in IN B-PP O
iron NN B-NP O
transport NN I-NP O
, , O O
the DT B-NP O
TfR NN I-NP O
, , O O
and CC O O
raise VB B-VP O
the DT B-NP O
possibility NN I-NP O
that IN B-SBAR O
alterations NNS B-NP O
in IN B-PP O
this DT B-NP O
regulatory JJ I-NP O
mechanism NN I-NP O
may MD B-VP O
play VB I-VP O
a DT B-NP O
role NN I-NP O
in IN B-PP O
the DT B-NP O
pathogenesis NN I-NP O
of IN B-PP O
hereditary JJ B-NP B-Disease
hemochromatosis NN I-NP I-Disease
. . O O

. . O O

Genomic JJ B-NP O
organization NN I-NP O
of IN B-PP O
the DT B-NP O
UBE3A NN I-NP O
/ SYM B-NP O
E6 NN I-NP O
- HYPH B-NP O
AP NN I-NP O
gene NN I-NP O
and CC O O
related JJ B-NP O
pseudogenes NNS I-NP O
. . O O

The DT B-NP O
UBE3A NN I-NP O
gene NN I-NP O
encodes VBZ B-VP O
the DT B-NP O
E6 NN I-NP O
- HYPH O O
AP NN B-NP O
ubiquitin NN I-NP O
- HYPH B-NP O
protein NN I-NP O
ligase NN I-NP O
and CC O O
has VBZ B-VP O
recently RB I-VP O
been VBN I-VP O
shown VBN I-VP O
to TO I-VP O
be VB I-VP O
mutated VBN I-VP O
in IN B-PP O
Angelman NNP B-NP B-Disease
syndrome NN I-NP I-Disease
patients NNS I-NP O
who WP B-NP O
lack VBP B-VP O
15q11 CD B-NP O
- HYPH I-NP O
q13 NN I-NP O
deletions NNS I-NP O
or CC O O
chromosome NN B-NP O
15 CD I-NP O
paternal JJ I-NP O
uniparental JJ I-NP B-Disease
disomy NN I-NP I-Disease
. . O O

Previous JJ B-NP O
UBE3A NN I-NP O
cDNA NN I-NP O
analysis NN I-NP O
has VBZ B-VP O
shown VBN I-VP O
a DT B-NP O
coding VBG I-NP O
region NN I-NP O
of IN B-PP O
approximately RB B-NP O
2 CD I-NP O
. . O O

6 CD B-NP O
kb NN I-NP O
and CC O O
a DT B-NP O
3 CD I-NP O
- HYPH I-NP O
untranslated JJ I-NP O
region NN I-NP O
( ( O O
UTR NN B-NP O
) ) O O
of IN B-PP O
< SYM B-NP O
50 CD I-NP O
bp NN I-NP O
, , O O
whereas IN O O
Northern NN B-NP O
analysis NN I-NP O
has VBZ B-VP O
indicated VBN I-VP O
mRNA NN B-NP O
sizes NNS I-NP O
of IN B-PP O
5 CD B-NP O
- HYPH I-NP O
8 CD I-NP O
kb NN I-NP O
. . O O

We PRP B-NP O
have VBP B-VP O
analyzed VBN I-VP O
additional JJ B-NP O
cDNA NN I-NP O
clones NNS I-NP O
and CC O O
provide VBP B-VP O
evidence NN B-NP O
for IN B-PP O
an DT B-NP O
additional JJ I-NP O
0 CD I-NP O
. . O O

5 CD B-NP O
kb NN I-NP O
of IN B-PP O
5 CD B-NP O
- HYPH I-NP O
UTR NN I-NP O
and CC O O
> JJR B-NP O
2 CD I-NP O
kb NN I-NP O
of IN B-PP O
3 CD B-NP O
- HYPH I-NP O
UTR NN I-NP O
. . O O

We PRP B-NP O
have VBP B-VP O
established VBN I-VP O
the DT B-NP O
genomic JJ I-NP O
organization NN I-NP O
of IN B-PP O
UBE3A NN B-NP O
and CC O O
the DT B-NP O
sequence NN I-NP O
of IN B-PP O
intron NN B-NP O
- HYPH B-NP O
exon NN I-NP O
borders NNS I-NP O
. . O O

We PRP B-NP O
have VBP B-VP O
also RB I-VP O
mapped VBN I-VP O
two CD B-NP O
highly RB I-NP O
homologous JJ I-NP O
processed VBN I-NP O
pseudogenes NNS I-NP O
, , I-NP O
UBE3AP1 NN I-NP O
and CC I-NP O
UBE3AP2 NN I-NP O
, , O O
to TO B-PP O
chromosomes NNS B-NP O
2 CD I-NP O
and CC I-NP O
21 CD I-NP O
, , O O
respectively RB B-ADVP O
, , O O
and CC O O
determined VBD B-VP O
their PRP$ B-NP O
genomic JJ I-NP O
organization NN I-NP O
. . O O

These DT B-NP O
results NNS I-NP O
will MD B-VP O
form VB I-VP O
the DT B-NP O
basis NN I-NP O
for IN B-PP O
studies NNS B-NP O
of IN B-PP O
mutation NN B-NP O
and CC I-NP O
imprinting NN I-NP O
of IN B-PP O
UBE3A NN B-NP O
. . O O

Mutation NN B-NP O
spectrum NN I-NP O
and CC I-NP O
genotype NN I-NP O
- HYPH B-NP O
phenotype NN I-NP O
analyses NNS I-NP O
in IN B-PP O
Cowden NNP B-NP B-Disease
disease NN I-NP I-Disease
and CC O O
Bannayan NNP B-NP B-Disease
- HYPH B-NP I-Disease
Zonana NNP I-NP I-Disease
syndrome NN I-NP I-Disease
, , O O
two CD B-NP O
hamartoma NN I-NP B-Disease
syndromes NNS I-NP I-Disease
with IN B-PP O
germline NN B-NP O
PTEN NN I-NP O
mutation NN I-NP O
. . O O

The DT B-NP O
tumour NN I-NP B-Disease
suppressor NN I-NP O
gene NN I-NP O
PTEN NN I-NP O
, , O O
which WDT B-NP O
maps VBZ B-VP O
to TO B-PP O
10q23 CD B-NP O
. . O O

3 CD B-NP O
and CC O O
encodes VBZ B-VP O
a DT B-NP O
403 CD I-NP O
amino NN I-NP O
acid NN I-NP O
dual JJ I-NP O
specificity NN I-NP O
phosphatase NN I-NP O
( ( O O
protein NN B-NP O
tyrosine NN I-NP O
phosphatase NN I-NP O
; : O O
PTPase NN B-NP O
) ) O O
, , O O
was VBD B-VP O
shown VBN I-VP O
recently RB B-ADVP O
to TO B-VP O
play VB I-VP O
a DT B-NP O
broad JJ I-NP O
role NN I-NP O
in IN B-PP O
human JJ B-NP O
malignancy NN I-NP B-Disease
. . O O

Somatic JJ B-NP O
PTEN NN I-NP O
deletions NNS I-NP O
and CC I-NP O
mutations NNS I-NP O
were VBD B-VP O
observed VBN I-VP O
in IN B-PP O
sporadic JJ B-NP B-Disease
breast NN I-NP I-Disease
, , I-NP I-Disease
brain NN I-NP I-Disease
, , I-NP I-Disease
prostate NN I-NP I-Disease
and CC I-NP I-Disease
kidney NN I-NP I-Disease
cancer NN I-NP I-Disease
cell NN I-NP O
lines NNS I-NP O
and CC B-PP O
in IN B-PP O
several JJ B-NP O
primary JJ I-NP O
tumours NNS I-NP B-Disease
such JJ B-PP O
as IN I-PP O
endometrial JJ B-NP B-Disease
carcinomas NNS I-NP I-Disease
, , O O
malignant JJ B-NP B-Disease
melanoma NN I-NP I-Disease
and CC O O
thyroid JJ B-NP B-Disease
tumours NNS I-NP I-Disease
. . O O

In IN B-PP O
addition NN B-NP O
, , O O
PTEN NN B-NP O
was VBD B-VP O
identified VBN I-VP O
as IN B-PP O
the DT B-NP O
susceptibility NN I-NP O
gene NN I-NP O
for IN B-PP O
two CD B-NP O
hamartoma NN I-NP B-Disease
syndromes NNS I-NP I-Disease
Cowden NN I-NP B-Disease
disease NN I-NP I-Disease
( ( O O
CD NN B-NP B-Disease
; : O O
MIM NN B-NP O
158350 CD I-NP O
) ) O O
and CC O O
Bannayan NNP B-NP B-Disease
- HYPH I-NP I-Disease
Zonana NNP I-NP I-Disease
( ( O I-Disease
BZS NNP B-NP I-Disease
) ) O I-Disease
or CC O I-Disease
Ruvalcaba NNP B-NP I-Disease
- HYPH B-NP I-Disease
Riley NNP I-NP I-Disease
- HYPH I-NP I-Disease
Smith NNP I-NP I-Disease
syndrome NN I-NP I-Disease
( ( O O
MIM NN B-NP O
153480 CD I-NP O
) ) O O
. . O O

Constitutive JJ B-NP O
DNA NN I-NP O
from IN B-PP O
37 CD B-NP O
CD NN I-NP B-Disease
families NNS I-NP O
and CC O O
seven CD B-NP O
BZS NN I-NP B-Disease
families NNS I-NP O
was VBD B-VP O
screened VBN I-VP O
for IN B-PP O
germline NN B-NP O
PTEN NN I-NP O
mutations NNS I-NP O
. . O O

PTEN NN B-NP O
mutations NNS I-NP O
were VBD B-VP O
identified VBN I-VP O
in IN B-PP O
30 CD B-NP O
of IN B-PP O
37 CD B-NP O
( ( O O
81 CD B-NP O
% NN I-NP O
) ) O O
CD NN B-NP B-Disease
families NNS I-NP O
, , O O
including VBG B-PP O
missense JJ B-NP O
and CC I-NP O
nonsense JJ I-NP O
point NN I-NP O
mutations NNS I-NP O
, , O O
deletions NNS B-NP O
, , O O
insertions NNS B-NP O
, , O O
a DT B-NP O
deletion NN I-NP O
/ SYM B-NP O
insertion NN B-NP O
and CC I-NP O
splice NN I-NP O
site NN I-NP O
mutations NNS I-NP O
. . O O

These DT B-NP O
mutations NNS I-NP O
were VBD B-VP O
scattered VBN I-VP O
over IN B-PP O
the DT B-NP O
entire JJ I-NP O
length NN I-NP O
of IN B-PP O
PTEN NN B-NP O
, , O O
with IN B-PP O
the DT B-NP O
exception NN I-NP O
of IN B-PP O
the DT B-NP O
first JJ I-NP O
, , I-NP O
fourth JJ I-NP O
and CC I-NP O
last JJ I-NP O
exons NNS I-NP O
. . O O

A DT B-NP O
hot JJ I-NP O
spot NN I-NP O
for IN B-PP O
PTEN NN B-NP O
mutation NN I-NP O
in IN B-PP O
CD NN B-NP B-Disease
was VBD B-VP O
identified VBN I-VP O
in IN B-PP O
exon NN B-NP O
5 CD I-NP O
that WDT B-NP O
contains VBZ B-VP O
the DT B-NP O
PTPase NN I-NP O
core NN I-NP O
motif NN I-NP O
, , O O
with IN B-PP O
13 CD B-NP O
of IN B-PP O
30 CD B-NP O
( ( O O
43 CD B-NP O
% NN I-NP O
) ) O O
CD NN B-NP B-Disease
mutations NNS I-NP O
identified VBN B-VP O
in IN B-PP O
this DT B-NP O
exon NN I-NP O
. . O O

Seven CD B-NP O
of IN B-PP O
30 CD B-NP O
( ( O O
23 CD B-NP O
% NN I-NP O
) ) O O
were VBD B-VP O
within IN B-PP O
the DT B-NP O
core NN I-NP O
motif NN I-NP O
, , O O
the DT B-NP O
majority NN I-NP O
( ( O O
five CD B-NP O
of IN B-PP O
seven CD B-NP O
) ) O O
of IN B-PP O
which WDT B-NP O
were VBD B-VP O
missense JJ B-NP O
mutations NNS I-NP O
, , O O
possibly RB B-VP O
pointing VBG I-VP O
to TO B-PP O
the DT B-NP O
functional JJ I-NP O
significance NN I-NP O
of IN B-PP O
this DT B-NP O
region NN I-NP O
. . O O

Germline NN B-NP O
PTEN NN I-NP O
mutations NNS I-NP O
were VBD B-VP O
identified VBN I-VP O
in IN B-PP O
four CD B-NP O
of IN B-PP O
seven CD B-NP O
( ( O O
57 CD B-NP O
% NN I-NP O
) ) O O
BZS NN B-NP B-Disease
families NNS I-NP O
studied VBN B-VP O
. . O O

Interestingly RB B-ADVP O
, , O O
none NN B-NP O
of IN B-PP O
these DT B-NP O
mutations NNS I-NP O
was VBD B-VP O
observed VBN I-VP O
in IN B-PP O
the DT B-NP O
PTPase NN I-NP O
core NN I-NP O
motif NN I-NP O
. . O O

It PRP B-NP O
is VBZ B-VP O
also RB B-ADVP O
worthy JJ B-ADJP O
of IN B-PP O
note NN B-NP O
that IN B-SBAR O
a DT B-NP O
single JJ I-NP O
nonsense JJ I-NP O
point NN I-NP O
mutation NN I-NP O
, , O O
R233X NN B-NP O
, , O O
was VBD B-VP O
observed VBN I-VP O
in IN B-PP O
the DT B-NP O
germline NN I-NP O
DNA NN I-NP O
from IN B-PP O
two CD B-NP O
unrelated JJ I-NP O
CD NN I-NP B-Disease
families NNS I-NP O
and CC O O
one CD B-NP O
BZS NN I-NP B-Disease
family NN I-NP O
. . O O

Genotype NN B-NP O
- HYPH I-NP O
phenotype NN I-NP O
studies NNS I-NP O
were VBD B-VP O
not RB I-VP O
performed VBN I-VP O
on IN B-PP O
this DT B-NP O
small JJ I-NP O
group NN I-NP O
of IN B-PP O
BZS NN B-NP B-Disease
families NNS I-NP O
. . O O

However RB B-ADVP O
, , O O
genotype NN B-NP O
- HYPH I-NP O
phenotype NN I-NP O
analysis NN I-NP O
inthe VBP B-VP O
group NN B-NP O
of IN B-PP O
CD NN B-NP B-Disease
families NNS I-NP O
revealed VBD B-VP O
two CD B-NP O
possible JJ I-NP O
associations NNS I-NP O
worthy JJ B-ADJP O
of IN B-PP O
follow VB B-VP O
- HYPH O O
up RP B-PRT O
in IN B-PP O
independent JJ B-NP O
analyses NNS I-NP O
. . O O

The DT B-NP O
first JJ I-NP O
was VBD B-VP O
an DT B-NP O
association NN I-NP O
noted VBN B-VP O
in IN B-PP O
the DT B-NP O
group NN I-NP O
of IN B-PP O
CD NN B-NP B-Disease
families NNS I-NP O
with IN B-PP O
breast NN B-NP B-Disease
disease NN I-NP I-Disease
. . O O

A DT B-NP O
correlation NN I-NP O
was VBD B-VP O
observed VBN I-VP O
between IN B-PP O
the DT B-NP O
presence NN I-NP O
/ SYM B-NP O
absence NN I-NP O
of IN B-PP O
a DT B-NP O
PTEN NN I-NP O
mutation NN I-NP O
and CC O O
the DT B-NP O
type NN I-NP O
of IN B-PP O
breast NN B-NP O
involvement NN I-NP O
( ( O O
unaffected JJ B-ADJP O
versus IN B-PP O
benign JJ B-NP O
versus CC I-NP O
malignant JJ I-NP O
) ) O O
. . O O

Specifically RB B-ADVP O
and CC O O
more RBR B-ADVP O
directly RB I-ADVP O
, , O O
an DT B-NP O
association NN I-NP O
was VBD B-VP O
also RB I-VP O
observed VBN I-VP O
between IN B-PP O
the DT B-NP O
presence NN I-NP O
of IN B-PP O
a DT B-NP O
PTEN NN I-NP O
mutation NN I-NP O
and CC O O
malignant JJ B-NP B-Disease
breast NN I-NP I-Disease
disease NN I-NP I-Disease
. . O O

Secondly RB B-ADVP O
, , O O
there EX B-NP O
appeared VBD B-VP O
to TO I-VP O
be VB I-VP O
an DT B-NP O
interdependent JJ I-NP O
association NN I-NP O
between IN B-PP O
mutations NNS B-NP O
upstream RB B-ADVP O
and CC O O
within IN B-PP O
the DT B-NP O
PTPase NN I-NP O
core NN I-NP O
motif NN I-NP O
, , O O
the DT B-NP O
core NN I-NP O
motif NN I-NP O
containing VBG B-VP O
the DT B-NP O
majority NN I-NP O
of IN B-PP O
missense JJ B-NP O
mutations NNS I-NP O
, , O O
and CC O O
the DT B-NP O
involvement NN I-NP O
of IN B-PP O
all DT B-NP O
major JJ I-NP O
organ NN I-NP O
systems NNS I-NP O
( ( O O
central JJ B-NP O
nervous JJ I-NP O
system NN I-NP O
, , O O
thyroid NN B-NP O
, , O O
breast NN B-NP O
, , O O
skin NN B-NP O
and CC O O
gastrointestinal JJ B-NP O
tract NN I-NP O
) ) O O
. . O O

However RB B-ADVP O
, , O O
these DT B-NP O
observations NNS I-NP O
would MD B-VP O
need VB I-VP O
to TO I-VP O
be VB I-VP O
confirmed VBN I-VP O
by IN B-PP O
studying VBG B-VP O
a DT B-NP O
larger JJR I-NP O
number NN I-NP O
of IN B-PP O
CD NN B-NP B-Disease
families NNS I-NP O
. . O O

Molecular JJ B-NP O
defects NNS I-NP O
leading VBG B-VP O
to TO B-PP O
human JJ B-NP O
complement NN I-NP B-Disease
component NN I-NP I-Disease
C6 NN I-NP I-Disease
deficiency NN I-NP I-Disease
in IN B-PP O
an DT B-NP O
African JJ I-NP O
- HYPH I-NP O
American JJ I-NP O
family NN I-NP O
. . O O

Complement NN B-NP B-Disease
component NN I-NP I-Disease
C6 NN I-NP I-Disease
deficiency NN I-NP I-Disease
( ( O O
C6D NN B-NP B-Disease
) ) O O
was VBD B-VP O
diagnosed VBN I-VP O
in IN B-PP O
a DT B-NP O
16 CD I-NP O
- HYPH I-NP O
year NN I-NP O
- HYPH O O
old JJ B-NP O
African JJ I-NP O
- HYPH I-NP O
American JJ I-NP O
male NN I-NP O
with IN B-PP O
meningococcal JJ B-NP B-Disease
meningitis NN I-NP I-Disease
. . O O

The DT B-NP O
patients NNS I-NP O
father NN I-NP O
and CC O O
two CD B-NP O
brothers NNS I-NP O
also RB B-ADVP O
had VBD B-VP O
C6D NN B-NP B-Disease
, , O O
but CC O O
gave VBD B-VP O
no DT B-NP O
history NN I-NP O
of IN B-PP O
meningitis NN B-NP B-Disease
or CC O O
other JJ B-NP O
neisserial JJ I-NP B-Disease
infection NN I-NP I-Disease
. . O O

By IN B-PP O
using VBG B-VP O
exon NN B-NP O
- HYPH B-NP O
specific JJ I-NP O
polymerase NN I-NP O
chain NN I-NP O
reaction NN I-NP O
( ( O O
PCR NN B-NP O
) ) O O
/ SYM B-NP O
single JJ I-NP O
- HYPH I-NP O
strand NN I-NP O
conformation NN I-NP O
polymorphism NN I-NP O
as IN B-PP O
a DT B-NP O
screening NN I-NP O
step NN I-NP O
and CC I-NP O
nucleotide NN I-NP O
sequencing NN I-NP O
of IN B-PP O
target NN B-NP O
exons NNS I-NP O
, , O O
we PRP B-NP O
determined VBD B-VP O
that IN B-SBAR O
the DT B-NP O
proband NN I-NP O
was VBD B-VP O
a DT B-NP O
compound NN I-NP O
heterozygote NN I-NP O
for IN B-PP O
two CD B-NP O
C6 NN I-NP O
gene NN I-NP O
mutations NNS I-NP O
. . O O

The DT B-NP O
first JJ I-NP O
, , I-NP O
1195delC NN I-NP O
located JJ I-NP O
in IN B-PP O
exon NN B-NP O
7 CD I-NP O
, , O O
is VBZ B-VP O
a DT B-NP O
novel JJ I-NP O
mutation NN I-NP O
, , O O
while IN B-SBAR O
the DT B-NP O
second JJ I-NP O
, , I-NP O
1936delG NN I-NP O
in IN B-PP O
exon NN B-NP O
12 CD I-NP O
, , O O
has VBZ B-VP O
been VBN I-VP O
described VBN I-VP O
before RB B-ADVP O
to TO B-VP O
cause VB I-VP O
C6D NN B-NP B-Disease
in IN B-PP O
an DT B-NP O
unrelated JJ I-NP O
African JJ I-NP O
- HYPH I-NP O
American JJ I-NP O
individual NN I-NP O
. . O O

Both DT B-NP O
mutations NNS I-NP O
result VBP B-VP O
in IN B-PP O
premature JJ B-NP O
termination NN I-NP O
codons NNS I-NP O
and CC O O
C6 NN B-NP O
alleles NNS I-NP O
. . O O

Allele NN B-NP O
- HYPH I-NP O
specific JJ I-NP O
PCR NN I-NP O
indicated VBD B-VP O
that IN B-SBAR O
the DT B-NP O
probands NNS I-NP O
two CD B-NP O
brothers NNS I-NP O
also RB B-ADVP O
inherited VBD B-VP O
the DT B-NP O
1195delC NN I-NP O
mutation NN I-NP O
from IN B-PP O
their PRP$ B-NP O
heterozygous JJ I-NP O
mother NN I-NP O
and CC O O
the DT B-NP O
1936delG NN I-NP O
mutation NN I-NP O
from IN B-PP O
their PRP$ B-NP O
homozygous JJ I-NP O
father NN I-NP O
. . O O

. . O O

PAX6 NN B-NP O
mutations NNS I-NP O
reviewed VBN B-VP O
. . O O

Mutations NNS B-NP O
in IN B-PP O
PAX6 NN B-NP O
are VBP B-VP O
responsible JJ B-ADJP O
for IN B-PP O
human JJ B-NP O
aniridia NN I-NP B-Disease
and CC O O
have VBP B-VP O
also RB I-VP O
been VBN I-VP O
found VBN I-VP O
in IN B-PP O
patients NNS B-NP O
with IN B-PP O
Peters NNP B-NP B-Disease
anomaly RB B-ADVP I-Disease
, , O O
with IN B-PP O
congenital JJ B-NP B-Disease
cataracts NNS I-NP I-Disease
, , O O
with IN B-PP O
autosomal JJ B-NP B-Disease
dominant JJ I-NP I-Disease
keratitis NN I-NP I-Disease
, , O O
and CC O O
with IN B-PP O
isolated VBN B-NP B-Disease
foveal JJ I-NP I-Disease
hypoplasia NN I-NP I-Disease
. . O O

No DT B-NP O
locus NN I-NP O
other JJ B-ADJP O
than IN B-PP O
chromosome NN B-NP O
11p13 NN I-NP O
has VBZ B-VP O
been VBN I-VP O
implicated VBN I-VP O
in IN B-PP O
aniridia NN B-NP B-Disease
, , O O
and CC O O
PAX6 NN B-NP O
is VBZ B-VP O
clearly RB B-ADVP O
the DT B-NP O
major JJ I-NP O
, , O O
if IN B-SBAR O
not RB B-CONJP O
only RB I-CONJP O
, , O O
gene NN B-NP O
responsible JJ B-ADJP O
. . O O

Twenty CD B-NP O
- HYPH I-NP O
eight CD I-NP O
percent NN I-NP O
of IN B-PP O
identified VBN B-NP O
PAX6 NN I-NP O
mutations NNS I-NP O
are VBP B-VP O
C NN B-NP O
- HYPH B-NP O
T NN I-NP O
changes NNS I-NP O
at IN B-PP O
CpG NN B-NP O
dinucleotides NNS I-NP O
, , O O
20 CD B-NP O
% NN I-NP O
are VBP B-VP O
splicing VBG I-VP O
errors NNS B-NP O
, , O O
and CC O O
more JJR B-NP O
than IN I-NP O
30 CD I-NP O
% NN I-NP O
are VBP B-VP O
deletion NN B-NP O
or CC I-NP O
insertion NN I-NP O
events NNS I-NP O
. . O O

There EX B-NP O
is VBZ B-VP O
a DT B-NP O
noticeably RB I-NP O
elevated JJ I-NP O
level NN I-NP O
of IN B-PP O
mutation NN B-NP O
in IN B-PP O
the DT B-NP O
paired JJ I-NP O
domain NN I-NP O
compared VBN B-PP O
with IN B-PP O
the DT B-NP O
rest NN I-NP O
of IN B-PP O
the DT B-NP O
gene NN I-NP O
. . O O

Increased VBN B-NP O
mutation NN I-NP O
in IN B-PP O
the DT B-NP O
homeodomain NN I-NP O
is VBZ B-VP O
accounted VBN I-VP O
for IN B-PP O
by IN B-PP O
the DT B-NP O
hypermutable JJ I-NP O
CpG NN I-NP O
dinucleotide NN I-NP O
in IN B-PP O
codon NN B-NP O
240 CD I-NP O
. . O O

Very RB B-ADVP O
nearly RB B-NP O
all DT I-NP O
mutations NNS I-NP O
appear VBP B-VP O
to TO I-VP O
cause VB I-VP O
loss NN B-NP O
of IN B-PP O
function NN B-NP O
of IN B-PP O
the DT B-NP O
mutant JJ I-NP O
allele NN I-NP O
, , O O
and CC O O
more JJR B-NP O
than IN I-NP O
80 CD I-NP O
% NN I-NP O
of IN B-PP O
exonic JJ B-NP O
substitutions NNS I-NP O
result VBP B-VP O
in IN B-PP O
nonsense JJ B-NP O
codons NNS I-NP O
. . O O

In IN B-PP O
a DT B-NP O
gene NN I-NP O
with IN B-PP O
such JJ B-NP O
extraordinarily RB I-NP O
high JJ I-NP O
sequence NN I-NP O
conservation NN I-NP O
throughout IN B-PP O
evolution NN B-NP O
, , O O
there EX B-NP O
are VBP B-VP O
presumed VBN I-VP O
undiscovered JJ B-NP O
missense JJ I-NP O
mutations NNS I-NP O
, , O O
these DT B-NP O
are VBP B-VP O
hypothesized VBN I-VP O
to TO I-VP O
exist VB I-VP O
in IN B-PP O
as RB O O
- HYPH B-ADJP O
yet RB B-NP O
unidentified JJ I-NP O
phenotypes NNS I-NP O
. . O O

. . O O

Genetic JJ B-NP O
heterogeneity NN I-NP O
and CC I-NP O
penetrance NN I-NP O
analysis NN I-NP O
of IN B-PP O
the DT B-NP O
BRCA1 NN I-NP O
and CC I-NP O
BRCA2 NN I-NP O
genes NNS I-NP O
in IN B-PP O
breast NN B-NP B-Disease
cancer NN I-NP I-Disease
families NNS I-NP O
. . O O

The DT B-NP O
Breast NNP I-NP B-Disease
Cancer NNP I-NP I-Disease
Linkage NNP I-NP O
Consortium NNP I-NP O
. . O O

The DT B-NP O
contribution NN I-NP O
of IN B-PP O
BRCA1 NN B-NP O
and CC I-NP O
BRCA2 NN I-NP O
to TO B-PP O
inherited VBN B-NP B-Disease
breast NN I-NP I-Disease
cancer NN I-NP I-Disease
was VBD B-VP O
assessed VBN I-VP O
by IN B-PP O
linkage NN B-NP O
and CC I-NP O
mutation NN I-NP O
analysis NN I-NP O
in IN B-PP O
237 CD B-NP O
families NNS I-NP O
, , O O
each DT B-NP O
with IN B-PP O
at IN B-NP O
least JJS I-NP O
four CD I-NP O
cases NNS I-NP O
of IN B-PP O
breast NN B-NP B-Disease
cancer NN I-NP I-Disease
, , O O
collected VBN B-VP O
by IN B-PP O
the DT B-NP O
Breast NNP I-NP B-Disease
Cancer NNP I-NP I-Disease
Linkage NNP I-NP O
Consortium NNP I-NP O
. . O O

Families NNS B-NP O
were VBD B-VP O
included VBN I-VP O
without IN B-PP O
regard NN B-NP O
to TO B-PP O
the DT B-NP O
occurrence NN I-NP O
of IN B-PP O
ovarian JJ B-NP B-Disease
or CC I-NP I-Disease
other JJ I-NP I-Disease
cancers NNS I-NP I-Disease
. . O O

Overall RB B-ADVP O
, , O O
disease NN B-NP O
was VBD B-VP O
linked VBN I-VP O
to TO B-PP O
BRCA1 NN B-NP O
in IN B-PP O
an DT B-NP O
estimated VBN I-NP O
52 CD I-NP O
% NN I-NP O
of IN B-PP O
families NNS B-NP O
, , O O
to TO B-PP O
BRCA2 NN B-NP O
in IN B-PP O
32 CD B-NP O
% NN I-NP O
of IN B-PP O
families NNS B-NP O
, , B-PP O
and CC I-PP O
to TO B-PP O
neither CC O O
gene NN B-NP O
in IN B-PP O
16 CD B-NP O
% NN I-NP O
( ( O O
95 CD B-NP O
% NN I-NP O
confidence NN I-NP O
interval NN I-NP O
[ ( O O
CI NN B-NP O
] ) O O
6 CD B-NP O
% NN I-NP O
- HYPH O O
28 CD B-NP O
% NN I-NP O
) ) O O
, , O O
suggesting VBG B-VP O
other JJ B-NP O
predisposition NN I-NP O
genes NNS I-NP O
. . O O

The DT B-NP O
majority NN I-NP O
( ( O O
81 CD B-NP O
% NN I-NP O
) ) O O
of IN B-PP O
the DT B-NP O
breast NN I-NP B-Disease
- HYPH B-NP I-Disease
ovarian JJ I-NP I-Disease
cancer NN I-NP I-Disease
families NNS I-NP O
were VBD B-VP O
due IN B-PP O
to TO B-PP O
BRCA1 NN B-NP O
, , O O
with IN B-PP O
most JJS B-NP O
others NNS I-NP O
( ( O O
14 CD B-NP O
% NN I-NP O
) ) O O
due IN B-PP O
to TO I-PP O
BRCA2 NN B-NP O
. . O O

Conversely RB B-ADVP O
, , O O
the DT B-NP O
majority NN I-NP O
of IN B-PP O
families NNS B-NP O
with IN B-PP O
male JJ B-NP B-Disease
and CC I-NP I-Disease
female JJ I-NP I-Disease
breast NN I-NP I-Disease
cancer NN I-NP I-Disease
were VBD B-VP O
due JJ B-ADJP O
to TO B-PP O
BRCA2 NN B-NP O
( ( O O
76 CD B-NP O
% NN I-NP O
) ) O O
. . O O

The DT B-NP O
largest JJS I-NP O
proportion NN I-NP O
( ( O O
67 CD B-NP O
% NN I-NP O
) ) O O
of IN B-PP O
families NNS B-NP O
due JJ B-PP O
to TO B-PP O
other JJ B-NP O
genes NNS I-NP O
was VBD B-VP O
found VBN I-VP O
in IN B-PP O
families NNS B-NP O
with IN B-PP O
four CD B-NP O
or CC I-NP O
five CD I-NP O
cases NNS I-NP O
of IN B-PP O
female JJ B-NP O
breast NN I-NP B-Disease
cancer NN I-NP I-Disease
only RB B-ADVP O
. . O O

These DT B-NP O
estimates NNS I-NP O
were VBD B-VP O
not RB I-VP O
substantially RB I-VP O
affected VBN I-VP O
either CC O O
by IN B-PP O
changing VBG B-VP O
the DT B-NP O
assumed VBN I-NP O
penetrance NN I-NP O
model NN I-NP O
for IN B-PP O
BRCA1 NN B-NP O
or CC B-PP O
by IN B-PP O
including VBG B-VP O
or CC I-VP O
excluding VBG I-VP O
BRCA1 NN B-NP O
mutation NN I-NP O
data NNS I-NP O
. . O O

Among IN B-PP O
those DT B-NP O
families NNS I-NP O
with IN B-PP O
disease NN B-NP O
due JJ B-ADJP O
to TO B-PP O
BRCA1 NN B-NP O
that WDT B-NP O
were VBD B-VP O
tested VBN I-VP O
by IN B-PP O
one CD B-NP O
of IN B-PP O
the DT B-NP O
standard JJ I-NP O
screening NN I-NP O
methods NNS I-NP O
, , O O
mutations NNS B-NP O
were VBD B-VP O
detected VBN I-VP O
in IN B-PP O
the DT B-NP O
coding VBG I-NP O
sequence NN I-NP O
or CC I-NP O
splice NN I-NP O
sites NNS I-NP O
in IN B-PP O
an DT B-NP O
estimated VBN I-NP O
63 CD I-NP O
% NN I-NP O
( ( O O
95 CD B-NP O
% NN I-NP O
CI NN I-NP O
51 CD B-NP O
% NN I-NP O
- HYPH O O
77 CD B-NP O
% NN I-NP O
) ) O O
. . O O

The DT B-NP O
estimated VBN I-NP O
sensitivity NN I-NP O
was VBD B-VP O
identical JJ B-ADJP O
for IN B-PP O
direct JJ B-NP O
sequencing NN I-NP O
and CC O O
other JJ B-NP O
techniques NNS I-NP O
. . O O

The DT B-NP O
penetrance NN I-NP O
of IN B-PP O
BRCA2 NN B-NP O
was VBD B-VP O
estimated VBN I-VP O
by IN B-PP O
maximizing VBG B-VP O
the DT B-NP O
LOD NN I-NP O
score NN I-NP O
in IN B-PP O
BRCA2 NN B-NP O
- HYPH B-NP O
mutation NN I-NP O
families NNS I-NP O
, , O O
over IN B-PP O
all DT B-NP O
possible JJ I-NP O
penetrance NN I-NP O
functions NNS I-NP O
. . O O

The DT B-NP O
estimated VBN I-NP O
cumulative JJ I-NP O
risk NN I-NP O
of IN B-PP O
breast NN B-NP B-Disease
cancer NN I-NP I-Disease
reached VBD B-VP O
28 CD B-NP O
% NN I-NP O
( ( O O
95 CD B-NP O
% NN I-NP O
CI NN I-NP O
9 CD B-NP O
% NN I-NP O
- HYPH O O
44 CD B-NP O
% NN I-NP O
) ) O O
by IN B-PP O
age NN B-NP O
50 CD B-NP O
years NNS I-NP O
and CC O O
84 CD B-NP O
% NN I-NP O
( ( O O
95 CD B-NP O
% NN I-NP O
CI NN I-NP O
43 CD B-NP O
% NN I-NP O
- HYPH O O
95 CD B-NP O
% NN I-NP O
) ) O O
by IN B-PP O
age NN B-NP O
70 CD B-NP O
years NNS I-NP O
. . O O

The DT B-NP O
corresponding VBG I-NP O
ovarian JJ I-NP B-Disease
cancer NN I-NP I-Disease
risks NNS I-NP O
were VBD B-VP O
0 CD B-NP O
. . O O

4 CD B-NP O
% NN I-NP O
( ( O O
95 CD B-NP O
% NN I-NP O
CI NN I-NP O
0 CD B-NP O
% NN I-NP O
- HYPH B-NP O
1 CD I-NP O
% NN I-NP O
) ) O O
by IN B-PP O
age NN B-NP O
50 CD B-NP O
years NNS I-NP O
and CC O O
27 CD B-NP O
% NN I-NP O
( ( O O
95 CD B-NP O
% NN I-NP O
CI NN I-NP O
0 CD B-NP O
% NN I-NP O
- HYPH O O
47 CD B-NP O
% NN I-NP O
) ) O O
by IN B-PP O
age NN B-NP O
70 CD B-NP O
years NNS I-NP O
. . O O

The DT B-NP O
lifetime NN I-NP O
risk NN I-NP O
of IN B-PP O
breast NN B-NP B-Disease
cancer NN I-NP I-Disease
appears VBZ B-VP O
similar JJ B-ADJP O
to TO B-PP O
the DT B-NP O
risk NN I-NP O
in IN B-PP O
BRCA1 NN B-NP O
carriers NNS I-NP O
, , O O
but CC O O
there EX B-NP O
was VBD B-VP O
some DT B-NP O
suggestion NN I-NP O
of IN B-PP O
a DT B-NP O
lower JJR I-NP O
risk NN I-NP O
in IN B-PP O
BRCA2 NN B-NP O
carriers NNS I-NP O
< SYM B-VP O
50 CD B-NP O
years NNS I-NP O
of IN B-PP O
age NN B-NP O
. . O O

Eye NN B-NP B-Disease
movement NN I-NP I-Disease
abnormalities NNS I-NP I-Disease
correlate VBP B-VP O
with IN B-PP O
genotype NN B-NP O
in IN B-PP O
autosomal JJ B-NP O
dominant JJ I-NP O
cerebellar JJ I-NP B-Disease
ataxia NN I-NP I-Disease
type NN I-NP I-Disease
I CD I-NP I-Disease
. . O O

We PRP B-NP O
compared VBD B-VP O
horizontal JJ B-NP O
eye NN I-NP O
movements NNS I-NP O
( ( O O
visually RB B-NP O
guided VBN I-NP O
saccades NNS I-NP O
, , O O
antisaccades NNS B-NP O
, , O O
and CC O O
smooth JJ B-NP O
pursuit NN I-NP O
) ) O O
in IN B-PP O
control JJ B-NP O
subjects NNS I-NP O
( ( O O
n NN B-NP O
= SYM B-VP O
14 CD B-NP O
) ) O O
and CC O O
patients NNS B-NP O
with IN B-PP O
three CD B-NP O
forms NNS I-NP O
of IN B-PP O
autosomal JJ B-NP O
dominant JJ I-NP O
cerebellar JJ I-NP B-Disease
ataxias NN I-NP I-Disease
type NN I-NP I-Disease
I CD I-NP I-Disease
spinocerebellar NN I-NP B-Disease
ataxias NNS I-NP I-Disease
1 CD B-NP I-Disease
and CC I-NP I-Disease
2 CD I-NP I-Disease
( ( O O
SCA1 NN B-NP B-Disease
, , O O
n NN B-NP O
= SYM B-VP O
11 CD B-NP O
; : O O
SCA2 NN B-NP B-Disease
, , O O
n NN B-NP O
= SYM B-VP O
10 CD B-NP O
) ) O O
and CC O O
SCA3 NN B-NP B-Disease
/ SYM O O
Machado NNP B-NP B-Disease
- HYPH I-NP I-Disease
Joseph NNP I-NP I-Disease
disease NN I-NP I-Disease
( ( O O
MJD NN B-NP B-Disease
) ) O O
( ( O O
n NN B-NP O
= SYM B-VP O
16 CD B-NP O
) ) O O
. . O O

In IN B-PP O
SCA1 NN B-NP B-Disease
, , O O
saccade NN B-NP O
amplitude NN I-NP O
was VBD B-VP O
significantly RB I-VP O
increased VBN I-VP O
, , O O
resulting VBG B-VP O
in IN B-PP O
hypermetria NN B-NP B-Disease
. . O O

The DT B-NP O
smooth JJ I-NP O
pursuit NN I-NP O
gain NN I-NP O
was VBD B-VP O
decreased VBN I-VP O
. . O O

In IN B-PP O
SCA2 NN B-NP B-Disease
, , O O
saccade NN B-NP O
velocity NN I-NP O
was VBD B-VP O
markedly RB I-VP O
decreased VBN I-VP O
. . O O

The DT B-NP O
percentage NN I-NP O
of IN B-PP O
errors NNS B-NP O
in IN B-PP O
antisaccades NNS B-NP O
was VBD B-VP O
greatly RB I-VP O
increased VBN I-VP O
and CC O O
was VBD B-VP O
significantly RB I-VP O
correlated VBN I-VP O
with IN B-PP O
age NN B-NP O
at IN B-PP O
disease NN B-NP O
onset NN I-NP O
. . O O

In IN B-PP O
addition NN B-NP O
, , O O
a DT B-NP O
correlation NN I-NP O
between IN B-PP O
smooth JJ B-NP O
pursuit NN I-NP O
gain NN I-NP O
and CC O O
the DT B-NP O
number NN I-NP O
of IN B-PP O
trinucleotide NN B-NP O
repeats NNS I-NP O
was VBD B-VP O
found VBN I-VP O
. . O O

In IN B-PP O
SCA3 NN B-NP B-Disease
, , O O
gaze NN B-NP B-Disease
- HYPH B-VP I-Disease
evoked VBN B-NP I-Disease
nystagmus NN I-NP I-Disease
was VBD B-VP O
often RB B-ADVP O
present JJ B-ADJP O
as IN B-SBAR O
was VBD B-VP O
saccade NN B-NP O
hypometria NN I-NP O
and CC O O
smooth JJ B-NP O
pursuit NN I-NP O
gain NN I-NP O
was VBD B-VP O
markedly RB I-VP O
decreased VBN I-VP O
. . O O

Three CD B-NP O
major JJ I-NP O
criteria NNS I-NP O
, , O O
saccade NN B-NP O
amplitude NN I-NP O
, , O O
saccade NN B-NP O
velocity NN I-NP O
, , O O
and CC O O
presence NN B-NP O
of IN B-PP O
gaze NN B-NP B-Disease
- HYPH B-NP I-Disease
evoked VBN I-NP I-Disease
nystagmus NN I-NP I-Disease
, , O O
permitted VBD B-VP O
the DT B-NP O
correct JJ I-NP O
assignment NN I-NP O
of IN B-PP O
90 CD B-NP O
% NN I-NP O
of IN B-PP O
the DT B-NP O
SCA1 NN I-NP B-Disease
, , O O
90 CD B-NP O
% NN I-NP O
of IN B-PP O
the DT B-NP O
SCA2 NN I-NP B-Disease
, , O O
and CC O O
93 CD B-NP O
% NN I-NP O
of IN B-PP O
the DT B-NP O
patients NNS I-NP O
with IN B-PP O
SCA3 NN B-NP B-Disease
to TO B-PP O
their PRP$ B-NP O
genetically RB I-NP O
confirmed VBN I-NP O
patient NN I-NP O
group NN I-NP O
and CC O O
, , O O
therefore RB B-ADVP O
, , O O
may MD B-VP O
help VB I-VP O
orient JJ B-NP O
diagnoses NNS I-NP O
of IN B-PP O
SCA1 NN B-NP B-Disease
, , O O
SCA2 NN B-NP B-Disease
, , O O
and CC O O
SCA3 NN B-NP B-Disease
at IN B-PP O
early JJ B-NP O
clinical JJ I-NP O
stages NNS I-NP O
of IN B-PP O
the DT B-NP O
diseases NNS I-NP O
. . O O

. . O O

Genetic JJ B-NP O
basis NN I-NP O
and CC O O
molecular JJ B-NP O
mechanism NN I-NP O
for IN B-PP O
idiopathic JJ B-NP B-Disease
ventricular JJ I-NP I-Disease
fibrillation NN I-NP I-Disease
. . O O

Ventricular JJ B-NP B-Disease
fibrillation NN I-NP I-Disease
causes VBZ B-VP O
more JJR B-NP O
than IN I-NP O
300 CD I-NP O
, , I-NP O
000 CD I-NP O
sudden JJ I-NP O
deaths NNS I-NP O
each DT B-NP O
year NN I-NP O
in IN B-PP O
the DT B-NP O
USA NNP I-NP O
alone RB B-ADVP O
. . O O

In IN B-PP O
approximately RB B-NP O
5 CD I-NP O
- HYPH I-NP O
12 CD I-NP O
% NN I-NP O
of IN B-PP O
these DT B-NP O
cases NNS I-NP O
, , O O
there EX B-NP O
are VBP B-VP O
no DT B-NP O
demonstrable JJ I-NP O
cardiac JJ I-NP O
or CC I-NP O
non AFX I-NP O
- HYPH I-NP O
cardiac JJ I-NP O
causes NNS I-NP O
to TO B-VP O
account VB I-VP O
for IN B-PP O
the DT B-NP O
episode NN I-NP O
, , O O
which WDT B-NP O
is VBZ B-VP O
therefore RB I-VP O
classified VBN I-VP O
as IN B-PP O
idiopathic JJ B-NP B-Disease
ventricular JJ I-NP I-Disease
fibrillation NN I-NP I-Disease
( ( O O
IVF NN B-NP B-Disease
) ) O O
. . O O

A DT B-NP O
distinct JJ I-NP O
group NN I-NP O
of IN B-PP O
IVF NN B-NP B-Disease
patients NNS I-NP O
has VBZ B-VP O
been VBN I-VP O
found VBN I-VP O
to TO I-VP O
present VB I-VP O
with IN B-PP O
a DT B-NP O
characteristic JJ I-NP O
electrocardiographic JJ I-NP O
pattern NN I-NP O
. . O O

Because IN B-PP O
of IN I-PP O
the DT B-NP O
small JJ I-NP O
size NN I-NP O
of IN B-PP O
most JJS B-NP O
pedigrees NNS I-NP O
and CC O O
the DT B-NP O
high JJ I-NP O
incidence NN I-NP O
of IN B-PP O
sudden JJ B-NP B-Disease
death NN I-NP I-Disease
, , O O
however RB B-ADVP O
, , O O
molecular JJ B-NP O
genetic JJ I-NP O
studies NNS I-NP O
of IN B-PP O
IVF NN B-NP B-Disease
have VBP B-VP O
not RB I-VP O
yet RB I-VP O
been VBN I-VP O
done VBN I-VP O
. . O O

Because IN B-SBAR O
IVF NN B-NP B-Disease
causes VBZ B-VP O
cardiac JJ B-NP O
rhythm NN I-NP O
disturbance NN I-NP O
, , O O
we PRP B-NP O
investigated VBD B-VP O
whether IN B-SBAR O
malfunction NN B-NP O
of IN B-PP O
ion NN B-NP O
channels NNS I-NP O
could MD B-VP O
cause VB I-VP O
the DT B-NP O
disorder NN I-NP O
by IN B-PP O
studying VBG B-VP O
mutations NNS B-NP O
in IN B-PP O
the DT B-NP O
cardiac JJ I-NP O
sodium NN I-NP O
channel NN I-NP O
gene NN I-NP O
SCN5A NN I-NP O
. . O O

We PRP B-NP O
have VBP B-VP O
now RB I-VP O
identified VBN I-VP O
a DT B-NP O
missense JJ I-NP O
mutation NN I-NP O
, , O O
a DT B-NP O
splice NN I-NP O
- HYPH I-NP O
donor NN I-NP O
mutation NN I-NP O
, , O O
and CC O O
a DT B-NP O
frameshift NN I-NP O
mutation NN I-NP O
in IN B-PP O
the DT B-NP O
coding VBG I-NP O
region NN I-NP O
of IN B-PP O
SCN5A NN B-NP O
in IN B-PP O
three CD B-NP O
IVF NN I-NP B-Disease
families NNS I-NP O
. . O O

We PRP B-NP O
show VBP B-VP O
that IN B-SBAR O
sodium NN B-NP O
channels NNS I-NP O
with IN B-PP O
the DT B-NP O
missense JJ I-NP O
mutation NN I-NP O
recover NN I-NP O
from IN B-PP O
inactivation NN B-NP O
more RBR B-ADVP O
rapidly RB I-ADVP O
than IN B-PP O
normal JJ B-ADJP O
and CC O O
that IN B-SBAR O
the DT B-NP O
frameshift NN I-NP O
mutation NN I-NP O
causes VBZ B-VP O
the DT B-NP O
sodium NN I-NP O
channel NN I-NP O
to TO B-VP O
be VB I-VP O
non AFX B-ADJP O
- HYPH I-ADJP O
functional JJ I-ADJP O
. . O O

Our PRP$ B-NP O
results NNS I-NP O
indicate VBP B-VP O
that IN B-SBAR O
mutations NNS B-NP O
in IN B-PP O
cardiac JJ B-NP O
ion NN I-NP O
- HYPH B-NP O
channel NN I-NP O
genes NNS I-NP O
contribute VBP B-VP O
to TO B-PP O
the DT B-NP O
risk NN I-NP O
of IN B-PP O
developing VBG B-VP O
IVF NN B-NP B-Disease
. . O O

. . O O

Molecular JJ B-NP O
heterogeneity NN I-NP O
in IN B-PP O
mucopolysaccharidosis NN B-NP B-Disease
IVA NN I-NP I-Disease
in IN B-PP O
Australia NNP B-NP O
and CC I-NP O
Northern NNP I-NP O
Ireland NNP I-NP O
: : O O
nine CD B-NP O
novel JJ I-NP O
mutations NNS I-NP O
including VBG B-PP O
T312S NN B-NP O
, , O O
a DT B-NP O
common JJ I-NP O
allele NN I-NP O
that WDT B-NP O
confers VBZ B-VP O
a DT B-NP O
mild JJ I-NP O
phenotype NN I-NP O
. . O O

Mucopolysaccharidosis NN B-NP B-Disease
IVA NN I-NP I-Disease
( ( O O
MPS NN B-NP B-Disease
IVA NN I-NP I-Disease
) ) O O
is VBZ B-VP O
an DT B-NP O
autosomal JJ I-NP B-Disease
recessive JJ I-NP I-Disease
lysosomal JJ I-NP I-Disease
storage NN I-NP I-Disease
disorder NN I-NP I-Disease
caused VBN B-VP O
by IN B-PP O
a DT B-NP O
genetic JJ I-NP B-Disease
defect NN I-NP I-Disease
in IN B-PP O
N NN B-NP O
- HYPH B-NP O
acetylgalactosamine NN I-NP O
- HYPH B-NP O
6 CD I-NP O
- HYPH I-NP O
sulfate NN I-NP O
sulfatase NN I-NP O
( ( O O
GALNS NN B-NP O
) ) O O
. . O O

Previous JJ B-NP O
studies NNS I-NP O
of IN B-PP O
patients NNS B-NP O
from IN B-PP O
a DT B-NP O
British JJ I-NP O
- HYPH I-NP O
Irish JJ I-NP O
population NN I-NP O
showed VBD B-VP O
that IN B-SBAR O
the DT B-NP O
I113F NN I-NP O
mutation NN I-NP O
is VBZ B-VP O
the DT B-NP O
most RBS I-NP O
common JJ I-NP O
single JJ I-NP O
mutation NN I-NP O
among IN B-PP O
MPS NN B-NP B-Disease
IVA NN I-NP I-Disease
patients NNS I-NP O
and CC O O
produces VBZ B-VP O
a DT B-NP O
severe JJ I-NP O
clinical JJ I-NP O
phenotype NN I-NP O
. . O O

We PRP B-NP O
studied VBD B-VP O
mutations NNS B-NP O
in IN B-PP O
the DT B-NP O
GALNS NN I-NP O
gene NN I-NP O
from IN B-PP O
23 CD B-NP O
additional JJ I-NP O
MPS NN I-NP B-Disease
IVA NN I-NP I-Disease
patients NNS I-NP O
( ( O O
15 CD B-NP O
from IN B-PP O
Australia NNP B-NP O
, , O O
8 CD B-NP O
from IN B-PP O
Northern NNP B-NP O
Ireland NNP I-NP O
) ) O O
, , O O
with IN B-PP O
various JJ B-NP O
clinical JJ I-NP O
phenotypes NNS I-NP O
( ( O O
severe JJ B-ADJP O
, , O O
16 CD B-NP O
cases NNS I-NP O
; : O O
intermediate NN B-NP O
, , O O
4 CD B-NP O
cases NNS I-NP O
; : O O
mild JJ B-ADJP O
, , O O
3 CD B-NP O
cases NNS I-NP O
) ) O O
. . O O

We PRP B-NP O
found VBD B-VP O
two CD B-NP O
common JJ I-NP O
mutations NNS I-NP O
that WDT B-NP O
together RB B-ADVP O
accounted VBD B-VP O
for IN B-PP O
32 CD B-NP O
% NN I-NP O
of IN B-PP O
the DT B-NP O
44 CD I-NP O
unrelated JJ I-NP O
alleles NNS I-NP O
in IN B-PP O
these DT B-NP O
patients NNS I-NP O
. . O O

One CD B-NP O
is VBZ B-VP O
the DT B-NP O
T312S NN I-NP O
mutation NN I-NP O
, , O O
a DT B-NP O
novel JJ I-NP O
mutation NN I-NP O
found VBN B-VP O
exclusively RB B-ADVP O
in IN B-PP O
milder NN B-NP O
patients NNS I-NP O
. . O O

The DT B-NP O
other JJ I-NP O
is VBZ B-VP O
the DT B-NP O
previously RB I-NP O
described VBN I-NP O
I113F NN I-NP O
that WDT B-NP O
produces VBZ B-VP O
a DT B-NP O
severe JJ I-NP O
phenotype NN I-NP O
. . O O

The DT B-NP O
I113F NN I-NP O
and CC I-NP O
T312S NN I-NP O
mutations NNS I-NP O
accounted VBD B-VP O
for IN B-PP O
8 CD B-NP O
( ( O O
18 CD B-NP O
% NN I-NP O
) ) O O
and CC O O
6 CD B-NP O
( ( O O
14 CD B-NP O
% NN I-NP O
) ) O O
of IN B-PP O
44 CD B-NP O
unrelated JJ I-NP O
alleles NNS I-NP O
, , O O
respectively RB B-ADVP O
. . O O

The DT B-NP O
relatively RB I-NP O
high JJ I-NP O
residual JJ I-NP O
GALNS NN I-NP O
activity NN I-NP O
seen VBN B-VP O
when WRB B-ADVP O
the DT B-NP O
T312S NN I-NP O
mutant JJ I-NP O
cDNA NN I-NP O
is VBZ B-VP O
overexpressed VBN I-VP O
in IN B-PP O
mutant JJ B-NP O
cells NNS I-NP O
provides VBZ B-VP O
an DT B-NP O
explanation NN I-NP O
for IN B-PP O
the DT B-NP O
mild JJ I-NP O
phenotype NN I-NP O
in IN B-PP O
patients NNS B-NP O
with IN B-PP O
this DT B-NP O
mutation NN I-NP O
. . O O

The DT B-NP O
distribution NN I-NP O
and CC I-NP O
relative JJ I-NP O
frequencies NNS I-NP O
of IN B-PP O
the DT B-NP O
I113F NN I-NP O
and CC I-NP O
T312S NN I-NP O
mutations NNS I-NP O
in IN B-PP O
Australia NNP B-NP O
corresponded VBD B-VP O
to TO B-PP O
those DT B-NP O
observed VBN B-VP O
in IN B-PP O
Northern NNP B-NP O
Ireland NNP I-NP O
and CC O O
are VBP B-VP O
unique JJ B-ADJP O
to TO B-PP O
these DT B-NP O
two CD I-NP O
populations NNS I-NP O
, , O O
suggesting VBG B-VP O
that IN B-SBAR O
both DT B-NP O
mutations NNS I-NP O
were VBD B-VP O
probably RB I-VP O
introduced VBN I-VP O
to TO B-PP O
Australia NNP B-NP O
by IN B-PP O
Irish JJ B-NP O
migrants NNS I-NP O
during IN B-PP O
the DT B-NP O
19th JJ I-NP O
century NN I-NP O
. . O O

Haplotype NN B-NP O
analysis NN I-NP O
using VBG B-VP O
6 CD B-NP O
RFLPs NNS I-NP O
provides VBZ B-VP O
additional JJ B-NP O
data NNS I-NP O
that IN B-SBAR O
the DT B-NP O
I113F NN I-NP O
mutation NN I-NP O
originated VBD B-VP O
from IN B-PP O
a DT B-NP O
common JJ I-NP O
ancestor NN I-NP O
. . O O

The DT B-NP O
other JJ I-NP O
9 CD I-NP O
novel JJ I-NP O
mutations NNS I-NP O
identified VBN B-VP O
in IN B-PP O
these DT B-NP O
23 CD I-NP O
patients NNS I-NP O
were VBD B-VP O
each DT O O
limited VBN B-VP O
to TO B-PP O
a DT B-NP O
single JJ I-NP O
family NN I-NP O
. . O O

These DT B-NP O
data NNS I-NP O
provide VBP B-VP O
further JJ B-NP O
evidence NN I-NP O
for IN B-PP O
extensive JJ B-NP O
allelic JJ I-NP O
heterogeneity NN I-NP O
in IN B-PP O
MPS NN B-NP B-Disease
IVA NN I-NP I-Disease
in IN B-PP O
British JJ B-NP O
- HYPH I-NP O
Irish JJ I-NP O
patients NNS I-NP O
and CC O O
provide VBP B-VP O
evidence NN B-NP O
for IN B-PP O
their PRP$ B-NP O
transmission NN I-NP O
to TO B-PP O
Australia NNP B-NP O
by IN B-PP O
British JJ B-NP O
- HYPH I-NP O
Irish JJ I-NP O
migrants NNS I-NP O
. . O O

. . O O

Identification NN B-NP O
of IN B-PP O
constitutional JJ B-NP O
WT1 NN I-NP O
mutations NNS I-NP O
, , O O
in IN B-PP O
patients NNS B-NP O
with IN B-PP O
isolated VBN B-NP O
diffuse JJ I-NP B-Disease
mesangial JJ I-NP I-Disease
sclerosis NN I-NP I-Disease
, , O O
and CC O O
analysis NN B-NP O
of IN B-PP O
genotype NN B-NP O
/ SYM B-NP O
phenotype NN I-NP O
correlations NNS I-NP O
by IN B-PP O
use NN B-NP O
of IN B-PP O
a DT B-NP O
computerized JJ I-NP O
mutation NN I-NP O
database NN I-NP O
. . O O

Constitutional JJ B-NP O
mutations NNS I-NP O
of IN B-PP O
the DT B-NP O
WT1 NN I-NP O
gene NN I-NP O
, , O O
encoding VBG B-VP O
a DT B-NP O
zinc NN I-NP O
- HYPH B-NP O
finger NN I-NP O
transcription NN I-NP O
factor NN I-NP O
involved VBN B-VP O
in IN B-PP O
renal JJ B-NP O
and CC I-NP O
gonadal JJ I-NP O
development NN I-NP O
, , O O
are VBP B-VP O
found VBN I-VP O
in IN B-PP O
most JJS B-NP O
patients NNS I-NP O
with IN B-PP O
Denys NNPS B-NP B-Disease
- HYPH B-NP I-Disease
Drash NN I-NP I-Disease
syndrome NN I-NP I-Disease
( ( O O
DDS NN B-NP B-Disease
) ) O O
, , O O
or CC O O
diffuse JJ B-NP B-Disease
mesangial JJ I-NP I-Disease
sclerosis NN I-NP I-Disease
( ( O O
DMS NN B-NP B-Disease
) ) O O
associated VBN B-VP O
with IN B-PP O
pseudohermaphroditism NN B-NP B-Disease
and CC O O
/ SYM B-NP O
or CC O O
Wilms NNP B-NP B-Disease
tumor NN I-NP I-Disease
( ( O O
WT NN B-NP B-Disease
) ) O O
. . O O

Most JJS B-NP O
mutations NNS I-NP O
in IN B-PP O
DDS NN B-NP B-Disease
patients NNS I-NP O
lie VBP B-VP O
in IN B-PP O
exon NN B-NP O
8 CD I-NP O
or CC O O
exon NN B-NP O
9 CD I-NP O
, , O O
encoding VBG B-VP O
zinc NN B-NP O
finger NN I-NP O
2 CD I-NP O
or CC I-NP O
zinc NN I-NP O
finger NN I-NP O
3 CD I-NP O
, , O O
respectively RB B-ADVP O
, , O O
with IN B-PP O
a DT B-NP O
hot JJ I-NP O
spot NN I-NP O
( ( O O
R394W NN B-NP O
) ) O O
in IN B-PP O
exon NN B-NP O
9 CD I-NP O
. . O O

We PRP B-NP O
analyzed VBD B-VP O
a DT B-NP O
series NN I-NP O
of IN B-PP O
24 CD B-NP O
patients NNS I-NP O
, , O O
10 CD B-NP O
with IN B-PP O
isolated VBN B-NP B-Disease
DMS NN I-NP I-Disease
( ( O O
IDMS NN B-NP B-Disease
) ) O O
, , O O
10 CD B-NP O
with IN B-PP O
DDS NN B-NP B-Disease
, , O O
and CC O O
4 CD B-NP O
with IN B-PP O
urogenital JJ B-NP B-Disease
abnormalities NNS I-NP I-Disease
and CC O O
/ SYM B-NP O
or CC O O
WT NN B-NP B-Disease
. . O O

We PRP B-NP O
report VBP B-VP O
WT1 NN B-NP O
heterozygous JJ I-NP O
mutations NNS I-NP O
in IN B-PP O
16 CD B-NP O
patients NNS I-NP O
, , O O
4 CD B-NP O
of IN B-PP O
whom WP B-NP O
presented VBD B-VP O
with IN B-PP O
IDMS NN B-NP B-Disease
. . O O

One CD B-NP O
male JJ I-NP O
and CC O O
two CD B-NP O
female JJ I-NP O
IDMS NN I-NP B-Disease
patients NNS I-NP O
with IN B-PP O
WT1 NN B-NP O
mutations NNS I-NP O
underwent VBD B-VP O
normal JJ B-NP O
puberty NN I-NP O
. . O O

Two CD B-NP O
mutations NNS I-NP O
associated VBN B-VP O
with IN B-PP O
IDMS NN B-NP B-Disease
are VBP B-VP O
different JJ B-ADJP O
from IN B-PP O
those DT B-NP O
described VBN B-VP O
in IN B-PP O
DDS NN B-NP B-Disease
patients NNS I-NP O
. . O O

No DT B-NP O
WT1 NN I-NP O
mutations NNS I-NP O
were VBD B-VP O
detected VBN I-VP O
in IN B-PP O
the DT B-NP O
six CD I-NP O
other JJ I-NP O
IDMS NN I-NP B-Disease
patients NNS I-NP O
, , O O
suggesting VBG B-VP O
genetic JJ B-NP O
heterogeneity NN I-NP O
of IN B-PP O
this DT B-NP O
disease NN I-NP O
. . O O

We PRP B-NP O
analyzed VBD B-VP O
genotype NN B-NP O
/ SYM B-NP O
phenotype NN I-NP O
correlations NNS I-NP O
, , O O
on IN B-PP O
the DT B-NP O
basis NN I-NP O
of IN B-PP O
the DT B-NP O
constitution NN I-NP O
of IN B-PP O
a DT B-NP O
WT1 NN I-NP O
mutation NN I-NP O
database NN I-NP O
of IN B-PP O
84 CD B-NP O
germ NN I-NP O
- HYPH B-NP O
line NN I-NP O
mutations NNS I-NP O
, , O O
to TO B-VP O
compare VB I-VP O
the DT B-NP O
distribution NN I-NP O
and CC I-NP O
type NN I-NP O
of IN B-PP O
mutations NNS B-NP O
, , O O
according VBG B-PP O
to TO B-PP O
the DT B-NP O
different JJ I-NP O
symptoms NNS I-NP O
. . O O

This DT B-NP O
demonstrated VBD B-VP O
( ( B-LST O
1 LS I-LST O
) ) O O
the DT B-NP O
association NN I-NP O
between IN B-PP O
mutations NNS B-NP O
in IN B-PP O
exons NNS B-NP O
8 CD B-NP O
and CC I-NP O
9 CD I-NP O
and CC O O
DMS NN B-NP B-Disease
; : O O
( ( B-LST O
2 LS I-LST O
) ) O O
among IN B-PP O
patients NNS B-NP O
with IN B-PP O
DMS NN B-NP B-Disease
, , O O
a DT B-NP O
higher JJR I-NP O
frequency NN I-NP O
of IN B-PP O
exon NN B-NP O
8 CD B-NP O
mutations NNS I-NP O
among IN B-PP O
46 CD B-NP O
, , O O
XY NN B-NP O
patients NNS I-NP O
with IN B-PP O
female JJ B-NP O
phenotype NN I-NP O
than IN B-PP O
among IN B-PP O
46 CD B-NP O
, , O O
XY NN B-NP O
patients NNS I-NP O
with IN B-PP O
sexual JJ B-NP O
ambiguity NN I-NP O
or CC O O
male JJ B-NP O
phenotype NN I-NP O
; : O O
and CC O O
( ( B-LST O
3 LS I-LST O
) ) O O
statistically RB B-NP O
significant JJ I-NP O
evidence NN I-NP O
that IN B-SBAR O
mutations NNS B-NP O
in IN B-PP O
exons NNS B-NP O
8 CD B-NP O
and CC I-NP O
9 CD I-NP O
preferentially RB B-VP O
affect VB I-VP O
amino NN B-NP O
acids NNS I-NP O
with IN B-PP O
different JJ B-NP O
functions NNS I-NP O
. . O O

. . O O

The DT B-NP O
185delAG NN I-NP O
BRCA1 NN I-NP O
mutation NN I-NP O
originated VBD B-VP O
before IN B-SBAR O
the DT B-NP O
dispersion NN I-NP O
of IN B-PP O
Jews NNPS B-NP O
in IN B-PP O
the DT B-NP O
diaspora NN I-NP O
and CC O O
is VBZ B-VP O
not RB I-VP O
limited VBN I-VP O
to TO B-PP O
Ashkenazim NNP B-NP O
. . O O

The DT B-NP O
185delAG NN I-NP O
mutation NN I-NP O
in IN B-PP O
BRCA1 NN B-NP O
is VBZ B-VP O
detected VBN I-VP O
in IN B-PP O
Ashkenazi NNP B-NP O
Jews NNP I-NP O
both CC B-PP O
in IN B-PP O
familial JJ B-NP B-Disease
breast NN I-NP I-Disease
and CC O I-Disease
ovarian JJ B-NP I-Disease
cancer NN I-NP I-Disease
and CC B-PP O
in IN B-PP O
the DT B-NP O
general JJ I-NP O
population NN I-NP O
. . O O

All DT B-NP O
tested VBN I-NP O
Ashkenazi NNP I-NP O
mutation NN I-NP O
carriers NNS I-NP O
share VBP B-VP O
the DT B-NP O
same JJ I-NP O
allelic JJ I-NP O
pattern NN I-NP O
at IN B-PP O
the DT B-NP O
BRCA1 NN I-NP O
locus NN I-NP O
. . O O

Our PRP$ B-NP O
previous JJ I-NP O
study NN I-NP O
showed VBD B-VP O
that IN B-SBAR O
this DT B-NP O
Ashkenazi NNP I-NP O
mutation NN I-NP O
also RB B-ADVP O
occurs VBZ B-VP O
in IN B-PP O
Iraqi NNP B-NP O
Jews NNPS I-NP O
with IN B-PP O
a DT B-NP O
similar JJ I-NP O
allelic JJ I-NP O
pattern NN I-NP O
. . O O

We PRP B-NP O
extended VBD B-VP O
our PRP$ B-NP O
analysis NN I-NP O
to TO B-PP O
other JJ B-NP O
non AFX I-NP O
- HYPH I-NP O
Ashkenazi NN I-NP O
subsets NNS I-NP O
354 CD B-NP O
of IN B-PP O
Moroccan NNP B-NP O
origin NN I-NP O
, , O O
200 CD B-NP O
Yemenites NNS I-NP O
and CC O O
150 CD B-NP O
Iranian JJ I-NP O
Jews NNS I-NP O
. . O O

Heteroduplex NN B-NP O
analysis NN I-NP O
complemented VBN B-VP O
by IN B-PP O
direct JJ B-NP O
DNA NN I-NP O
sequencing NN I-NP O
of IN B-PP O
abnormally RB B-VP O
migrating VBG I-VP O
bands NNS B-NP O
were VBD B-VP O
employed VBN I-VP O
. . O O

Four CD B-NP O
of IN B-PP O
Moroccan NN B-NP O
origin NN I-NP O
( ( O O
1 CD B-NP O
. . O O

1 CD B-NP O
% NN I-NP O
) ) O O
and CC O O
none NN B-NP O
of IN B-PP O
the DT B-NP O
Yemenites NNPS I-NP O
or CC I-NP O
Iranians NNPS I-NP O
was VBD B-VP O
a DT B-NP O
carrier NN I-NP O
of IN B-PP O
the DT B-NP O
185delAG NN I-NP O
mutation NN I-NP O
. . O O

BRCA1 NN B-NP O
allelic JJ I-NP O
patterns NNS I-NP O
were VBD B-VP O
determined VBN I-VP O
for IN B-PP O
four CD B-NP O
of IN B-PP O
these DT B-NP O
individuals NNS I-NP O
and CC O O
for IN B-PP O
12 CD B-NP O
additional JJ I-NP O
non AFX I-NP O
- HYPH I-NP O
Ashkenazi NN I-NP O
185delAG NN I-NP O
mutation NN I-NP O
carriers NNS I-NP O
who WP B-NP O
had VBD B-VP O
breast NN B-NP B-Disease
/ SYM O I-Disease
ovarian JJ B-NP I-Disease
cancer NN I-NP I-Disease
. . O O

Six CD B-NP O
non AFX I-NP O
- HYPH I-NP O
Ashkenazi NN I-NP O
individuals NNS I-NP O
shared VBD B-VP O
the DT B-NP O
common JJ I-NP O
Ashkenazi NNP I-NP O
haplotype NN I-NP O
, , O O
four CD B-NP O
had VBD B-VP O
a DT B-NP O
closely RB I-NP O
related JJ I-NP O
pattern NN I-NP O
, , O O
and CC O O
the DT B-NP O
rest NN I-NP O
( ( O O
n NN B-NP O
= SYM B-VP O
6 CD B-NP O
) ) O O
displayed VBD B-VP O
a DT B-NP O
distinct JJ I-NP O
BRCA1 NN I-NP O
allelic JJ I-NP O
pattern NN I-NP O
. . O O

We PRP B-NP O
conclude VBP B-VP O
that IN B-SBAR O
the DT B-NP O
185delAG NN I-NP O
BRCA1 NN I-NP O
mutation NN I-NP O
occurs VBZ B-VP O
in IN B-PP O
some DT B-NP O
non AFX I-NP O
- HYPH I-NP O
Ashkenazi NN I-NP O
populations NNS I-NP O
at IN B-PP O
rates NNS B-NP O
comparable JJ B-ADJP O
with IN B-PP O
that DT B-NP O
of IN B-PP O
Ashkenazim NN B-NP O
. . O O

The DT B-NP O
majority NN I-NP O
of IN B-PP O
Jewish JJ B-NP O
185delAG NN I-NP O
mutation NN I-NP O
carriers NNS I-NP O
have VBP B-VP O
a DT B-NP O
common JJ I-NP O
allelic JJ I-NP O
pattern NN I-NP O
, , O O
supporting VBG B-VP O
the DT B-NP O
founder NN I-NP O
effect NN I-NP O
notion NN I-NP O
, , O O
but CC O O
dating VBG B-VP O
the DT B-NP O
mutations NNS I-NP O
origin VBP B-VP O
to TO B-PP O
an DT B-NP O
earlier JJR I-NP O
date NN I-NP O
than IN B-SBAR O
currently RB B-ADVP O
estimated VBN B-VP O
. . O O

However RB B-ADVP O
, , O O
the DT B-NP O
different JJ I-NP O
allelic JJ I-NP O
pattern NN I-NP O
at IN B-PP O
the DT B-NP O
BRCA1 NN I-NP O
locus NN I-NP O
even RB B-ADVP O
in IN B-PP O
some DT B-NP O
Jewish JJ I-NP O
mutation NN I-NP O
carriers NNS I-NP O
, , O O
might MD B-VP O
suggest VB I-VP O
that IN B-SBAR O
the DT B-NP O
mutation NN I-NP O
arose VBD B-VP O
independently RB B-ADVP O
. . O O

. . O O

Crystal JJ B-NP O
structure NN I-NP O
of IN B-PP O
the DT B-NP O
hemochromatosis NN I-NP B-Disease
protein NN I-NP O
HFE NN I-NP O
and CC O O
characterization NN B-NP O
of IN B-PP O
its PRP$ B-NP O
interaction NN I-NP O
with IN B-PP O
transferrin NN B-NP O
receptor NN I-NP O
. . O O

HFE NN B-NP O
is VBZ B-VP O
an DT B-NP O
MHC NN I-NP O
- HYPH B-NP O
related VBN I-NP O
protein NN I-NP O
that WDT B-NP O
is VBZ B-VP O
mutated VBN I-VP O
in IN B-PP O
the DT B-NP O
iron NN I-NP B-Disease
- HYPH B-NP I-Disease
overload NN I-NP I-Disease
disease NN I-NP I-Disease
hereditary JJ I-NP B-Disease
hemochromatosis NN I-NP I-Disease
. . O O

HFE NN B-NP O
binds VBZ B-VP O
to TO B-PP O
transferrin NN B-NP O
receptor NN I-NP O
( ( O O
TfR NN B-NP O
) ) O O
and CC O O
reduces VBZ B-VP O
its PRP$ B-NP O
affinity NN I-NP O
for IN B-PP O
iron NN B-NP O
- HYPH B-NP O
loaded VBN I-NP O
transferrin NN I-NP O
, , O O
implicating VBG B-VP O
HFE NN B-NP O
in IN B-PP O
iron NN B-NP O
metabolism NN I-NP O
. . O O

The DT B-NP O
2 CD I-NP O
. . O O

6 CD B-NP O
A NN I-NP O
crystal NN I-NP O
structure NN I-NP O
of IN B-PP O
HFE NN B-NP O
reveals VBZ B-VP O
the DT B-NP O
locations NNS I-NP O
of IN B-PP O
hemochromatosis NN B-NP B-Disease
mutations NNS I-NP O
and CC O O
a DT B-NP O
patch NN I-NP O
of IN B-PP O
histidines NNS B-NP O
that WDT B-NP O
could MD B-VP O
be VB I-VP O
involved VBN I-VP O
in IN B-PP O
pH NN B-NP O
- HYPH B-NP O
dependent JJ I-NP O
interactions NNS I-NP O
. . O O

We PRP B-NP O
also RB B-ADVP O
demonstrate VBP B-VP O
that IN B-SBAR O
soluble JJ B-NP O
TfR NN I-NP O
and CC I-NP O
HFE NN I-NP O
bind VBP B-VP O
tightly RB B-ADVP O
at IN B-PP O
the DT B-NP O
basic JJ I-NP O
pH NN I-NP O
of IN B-PP O
the DT B-NP O
cell NN I-NP O
surface NN I-NP O
, , O O
but CC O O
not RB O O
at IN B-PP O
the DT B-NP O
acidic JJ I-NP O
pH NN I-NP O
of IN B-PP O
intracellular JJ B-NP O
vesicles NNS I-NP O
. . O O

TfR NN B-NP O
HFE NN I-NP O
stoichiometry NN I-NP O
( ( O O
2 CD B-NP O
1 CD I-NP O
) ) O O
differs VBZ B-VP O
from IN B-PP O
TfR NN B-NP O
transferrin NN I-NP O
stoichiometry NN I-NP O
( ( O O
2 CD B-NP O
2 CD I-NP O
) ) O O
, , O O
implying VBG B-VP O
a DT B-NP O
different JJ I-NP O
mode NN I-NP O
of IN B-PP O
binding NN B-NP O
for IN B-PP O
HFE NN B-NP O
and CC I-NP O
transferrin NN I-NP O
to TO B-PP O
TfR NN B-NP O
, , O O
consistent JJ B-ADJP O
with IN B-PP O
our PRP$ B-NP O
demonstration NN I-NP O
that IN B-SBAR O
HFE NN B-NP O
, , O O
transferrin NN B-NP O
, , O O
and CC O O
TfR NN B-NP O
form VBP B-VP O
a DT B-NP O
ternary JJ I-NP O
complex NN I-NP O
. . O O

Identification NN B-NP O
of IN B-PP O
three CD B-NP O
novel JJ I-NP O
mutations NNS I-NP O
and CC O O
a DT B-NP O
high JJ I-NP O
frequency NN I-NP O
of IN B-PP O
the DT B-NP O
Arg778Leu NN I-NP O
mutation NN I-NP O
in IN B-PP O
Korean JJ B-NP O
patients NNS I-NP O
with IN B-PP O
Wilson NNP B-NP B-Disease
disease NN I-NP I-Disease
. . O O

Four CD B-NP O
mutations NNS I-NP O
- SYM O O
- HYPH O O
R778L NN B-NP O
, , O O
A874V NN B-NP O
, , O O
L1083F NN B-NP O
, , O O
and CC O O
2304delC NN B-NP O
- HYPH O O
- SYM B-NP O
in IN B-PP O
the DT B-NP O
copper NN I-NP O
- HYPH O O
transporting VBG B-VP O
enzyme NN B-NP O
, , O O
P NN B-NP O
- HYPH I-NP O
type NN I-NP O
ATPase NN I-NP O
( ( O O
ATP7B NN B-NP O
) ) O O
, , O O
were VBD B-VP O
identified VBN I-VP O
in IN B-PP O
Korean JJ B-NP O
Patients NNS I-NP O
with IN B-PP O
Wilson NNP B-NP B-Disease
disease NN I-NP I-Disease
. . O O

Arg778Leu NN B-NP O
, , O O
the DT B-NP O
most RBS I-NP O
frequently RB I-NP O
reported VBN I-NP O
mutation NN I-NP O
of IN B-PP O
this DT B-NP O
enzyme NN I-NP O
, , O O
was VBD B-VP O
found VBN I-VP O
in IN B-PP O
six CD B-NP O
of IN B-PP O
eight CD B-NP O
unrelated JJ I-NP O
patients NNS I-NP O
studied VBN B-VP O
, , O O
an DT B-NP O
allele NN I-NP O
frequency NN I-NP O
of IN B-PP O
37 CD B-NP O
. . O O

5 CD B-NP O
% NN I-NP O
, , O O
which WDT B-NP O
is VBZ B-VP O
considerably RB B-ADJP O
higher JJR I-ADJP O
than IN B-PP O
those DT B-NP O
in IN B-PP O
other JJ B-NP O
Asian JJ I-NP O
populations NNS I-NP O
. . O O

The DT B-NP O
novel JJ I-NP O
single JJ I-NP O
nucleotide NN I-NP O
deletion NN I-NP O
, , O O
2304delC NN B-NP O
, , O O
was VBD B-VP O
found VBN I-VP O
in IN B-PP O
one CD B-NP O
patient NN I-NP O
. . O O

Since IN B-SBAR O
a DT B-NP O
mutation NN I-NP O
at IN B-PP O
cDNA NN B-NP O
nucleotide NN I-NP O
2302 CD I-NP O
( ( O O
2302insC NN B-NP O
) ) O O
had VBD B-VP O
been VBN I-VP O
previously RB I-VP O
described VBN I-VP O
, , O O
this DT B-NP O
region NN I-NP O
of IN B-PP O
the DT B-NP O
ATP7B NN I-NP O
gene NN I-NP O
may MD B-VP O
be VB I-VP O
susceptible JJ B-ADJP O
to TO B-PP O
gene NN B-NP O
rearrangements NNS I-NP O
causing VBG B-VP O
Wilson NNP B-NP B-Disease
disease NN I-NP I-Disease
. . O O

Disruption NN B-NP O
of IN B-PP O
splicing NN B-NP O
regulated VBN B-VP O
by IN B-PP O
a DT B-NP O
CUG NN I-NP O
- HYPH O O
binding VBG B-NP O
protein NN I-NP O
in IN B-PP O
myotonic JJ B-NP B-Disease
dystrophy NN I-NP I-Disease
. . O O

Myotonic JJ B-NP B-Disease
dystrophy NN I-NP I-Disease
( ( O O
DM NN B-NP B-Disease
) ) O O
is VBZ B-VP O
caused VBN I-VP O
by IN B-PP O
a DT B-NP O
CTG NN I-NP O
expansion NN I-NP O
in IN B-PP O
the DT B-NP O
3 CD I-NP O
untranslated JJ I-NP O
region NN I-NP O
of IN B-PP O
the DT B-NP O
DM NN I-NP B-Disease
gene NN I-NP O
. . O O

One CD B-NP O
model NN I-NP O
of IN B-PP O
DM NN B-NP B-Disease
pathogenesis NN I-NP O
suggests VBZ B-VP O
that IN B-SBAR O
RNAs NNS B-NP O
from IN B-PP O
the DT B-NP O
expanded VBN I-NP O
allele NN I-NP O
create VB B-VP O
a DT B-NP O
gain NN I-NP O
- HYPH B-NP O
of IN B-PP O
- HYPH B-NP O
function NN I-NP O
mutation NN I-NP O
by IN B-PP O
the DT B-NP O
inappropriate JJ I-NP O
binding NN I-NP O
of IN B-PP O
proteins NNS B-NP O
to TO B-PP O
the DT B-NP O
CUG NN I-NP O
repeats NNS I-NP O
. . O O

Data NNS B-NP O
presented VBN B-VP O
here RB B-ADVP O
indicate VBP B-VP O
that IN B-SBAR O
the DT B-NP O
conserved VBN I-NP O
heterogeneous JJ I-NP O
nuclear JJ I-NP O
ribonucleoprotein NN I-NP O
, , O O
CUG NN B-NP O
- HYPH O O
binding VBG B-VP O
protein NN B-NP O
( ( O O
CUG NN B-NP O
- HYPH B-NP O
BP NN I-NP O
) ) O O
, , O O
may MD B-VP O
mediate VB I-VP O
the DT B-NP O
trans AFX I-NP O
- HYPH I-NP O
dominant JJ I-NP O
effect NN I-NP O
of IN B-PP O
the DT B-NP O
RNA NN I-NP O
. . O O

CUG NN B-NP O
- HYPH I-NP O
BP NN I-NP O
was VBD B-VP O
found VBN I-VP O
to TO I-VP O
bind VB I-VP O
to TO B-PP O
the DT B-NP O
human JJ I-NP O
cardiac JJ I-NP O
troponin NN I-NP O
T NN I-NP O
( ( O O
cTNT NN B-NP O
) ) O O
pre AFX O O
- HYPH O O
messenger NN B-NP O
RNA NN I-NP O
and CC O O
regulate VB B-VP O
its PRP$ B-NP O
alternative JJ I-NP O
splicing NN I-NP O
. . O O

Splicing NN B-NP O
of IN B-PP O
cTNT NN B-NP O
was VBD B-VP O
disrupted VBN I-VP O
in IN B-PP O
DM NN B-NP B-Disease
striated VBN I-NP O
muscle NN I-NP O
and CC B-PP O
in IN B-PP O
normal JJ B-NP O
cells NNS I-NP O
expressing VBG B-VP O
transcripts NNS B-NP O
that WDT B-NP O
contain VBP B-VP O
CUG NN B-NP O
repeats NNS I-NP O
. . O O

Altered VBN B-NP O
expression NN I-NP O
of IN B-PP O
genes NNS B-NP O
regulated VBN B-VP O
posttranscriptionally RB B-ADVP O
by IN B-PP O
CUG NN B-NP O
- HYPH I-NP O
BP NN I-NP O
therefore RB B-ADVP O
may MD B-VP O
contribute VB I-VP O
to TO B-PP O
DM NN B-NP B-Disease
pathogenesis NN I-NP O
. . O O

. . O O

Identification NN B-NP O
of IN B-PP O
a DT B-NP O
novel JJ I-NP O
nonsense JJ I-NP O
mutation NN I-NP O
and CC O O
a DT B-NP O
missense JJ I-NP O
substitution NN I-NP O
in IN B-PP O
the DT B-NP O
vasopressin NN I-NP O
- HYPH O O
neurophysin NN B-NP O
II CD I-NP O
gene NN I-NP O
in IN B-PP O
two CD B-NP O
Spanish JJ I-NP O
kindreds NNS I-NP O
with IN B-PP O
familial JJ B-NP B-Disease
neurohypophyseal JJ I-NP I-Disease
diabetes NN I-NP I-Disease
insipidus NN I-NP I-Disease
. . O O

Familial JJ B-NP B-Disease
neurohypophyseal JJ I-NP I-Disease
diabetes NN I-NP I-Disease
insipidus NN I-NP I-Disease
( ( O O
FNDI NN B-NP B-Disease
) ) O O
is VBZ B-VP O
an DT B-NP O
autosomal JJ I-NP B-Disease
dominant JJ I-NP I-Disease
disease NN I-NP I-Disease
caused VBN B-VP O
by IN B-PP O
deficiency NN B-NP O
in IN B-PP O
the DT B-NP O
antidiuretic JJ I-NP O
hormone NN I-NP O
arginine NN I-NP O
vasopressin NN I-NP O
( ( O O
AVP NN B-NP O
) ) O O
encoded VBN B-VP O
by IN B-PP O
the DT B-NP O
AVP NN I-NP O
- HYPH O O
neurophysin NN B-NP O
II CD I-NP O
( ( O O
AVP NN B-NP O
- HYPH B-NP O
NPII NN I-NP O
) ) O O
gene NN B-NP O
on IN B-PP O
chromosome NN B-NP O
20p13 CD I-NP O
. . O O

In IN B-PP O
this DT B-NP O
study NN I-NP O
, , O O
we PRP B-NP O
analyzed VBD B-VP O
two CD B-NP O
families NNS I-NP O
with IN B-PP O
FNDI NN B-NP B-Disease
using VBG B-VP O
direct JJ B-NP O
automated VBN I-NP O
fluorescent JJ I-NP O
, , I-NP O
solid JJ I-NP O
phase NN I-NP O
, , O O
single JJ B-NP O
- HYPH I-NP O
stranded JJ I-NP O
DNA NN I-NP O
sequencing NN I-NP O
of IN B-PP O
PCR NN B-NP O
- HYPH O O
amplified VBN B-NP O
AVP NN I-NP O
- HYPH B-NP O
NPII NN I-NP O
DNA NN I-NP O
. . O O

In IN B-PP O
one CD B-NP O
of IN B-PP O
the DT B-NP O
families NNS I-NP O
, , O O
affected VBN B-NP O
individuals NNS I-NP O
presented VBD B-VP O
a DT B-NP O
novel JJ I-NP O
nonsense JJ I-NP O
mutation NN I-NP O
in IN B-PP O
exon NN B-NP O
3 CD I-NP O
of IN B-PP O
the DT B-NP O
gene NN I-NP O
, , O O
consisting VBG B-VP O
in IN B-PP O
a DT B-NP O
G NN I-NP O
to TO B-PP O
T NN B-NP O
transition NN I-NP O
at IN B-PP O
nucleotide NN B-NP O
2101 CD I-NP O
, , O O
which WDT B-NP O
produces VBZ B-VP O
a DT B-NP O
stop NN I-NP O
signal NN I-NP O
in IN B-PP O
codon NN B-NP O
82 CD I-NP O
( ( O O
Glu NN B-NP O
) ) O O
of IN B-PP O
NPII NN B-NP O
. . O O

The DT B-NP O
premature JJ I-NP O
termination NN I-NP O
eliminates VBZ B-VP O
part NN B-NP O
of IN B-PP O
the DT B-NP O
C NN I-NP O
- HYPH B-NP O
terminal JJ I-NP O
domain NN I-NP O
of IN B-PP O
NPII NN B-NP O
, , O O
including VBG B-PP O
a DT B-NP O
cysteine NN I-NP O
residue NN I-NP O
in IN B-PP O
position NN B-NP O
85 CD I-NP O
, , O O
which WDT B-NP O
could MD B-VP O
be VB I-VP O
involved VBN I-VP O
in IN B-PP O
the DT B-NP O
correct JJ I-NP O
folding NN I-NP O
of IN B-PP O
the DT B-NP O
prohormone NN I-NP O
. . O O

In IN B-PP O
the DT B-NP O
second JJ I-NP O
family NN I-NP O
, , O O
a DT B-NP O
G279A NN I-NP O
substitution NN I-NP O
at IN B-PP O
position NN B-NP O
- HYPH B-NP O
1 CD I-NP O
of IN B-PP O
the DT B-NP O
signal NN I-NP O
peptide NN I-NP O
was VBD B-VP O
observed VBN I-VP O
in IN B-PP O
all DT B-NP O
affected VBN I-NP O
individuals NNS I-NP O
. . O O

This DT B-NP O
missense JJ I-NP O
mutation NN I-NP O
, , O O
which WDT B-NP O
replaces VBZ B-VP O
Ala NN B-NP O
with IN B-PP O
Thr NN B-NP O
, , O O
is VBZ B-VP O
frequent JJ B-ADJP O
among IN B-PP O
FNDI NNP B-NP B-Disease
patients NNS I-NP O
and CC O O
is VBZ B-VP O
thought VBN I-VP O
to TO I-VP O
reduce VB I-VP O
the DT B-NP O
efficiency NN I-NP O
of IN B-PP O
cleavage NN B-NP O
by IN B-PP O
signal NN B-NP O
peptidases NNS I-NP O
. . O O

. . O O

Genetic JJ B-NP O
heterogeneity NN I-NP O
of IN B-PP O
Saethre NNP B-NP B-Disease
- HYPH I-NP I-Disease
Chotzen NNP I-NP I-Disease
syndrome NN I-NP I-Disease
, , O O
due IN B-PP O
to TO I-PP O
TWIST NN B-NP O
and CC I-NP O
FGFR NN I-NP O
mutations NNS I-NP O
. . O O

Thirty CD B-NP O
- HYPH I-NP O
two CD I-NP O
unrelated JJ I-NP O
patients NNS I-NP O
with IN B-PP O
features NNS B-NP O
of IN B-PP O
Saethre NNP B-NP B-Disease
- HYPH I-NP I-Disease
Chotzen NNP I-NP I-Disease
syndrome NN I-NP I-Disease
, , O O
a DT B-NP O
common JJ I-NP O
autosomal JJ I-NP B-Disease
dominant JJ I-NP I-Disease
condition NN I-NP I-Disease
of IN B-PP O
craniosynostosis NN B-NP B-Disease
and CC I-NP O
limb NN I-NP B-Disease
anomalies NNS I-NP I-Disease
, , O O
were VBD B-VP O
screened VBN I-VP O
for IN B-PP O
mutations NNS B-NP O
in IN B-PP O
TWIST NN B-NP O
, , O O
FGFR2 NN B-NP O
, , O O
and CC O O
FGFR3 NN B-NP O
. . O O

Nine CD B-NP O
novel JJ I-NP O
and CC I-NP O
three CD I-NP O
recurrent JJ I-NP O
TWIST NN I-NP O
mutations NNS I-NP O
were VBD B-VP O
found VBN I-VP O
in IN B-PP O
12 CD B-NP O
families NNS I-NP O
. . O O

Seven CD B-NP O
families NNS I-NP O
were VBD B-VP O
found VBN I-VP O
to TO I-VP O
have VB I-VP O
the DT B-NP O
FGFR3 NN I-NP O
P250R NN I-NP O
mutation NN I-NP O
, , O O
and CC O O
one CD B-NP O
individual NN I-NP O
was VBD B-VP O
found VBN I-VP O
to TO I-VP O
have VB I-VP O
an DT B-NP O
FGFR2 NN I-NP O
VV269 NN I-NP O
- HYPH O O
270 CD B-NP O
deletion NN I-NP O
. . O O

To TO B-PP O
date NN B-NP O
, , O O
our PRP$ B-NP O
detection NN I-NP O
rate NN I-NP O
for IN B-PP O
TWIST NN B-NP O
or CC I-NP O
FGFR NN I-NP O
mutations NNS I-NP O
is VBZ B-VP O
68 CD B-NP O
% NN I-NP O
in IN B-PP O
our PRP$ B-NP O
Saethre NNP I-NP B-Disease
- HYPH I-NP I-Disease
Chotzen NNP I-NP I-Disease
syndrome NN I-NP I-Disease
patients NNS I-NP O
, , O O
including VBG B-PP O
our PRP$ B-NP O
five CD I-NP O
patients NNS I-NP O
elsewhere RB B-VP O
reported VBN I-VP O
with IN B-PP O
TWIST NN B-NP O
mutations NNS I-NP O
. . O O

More JJR B-NP O
than IN I-NP O
35 CD I-NP O
different JJ I-NP O
TWIST NN I-NP O
mutations NNS I-NP O
are VBP B-VP O
now RB I-VP O
known VBN I-VP O
in IN B-PP O
the DT B-NP O
literature NN I-NP O
. . O O

The DT B-NP O
most RBS I-NP O
common JJ I-NP O
phenotypic JJ I-NP O
features NNS I-NP O
, , O O
present JJ B-ADJP O
in IN B-PP O
more JJR B-NP O
than IN I-NP O
a DT I-NP O
third JJ I-NP O
of IN B-PP O
our PRP$ B-NP O
patients NNS I-NP O
with IN B-PP O
TWIST NN B-NP O
mutations NNS I-NP O
, , O O
are VBP B-VP O
coronal JJ B-NP B-Disease
synostosis NN I-NP I-Disease
, , O O
brachycephaly RB B-ADVP B-Disease
, , O O
low JJ B-NP B-Disease
frontal JJ I-NP I-Disease
hairline NN I-NP I-Disease
, , O O
facial JJ B-NP B-Disease
asymmetry NN I-NP I-Disease
, , O O
ptosis NN B-NP B-Disease
, , O O
hypertelorism NN B-NP B-Disease
, , O O
broad JJ B-NP B-Disease
great JJ I-NP I-Disease
toes NNS I-NP I-Disease
, , O O
and CC O O
clinodactyly RB B-ADVP B-Disease
. . O O

Significant JJ B-NP O
intra AFX I-NP O
- HYPH I-NP O
and CC I-NP O
interfamilial JJ I-NP O
phenotypic JJ I-NP O
variability NN I-NP O
is VBZ B-VP O
present JJ B-ADJP O
for IN B-PP O
either DT B-NP O
TWIST NN I-NP O
mutations NNS I-NP O
or CC O O
FGFR NN B-NP O
mutations NNS I-NP O
. . O O

The DT B-NP O
overlap NN I-NP O
in IN B-PP O
clinical JJ B-NP O
features NNS I-NP O
and CC O O
the DT B-NP O
presence NN I-NP O
, , O O
in IN B-PP O
the DT B-NP O
same JJ I-NP O
genes NNS I-NP O
, , O O
of IN B-PP O
mutations NNS B-NP O
for IN B-PP O
more JJR B-NP O
than IN I-NP O
one CD I-NP O
craniosynostotic JJ I-NP B-Disease
condition NN I-NP I-Disease
- HYPH B-VP O
such JJ B-PP O
as IN I-PP O
Saethre NNP B-NP B-Disease
- HYPH O I-Disease
Chotzen NNP B-NP I-Disease
, , O I-Disease
Crouzon NNP B-NP I-Disease
, , O I-Disease
and CC O I-Disease
Pfeiffer NN B-NP I-Disease
syndromes NNS I-NP I-Disease
- HYPH O O
support VBP B-VP O
the DT B-NP O
hypothesis NN I-NP O
that IN B-SBAR O
TWIST NN B-NP O
and CC I-NP O
FGFRs NNS I-NP O
are VBP B-VP O
components NNS B-NP O
of IN B-PP O
the DT B-NP O
same JJ I-NP O
molecular JJ I-NP O
pathway NN I-NP O
involved VBN B-VP O
in IN B-PP O
the DT B-NP O
modulation NN I-NP O
of IN B-PP O
craniofacial JJ B-NP O
and CC I-NP O
limb NN I-NP O
development NN I-NP O
in IN B-PP O
humans NNS B-NP O
. . O O

. . O O

Mutation NN B-NP O
analysis NN I-NP O
of IN B-PP O
UBE3A NN B-NP O
in IN B-PP O
Angelman NNP B-NP B-Disease
syndrome NN I-NP I-Disease
patients NNS I-NP O
. . O O

Angelman NN B-NP B-Disease
syndrome NN I-NP I-Disease
( ( O O
AS NN B-NP B-Disease
) ) O O
is VBZ B-VP O
caused VBN I-VP O
by IN B-PP O
chromosome NN B-NP O
15q11 CD I-NP O
- HYPH I-NP O
q13 NN I-NP O
deletions NNS I-NP O
of IN B-PP O
maternal JJ B-NP O
origin NN I-NP O
, , O O
by IN B-PP O
paternal JJ B-NP O
uniparental JJ I-NP B-Disease
disomy NN I-NP I-Disease
( ( O O
UPD NN B-NP B-Disease
) ) O O
15 CD B-NP O
, , O O
by IN B-PP O
imprinting VBG B-VP O
defects NNS B-NP O
, , O O
and CC O O
by IN B-PP O
mutations NNS B-NP O
in IN B-PP O
the DT B-NP O
UBE3A NN I-NP O
gene NN I-NP O
. . O O

UBE3A NN B-NP O
encodes VBZ B-VP O
a DT B-NP O
ubiquitin NN I-NP O
- HYPH B-NP O
protein NN I-NP O
ligase NN I-NP O
and CC O O
shows VBZ B-VP O
brain NN B-NP O
- HYPH I-NP O
specific JJ I-NP O
imprinting NN I-NP O
. . O O

Here RB B-ADVP O
we PRP B-NP O
describe VBP B-VP O
UBE3A NN B-NP O
coding NN I-NP O
- HYPH B-NP O
region NN I-NP O
mutations NNS I-NP O
detected VBN B-VP O
by IN B-PP O
SSCP NN B-NP O
analysis NN I-NP O
in IN B-PP O
13 CD B-NP O
AS JJ I-NP B-Disease
individuals NNS I-NP O
or CC I-NP O
families NNS I-NP O
. . O O

Two CD B-NP O
identical JJ I-NP O
de FW I-NP O
novo FW I-NP O
5 CD I-NP O
- HYPH I-NP O
bp NN I-NP O
duplications NNS I-NP O
in IN B-PP O
exon NN B-NP O
16 CD I-NP O
were VBD B-VP O
found VBN I-VP O
. . O O

Among IN B-PP O
the DT B-NP O
other JJ I-NP O
11 CD I-NP O
unique JJ I-NP O
mutations NNS I-NP O
, , O O
8 CD B-NP O
were VBD B-VP O
small JJ B-NP O
deletions NNS I-NP O
or CC I-NP O
insertions NNS I-NP O
predicted VBN B-VP O
to TO B-VP O
cause VB I-VP O
frameshifts NNS B-NP O
, , O O
1 CD B-NP O
was VBD B-VP O
a DT B-NP O
mutation NN I-NP O
to TO B-PP O
a DT B-NP O
stop NN I-NP O
codon NN I-NP O
, , O O
1 CD B-NP O
was VBD B-VP O
a DT B-NP O
missense JJ I-NP O
mutation NN I-NP O
, , O O
and CC O O
1 CD B-NP O
was VBD B-VP O
predicted VBN I-VP O
to TO I-VP O
cause VB I-VP O
insertion NN B-NP O
of IN B-PP O
an DT B-NP O
isoleucine NN I-NP O
in IN B-PP O
the DT B-NP O
hect NN I-NP O
domain NN I-NP O
of IN B-PP O
the DT B-NP O
UBE3A NN I-NP O
protein NN I-NP O
, , O O
which WDT B-NP O
functions VBZ B-VP O
in IN B-PP O
E2 NN B-NP O
binding NN I-NP O
and CC O O
ubiquitin NN B-NP O
transfer NN I-NP O
. . O O

Eight CD B-NP O
of IN B-PP O
the DT B-NP O
cases NNS I-NP O
were VBD B-VP O
familial JJ B-ADJP O
, , O O
and CC O O
five CD B-NP O
were VBD B-VP O
sporadic JJ B-ADJP O
. . O O

In IN B-PP O
two CD B-NP O
familial JJ I-NP O
cases NNS I-NP O
and CC O O
one CD B-NP O
sporadic JJ I-NP O
case NN I-NP O
, , O O
mosaicism NN B-NP O
for IN B-PP O
UBE3A NN B-NP O
mutations NNS I-NP O
was VBD B-VP O
detected VBN I-VP O
in IN B-PP O
the DT B-NP O
mother NN I-NP O
of IN B-PP O
three CD B-NP O
AS JJ I-NP B-Disease
sons NNS I-NP O
, , O O
in IN B-PP O
the DT B-NP O
maternal JJ I-NP O
grandfather NN I-NP O
of IN B-PP O
two CD B-NP O
AS JJ I-NP B-Disease
first JJ I-NP O
cousins NNS I-NP O
, , O O
and CC O O
in IN B-PP O
the DT B-NP O
mother NN I-NP O
of IN B-PP O
an DT B-NP O
AS JJ I-NP B-Disease
daughter NN I-NP O
. . O O

The DT B-NP O
frequencies NNS I-NP O
with IN B-PP O
which WDT B-NP O
we PRP B-NP O
detected VBD B-VP O
mutations NNS B-NP O
were VBD B-VP O
5 CD B-NP O
( ( O O
14 CD B-NP O
% NN I-NP O
) ) O O
of IN B-PP O
35 CD B-NP O
in IN B-PP O
sporadic JJ B-NP O
cases NNS I-NP O
and CC O O
8 CD B-NP O
( ( O O
80 CD B-NP O
% NN I-NP O
) ) O O
of IN B-PP O
10 CD B-NP O
in IN B-PP O
familial JJ B-NP O
cases NNS I-NP O
. . O O

. . O O

The DT B-NP O
hemochromatosis NN I-NP B-Disease
845 CD I-NP O
G NN I-NP O
- SYM B-NP O
- HYPH B-NP O
> SYM I-NP O
A NN I-NP O
and CC O O
187 CD B-NP O
C NN I-NP O
- SYM B-NP O
- HYPH B-NP O
> SYM I-NP O
G NN I-NP O
mutations NNS I-NP O
: : O O
prevalence NN B-NP O
in IN B-PP O
non AFX B-NP O
- HYPH I-NP O
Caucasian JJ I-NP O
populations NNS I-NP O
. . O O

Hemochromatosis NN B-NP B-Disease
, , O O
the DT B-NP O
inherited VBN I-NP B-Disease
disorder NN I-NP I-Disease
of IN B-PP I-Disease
iron NN B-NP I-Disease
metabolism NN I-NP I-Disease
, , O O
leads VBZ B-VP O
, , O O
if IN B-SBAR O
untreated JJ B-ADJP O
, , O O
to TO B-PP O
progressive JJ B-NP O
iron NN I-NP B-Disease
overload NN I-NP I-Disease
and CC O O
premature JJ B-NP B-Disease
death NN I-NP I-Disease
. . O O

The DT B-NP O
hemochromatosis NN I-NP B-Disease
gene NN I-NP O
, , O O
HFE NN B-NP O
, , O O
recently RB B-ADVP O
has VBZ B-VP O
been VBN I-VP O
identified VBN I-VP O
, , O O
and CC O O
characterization NN B-NP O
of IN B-PP O
this DT B-NP O
gene NN I-NP O
has VBZ B-VP O
shown VBN I-VP O
that IN B-SBAR O
it PRP B-NP O
contains VBZ B-VP O
two CD B-NP O
mutations NNS I-NP O
that WDT B-NP O
result VBP B-VP O
in IN B-PP O
amino JJ B-NP O
acid NN I-NP O
substitutions NNS I-NP O
- HYPH B-NP O
cDNA NN I-NP O
nucleotides NNS I-NP O
845 CD B-NP O
G NN I-NP O
- SYM O O
- HYPH O O
> SYM O O
A NN B-NP O
( ( O O
C282Y NN B-NP O
) ) O O
and CC O O
187 CD B-NP O
C NN I-NP O
- SYM O O
- HYPH O O
> SYM O O
G NN B-NP O
( ( O O
H63D NN B-NP O
) ) O O
. . O O

Although IN B-SBAR O
hemochromatosis NN B-NP B-Disease
is VBZ B-VP O
common JJ B-ADJP O
in IN B-PP O
Caucasians NNPS B-NP O
, , O O
affecting VBG B-VP O
> SYM B-NP O
= SYM B-VP O
1 CD B-NP O
/ SYM O O
300 CD B-NP O
individuals NNS I-NP O
of IN B-PP O
northern JJ B-NP O
European JJ I-NP O
origin NN I-NP O
, , O O
it PRP B-NP O
has VBZ B-VP O
not RB I-VP O
been VBN I-VP O
recognized VBN I-VP O
in IN B-PP O
other JJ B-NP O
populations NNS I-NP O
. . O O

The DT B-NP O
present JJ I-NP O
study NN I-NP O
used VBD B-VP O
PCR NN B-NP O
and CC I-NP O
restriction NN I-NP O
- HYPH B-NP O
enzyme NN I-NP O
digestion NN I-NP O
to TO B-VP O
analyze VB I-VP O
the DT B-NP O
frequency NN I-NP O
of IN B-PP O
the DT B-NP O
845 CD I-NP O
G NN I-NP O
- SYM B-NP O
- HYPH B-NP O
> SYM I-NP O
A NN I-NP O
and CC O O
187 CD B-NP O
C NN I-NP O
- SYM B-NP O
- HYPH B-NP O
> SYM I-NP O
G NN I-NP O
mutations NNS I-NP O
in IN B-PP O
HLA NN B-NP O
- HYPH B-NP O
typed VBN I-NP O
samples NNS I-NP O
from IN B-PP O
non AFX B-NP O
- HYPH I-NP O
Caucasian JJ I-NP O
populations NNS I-NP O
, , O O
comprising VBG B-VP O
Australian JJ B-NP O
Aboriginal NNP I-NP O
, , O O
Chinese NNP B-NP O
, , O O
and CC O O
Pacific NNP B-NP O
Islanders NNPS I-NP O
. . O O

Results NNS B-NP O
showed VBD B-VP O
that IN B-SBAR O
the DT B-NP O
845 CD I-NP O
G NN I-NP O
- SYM B-NP O
- HYPH B-NP O
> SYM I-NP O
A NN I-NP O
mutation NN I-NP O
was VBD B-VP O
present JJ B-ADJP O
in IN B-PP O
these DT B-NP O
populations NNS I-NP O
( ( O O
allele NN B-NP O
frequency NN I-NP O
0 CD I-NP O
. . O O

32 CD B-NP O
% NN I-NP O
) ) O O
, , O O
and CC O O
, , O O
furthermore RB B-ADVP O
, , O O
it PRP B-NP O
was VBD B-VP O
always RB I-VP O
seen VBN I-VP O
in IN B-PP O
conjunction NN B-NP O
with IN B-PP O
HLA NN B-NP O
haplotypes NNS I-NP O
common JJ B-ADJP O
in IN B-PP O
Caucasians NNPS B-NP O
, , O O
suggesting VBG B-VP O
that IN B-SBAR O
845 CD B-NP O
G NN I-NP O
- SYM B-NP O
- HYPH B-NP O
> SYM I-NP O
A NN I-NP O
may MD B-VP O
have VB I-VP O
been VBN I-VP O
introduced VBN I-VP O
into IN B-PP O
these DT B-NP O
populations NNS I-NP O
by IN B-PP O
Caucasian JJ B-NP O
admixture NN I-NP O
. . O O

187 CD B-NP O
C JJ I-NP O
- SYM I-NP O
- HYPH I-NP O
> SYM I-NP O
G NN B-NP O
was VBD B-VP O
present JJ B-ADJP O
at IN B-PP O
an DT B-NP O
allele NN I-NP O
frequency NN I-NP O
of IN B-PP O
2 CD B-NP O
. . O O

68 CD B-NP O
% NN I-NP O
in IN B-PP O
the DT B-NP O
two CD I-NP O
populations NNS I-NP O
analyzed VBN B-VP O
( ( O O
Australian JJ B-NP O
Aboriginal JJ I-NP O
and CC I-NP O
Chinese JJ I-NP O
) ) O O
. . O O

In IN B-PP O
the DT B-NP O
Australian JJ I-NP O
Aboriginal JJ I-NP O
samples NNS I-NP O
, , O O
187 CD B-NP O
C JJ I-NP O
- SYM I-NP O
- HYPH I-NP O
> SYM I-NP O
G NN I-NP O
was VBD B-VP O
found VBN I-VP O
to TO I-VP O
be VB I-VP O
associated VBN I-VP O
with IN B-PP O
HLA NN B-NP O
haplotypes NNS I-NP O
common JJ B-ADJP O
in IN B-PP O
Caucasians NNPS B-NP O
, , O O
suggesting VBG B-VP O
that IN B-SBAR O
it PRP B-NP O
was VBD B-VP O
introduced VBN I-VP O
by IN B-PP O
recent JJ B-NP O
admixture NN I-NP O
. . O O

In IN B-PP O
the DT B-NP O
Chinese JJ I-NP O
samples NNS I-NP O
analyzed VBN B-VP O
, , O O
187 CD B-NP O
C JJ I-NP O
- SYM I-NP O
- HYPH I-NP O
> SYM I-NP O
G NN B-NP O
was VBD B-VP O
present JJ B-ADJP O
in IN B-PP O
association NN B-NP O
with IN B-PP O
a DT B-NP O
wide JJ I-NP O
variety NN I-NP O
of IN B-PP O
HLA NN B-NP O
haplotypes NNS I-NP O
, , O O
showing VBG B-VP O
this DT B-NP O
mutation NN I-NP O
to TO B-VP O
be VB I-VP O
widespread JJ B-ADJP O
and CC I-ADJP O
likely JJ I-ADJP O
to TO B-VP O
predate VB I-VP O
the DT O O
more RBR B-ADVP O
genetically RB I-ADVP O
restricted JJ B-NP O
845 CD I-NP O
G NN I-NP O
- SYM B-NP O
- HYPH B-VP O
> SYM B-NP O
A DT B-NP O
mutation NN I-NP O
. . O O

Genotype NN B-NP O
- HYPH I-NP O
phenotype NN I-NP O
correlations NNS I-NP O
in IN B-PP O
attenuated VBN B-NP B-Disease
adenomatous JJ I-NP I-Disease
polyposis NN I-NP I-Disease
coli NN I-NP I-Disease
. . O O

Germ NN B-NP O
- HYPH I-NP O
line NN I-NP O
mutations NNS I-NP O
of IN B-PP O
the DT B-NP O
tumor NN I-NP B-Disease
suppressor NN I-NP O
APC NN I-NP O
are VBP B-VP O
implicated VBN I-VP O
in IN B-PP O
attenuated VBN B-NP B-Disease
adenomatous JJ I-NP I-Disease
polyposis NN I-NP I-Disease
coli NN I-NP I-Disease
( ( O O
AAPC NN B-NP B-Disease
) ) O O
, , O O
a DT B-NP O
variant NN I-NP O
of IN B-PP O
familial JJ B-NP B-Disease
adenomatous JJ I-NP I-Disease
polyposis NN I-NP I-Disease
( ( O O
FAP NN B-NP B-Disease
) ) O O
. . O O

AAPC NN B-NP B-Disease
is VBZ B-VP O
recognized VBN I-VP O
by IN B-PP O
the DT B-NP O
occurrence NN I-NP O
of IN B-PP O
< SYM B-NP O
100 CD I-NP O
colonic JJ I-NP B-Disease
adenomas NNS I-NP I-Disease
and CC O O
a DT B-NP O
later JJ I-NP O
onset NN I-NP O
of IN B-PP O
colorectal JJ B-NP B-Disease
cancer NN I-NP I-Disease
( ( O O
age NN B-NP O
> SYM O O
40 CD B-NP O
years NNS I-NP O
) ) O O
. . O O

The DT B-NP O
aim NN I-NP O
of IN B-PP O
this DT B-NP O
study NN I-NP O
was VBD B-VP O
to TO B-VP O
assess VB I-VP O
genotype NN B-NP O
- HYPH B-NP O
phenotype NN I-NP O
correlations NNS I-NP O
in IN B-PP O
AAPC NN B-NP B-Disease
families NNS I-NP O
. . O O

By IN B-PP O
protein NN B-NP O
- HYPH O O
truncation NN B-NP O
test NN I-NP O
( ( O O
PTT NN B-NP O
) ) O O
assay NN B-NP O
, , O O
the DT B-NP O
entire JJ I-NP O
coding VBG I-NP O
region NN I-NP O
of IN B-PP O
the DT B-NP O
APC NN I-NP B-Disease
gene NN I-NP O
was VBD B-VP O
screened VBN I-VP O
in IN B-PP O
affected VBN B-NP O
individuals NNS I-NP O
from IN B-PP O
11 CD B-NP O
AAPC NN I-NP B-Disease
kindreds NNS I-NP O
, , O O
and CC O O
their PRP$ B-NP O
phenotypic JJ I-NP O
differences NNS I-NP O
were VBD B-VP O
examined VBN I-VP O
. . O O

Five CD B-NP O
novel JJ I-NP O
germ NN I-NP O
- HYPH I-NP O
line NN I-NP O
APC NN I-NP B-Disease
mutations NNS I-NP O
were VBD B-VP O
identified VBN I-VP O
in IN B-PP O
seven CD B-NP O
kindreds NNS I-NP O
. . O O

Mutations NNS B-NP O
were VBD B-VP O
located VBN I-VP O
in IN B-PP O
three CD B-NP O
different JJ I-NP O
regions NNS I-NP O
of IN B-PP O
the DT B-NP O
APC NN I-NP B-Disease
gene NN I-NP O
( ( O O
1 CD B-NP O
) ) O O
at IN B-PP O
the DT B-NP O
5 CD I-NP O
end NN I-NP O
spanning VBG B-VP O
exons NNS B-NP O
4 CD B-NP O
and CC I-NP O
5 CD I-NP O
, , O O
( ( B-LST O
2 LS I-LST O
) ) O O
within IN B-PP O
exon NN B-NP O
9 CD I-NP O
, , O O
and CC O O
( ( B-LST O
3 LS I-LST O
) ) O O
at IN B-PP O
the DT B-NP O
3 CD I-NP O
distal JJ I-NP O
end NN I-NP O
of IN B-PP O
the DT B-NP O
gene NN I-NP O
. . O O

Variability NN B-NP O
in IN B-PP O
the DT B-NP O
number NN I-NP O
of IN B-PP O
colorectal JJ B-NP B-Disease
adenomas NNS I-NP I-Disease
was VBD B-VP O
most RBS B-ADJP O
apparent JJ I-ADJP O
in IN B-PP O
individuals NNS B-NP O
with IN B-PP O
mutations NNS B-NP O
in IN B-PP O
region NN B-NP O
1 CD I-NP O
, , O O
and CC O O
upper JJ B-NP O
- HYPH I-NP O
gastrointestinal JJ I-NP O
manifestations NNS I-NP O
were VBD B-VP O
more RBR B-ADJP O
severe JJ I-ADJP O
in IN B-PP O
them PRP B-NP O
. . O O

In IN B-PP O
individuals NNS B-NP O
with IN B-PP O
mutations NNS B-NP O
in IN B-PP O
either CC O O
region NN B-NP O
2 CD I-NP O
or CC O O
region NN B-NP O
3 CD I-NP O
, , O O
the DT B-NP O
average JJ I-NP O
number NN I-NP O
of IN B-PP O
adenomas NNS B-NP B-Disease
tended VBD B-VP O
to TO I-VP O
be VB I-VP O
lower JJR B-ADJP O
than IN B-PP O
those DT B-NP O
in IN B-PP O
individuals NNS B-NP O
with IN B-PP O
mutations NNS B-NP O
in IN B-PP O
region NN B-NP O
1 CD I-NP O
, , O O
although IN B-SBAR O
age NN B-NP O
at IN B-PP O
diagnosis NN B-NP O
was VBD B-VP O
similar JJ B-ADJP O
. . O O

In IN B-PP O
all DT B-NP O
AAPC NN I-NP B-Disease
kindreds NNS I-NP O
, , O O
a DT B-NP O
predominance NN I-NP O
of IN B-PP O
right JJ B-NP O
- HYPH I-NP O
sided JJ I-NP O
colorectal JJ I-NP B-Disease
adenomas NNS I-NP I-Disease
and CC O O
rectal JJ B-NP B-Disease
polyp NN I-NP I-Disease
sparing NN I-NP O
was VBD B-VP O
observed VBN I-VP O
. . O O

No DT B-NP O
desmoid JJ I-NP B-Disease
tumors NNS I-NP I-Disease
were VBD B-VP O
found VBN I-VP O
in IN B-PP O
these DT B-NP O
kindreds NNS I-NP O
. . O O

Our PRP$ B-NP O
data NNS I-NP O
suggest VBP B-VP O
that IN B-SBAR O
, , O O
in IN B-PP O
AAPC NN B-NP B-Disease
families NNS I-NP O
, , O O
the DT B-NP O
location NN I-NP O
of IN B-PP O
the DT B-NP O
APC NN I-NP B-Disease
mutation NN I-NP O
may MD B-VP O
partially RB I-VP O
predict VB I-VP O
specific JJ B-NP O
phenotypic JJ I-NP O
expression NN I-NP O
. . O O

This DT B-NP O
should MD B-VP O
help VB I-VP O
in IN B-PP O
the DT B-NP O
design NN I-NP O
of IN B-PP O
tailored VBN B-NP O
clinical JJ I-NP O
- HYPH I-NP O
management NN I-NP O
protocols NNS I-NP O
in IN B-PP O
this DT B-NP O
subset NN I-NP O
of IN B-PP O
FAP NN B-NP B-Disease
patients NNS I-NP O
. . O O

. . O O

Wilms NNP B-NP B-Disease
' POS B-NP I-Disease
tumor NN I-NP I-Disease
1 CD I-NP O
and CC I-NP O
Dax NN I-NP O
- HYPH B-NP O
1 CD I-NP O
modulate VBP B-VP O
the DT B-NP O
orphan NN I-NP O
nuclear JJ I-NP O
receptor NN I-NP O
SF NN I-NP O
- HYPH B-NP O
1 CD I-NP O
in IN B-PP O
sex NN B-NP O
- HYPH I-NP O
specific JJ I-NP O
gene NN I-NP O
expression NN I-NP O
. . O O

Products NNS B-NP O
of IN B-PP O
steroidogenic JJ B-NP O
factor NN I-NP O
1 CD I-NP O
( ( O O
SF NN B-NP O
- HYPH B-NP O
1 CD I-NP O
) ) O O
and CC O O
Wilms NNP B-NP B-Disease
tumor NN I-NP I-Disease
1 CD I-NP O
( ( O O
WT1 NN B-NP O
) ) O O
genes NNS B-NP O
are VBP B-VP O
essential JJ B-ADJP O
for IN B-PP O
mammalian JJ B-NP O
gonadogenesis NN I-NP O
prior JJ B-ADJP O
to TO B-PP O
sexual JJ B-NP O
differentiation NN I-NP O
. . O O

In IN B-PP O
males NNS B-NP O
, , O O
SF NN B-NP O
- HYPH B-NP O
1 CD I-NP O
participates NNS I-NP O
in IN B-PP O
sexual JJ B-NP O
development NN I-NP O
by IN B-PP O
regulating VBG B-VP O
expression NN B-NP O
of IN B-PP O
the DT B-NP O
polypeptide NN I-NP O
hormone NN I-NP O
Mullerian JJ I-NP O
inhibiting VBG I-NP O
substance NN I-NP O
( ( O O
MIS NN B-NP O
) ) O O
. . O O

Here RB B-ADVP O
, , O O
we PRP B-NP O
show VBP B-VP O
that IN B-SBAR O
WT1 NN B-NP O
- HYPH B-NP O
KTS NN I-NP O
isoforms NNS I-NP O
associate VBP B-VP O
and CC I-VP O
synergize VBP I-VP O
with IN B-PP O
SF NN B-NP O
- HYPH B-NP O
1 CD I-NP O
to TO B-VP O
promote VB I-VP O
MIS NN B-NP O
expression NN I-NP O
. . O O

In IN B-PP O
contrast NN B-NP O
, , O O
WT1 NN B-NP O
missense JJ I-NP O
mutations NNS I-NP O
, , O O
associated VBN B-VP O
with IN B-PP O
male JJ B-NP B-Disease
pseudohermaphroditism NN I-NP I-Disease
in IN B-PP O
Denys NNP B-NP B-Disease
- HYPH B-NP I-Disease
Drash NNP I-NP I-Disease
syndrome NN I-NP I-Disease
, , O O
fail VBP B-VP O
to TO I-VP O
synergize VB I-VP O
with IN B-PP O
SF NN B-NP O
- HYPH B-NP O
1 CD I-NP O
. . O O

Additionally RB B-ADVP O
, , O O
the DT B-NP O
X NN I-NP O
- HYPH B-VP O
linked VBN I-VP O
, , O O
candidate NN B-NP O
dosage NN I-NP O
- HYPH B-NP O
sensitive JJ I-NP O
sex NN I-NP O
- HYPH B-NP O
reversal NN I-NP O
gene NN I-NP O
, , O O
Dax NN B-NP O
- HYPH B-NP O
1 CD I-NP O
, , O O
antagonizes VBZ B-VP O
synergy NN B-NP O
between IN B-PP O
SF NN B-NP O
- HYPH B-NP O
1 CD I-NP O
and CC I-NP O
WT1 NN I-NP O
, , O O
most RBS B-ADVP O
likely RB I-ADVP O
through IN B-PP O
a DT B-NP O
direct JJ I-NP O
interaction NN I-NP O
with IN B-PP O
SF NN B-NP O
- HYPH B-NP O
1 CD I-NP O
. . O O

We PRP B-NP O
propose VBP B-VP O
that IN B-SBAR O
WT1 NN B-NP O
and CC I-NP O
Dax NN I-NP O
- HYPH B-NP O
1 CD I-NP O
functionally RB B-ADVP O
oppose VBP B-VP O
each DT B-NP O
other JJ I-NP O
in IN B-PP O
testis NN B-NP O
development NN I-NP O
by IN B-PP O
modulating VBG B-VP O
SF NN B-NP O
- HYPH B-NP O
1 CD I-NP O
- HYPH I-NP O
mediated VBN I-NP O
transactivation NN I-NP O
. . O O

. . O O

A DT B-NP O
mouse NN I-NP O
model NN I-NP O
for IN B-PP O
Prader NNP B-NP B-Disease
- HYPH I-NP I-Disease
Willi NNP I-NP I-Disease
syndrome NN I-NP I-Disease
imprinting NN I-NP O
- HYPH B-NP O
centre NN I-NP O
mutations NNS I-NP O
. . O O

Imprinting NN B-NP O
in IN B-PP O
the DT B-NP O
15q11 CD I-NP O
- HYPH I-NP O
q13 NN I-NP O
region NN I-NP O
involves VBZ B-VP O
an DT B-NP O
imprinting NN I-NP O
centre NN I-NP O
( ( O O
IC NN B-NP O
) ) O O
, , O O
mapping VBG B-VP O
in IN B-PP O
part NN B-NP O
to TO B-PP O
the DT B-NP O
promoter NN I-NP O
and CC I-NP O
first JJ I-NP O
exon NN I-NP O
of IN B-PP O
SNRPN NN B-NP O
. . O O

Deletion NN B-NP O
of IN B-PP O
this DT B-NP O
IC NN I-NP O
abolishes VBZ B-VP O
local JJ B-NP O
paternally RB I-NP O
derived VBN I-NP O
gene NN I-NP O
expression NN I-NP O
and CC O O
results VBZ B-VP O
in IN B-PP O
Prader NNP B-NP B-Disease
- HYPH B-NP I-Disease
Willi NNP I-NP I-Disease
syndrome NN I-NP I-Disease
( ( O O
PWS NN B-NP B-Disease
) ) O O
. . O O

We PRP B-NP O
have VBP B-VP O
created VBN I-VP O
two CD B-NP O
deletion NN I-NP O
mutations NNS I-NP O
in IN B-PP O
mice NNS B-NP O
to TO B-VP O
understand VB I-VP O
PWS NN B-NP B-Disease
and CC O O
the DT B-NP O
mechanism NN I-NP O
of IN B-PP O
this DT B-NP O
IC NN I-NP O
. . O O

Mice NNS B-NP O
harbouring VBG B-VP O
an DT B-NP O
intragenic JJ I-NP O
deletion NN I-NP O
in IN B-PP O
Snrpn NN B-NP O
are VBP B-VP O
phenotypically RB B-ADJP O
normal JJ I-ADJP O
, , O O
suggesting VBG B-VP O
that IN B-SBAR O
mutations NNS B-NP O
of IN B-PP O
SNRPN NN B-NP O
are VBP B-VP O
not RB O O
sufficient JJ B-ADJP O
to TO B-VP O
induce VB I-VP O
PWS NN B-NP B-Disease
. . O O

Mice NNS B-NP O
with IN B-PP O
a DT B-NP O
larger JJR I-NP O
deletion NN I-NP O
involving VBG B-VP O
both CC O O
Snrpn NN B-NP O
and CC O O
the DT B-NP O
putative JJ I-NP O
PWS NN I-NP O
- HYPH B-NP O
IC NN I-NP O
lack NN I-NP O
expression NN I-NP O
of IN B-PP O
the DT B-NP O
imprinted VBN I-NP O
genes NNS I-NP O
Zfp127 NN I-NP O
( ( O O
mouse NN B-NP O
homologue NN I-NP O
of IN B-PP O
ZNF127 NN B-NP O
) ) O O
, , O O
Ndn NN B-NP O
and CC I-NP O
Ipw NN I-NP O
, , O O
and CC O O
manifest JJS B-NP O
several JJ I-NP O
phenotypes NNS I-NP O
common JJ B-ADJP O
to TO B-PP O
PWS NN B-NP B-Disease
infants NNS I-NP O
. . O O

These DT B-NP O
data NNS I-NP O
demonstrate VBP B-VP O
that IN B-SBAR O
both CC O O
the DT B-NP O
position NN I-NP O
of IN B-PP O
the DT B-NP O
IC NN I-NP O
and CC O O
its PRP$ B-NP O
role NN I-NP O
in IN B-PP O
the DT B-NP O
coordinate JJ I-NP O
expression NN I-NP O
of IN B-PP O
genes NNS B-NP O
is VBZ B-VP O
conserved VBN I-VP O
between IN B-PP O
mouse NN B-NP O
and CC O O
human JJ B-ADJP O
, , O O
and CC O O
indicate VBP B-VP O
that IN B-SBAR O
the DT B-NP O
mouse NN I-NP O
is VBZ B-VP O
a DT B-NP O
suitable JJ I-NP O
model NN I-NP O
system NN I-NP O
in IN B-PP O
which WDT B-NP O
to TO B-VP O
investigate VB I-VP O
the DT B-NP O
molecular JJ I-NP O
mechanisms NNS I-NP O
of IN B-PP O
imprinting NN B-NP O
in IN B-PP O
this DT B-NP O
region NN I-NP O
of IN B-PP O
the DT B-NP O
genome NN I-NP O
. . O O

. . O O

Mutations NNS B-NP O
of IN B-PP O
the DT B-NP O
ATM NN I-NP O
gene NN I-NP O
detected VBN B-VP O
in IN B-PP O
Japanese JJ B-NP O
ataxia NN I-NP B-Disease
- HYPH O I-Disease
telangiectasia NN B-NP I-Disease
patients NNS I-NP O
: : O O
possible JJ B-NP O
preponderance NN I-NP O
of IN B-PP O
the DT B-NP O
two CD I-NP O
founder NN I-NP O
mutations NNS I-NP O
4612del165 CD B-NP O
and CC I-NP O
7883del5 CD I-NP O
. . O O

The DT B-NP O
ATM NN I-NP O
( ( O O
A NN B-NP O
- HYPH I-NP O
T NN I-NP O
, , O O
mutated VBN B-VP O
) ) O O
gene NN B-NP O
on IN B-PP O
human JJ B-NP O
chromosome NN I-NP O
11q22 NN I-NP O
. . O O

3 CD B-NP O
has VBZ B-VP O
recently RB I-VP O
been VBN I-VP O
identified VBN I-VP O
as IN B-PP O
the DT B-NP O
gene NN I-NP O
responsible JJ B-ADJP O
for IN B-PP O
the DT B-NP O
human JJ I-NP O
recessive JJ I-NP B-Disease
disease NN I-NP I-Disease
ataxia NN I-NP B-Disease
- HYPH B-NP I-Disease
telangiectasia NN I-NP I-Disease
( ( O O
A NN B-NP B-Disease
- HYPH O I-Disease
T NN B-NP I-Disease
) ) O O
. . O O

In IN B-SBAR O
order NN O O
to TO B-VP O
define VB I-VP O
the DT B-NP O
types NNS I-NP O
of IN B-PP O
disease NN B-NP O
- HYPH O O
causing VBG B-VP O
ATM NN B-NP O
mutations NNS I-NP O
in IN B-PP O
Japanese JJ B-NP O
A NN I-NP B-Disease
- HYPH I-NP I-Disease
T NN I-NP I-Disease
patients NNS I-NP O
as RB B-CONJP O
well RB I-CONJP O
as IN I-CONJP O
to TO B-VP O
look VB I-VP O
for IN B-PP O
possible JJ B-NP O
mutational JJ I-NP O
hotspots NNS I-NP O
, , O O
reverse NN B-NP O
- HYPH B-VP O
transcribed VBN B-NP O
RNA NN I-NP O
derived VBN B-VP O
from IN B-PP O
ten CD B-NP O
patients NNS I-NP O
belonging VBG B-VP O
to TO B-PP O
eight CD B-NP O
unrelated JJ I-NP O
Japanese JJ I-NP O
A NN I-NP B-Disease
- HYPH I-NP I-Disease
T NN I-NP I-Disease
families NNS I-NP O
was VBD B-VP O
analyzed VBN I-VP O
for IN B-PP O
mutations NNS B-NP O
by IN B-PP O
the DT B-NP O
restriction NN I-NP O
endonuclease NN I-NP O
fingerprinting NN I-NP O
method NN I-NP O
. . O O

As IN B-SBAR O
has VBZ B-VP O
been VBN I-VP O
reported VBN I-VP O
by IN B-PP O
others NNS B-NP O
, , O O
mutations NNS B-NP O
that WDT B-NP O
lead VBP B-VP O
to TO I-VP O
exon VB I-VP O
skipping NN B-NP O
or CC O O
premature JJ B-NP O
protein NN I-NP O
truncation NN I-NP O
were VBD B-VP O
also RB B-ADVP O
predominant JJ B-ADJP O
in IN B-PP O
our PRP$ B-NP O
mutants NNS I-NP O
. . O O

Six CD B-NP O
different JJ I-NP O
mutations NNS I-NP O
were VBD B-VP O
identified VBN I-VP O
on IN B-PP O
12 CD B-NP O
of IN B-PP O
the DT B-NP O
16 CD I-NP O
alleles NNS I-NP O
examined VBN B-VP O
. . O O

Four CD B-NP O
were VBD B-VP O
deletions NNS B-NP O
involving VBG B-VP O
a DT B-NP O
loss NN I-NP O
of IN B-PP O
a DT B-NP O
single JJ I-NP O
exon NN I-NP O
exon NN I-NP O
7 CD I-NP O
, , O O
exon NN B-NP O
16 CD I-NP O
, , O O
exon NN B-NP O
33 CD I-NP O
or CC O O
exon NN B-NP O
35 CD I-NP O
. . O O

The DT B-NP O
others NNS I-NP O
were VBD B-VP O
minute JJ B-NP O
deletions NNS I-NP O
, , O O
4649delA NN B-NP O
in IN B-PP O
exon NN B-NP O
33 CD I-NP O
and CC I-NP O
7883del5 CD I-NP O
in IN B-PP O
exon NN B-NP O
55 CD I-NP O
. . O O

The DT B-NP O
mutations NNS I-NP O
4612del165 CD I-NP O
and CC I-NP O
7883del5 CD I-NP O
were VBD B-VP O
found VBN I-VP O
in IN B-PP O
more JJR B-NP O
than IN I-NP O
two CD I-NP O
unrelated JJ I-NP O
families NNS I-NP O
; : O O
44 CD B-NP O
% NN I-NP O
( ( O O
7 CD B-NP O
of IN B-PP O
16 CD B-NP O
) ) O O
of IN B-PP O
the DT B-NP O
mutant JJ I-NP O
alleles NNS I-NP O
had VBD B-VP O
one CD B-NP O
of IN B-PP O
the DT B-NP O
two CD I-NP O
mutations NNS I-NP O
. . O O

The DT B-NP O
4612del165 CD I-NP O
mutations NNS I-NP O
in IN B-PP O
three CD B-NP O
different JJ I-NP O
families NNS I-NP O
were VBD B-VP O
all DT O O
ascribed VBN B-VP O
to TO B-PP O
the DT B-NP O
same JJ I-NP O
T NN I-NP O
- SYM B-NP O
- SYM I-NP O
> SYM I-NP O
A NN I-NP O
substitution NN I-NP O
at IN B-PP O
the DT B-NP O
splice NN I-NP O
donor NN I-NP O
site NN I-NP O
in IN B-PP O
intron NN B-NP O
33 CD I-NP O
. . O O

Microsatellite NN B-NP O
genotyping NN I-NP O
around IN B-PP O
the DT B-NP O
ATM NN I-NP O
locus NN I-NP O
also RB B-ADVP O
indicated VBD B-VP O
that IN B-SBAR O
a DT B-NP O
common JJ I-NP O
haplotype NN I-NP O
was VBD B-VP O
shared VBN I-VP O
by IN B-PP O
the DT B-NP O
mutant JJ I-NP O
alleles NNS I-NP O
in IN B-PP O
both DT B-NP O
mutations NNS I-NP O
. . O O

This DT B-NP O
suggests VBZ B-VP O
that IN B-SBAR O
these DT B-NP O
two CD I-NP O
founder NN I-NP O
mutations NNS I-NP O
may MD B-VP O
be VB I-VP O
predominant JJ B-ADJP O
among IN B-PP O
Japanese JJ B-NP O
ATM NN I-NP O
mutant JJ I-NP O
alleles NNS I-NP O
. . O O

W474C NN B-NP O
amino JJ I-NP O
acid NN I-NP O
substitution NN I-NP O
affects VBZ B-VP O
early JJ B-NP O
processing NN I-NP O
of IN B-PP O
the DT B-NP O
alpha SYM I-NP O
- HYPH I-NP O
subunit NN I-NP O
of IN B-PP O
beta SYM B-NP O
- HYPH I-NP O
hexosaminidase NN I-NP O
A NN I-NP O
and CC O O
is VBZ B-VP O
associated VBN I-VP O
with IN B-PP O
subacute JJ B-NP O
G NN I-NP B-Disease
( ( O I-Disease
M2 NN B-NP I-Disease
) ) O I-Disease
gangliosidosis NN B-NP I-Disease
. . O O

Mutations NNS B-NP O
in IN B-PP O
the DT B-NP O
HEXA NN I-NP O
gene NN I-NP O
, , O O
encoding VBG B-VP O
the DT B-NP O
alpha SYM I-NP O
- HYPH I-NP O
subunit NN I-NP O
of IN B-PP O
beta SYM B-NP O
- HYPH O O
hexosaminidase NN B-NP O
A NN I-NP O
( ( O O
Hex NN B-NP O
A NN I-NP O
) ) O O
, , O O
that WDT B-NP O
abolish VBP B-VP O
Hex NNP B-NP O
A NNP I-NP O
enzyme NN I-NP O
activity NN I-NP O
cause VBP B-VP O
Tay NNP B-NP B-Disease
- HYPH I-NP I-Disease
Sachs NNP I-NP I-Disease
disease NN I-NP I-Disease
( ( O O
TSD NN B-NP B-Disease
) ) O O
, , O O
the DT B-NP O
fatal JJ I-NP O
infantile JJ I-NP B-Disease
form NN I-NP I-Disease
of IN B-PP I-Disease
G NN B-NP I-Disease
( ( O I-Disease
M2 NN B-NP I-Disease
) ) O I-Disease
gangliosidosis NN B-NP I-Disease
, , O I-Disease
Type NN B-NP I-Disease
1 CD I-NP I-Disease
. . O O

Less RBR B-ADJP O
severe JJ I-ADJP O
, , O O
subacute JJ O O
( ( O O
juvenile JJ B-NP O
- HYPH I-NP O
onset NN I-NP O
) ) O O
and CC O O
chronic JJ O O
( ( O O
adult JJ B-NP O
- HYPH I-NP O
onset NN I-NP O
) ) O O
variants NNS B-NP O
are VBP B-VP O
characterized VBN I-VP O
by IN B-PP O
a DT B-NP O
broad JJ I-NP O
spectrum NN I-NP O
of IN B-PP O
clinical JJ B-NP O
manifestations NNS I-NP O
and CC O O
are VBP B-VP O
associated VBN I-VP O
with IN B-PP O
residual JJ B-NP O
levels NNS I-NP O
of IN B-PP O
Hex NNP B-NP O
A NNP I-NP O
enzyme NN I-NP O
activity NN I-NP O
. . O O

We PRP B-NP O
identified VBD B-VP O
a DT B-NP O
1422 CD I-NP O
G NN I-NP O
- SYM O O
- HYPH O O
> SYM O O
C NN B-NP O
( ( O O
amino NN B-NP O
acid NN I-NP O
W474C NN I-NP O
) ) O O
substitution NN B-NP O
in IN B-PP O
the DT B-NP O
first JJ I-NP O
position NN I-NP O
of IN B-PP O
exon NN B-NP O
13 CD I-NP O
of IN B-PP O
HEXA NN B-NP O
of IN B-PP O
a DT B-NP O
non AFX I-NP O
- HYPH I-NP O
Jewish JJ I-NP O
proband NN I-NP O
who WP B-NP O
manifested VBD B-VP O
a DT B-NP O
subacute JJ I-NP O
variant NN I-NP O
of IN B-PP O
G NN B-NP B-Disease
( ( O I-Disease
M2 NN B-NP I-Disease
) ) O I-Disease
gangliosidosis NN B-NP I-Disease
. . O O

On IN B-PP O
the DT B-NP O
second JJ I-NP O
maternally RB I-NP O
inherited VBN I-NP O
allele NN I-NP O
, , O O
we PRP B-NP O
identified VBD B-VP O
the DT B-NP O
common JJ I-NP O
infantile JJ I-NP O
disease NN I-NP O
- HYPH O O
causing VBG B-VP O
4 CD B-NP O
- HYPH I-NP O
bp NN I-NP O
insertion NN I-NP O
, , O O
+ SYM O O
TATC NN B-NP O
1278 CD I-NP O
, , O O
in IN B-PP O
exon NN B-NP O
11 CD I-NP O
. . O O

Pulse NN B-NP O
- HYPH I-NP O
chase NN I-NP O
analysis NN I-NP O
using VBG B-VP O
proband NN B-NP O
fibroblasts NNS I-NP O
revealed VBD B-VP O
that IN B-SBAR O
the DT B-NP O
W474C NN I-NP O
- HYPH O O
containing VBG B-VP O
alpha SYM B-NP O
- HYPH B-NP O
subunit NN I-NP O
precursor NN I-NP O
was VBD B-VP O
normally RB I-VP O
synthesized VBN I-VP O
, , O O
but CC O O
not RB B-VP O
phosphorylated VBN I-VP O
or CC I-VP O
secreted VBN I-VP O
, , O O
and CC O O
the DT B-NP O
mature JJ I-NP O
lysosomal JJ I-NP O
alpha SYM I-NP O
- HYPH I-NP O
subunit NN B-NP O
was VBD B-VP O
not RB I-VP O
detected VBN I-VP O
. . O O

When WRB B-ADVP O
the DT B-NP O
W474C NN I-NP O
- HYPH O O
containing VBG B-VP O
alpha SYM B-NP O
- HYPH O O
subunit NN B-NP O
was VBD B-VP O
transiently RB B-ADVP O
co AFX B-ADJP O
- HYPH O O
expressed VBN B-VP O
with IN B-PP O
the DT B-NP O
beta SYM I-NP O
- HYPH I-NP O
subunit NN I-NP O
to TO B-VP O
produce VB I-VP O
Hex NN B-NP O
A NN I-NP O
( ( O O
alphabeta NN B-NP O
) ) O O
in IN B-PP O
COS NN B-NP O
- HYPH B-NP O
7 CD I-NP O
cells NNS I-NP O
, , O O
the DT B-NP O
mature JJ I-NP O
alpha SYM I-NP O
- HYPH I-NP O
subunit NN B-NP O
was VBD B-VP O
present JJ B-ADJP O
, , O O
but CC O O
its PRP$ B-NP O
level NN I-NP O
was VBD B-VP O
much RB B-ADJP O
lower JJR I-ADJP O
than IN B-PP O
that DT B-NP O
from IN B-PP O
normal JJ B-NP O
alpha SYM I-NP O
- HYPH I-NP O
subunit NN I-NP O
transfections NNS I-NP O
, , O O
although IN B-SBAR O
higher JJR B-ADJP O
than IN B-PP O
in IN B-PP O
those DT B-NP O
cells NNS I-NP O
transfected VBN B-VP O
with IN B-PP O
an DT B-NP O
alpha SYM I-NP O
- HYPH I-NP O
subunit NN I-NP O
associated VBN B-VP O
with IN B-PP O
infantile JJ B-NP O
TSD NN I-NP B-Disease
. . O O

Furthermore RB B-ADVP O
, , O O
the DT B-NP O
precursor NN I-NP O
level NN I-NP O
of IN B-PP O
the DT B-NP O
W474C NN I-NP O
alpha SYM O O
- HYPH O O
subunit NN B-NP O
was VBD B-VP O
found VBN I-VP O
to TO I-VP O
accumulate VB I-VP O
in IN B-PP O
comparison NN B-NP O
to TO B-PP O
the DT B-NP O
normal JJ I-NP O
alpha SYM I-NP O
- HYPH I-NP O
subunit NN I-NP O
precursor NN I-NP O
levels NNS I-NP O
. . O O

We PRP B-NP O
conclude VBP B-VP O
that IN B-SBAR O
the DT B-NP O
1422 CD I-NP O
G NN I-NP O
- SYM B-NP O
- HYPH B-NP O
> SYM I-NP O
C NN I-NP O
mutation NN I-NP O
is VBZ B-VP O
the DT B-NP O
cause NN I-NP O
of IN B-PP O
Hex NNP B-NP B-Disease
A NNP I-NP I-Disease
enzyme NN I-NP I-Disease
deficiency NN I-NP I-Disease
in IN B-PP O
the DT B-NP O
proband NN I-NP O
. . O O

The DT B-NP O
resulting VBG I-NP O
W474C NN I-NP O
substitution NN I-NP O
clearly RB B-ADVP O
interferes VBZ B-VP O
with IN B-PP O
alpha SYM B-NP O
- HYPH I-NP O
subunit NN I-NP O
processing NN I-NP O
, , O O
but CC O O
because IN B-SBAR O
the DT B-NP O
base NN I-NP O
substitution NN I-NP O
falls VBZ B-VP O
at IN B-PP O
the DT B-NP O
first JJ I-NP O
position NN I-NP O
of IN B-PP O
exon NN B-NP O
13 CD I-NP O
, , O O
aberrant JJ B-NP O
splicing NN I-NP O
may MD B-VP O
also RB I-VP O
contribute VB I-VP O
to TO B-PP O
Hex NNP B-NP B-Disease
A NNP I-NP I-Disease
deficiency NN I-NP I-Disease
in IN B-PP O
this DT B-NP O
proband NN I-NP O
. . O O

. . O O

Two CD B-NP O
frequent JJ I-NP O
missense JJ I-NP O
mutations NNS I-NP O
in IN B-PP O
Pendred JJ B-NP B-Disease
syndrome NN I-NP I-Disease
. . O O

Pendred VBN B-NP B-Disease
syndrome NN I-NP I-Disease
is VBZ B-VP O
an DT B-NP O
autosomal JJ I-NP B-Disease
recessive JJ I-NP I-Disease
disorder NN I-NP I-Disease
characterized VBN B-VP O
by IN B-PP O
early JJ B-NP O
childhood NN I-NP O
deafness NN I-NP B-Disease
and CC I-NP O
goiter NN I-NP B-Disease
. . O O

A DT B-NP O
century NN I-NP O
after IN B-PP O
its PRP$ B-NP O
recognition NN I-NP O
as IN B-PP O
a DT B-NP O
syndrome NN I-NP O
by IN B-PP O
Vaughan NNP B-NP O
Pendred NNP I-NP O
, , O O
the DT B-NP O
disease NN I-NP O
gene NN I-NP O
( ( O O
PDS NN B-NP O
) ) O O
was VBD B-VP O
mapped VBN I-VP O
to TO B-PP O
chromosome NN B-NP O
7q22 NN I-NP O
- HYPH B-NP O
q31 NN I-NP O
. . O O

1 CD B-NP O
and CC O O
, , O O
recently RB B-ADVP O
, , O O
found VBN B-VP O
to TO I-VP O
encode VB I-VP O
a DT B-NP O
putative JJ I-NP O
sulfate NN I-NP O
transporter NN I-NP O
. . O O

We PRP B-NP O
performed VBD B-VP O
mutation NN B-NP O
analysis NN I-NP O
of IN B-PP O
the DT B-NP O
PDS NN I-NP B-Disease
gene NN I-NP O
in IN B-PP O
patients NNS B-NP O
from IN B-PP O
14 CD B-NP O
Pendred NNP I-NP B-Disease
families NNS I-NP O
originating VBG B-VP O
from IN B-PP O
seven CD B-NP O
countries NNS I-NP O
and CC O O
identified VBD B-VP O
all DT B-NP O
mutations NNS I-NP O
. . O O

The DT B-NP O
mutations NNS I-NP O
include VBP B-VP O
three CD B-NP O
single JJ I-NP O
base NN I-NP O
deletions NNS I-NP O
, , O O
one CD B-NP O
splice NN I-NP O
site NN I-NP O
mutation NN I-NP O
and CC O O
10 CD B-NP O
missense JJ I-NP O
mutations NNS I-NP O
. . O O

One CD B-NP O
missense JJ I-NP O
mutation NN I-NP O
( ( O O
L236P NN B-NP O
) ) O O
was VBD B-VP O
found VBN I-VP O
in IN B-PP O
a DT B-NP O
homozygous JJ I-NP O
state NN I-NP O
in IN B-PP O
two CD B-NP O
consanguineous JJ I-NP O
families NNS I-NP O
and CC B-PP O
in IN B-PP O
a DT B-NP O
heterozygous JJ I-NP O
state NN I-NP O
in IN B-PP O
five CD B-NP O
additional JJ I-NP O
non AFX I-NP O
- HYPH I-NP O
consanguineous JJ I-NP O
families NNS I-NP O
. . O O

Another DT B-NP O
missense JJ I-NP O
mutation NN I-NP O
( ( O O
T416P NN B-NP O
) ) O O
was VBD B-VP O
found VBN I-VP O
in IN B-PP O
a DT B-NP O
homozygous JJ I-NP O
state NN I-NP O
in IN B-PP O
one CD B-NP O
family NN I-NP O
and CC B-PP O
in IN B-PP O
a DT B-NP O
heterozygous JJ I-NP O
state NN I-NP O
in IN B-PP O
four CD B-NP O
families NNS I-NP O
. . O O

Pendred JJ B-NP B-Disease
patients NNS I-NP O
in IN B-PP O
three CD B-NP O
non AFX I-NP O
- HYPH I-NP O
consanguineous JJ I-NP O
families NNS I-NP O
were VBD B-VP O
shown VBN I-VP O
to TO I-VP O
be VB I-VP O
compound JJ B-NP O
heterozygotes NNS I-NP O
for IN B-PP O
L236P NN B-NP O
and CC I-NP O
T416P NN I-NP O
. . O O

In IN B-PP O
total NN B-NP O
, , O O
one CD B-NP O
or CC O O
both DT B-NP O
of IN B-PP O
these DT B-NP O
mutations NNS I-NP O
were VBD B-VP O
found VBN I-VP O
in IN B-PP O
nine CD B-NP O
of IN B-PP O
the DT B-NP O
14 CD I-NP O
families NNS I-NP O
analyzed VBN B-VP O
. . O O

The DT B-NP O
identification NN I-NP O
of IN B-PP O
two CD B-NP O
frequent JJ I-NP O
PDS NN I-NP B-Disease
mutations NNS I-NP O
will MD B-VP O
facilitate VB I-VP O
the DT B-NP O
molecular JJ I-NP O
diagnosis NN I-NP O
of IN B-PP O
Pendred NNP B-NP B-Disease
syndrome NN I-NP I-Disease
. . O O

Insertional JJ B-NP O
mutation NN I-NP O
by IN B-PP O
transposable JJ B-NP O
element NN I-NP O
, , O O
L1 NN B-NP O
, , O O
in IN B-PP O
the DT B-NP O
DMD NN I-NP B-Disease
gene NN I-NP O
results VBZ B-VP O
in IN B-PP O
X NN B-NP B-Disease
- HYPH O I-Disease
linked VBN B-VP I-Disease
dilated VBN B-NP I-Disease
cardiomyopathy NN I-NP I-Disease
. . O O

X NN B-NP B-Disease
- HYPH B-VP I-Disease
linked VBN I-VP I-Disease
dilated VBN B-NP I-Disease
cardiomyopathy NN I-NP I-Disease
( ( O O
XLDCM NN B-NP B-Disease
) ) O O
is VBZ B-VP O
a DT B-NP O
clinical JJ I-NP O
phenotype NN I-NP O
of IN B-PP O
dystrophinopathy NN B-NP B-Disease
which WDT B-NP O
is VBZ B-VP O
characterized VBN I-VP O
by IN B-PP O
preferential JJ B-NP O
myocardial JJ I-NP B-Disease
involvement NN I-NP I-Disease
without IN B-PP O
any DT B-NP O
overt JJ I-NP O
clinical JJ I-NP O
signs NNS I-NP O
of IN B-PP O
skeletal JJ B-NP B-Disease
myopathy NN I-NP I-Disease
. . O O

To TO B-PP O
date NN B-NP O
, , O O
several JJ B-NP O
mutations NNS I-NP O
in IN B-PP O
the DT B-NP O
Duchenne NNP I-NP B-Disease
muscular JJ I-NP I-Disease
dystrophy NN I-NP I-Disease
gene NN I-NP O
, , O O
DMD NN B-NP O
, , O O
have VBP B-VP O
been VBN I-VP O
identified VBN I-VP O
in IN B-PP O
patients NNS B-NP O
with IN B-PP O
XLDCM NN B-NP B-Disease
, , O O
but CC O O
a DT B-NP O
pathogenic JJ I-NP O
correlation NN I-NP O
of IN B-PP O
these DT B-NP O
cardiospecific JJ I-NP O
mutations NNS I-NP O
in IN B-PP O
DMD NN B-NP O
with IN B-PP O
the DT B-NP O
XLDCM NN I-NP B-Disease
phenotype NN I-NP O
has VBZ B-VP O
remained VBN I-VP O
to TO I-VP O
be VB I-VP O
elucidated VBN I-VP O
. . O O

We PRP B-NP O
report VBP B-VP O
here RB B-ADVP O
the DT B-NP O
identification NN I-NP O
of IN B-PP O
a DT B-NP O
unique JJ I-NP O
de FW I-NP O
novo FW I-NP O
L1 NN I-NP O
insertion NN I-NP O
in IN B-PP O
the DT B-NP O
muscle NN I-NP O
exon NN I-NP O
1 CD I-NP O
in IN B-PP O
DMD NN B-NP O
in IN B-PP O
three CD B-NP O
XLDCM NN I-NP B-Disease
patients NNS I-NP O
from IN B-PP O
two CD B-NP O
unrelated JJ I-NP O
Japanese JJ I-NP O
families NNS I-NP O
. . O O

The DT B-NP O
insertion NN I-NP O
was VBD B-VP O
a DT B-NP O
5 CD I-NP O
- HYPH I-NP O
truncated VBN I-NP O
form NN I-NP O
of IN B-PP O
human JJ B-NP O
L1 NN I-NP O
inversely RB B-VP O
integrated VBN I-VP O
in IN B-PP O
the DT B-NP O
5 CD I-NP O
- HYPH I-NP O
untranslated JJ I-NP O
region NN I-NP O
in IN B-PP O
the DT B-NP O
muscle NN I-NP O
exon NN I-NP O
1 CD I-NP O
, , O O
which WDT B-NP O
affected VBD B-VP O
the DT B-NP O
transcription NN I-NP O
or CC O O
the DT B-NP O
stability NN I-NP O
of IN B-PP O
the DT B-NP O
muscle NN I-NP O
form NN I-NP O
of IN B-PP O
dystrophin NN B-NP O
transcripts NNS I-NP O
but CC B-NP O
not RB I-NP O
that DT B-NP O
of IN B-PP O
the DT B-NP O
brain NN I-NP O
or CC I-NP O
Purkinje NN I-NP O
cell NN I-NP O
form NN I-NP O
, , O O
probably RB B-ADVP O
due IN B-PP O
to TO B-PP O
its PRP$ B-NP O
unique JJ I-NP O
site NN I-NP O
of IN B-PP O
integration NN B-NP O
. . O O

We PRP B-NP O
speculate VBP B-VP O
that IN B-SBAR O
this DT B-NP O
insertion NN I-NP O
of IN B-PP O
an DT B-NP O
L1 NN I-NP O
sequence NN I-NP O
in IN B-PP O
DMD NN B-NP O
is VBZ B-VP O
responsible JJ B-ADJP O
for IN B-PP O
some DT B-NP O
of IN B-PP O
the DT B-NP O
population NN I-NP O
of IN B-PP O
Japanese JJ B-NP O
patients NNS I-NP O
with IN B-PP O
XLDCM NN B-NP B-Disease
. . O O

. . O O

Severe JJ B-NP O
early JJ I-NP O
- HYPH I-NP O
onset NN I-NP O
obesity NN I-NP B-Disease
, , O O
adrenal JJ B-NP B-Disease
insufficiency NN I-NP I-Disease
and CC O O
red JJ B-NP O
hair NN I-NP O
pigmentation NN I-NP O
caused VBN B-VP O
by IN B-PP O
POMC NN B-NP O
mutations NNS I-NP O
in IN B-PP O
humans NNS B-NP O
. . O O

Sequential JJ B-NP O
cleavage NN I-NP O
of IN B-PP O
the DT B-NP O
precursor NN I-NP O
protein NN I-NP O
pre AFX O O
- HYPH O O
pro AFX O O
- HYPH O O
opiomelanocortin NN B-NP O
( ( O O
POMC NN B-NP O
) ) O O
generates VBZ B-VP O
the DT B-NP O
melanocortin NN I-NP O
peptides NNS I-NP O
adrenocorticotrophin NN I-NP O
( ( O O
ACTH NN B-NP O
) ) O O
, , O O
melanocyte NN B-NP O
- HYPH O O
stimulating VBG B-VP O
hormones NNS B-NP O
( ( O O
MSH NN B-NP O
) ) O O
alpha NN B-NP O
, , O O
beta NN B-NP O
and CC I-NP O
gamma NN I-NP O
as RB B-CONJP O
well RB I-CONJP O
as IN I-CONJP O
the DT B-NP O
opioid JJ I-NP O
- HYPH I-NP O
receptor NN I-NP O
ligand NN I-NP O
beta SYM B-VP O
- HYPH O O
endorphin NN B-NP O
. . O O

While IN B-SBAR O
a DT B-NP O
few JJ I-NP O
cases NNS I-NP O
of IN B-PP O
isolated VBN B-NP O
ACTH NN I-NP B-Disease
deficiency NN I-NP I-Disease
have VBP B-VP O
been VBN I-VP O
reported VBN I-VP O
( ( O O
OMIM NN B-NP O
201400 CD I-NP O
) ) O O
, , O O
an DT B-NP O
inherited VBN I-NP O
POMC NN I-NP O
defect NN I-NP O
has VBZ B-VP O
not RB I-VP O
been VBN I-VP O
described VBN I-VP O
so RB B-ADVP O
far RB I-ADVP O
. . O O

Recent JJ B-NP O
studies NNS I-NP O
in IN B-PP O
animal NN B-NP O
models NNS I-NP O
elucidated VBD B-VP O
a DT B-NP O
central JJ I-NP O
role NN I-NP O
of IN B-PP O
alpha SYM B-NP O
- HYPH B-VP O
MSH NN B-NP O
in IN B-PP O
the DT B-NP O
regulation NN I-NP O
of IN B-PP O
food NN B-NP O
intake NN I-NP O
by IN B-PP O
activation NN B-NP O
of IN B-PP O
the DT B-NP O
brain NN I-NP O
melanocortin NN I-NP O
- HYPH B-NP O
4 CD I-NP O
- HYPH I-NP O
receptor NN I-NP O
( ( O O
MC4 NN B-NP O
- HYPH I-NP O
R NN I-NP O
; : O O
refs NNS B-NP O
3 CD B-NP O
- HYPH I-NP O
5 CD I-NP O
) ) O O
and CC O O
the DT B-NP O
linkage NN I-NP O
of IN B-PP O
human JJ B-NP O
obesity NN I-NP B-Disease
to TO B-PP O
chromosome NN B-NP O
2 CD I-NP O
in IN B-PP O
close JJ B-NP O
proximity NN I-NP O
to TO B-PP O
the DT B-NP O
POMC NN I-NP O
locus NN I-NP O
, , O O
led VBD B-VP O
to TO B-PP O
the DT B-NP O
proposal NN I-NP O
of IN B-PP O
an DT B-NP O
association NN I-NP O
of IN B-PP O
POMC NN B-NP O
with IN B-PP O
human JJ B-NP O
obesity NN I-NP B-Disease
. . O O

The DT B-NP O
dual JJ I-NP O
role NN I-NP O
of IN B-PP O
alpha SYM B-NP O
- HYPH B-VP O
MSH NN B-NP O
in IN B-PP O
regulating VBG B-VP O
food NN B-NP O
intake NN I-NP O
and CC O O
influencing VBG B-VP O
hair NN B-NP O
pigmentation NN I-NP O
predicts VBZ B-VP O
that IN B-SBAR O
the DT B-NP O
phenotype NN I-NP O
associated VBN B-VP O
with IN B-PP O
a DT B-NP O
defect NN I-NP O
in IN B-PP O
POMC NN B-NP O
function NN I-NP O
would MD B-VP O
include VB I-VP O
obesity NN B-NP B-Disease
, , O O
alteration NN B-NP O
in IN B-PP O
pigmentation NN B-NP O
and CC O O
ACTH NN B-NP B-Disease
deficiency NN I-NP I-Disease
. . O O

The DT B-NP O
observation NN I-NP O
of IN B-PP O
these DT B-NP O
symptoms NNS I-NP O
in IN B-PP O
two CD B-NP O
probands NNS I-NP O
prompted VBD B-VP O
us PRP B-NP O
to TO B-VP O
search VB I-VP O
for IN B-PP O
mutations NNS B-NP O
within IN B-PP O
their PRP$ B-NP O
POMC NN I-NP O
genes NNS I-NP O
. . O O

Patient NN B-NP O
1 CD I-NP O
was VBD B-VP O
found VBN I-VP O
to TO I-VP O
be VB I-VP O
a DT B-NP O
compound NN I-NP O
heterozygote NN I-NP O
for IN B-PP O
two CD B-NP O
mutations NNS I-NP O
in IN B-PP O
exon NN B-NP O
3 CD I-NP O
( ( O O
G7013T NN B-NP O
, , O O
C7133delta NN B-NP O
) ) O O
which WDT B-NP O
interfere VBP B-VP O
with IN B-PP O
appropriate JJ B-NP O
synthesis NN I-NP O
of IN B-PP O
ACTH NN B-NP O
and CC O O
alpha SYM B-NP O
- HYPH O O
MSH NN B-NP O
. . O O

Patient NN B-NP O
2 CD I-NP O
was VBD B-VP O
homozygous JJ B-ADJP O
for IN B-PP O
a DT B-NP O
mutation NN I-NP O
in IN B-PP O
exon NN B-NP O
2 CD I-NP O
( ( O O
C3804A NN B-NP O
) ) O O
which WDT B-NP O
abolishes VBZ B-VP O
POMC NN B-NP O
translation NN I-NP O
. . O O

These DT B-NP O
findings NNS I-NP O
represent VBP B-VP O
the DT B-NP O
first JJ I-NP O
examples NNS I-NP O
of IN B-PP O
a DT B-NP O
genetic JJ I-NP B-Disease
defect NN I-NP I-Disease
within IN B-PP O
the DT B-NP O
POMC NN I-NP O
gene NN I-NP O
and CC O O
define VB B-VP O
a DT B-NP O
new JJ I-NP O
monogenic JJ I-NP B-Disease
endocrine JJ I-NP I-Disease
disorder NN I-NP I-Disease
resulting VBG B-VP O
in IN B-PP O
early JJ B-NP O
- HYPH I-NP O
onset NN I-NP O
obesity NN I-NP B-Disease
, , O O
adrenal JJ B-NP B-Disease
insufficiency NN I-NP I-Disease
and CC O O
red JJ B-NP O
hair NN I-NP O
pigmentation NN I-NP O
. . O O

. . O O

A DT B-NP O
European JJ I-NP O
multicenter JJ I-NP O
study NN I-NP O
of IN B-PP O
phenylalanine NN B-NP B-Disease
hydroxylase NN I-NP I-Disease
deficiency NN I-NP I-Disease
: : O O
classification NN B-NP O
of IN B-PP O
105 CD B-NP O
mutations NNS I-NP O
and CC O O
a DT B-NP O
general JJ I-NP O
system NN I-NP O
for IN B-PP O
genotype NN B-NP O
- HYPH O O
based VBN B-NP O
prediction NN I-NP O
of IN B-PP O
metabolic JJ B-NP O
phenotype NN I-NP O
. . O O

Phenylketonuria NN B-NP B-Disease
( ( O O
PKU NN B-NP B-Disease
) ) O O
and CC O O
mild JJ B-NP B-Disease
hyperphenylalaninemia NN I-NP I-Disease
( ( O O
MHP NN B-NP B-Disease
) ) O O
are VBP B-VP O
allelic JJ B-NP B-Disease
disorders NNS I-NP I-Disease
caused VBN B-VP O
by IN B-PP O
mutations NNS B-NP O
in IN B-PP O
the DT B-NP O
gene NN I-NP O
encoding VBG B-VP O
phenylalanine NN B-NP O
hydroxylase NN I-NP O
( ( O O
PAH NN B-NP O
) ) O O
. . O O

Previous JJ B-NP O
studies NNS I-NP O
have VBP B-VP O
suggested VBN I-VP O
that IN B-SBAR O
the DT B-NP O
highly RB I-NP O
variable JJ I-NP O
metabolic JJ I-NP O
phenotypes NNS I-NP O
of IN B-PP O
PAH NN B-NP B-Disease
deficiency NN I-NP I-Disease
correlate VBP B-VP O
with IN B-PP O
PAH NN B-NP O
genotypes NNS I-NP O
. . O O

We PRP B-NP O
identified VBD B-VP O
both CC O O
causative JJ B-NP O
mutations NNS I-NP O
in IN B-PP O
686 CD B-NP O
patients NNS I-NP O
from IN B-PP O
seven CD B-NP O
European JJ I-NP O
centers NNS I-NP O
. . O O

On IN B-PP O
the DT B-NP O
basis NN I-NP O
of IN B-PP O
the DT B-NP O
phenotypic JJ I-NP O
characteristics NNS I-NP O
of IN B-PP O
297 CD B-NP O
functionally RB I-NP O
hemizygous JJ I-NP O
patients NNS I-NP O
, , O O
105 CD B-NP O
of IN B-PP O
the DT B-NP O
mutations NNS I-NP O
were VBD B-VP O
assigned VBN I-VP O
to TO B-PP O
one CD B-NP O
of IN B-PP O
four CD B-NP O
arbitrary JJ I-NP O
phenotype NN I-NP O
categories NNS I-NP O
. . O O

We PRP B-NP O
proposed VBD B-VP O
and CC I-VP O
tested VBD I-VP O
a DT B-NP O
simple JJ I-NP O
model NN I-NP O
for IN B-PP O
correlation NN B-NP O
between IN B-PP O
genotype NN B-NP O
and CC O O
phenotypic JJ B-NP O
outcome NN I-NP O
. . O O

The DT B-NP O
observed VBN I-NP O
phenotype NN I-NP O
matched VBD B-VP O
the DT B-NP O
predicted VBN I-NP O
phenotype NN I-NP O
in IN B-PP O
79 CD B-NP O
% NN I-NP O
of IN B-PP O
the DT B-NP O
cases NNS I-NP O
, , O O
and CC O O
in IN B-PP O
only RB B-NP O
5 CD I-NP O
of IN B-PP O
184 CD B-NP O
patients NNS I-NP O
was VBD B-VP O
the DT B-NP O
observed VBN I-NP O
phenotype NN I-NP O
more JJR B-NP O
than IN I-NP O
one CD I-NP O
category NN I-NP O
away RB B-ADVP O
from IN B-PP O
that DT B-NP O
expected VBN B-VP O
. . O O

Among IN B-PP O
the DT B-NP O
seven CD I-NP O
contributing VBG I-NP O
centers NNS I-NP O
, , O O
the DT B-NP O
proportion NN I-NP O
of IN B-PP O
patients NNS B-NP O
for IN B-PP O
whom WP B-NP O
the DT B-NP O
observed VBN I-NP O
phenotype NN I-NP O
did VBD B-VP O
not RB I-VP O
match VB I-VP O
the DT B-NP O
predicted VBN I-NP O
phenotype NN I-NP O
was VBD B-VP O
4 CD B-NP O
% NN I-NP O
- HYPH O O
23 CD B-NP O
% NN I-NP O
( ( O O
P NN B-NP O
< SYM B-NP O
. . I-NP O

0001 CD I-NP O
) ) O O
, , O O
suggesting VBG B-VP O
that IN B-SBAR O
differences NNS B-NP O
in IN B-PP O
methods NNS B-NP O
used VBN B-VP O
for IN B-PP O
mutation NN B-NP O
detection NN I-NP O
or CC O O
phenotype NN B-NP O
classification NN I-NP O
may MD B-VP O
account VB I-VP O
for IN B-PP O
a DT B-NP O
considerable JJ I-NP O
proportion NN I-NP O
of IN B-PP O
genotype NN B-NP O
- HYPH B-NP O
phenotype NN I-NP O
inconsistencies NNS I-NP O
. . O O

Our PRP$ B-NP O
data NNS I-NP O
indicate VBP B-VP O
that IN B-SBAR O
the DT B-NP O
PAH NN I-NP O
- HYPH B-NP O
mutation NN I-NP O
genotype NN I-NP O
is VBZ B-VP O
the DT B-NP O
main JJ I-NP O
determinant NN I-NP O
of IN B-PP O
metabolic JJ B-NP O
phenotype NN I-NP O
in IN B-PP O
most JJS B-NP O
patients NNS I-NP O
with IN B-PP O
PAH NN B-NP B-Disease
deficiency NN I-NP I-Disease
. . O O

In IN B-PP O
the DT B-NP O
present JJ I-NP O
study NN I-NP O
, , O O
the DT B-NP O
classification NN I-NP O
of IN B-PP O
105 CD B-NP O
PAH NN I-NP O
mutations NNS I-NP O
may MD B-VP O
allow VB I-VP O
the DT B-NP O
prediction NN I-NP O
of IN B-PP O
the DT B-NP O
biochemical JJ I-NP O
phenotype NN I-NP O
in IN B-PP O
> JJR B-NP O
10 CD I-NP O
, , I-NP O
000 CD I-NP O
genotypes NNS I-NP O
, , O O
which WDT B-NP O
may MD B-VP O
be VB I-VP O
useful JJ B-ADJP O
for IN B-PP O
the DT B-NP O
management NN I-NP O
of IN B-PP O
hyperphenylalaninemia NN B-NP B-Disease
in IN B-PP O
newborns NNS B-NP O
. . O O

Somatic JJ B-NP O
instability NN I-NP O
of IN B-PP O
the DT B-NP O
CTG NN I-NP O
repeat NN I-NP O
in IN B-PP O
mice NNS B-NP O
transgenic JJ B-ADJP O
for IN B-PP O
the DT B-NP O
myotonic JJ I-NP B-Disease
dystrophy NN I-NP I-Disease
region NN I-NP O
is VBZ B-VP O
age NN B-NP O
dependent JJ I-NP O
but CC O O
not RB B-VP O
correlated VBD I-VP O
to TO B-PP O
the DT B-NP O
relative JJ I-NP O
intertissue NN I-NP O
transcription NN I-NP O
levels NNS I-NP O
and CC O O
proliferative JJ B-NP O
capacities NNS I-NP O
. . O O

A DT B-NP O
( ( O O
CTG NN O O
) ) O O
nexpansion NN B-NP O
in IN B-PP O
the DT B-NP O
3 CD I-NP O
- HYPH I-NP O
untranslated JJ I-NP O
region NN I-NP O
( ( O O
UTR NN B-NP O
) ) O O
of IN B-PP O
the DT B-NP O
DM NN I-NP O
protein NN I-NP O
kinase NN I-NP O
gene NN I-NP O
( ( O O
DMPK NN B-NP O
) ) O O
is VBZ B-VP O
responsible JJ B-ADJP O
for IN B-PP O
causing VBG B-VP O
myotonic JJ B-NP B-Disease
dystrophy NN I-NP I-Disease
( ( O O
DM NN B-NP B-Disease
) ) O O
. . O O

Major JJ B-NP O
instability NN I-NP O
, , O O
with IN B-PP O
very RB B-NP O
large JJ I-NP O
expansions NNS I-NP O
between IN B-PP O
generations NNS B-NP O
and CC O O
high JJ B-NP O
levels NNS I-NP O
of IN B-PP O
somatic JJ B-NP O
mosaicism NN I-NP O
, , O O
is VBZ B-VP O
observed VBN I-VP O
in IN B-PP O
patients NNS B-NP O
. . O O

There EX B-NP O
is VBZ B-VP O
a DT B-NP O
good JJ I-NP O
correlation NN I-NP O
between IN B-PP O
repeat NN B-NP O
size NN I-NP O
( ( O O
at IN B-ADVP O
least JJS I-ADVP O
in IN B-PP O
leucocytes NNS B-NP O
) ) O O
, , O O
clinical JJ B-NP O
severity NN I-NP O
and CC O O
age NN B-NP O
of IN B-PP O
onset NN B-NP O
. . O O

The DT B-NP O
trinucleotide NN I-NP O
repeat NN I-NP O
instability NN I-NP O
mechanisms NNS I-NP O
involved VBN B-VP O
in IN B-PP O
DM NN B-NP B-Disease
and CC O O
other JJ B-NP O
human JJ I-NP O
genetic JJ I-NP B-Disease
diseases NNS I-NP I-Disease
are VBP B-VP O
unknown JJ B-ADJP O
. . O O

We PRP B-NP O
studied VBD B-VP O
somatic JJ B-NP O
instability NN I-NP O
by IN B-PP O
measuring VBG B-VP O
the DT B-NP O
CTG NN I-NP O
repeat NN I-NP O
length NN I-NP O
at IN B-PP O
several JJ B-NP O
ages NNS I-NP O
in IN B-PP O
various JJ B-NP O
tissues NNS I-NP O
of IN B-PP O
transgenic JJ B-NP O
mice NNS I-NP O
carrying VBG B-VP O
a DT B-NP O
( ( O O
CTG NN O O
) ) O O
55expansion NN B-NP O
surrounded VBN B-VP O
by IN B-PP O
45 CD B-NP O
kb NN I-NP O
of IN B-PP O
the DT B-NP O
human JJ I-NP O
DM NN I-NP B-Disease
region NN I-NP O
, , O O
using VBG B-VP O
small JJ B-NP O
- HYPH I-NP O
pool NN I-NP O
PCR NN I-NP O
. . O O

These DT B-NP O
mice NNS I-NP O
have VBP B-VP O
been VBN I-VP O
shown VBN I-VP O
to TO I-VP O
reproduce VB I-VP O
the DT B-NP O
intergenerational JJ I-NP O
and CC I-NP O
somatic JJ I-NP O
instability NN I-NP O
of IN B-PP O
the DT B-NP O
55 CD I-NP O
CTG NN I-NP O
repeat NN I-NP O
suggesting VBG B-VP O
that IN B-SBAR O
surrounding VBG B-VP O
sequences NNS B-NP O
and CC O O
the DT B-NP O
chromatin NN I-NP O
environment NN I-NP O
are VBP B-VP O
involved VBN I-VP O
in IN B-PP O
instability NN B-NP O
mechanisms NNS I-NP O
. . O O

As IN B-SBAR O
observed VBN B-VP O
in IN B-PP O
some DT B-NP O
of IN B-PP O
the DT B-NP O
tissues NNS I-NP O
of IN B-PP O
DM NN B-NP B-Disease
patients NNS I-NP O
, , O O
there EX B-NP O
is VBZ B-VP O
a DT B-NP O
tendency NN I-NP O
for IN B-PP O
repeat NN B-NP O
length NN I-NP O
and CC O O
somatic JJ B-NP O
mosaicism NN I-NP O
to TO B-VP O
increase VB I-VP O
with IN B-PP O
the DT B-NP O
age NN I-NP O
of IN B-PP O
the DT B-NP O
mouse NN I-NP O
. . O O

Furthermore RB B-ADVP O
, , O O
we PRP B-NP O
observed VBD B-VP O
no DT B-NP O
correlation NN I-NP O
between IN B-PP O
the DT B-NP O
somatic JJ I-NP O
mutation NN I-NP O
rate NN I-NP O
and CC I-NP O
tissue NN I-NP O
proliferation NN I-NP O
capacity NN I-NP O
. . O O

The DT B-NP O
somatic JJ I-NP O
mutation NN I-NP O
rates NNS I-NP O
in IN B-PP O
different JJ B-NP O
tissues NNS I-NP O
were VBD B-VP O
also RB I-VP O
not RB I-VP O
correlated VBN I-VP O
to TO B-PP O
the DT B-NP O
relative JJ I-NP O
inter NN I-NP O
- HYPH B-NP O
tissue NN I-NP O
difference NN I-NP O
in IN B-PP O
transcriptional JJ B-NP O
levels NNS I-NP O
of IN B-PP O
the DT B-NP O
three CD I-NP O
genes NNS I-NP O
( ( O O
DMAHP NN B-NP O
, , O O
DMPK NN B-NP O
and CC O O
59 CD B-NP O
) ) O O
surrounding VBG B-VP O
the DT B-NP O
repeat NN I-NP O
. . O O

. . O O

A DT B-NP O
novel JJ I-NP O
missense JJ I-NP O
mutation NN I-NP O
in IN B-PP O
patients NNS B-NP O
from IN B-PP O
a DT B-NP O
retinoblastoma NN I-NP B-Disease
pedigree NN I-NP O
showing VBG B-VP O
only RB B-NP O
mild JJ I-NP O
expression NN I-NP O
of IN B-PP O
the DT B-NP O
tumor NN I-NP B-Disease
phenotype NN I-NP O
. . O O

We PRP B-NP O
have VBP B-VP O
used VBN I-VP O
single JJ B-NP O
strand NN I-NP O
conformation NN I-NP O
polymorphism NN I-NP O
analysis NN I-NP O
to TO B-VP O
study VB I-VP O
the DT B-NP O
27 CD I-NP O
exons NNS I-NP O
of IN B-PP O
the DT B-NP O
RB1 NN I-NP O
gene NN I-NP O
in IN B-PP O
individuals NNS B-NP O
from IN B-PP O
a DT B-NP O
family NN I-NP O
showing VBG B-VP O
mild JJ B-NP O
expression NN I-NP O
of IN B-PP O
the DT B-NP O
retinoblastoma NN I-NP B-Disease
phenotype NN I-NP O
. . O O

In IN B-PP O
this DT B-NP O
family NN I-NP O
affected VBD B-VP O
individuals NNS B-NP O
developed VBD B-VP O
unilateral JJ B-NP B-Disease
tumors NNS I-NP I-Disease
and CC O O
, , O O
as IN B-PP O
a DT B-NP O
result NN I-NP O
of IN B-PP O
linkage NN B-NP O
analysis NN I-NP O
, , O O
unaffected JJ B-NP O
mutation NN I-NP O
carriers NNS I-NP O
were VBD B-VP O
also RB I-VP O
identified VBN I-VP O
within IN B-PP O
the DT B-NP O
pedigree NN I-NP O
. . O O

A DT B-NP O
single JJ I-NP O
band NN I-NP O
shift NN I-NP O
using VBG B-VP O
SSCP NN B-NP O
was VBD B-VP O
identified VBN I-VP O
in IN B-PP O
exon NN B-NP O
21 CD I-NP O
which WDT B-NP O
resulted VBD B-VP O
in IN B-PP O
a DT B-NP O
missense JJ I-NP O
mutation NN I-NP O
converting VBG B-VP O
a DT B-NP O
cys NNS I-NP O
- SYM B-NP O
- HYPH B-NP O
> SYM I-NP O
arg NN I-NP O
at IN B-PP O
nucleotide NN B-NP O
position NN I-NP O
28 CD I-NP O
in IN B-PP O
the DT B-NP O
exon NN I-NP O
. . O O

The DT B-NP O
mutation NN I-NP O
destroyed VBD B-VP O
an DT B-NP O
NdeI NN I-NP O
restriction NN I-NP O
enzyme NN I-NP O
site NN I-NP O
. . O O

Analysis NN B-NP O
of IN B-PP O
all DT B-NP O
family NN I-NP O
members NNS I-NP O
demonstrated VBD B-VP O
that IN B-SBAR O
the DT B-NP O
missense JJ I-NP O
mutation NN I-NP O
co AFX O O
- HYPH O O
segregated VBN B-VP O
with IN B-PP O
patients NNS B-NP O
with IN B-PP O
tumors NNS B-NP B-Disease
or CC O O
who WP B-NP O
, , O O
as IN B-PP O
a DT B-NP O
result NN I-NP O
of IN B-PP O
linkage NN B-NP O
analysis NN I-NP O
had VBD B-VP O
been VBN I-VP O
predicted VBN I-VP O
to TO I-VP O
carry VB I-VP O
the DT B-NP O
predisposing VBG I-NP O
mutation NN I-NP O
. . O O

These DT B-NP O
observations NNS I-NP O
point VBP B-VP O
to TO B-PP O
another DT B-NP O
region NN I-NP O
of IN B-PP O
the DT B-NP O
RB1 NN I-NP O
gene NN I-NP O
where WRB B-ADVP O
mutations NNS B-NP O
only RB B-ADVP O
modify VBP B-VP O
the DT B-NP O
function NN I-NP O
of IN B-PP O
the DT B-NP O
gene NN I-NP O
and CC O O
raise VB B-VP O
important JJ B-NP O
questions NNS I-NP O
for IN B-PP O
genetic JJ B-NP O
counseling NN I-NP O
in IN B-PP O
families NNS B-NP O
with IN B-PP O
these DT B-NP O
distinctive JJ I-NP O
phenotypes NNS I-NP O
. . O O

. . O O

Maternal JJ B-NP B-Disease
disomy NN I-NP I-Disease
and CC O O
Prader NNP B-NP B-Disease
- HYPH I-NP I-Disease
Willi NNP I-NP I-Disease
syndrome NN I-NP I-Disease
consistent JJ B-ADJP O
with IN B-PP O
gamete NN B-NP O
complementation NN I-NP O
in IN B-PP O
a DT B-NP O
case NN I-NP O
of IN B-PP O
familial JJ B-NP O
translocation NN I-NP O
( ( O O
3 CD B-NP O
; : O O
15 CD B-NP O
) ) O O
( ( O O
p25 NN B-NP O
; : O O
q11 NN B-NP O
. . O O

2 CD B-NP O
) ) O O
. . O O

Maternal JJ B-NP B-Disease
uniparental JJ I-NP I-Disease
disomy NN I-NP I-Disease
( ( O I-Disease
UPD NN B-NP I-Disease
) ) O I-Disease
for IN B-PP I-Disease
chromosome NN B-NP I-Disease
15 CD I-NP I-Disease
is VBZ B-VP O
responsible JJ B-ADJP O
for IN B-PP O
an DT B-NP O
estimated VBN I-NP O
30 CD I-NP O
% NN I-NP O
of IN B-PP O
cases NNS B-NP O
of IN B-PP O
Prader NNP B-NP B-Disease
- HYPH I-NP I-Disease
Willi NNP I-NP I-Disease
syndrome NN I-NP I-Disease
( ( O O
PWS NN B-NP B-Disease
) ) O O
. . O O

We PRP B-NP O
report VBP B-VP O
on IN B-PP O
an DT B-NP O
unusual JJ I-NP O
case NN I-NP O
of IN B-PP O
maternal JJ B-NP B-Disease
disomy NN I-NP I-Disease
15 CD I-NP I-Disease
in IN B-PP O
PWS NN B-NP B-Disease
that WDT B-NP O
is VBZ B-VP O
most RBS B-ADJP O
consistent JJ I-ADJP O
with IN B-PP O
adjacent JJ B-NP O
- HYPH I-NP O
1 CD I-NP O
segregation NN I-NP O
of IN B-PP O
a DT B-NP O
paternal JJ I-NP O
t NN I-NP O
( ( O O
3 CD B-NP O
; : O O
15 CD B-NP O
) ) O O
( ( O O
p25 NN B-NP O
; : O O
q11 NN B-NP O
. . O O

2 CD B-NP O
) ) O O
with IN B-PP O
simultaneous JJ B-NP O
maternal JJ I-NP O
meiotic JJ I-NP O
nondisjunction NN I-NP O
for IN B-PP O
chromosome NN B-NP O
15 CD I-NP O
. . O O

The DT B-NP O
patient NN I-NP O
( ( O O
J NNP B-NP O
. . I-NP O

B NNP I-NP O
. . O O

) ) O O
, , O O
a DT B-NP O
17 CD I-NP O
- HYPH I-NP O
year NN I-NP O
- HYPH B-NP O
old JJ I-NP O
white JJ I-NP O
male NN I-NP O
with IN B-PP O
PWS NN B-NP B-Disease
, , O O
was VBD B-VP O
found VBN I-VP O
to TO I-VP O
have VB I-VP O
47 CD B-NP O
chromosomes NNS I-NP O
with IN B-PP O
a DT B-NP O
supernumerary JJ I-NP O
, , I-NP O
paternal JJ I-NP O
der NN I-NP O
( ( O O
15 CD B-NP O
) ) O O
consisting VBG B-VP O
of IN B-PP O
the DT B-NP O
short JJ I-NP O
arm NN I-NP O
and CC O O
the DT B-NP O
proximal JJ I-NP O
long JJ I-NP O
arm NN I-NP O
of IN B-PP O
chromosome NN B-NP O
15 CD I-NP O
, , O O
and CC O O
distal JJ B-NP O
chromosome NN I-NP O
arm NN I-NP O
3p NN I-NP O
. . O O

The DT B-NP O
t NN I-NP O
( ( O O
3 CD B-NP O
; : O O
15 CD B-NP O
) ) O O
was VBD B-VP O
present JJ B-ADJP O
in IN B-PP O
the DT B-NP O
balanced JJ I-NP O
state NN I-NP O
in IN B-PP O
the DT B-NP O
patients NNS I-NP O
father NN I-NP O
and CC O O
a DT B-NP O
sister NN I-NP O
. . O O

Fluorescent JJ B-NP O
in FW I-NP O
situ FW I-NP O
hybridization NN I-NP O
analysis NN I-NP O
demonstrated VBD B-VP O
that IN B-SBAR O
the DT B-NP O
PWS NN I-NP B-Disease
critical JJ I-NP O
region NN I-NP O
resided VBD B-VP O
on IN B-PP O
the DT B-NP O
derivative JJ I-NP O
chromosome NN I-NP O
3 CD I-NP O
and CC O O
that IN B-SBAR O
there EX B-NP O
was VBD B-VP O
no DT B-NP O
deletion NN I-NP O
of IN B-PP O
the DT B-NP O
PWS NN I-NP B-Disease
region NN I-NP O
on IN B-PP O
the DT B-NP O
normal JJ I-NP O
pair NN I-NP O
of IN B-PP O
15s NNS B-NP O
present JJ B-ADJP O
in IN B-PP O
J NNP B-NP O
. . O O

B NN B-NP O
. . O O

Methylation NN B-NP O
analysis NN I-NP O
at IN B-PP O
exon NN B-NP O
alpha NN I-NP O
of IN B-PP O
the DT B-NP O
small JJ I-NP O
nuclear JJ I-NP O
ribonucleoprotein NN I-NP O
- HYPH O O
associated VBN B-NP O
polypeptide NN I-NP O
N NN I-NP O
( ( O O
SNRPN NN B-NP O
) ) O O
gene NN B-NP O
showed VBD B-VP O
a DT B-NP O
pattern NN I-NP O
characteristic JJ B-ADJP O
of IN B-PP O
only RB B-NP O
the DT I-NP O
maternal JJ I-NP O
chromosome NN I-NP O
15 CD I-NP O
in IN B-PP O
J NNP B-NP O
. . O O

B NN B-NP O
. . O O

Maternal JJ B-NP B-Disease
disomy NN I-NP I-Disease
was VBD B-VP O
confirmed VBN I-VP O
by IN B-PP O
polymerase NN B-NP O
chain NN I-NP O
reaction NN I-NP O
analysis NN I-NP O
of IN B-PP O
microsatellite NN B-NP O
repeats NNS I-NP O
at IN B-PP O
the DT B-NP O
gamma SYM I-NP O
- HYPH I-NP O
aminobutyric JJ I-NP O
acid NN I-NP O
receptor NN I-NP O
beta3 NN I-NP O
subunit NN I-NP O
( ( O O
GABRB3 NN B-NP O
) ) O O
locus NN B-NP O
. . O O

A DT B-NP O
niece NN I-NP O
( ( O O
B NN B-NP O
. . O O

B NN B-NP O
. . O O

) ) O O
with IN B-PP O
45 CD B-NP O
chromosomes NNS I-NP O
and CC O O
the DT B-NP O
derivative JJ I-NP O
3 CD I-NP O
but CC O O
without IN B-PP O
the DT B-NP O
der NN I-NP O
( ( O O
15 CD B-NP O
) ) O O
demonstrated VBD B-VP O
a DT B-NP O
phenotype NN I-NP O
consistent JJ B-ADJP O
with IN B-PP O
that DT B-NP O
reported VBN B-VP O
for IN B-PP O
haploinsufficiency NN B-NP O
of IN B-PP O
distal JJ B-NP O
3 CD I-NP O
p NN I-NP O
. . O O

Uniparental JJ B-NP B-Disease
disomy NN I-NP I-Disease
associated VBN B-VP O
with IN B-PP O
unbalanced JJ B-NP O
segregation NN I-NP O
of IN B-PP O
non AFX B-NP O
- HYPH I-NP O
Robertsonian JJ I-NP O
translocations NNS I-NP O
has VBZ B-VP O
been VBN I-VP O
reported VBN I-VP O
previously RB B-ADVP O
but CC O O
has VBZ B-VP O
not RB O O
, , O O
to TO B-PP O
our PRP$ B-NP O
knowledge NN I-NP O
, , O O
been VBN B-VP O
observed VBN I-VP O
in IN B-PP O
a DT B-NP O
case NN I-NP O
of IN B-PP O
PWS NN B-NP B-Disease
. . O O

Furthermore RB B-ADVP O
, , O O
our PRP$ B-NP O
findings NNS I-NP O
are VBP B-VP O
best RB I-VP O
interpreted VBN I-VP O
as IN B-PP O
true JJ B-NP O
gamete NN I-NP O
complementation NN I-NP O
resulting VBG B-VP O
in IN B-PP O
maternal JJ B-NP B-Disease
UPD NNP I-NP I-Disease
15 CD I-NP I-Disease
and CC O O
PWS NN B-NP B-Disease
Schwartz NNP B-NP B-Disease
- HYPH I-NP I-Disease
Jampel NNP I-NP I-Disease
syndrome NN I-NP I-Disease
type NN I-NP I-Disease
2 CD I-NP I-Disease
and CC O O
Stuve NNP B-NP B-Disease
- HYPH I-NP I-Disease
Wiedemann NNP I-NP I-Disease
syndrome NN I-NP I-Disease
: : O O
a DT B-NP O
case NN I-NP O
for IN B-PP O
lumping VBG B-VP O
. . O O

Recent JJ B-NP O
studies NNS I-NP O
demonstrated VBD B-VP O
the DT B-NP O
existence NN I-NP O
of IN B-PP O
a DT B-NP O
genetically RB I-NP O
distinct JJ I-NP O
, , I-NP O
usually RB I-NP O
lethal JJ I-NP O
form NN I-NP O
of IN B-PP O
the DT B-NP O
Schwartz NNP I-NP B-Disease
- HYPH I-NP I-Disease
Jampel NNP I-NP I-Disease
syndrome NN I-NP I-Disease
( ( O O
SJS NN B-NP B-Disease
) ) O O
of IN B-PP O
myotonia NN B-NP B-Disease
and CC O O
skeletal JJ B-NP B-Disease
dysplasia NN I-NP I-Disease
, , O O
which WDT B-NP O
we PRP B-NP O
called VBD B-VP O
SJS NN B-NP B-Disease
type NN I-NP I-Disease
2 CD I-NP I-Disease
. . O O

This DT B-NP O
disorder NN I-NP O
is VBZ B-VP O
reminiscent JJ B-ADJP O
of IN B-PP O
another DT B-NP O
rare JJ I-NP O
condition NN I-NP O
, , O O
the DT B-NP O
Stuve NNP I-NP B-Disease
- HYPH I-NP I-Disease
Wiedemann NNP I-NP I-Disease
syndrome NN I-NP I-Disease
( ( O O
SWS NN B-NP B-Disease
) ) O O
, , O O
which WDT B-NP O
comprises VBZ B-VP O
campomelia NN B-NP B-Disease
at IN B-PP O
birth NN B-NP O
with IN B-PP O
skeletal JJ B-NP B-Disease
dysplasia NN I-NP I-Disease
, , O O
contractures NNS B-NP B-Disease
, , O O
and CC O O
early JJ B-NP B-Disease
death NN I-NP I-Disease
. . O O

To TO B-VP O
test VB I-VP O
for IN B-PP O
possible JJ B-NP O
nosologic JJ I-NP O
identity NN I-NP O
between IN B-PP O
these DT B-NP O
disorders NNS I-NP O
, , O O
we PRP B-NP O
reviewed VBD B-VP O
the DT B-NP O
literature NN I-NP O
and CC O O
obtained VBD B-VP O
a DT B-NP O
follow VB I-NP O
- HYPH O O
up RP B-PRT O
of IN B-PP O
the DT B-NP O
only JJ I-NP O
two CD I-NP O
surviving VBG I-NP O
patients NNS I-NP O
, , O O
one CD B-NP O
with IN B-PP O
SJS NN B-NP B-Disease
type NN I-NP I-Disease
2 CD I-NP I-Disease
at IN B-PP O
age NN B-NP O
10 CD B-NP O
years NNS I-NP O
and CC O O
another DT B-NP O
with IN B-PP O
SWS NN B-NP B-Disease
at IN B-PP O
age NN B-NP O
7 CD B-NP O
years NNS I-NP O
. . O O

Patients NNS B-NP O
reported VBN B-VP O
as IN B-PP O
having VBG B-VP O
either CC B-NP O
neonatal JJ I-NP O
SJS NN I-NP B-Disease
or CC I-NP O
SWS NN I-NP B-Disease
presented VBD B-VP O
a DT B-NP O
combination NN I-NP O
of IN B-PP O
a DT B-NP O
severe JJ I-NP O
, , I-NP O
prenatal JJ I-NP O
- HYPH I-NP O
onset NN I-NP O
neuromuscular JJ I-NP B-Disease
disorder NN I-NP I-Disease
( ( O O
with IN B-PP O
congenital JJ B-NP B-Disease
joint JJ I-NP I-Disease
contractures NNS I-NP I-Disease
, , O O
respiratory JJ B-NP O
and CC I-NP O
feeding NN I-NP O
difficulties NNS I-NP O
, , O O
tendency NN B-NP O
to TO B-PP O
hyperthermia NN B-NP B-Disease
, , O O
and CC O O
frequent JJ B-NP O
death NN I-NP O
in IN B-PP O
infancy NN B-NP O
) ) O O
with IN B-PP O
a DT B-NP O
distinct JJ I-NP O
campomelic JJ I-NP B-Disease
- HYPH I-NP I-Disease
metaphyseal JJ I-NP I-Disease
skeletal JJ I-NP I-Disease
dysplasia NN I-NP I-Disease
. . O O

The DT B-NP O
similarity NN I-NP O
of IN B-PP O
the DT B-NP O
clinical JJ I-NP O
and CC I-NP O
radiographic JJ I-NP O
findings NNS I-NP O
is VBZ B-VP O
so RB B-ADJP O
extensive JJ I-ADJP O
that IN B-SBAR O
these DT B-NP O
disorders NNS I-NP O
appear VBP B-VP O
to TO I-VP O
be VB I-VP O
a DT B-NP O
single JJ I-NP O
entity NN I-NP O
. . O O

The DT B-NP O
follow VB I-NP O
- HYPH B-VP O
up RP B-PRT O
observation NN B-NP O
of IN B-PP O
an DT B-NP O
identical JJ I-NP O
and CC I-NP O
unique JJ I-NP O
pattern NN I-NP O
of IN B-PP O
progressive JJ B-NP O
bone NN I-NP B-Disease
dysplasia NN I-NP I-Disease
in IN B-PP O
the DT B-NP O
two CD I-NP O
patients NNS I-NP O
( ( O O
one CD B-NP O
with IN B-PP O
SJS NN B-NP B-Disease
type NN I-NP I-Disease
2 CD I-NP I-Disease
, , O O
one CD B-NP O
with IN B-PP O
SWS NN B-NP B-Disease
) ) O O
surviving VBG B-VP O
beyond IN B-PP O
infancy NN B-NP O
adds VBZ B-VP O
to TO B-PP O
the DT B-NP O
evidence NN I-NP O
in IN B-PP O
favor NN B-NP O
of IN B-PP O
identity NN B-NP O
. . O O

The DT B-NP O
hypothesis NN I-NP O
that IN B-SBAR O
SWS NN B-NP B-Disease
and CC I-NP O
SJS NN I-NP B-Disease
type NN I-NP I-Disease
2 CD I-NP I-Disease
are VBP B-VP O
the DT B-NP O
same JJ I-NP O
disorder NN I-NP O
should MD B-VP O
be VB I-VP O
testable JJ B-ADJP O
by IN B-PP O
molecular JJ B-NP O
methods NNS I-NP O
. . O O

. . O O

A DT B-NP O
mouse NN I-NP O
model NN I-NP O
of IN B-PP O
severe JJ B-NP O
von NN I-NP B-Disease
Willebrand NN I-NP I-Disease
disease NN I-NP I-Disease
: : O O
defects NNS B-NP O
in IN B-PP O
hemostasis NN B-NP O
and CC I-NP O
thrombosis NN I-NP B-Disease
. . O O

von NN B-NP B-Disease
Willebrand NN I-NP I-Disease
factor NN I-NP I-Disease
( ( O I-Disease
vWf NN B-NP I-Disease
) ) O I-Disease
deficiency NN B-NP I-Disease
causes VBZ B-VP O
severe JJ B-NP O
von NN I-NP B-Disease
Willebrand NN I-NP I-Disease
disease NN I-NP I-Disease
in IN B-PP O
humans NNS B-NP O
. . O O

We PRP B-NP O
generated VBD B-VP O
a DT B-NP O
mouse NN I-NP O
model NN I-NP O
for IN B-PP O
this DT B-NP O
disease NN I-NP O
by IN B-PP O
using VBG B-VP O
gene NN B-NP O
targeting NN I-NP O
. . O O

vWf NN B-NP B-Disease
- HYPH I-NP I-Disease
deficient JJ I-NP I-Disease
mice NNS I-NP O
appeared VBD B-VP O
normal JJ B-ADJP O
at IN B-PP O
birth NN B-NP O
; : O O
they PRP B-NP O
were VBD B-VP O
viable JJ B-ADJP O
and CC I-ADJP O
fertile JJ I-ADJP O
. . O O

Neither CC O O
vWf NN B-NP O
nor CC O O
vWf NN B-NP O
propolypeptide NN I-NP O
( ( O O
von NN B-NP B-Disease
Willebrand NN I-NP I-Disease
antigen NN I-NP O
II CD I-NP O
) ) O O
were VBD B-VP O
detectable JJ B-ADJP O
in IN B-PP O
plasma NN B-NP O
, , O O
platelets NNS B-NP O
, , O O
or CC O O
endothelial JJ B-NP O
cells NNS I-NP O
of IN B-PP O
the DT B-NP O
homozygous JJ I-NP O
mutant JJ I-NP O
mice NNS I-NP O
. . O O

The DT B-NP O
mutant JJ I-NP O
mice NNS I-NP O
exhibited VBD B-VP O
defects NNS B-NP O
in IN B-PP O
hemostasis NN B-NP O
with IN B-PP O
a DT B-NP O
highly RB I-NP O
prolonged JJ I-NP O
bleeding NN I-NP O
time NN I-NP O
and CC O O
spontaneous JJ B-NP O
bleeding VBG I-NP O
events NNS I-NP O
in IN B-PP O
approximately RB B-NP O
10 CD I-NP O
% NN I-NP O
of IN B-PP O
neonates NNS B-NP O
. . O O

As IN B-PP O
in IN B-PP O
the DT B-NP O
human JJ I-NP O
disease NN I-NP O
, , O O
the DT B-NP O
factor NN I-NP O
VIII CD I-NP O
level NN I-NP O
in IN B-PP O
these DT B-NP O
mice NNS I-NP O
was VBD B-VP O
reduced VBN I-VP O
strongly RB B-ADVP O
as IN B-PP O
a DT B-NP O
result NN I-NP O
of IN B-PP O
the DT B-NP O
lack NN I-NP O
of IN B-PP O
protection NN B-NP O
provided VBN B-VP O
by IN B-PP O
vWf NN B-NP O
. . O O

Defective JJ B-NP O
thrombosis NN I-NP B-Disease
in IN B-PP O
mutant JJ B-NP O
mice NNS I-NP O
was VBD B-VP O
also RB B-ADVP O
evident JJ B-ADJP O
in IN B-PP O
an DT B-NP O
in FW I-NP O
vivo FW I-NP O
model NN I-NP O
of IN B-PP O
vascular JJ B-NP B-Disease
injury NN I-NP I-Disease
. . O O

In IN B-PP O
this DT B-NP O
model NN I-NP O
, , O O
the DT B-NP O
exteriorized VBN I-NP O
mesentery NN I-NP O
was VBD B-VP O
superfused VBN I-VP O
with IN B-PP O
ferric JJ B-NP O
chloride NN I-NP O
and CC O O
the DT B-NP O
accumulation NN I-NP O
of IN B-PP O
fluorescently RB B-NP O
labeled VBN I-NP O
platelets NNS I-NP O
was VBD B-VP O
observed VBN I-VP O
by IN B-PP O
intravital JJ B-NP O
microscopy NN I-NP O
. . O O

We PRP B-NP O
conclude VBP B-VP O
that IN B-SBAR O
these DT B-NP O
mice NNS I-NP O
very RB B-NP O
closely RB I-NP O
mimic JJ I-NP O
severe JJ I-NP O
human JJ I-NP O
von NN I-NP B-Disease
Willebrand NN I-NP I-Disease
disease NN I-NP I-Disease
and CC O O
will MD B-VP O
be VB I-VP O
very RB B-ADJP O
useful JJ I-ADJP O
for IN B-PP O
investigating VBG B-VP O
the DT B-NP O
role NN I-NP O
of IN B-PP O
vWf NN B-NP O
in IN B-PP O
normal JJ B-NP O
physiology NN I-NP O
and CC B-PP O
in IN B-PP O
disease NN B-NP O
models NNS I-NP O
. . O O

. . O O

Oral JJ B-NP O
contraceptives NNS I-NP O
and CC O O
the DT B-NP O
risk NN I-NP O
of IN B-PP O
hereditary JJ B-NP B-Disease
ovarian JJ I-NP I-Disease
cancer NN I-NP I-Disease
. . O O

Hereditary NNP B-NP B-Disease
Ovarian NNP I-NP I-Disease
Cancer NNP I-NP I-Disease
Clinical NNP I-NP O
Study NNP I-NP O
Group NNP I-NP O
. . O O

BACKGROUND NN B-NP O
Women NNS I-NP O
with IN B-PP O
mutations NNS B-NP O
in IN B-PP O
either CC O O
the DT B-NP O
BRCA1 NN I-NP O
or CC O O
the DT B-NP O
BRCA2 NN I-NP O
gene NN I-NP O
have VBP B-VP O
a DT B-NP O
high JJ I-NP O
lifetime NN I-NP O
risk NN I-NP O
of IN B-PP O
ovarian JJ B-NP B-Disease
cancer NN I-NP I-Disease
. . O O

Oral JJ B-NP O
contraceptives NNS I-NP O
protect VBP B-VP O
against IN B-PP O
ovarian JJ B-NP B-Disease
cancer NN I-NP I-Disease
in IN B-PP O
general JJ B-ADJP O
, , O O
but CC O O
it PRP B-NP O
is VBZ B-VP O
not RB I-VP O
known VBN I-VP O
whether IN B-SBAR O
they PRP B-NP O
also RB B-ADVP O
protect VBP B-VP O
against IN B-PP O
hereditary JJ B-NP B-Disease
forms NNS I-NP I-Disease
of IN B-PP I-Disease
ovarian JJ B-NP I-Disease
cancer NN I-NP I-Disease
. . O O

METHODS NNS B-NP O
We PRP B-NP O
enrolled VBD B-VP O
207 CD B-NP O
women NNS I-NP O
with IN B-PP O
hereditary JJ B-NP B-Disease
ovarian JJ I-NP I-Disease
cancer NN I-NP I-Disease
and CC O O
161 CD B-NP O
of IN B-PP O
their PRP$ B-NP O
sisters NNS I-NP O
as IN B-PP O
controls NNS B-NP O
in IN B-PP O
a DT B-NP O
case NN I-NP O
- HYPH B-NP O
control NN I-NP O
study NN I-NP O
. . O O

All PDT B-NP O
the DT I-NP O
patients NNS I-NP O
carried VBD B-VP O
a DT B-NP O
pathogenic JJ I-NP O
mutation NN I-NP O
in IN B-PP O
either CC O O
BRCA1 NN B-NP O
( ( O O
179 CD B-NP O
women NNS I-NP O
) ) O O
or CC O O
BRCA2 NN B-NP O
( ( O O
28 CD B-NP O
women NNS I-NP O
) ) O O
. . O O

The DT B-NP O
control NN I-NP O
women NNS I-NP O
were VBD B-VP O
enrolled VBN I-VP O
regardless RB B-ADVP O
of IN B-PP O
whether IN B-SBAR O
or CC O O
not RB O O
they PRP B-NP O
had VBD B-VP O
either DT B-NP O
mutation NN I-NP O
. . O O

Lifetime NN B-NP O
histories NNS I-NP O
of IN B-PP O
oral JJ B-NP O
- HYPH I-NP O
contraceptive JJ I-NP O
use NN I-NP O
were VBD B-VP O
obtained VBN I-VP O
by IN B-PP O
interview NN B-NP O
or CC B-PP O
by IN B-PP O
written VBN B-NP O
questionnaire NN I-NP O
and CC O O
were VBD B-VP O
compared VBN I-VP O
between IN B-PP O
patients NNS B-NP O
and CC O O
control NN B-NP O
women NNS I-NP O
, , O O
after IN B-PP O
adjustment NN B-NP O
for IN B-PP O
year NN B-NP O
of IN B-PP O
birth NN B-NP O
and CC I-NP O
parity NN I-NP O
. . O O

RESULTS NNS B-NP O
The DT B-NP O
adjusted VBN I-NP O
odds VBZ B-VP O
ratio NN B-NP O
for IN B-PP O
ovarian JJ B-NP B-Disease
cancer NN I-NP I-Disease
associated VBN B-VP O
with IN B-PP O
any DT B-NP O
past JJ I-NP O
use NN I-NP O
of IN B-PP O
oral JJ B-NP O
contraceptives NNS I-NP O
was VBD B-VP O
0 CD B-NP O
. . O O

5 CD B-NP O
( ( O O
95 CD B-NP O
percent NN I-NP O
confidence NN I-NP O
interval NN I-NP O
, , O O
0 CD B-NP O
. . I-NP O

3 CD I-NP O
to TO B-PP O
0 CD B-NP O
. . I-NP O

8 CD I-NP O
) ) O O
. . O O

The DT B-NP O
risk NN I-NP O
decreased VBD B-VP O
with IN B-PP O
increasing VBG B-NP O
duration NN I-NP O
of IN B-PP O
use NN B-NP O
( ( O O
P NN B-NP O
for IN B-PP O
trend NN B-NP O
, , O O
< SYM B-NP O
0 CD I-NP O
. SYM I-NP O

001 CD I-NP O
) ) O O
; : O O
use NN B-NP O
for IN B-PP O
six CD B-NP O
or CC I-NP O
more JJR I-NP O
years NNS I-NP O
was VBD B-VP O
associated VBN I-VP O
with IN B-PP O
a DT B-NP O
60 CD I-NP O
percent NN I-NP O
reduction NN I-NP O
in IN B-PP O
risk NN B-NP O
. . O O

Oral JJ B-NP O
- HYPH I-NP O
contraceptive JJ I-NP O
use NN I-NP O
protected VBD B-VP O
against IN B-PP O
ovarian JJ B-NP B-Disease
cancer NN I-NP I-Disease
both DT O O
for IN B-PP O
carriers NNS B-NP O
of IN B-PP O
the DT B-NP O
BRCA1 NN I-NP O
mutation NN I-NP O
( ( O O
odds NNS B-NP O
ratio NN I-NP O
, , O O
0 CD B-NP O
. . I-NP O

5 CD I-NP O
; : O O
95 CD B-NP O
percent NN I-NP O
confidence NN I-NP O
interval NN I-NP O
, , O O
0 CD B-NP O
. . I-NP O

3 CD I-NP O
to TO B-PP O
0 CD B-NP O
. . I-NP O

9 CD I-NP O
) ) O O
and CC O O
for IN B-PP O
carriers NNS B-NP O
of IN B-PP O
the DT B-NP O
BRCA2 NN I-NP O
mutation NN I-NP O
( ( O O
odds NNS B-NP O
ratio NN I-NP O
, , O O
0 CD B-NP O
. . I-NP O

4 CD I-NP O
; : O O
95 CD B-NP O
percent NN I-NP O
confidence NN I-NP O
interval NN I-NP O
, , O O
0 CD B-NP O
. . O O

2 CD B-NP O
to TO I-NP O
1 CD I-NP O
. . I-NP O

1 CD I-NP O
) ) O O
. . O O

CONCLUSIONS NNS B-NP O
Oral JJ B-ADJP O
- HYPH B-NP O
contraceptive JJ I-NP O
use NN I-NP O
may MD B-VP O
reduce VB I-VP O
the DT B-NP O
risk NN I-NP O
of IN B-PP O
ovarian JJ B-NP B-Disease
cancer NN I-NP I-Disease
in IN B-PP O
women NNS B-NP O
with IN B-PP O
pathogenic JJ B-NP O
mutations NNS I-NP O
in IN B-PP O
the DT B-NP O
BRCA1 NN I-NP O
or CC I-NP O
BRCA2 NN I-NP O
gene NN I-NP O
A DT B-NP O
Japanese JJ I-NP O
family NN I-NP O
with IN B-PP O
adrenoleukodystrophy NN B-NP B-Disease
with IN B-PP O
a DT B-NP O
codon NN I-NP O
291 CD I-NP O
deletion NN I-NP O
: : O O
a DT B-NP O
clinical JJ I-NP O
, , I-NP O
biochemical JJ I-NP O
, , I-NP O
pathological JJ I-NP O
, , O O
and CC O O
genetic JJ B-NP O
report NN I-NP O
. . O O

We PRP B-NP O
report VBP B-VP O
a DT B-NP O
Japanese JJ I-NP O
family NN I-NP O
with IN B-PP O
adrenoleukodystrophy NN B-NP B-Disease
( ( O O
ALD NN B-NP B-Disease
) ) O O
with IN B-PP O
a DT B-NP O
three CD I-NP O
base NN I-NP O
pair NN I-NP O
deletion NN I-NP O
( ( O O
delGAG NN B-NP O
291 CD I-NP O
) ) O O
in IN B-PP O
the DT B-NP O
ALD NN I-NP B-Disease
gene NN I-NP O
. . O O

A DT B-NP O
variety NN I-NP O
of IN B-PP O
phenotypes NNS B-NP O
were VBD B-VP O
observed VBN I-VP O
within IN B-PP O
this DT B-NP O
family NN I-NP O
. . O O

While IN B-SBAR O
the DT B-NP O
proband NN I-NP O
( ( O O
patient NN B-NP O
1 CD I-NP O
) ) O O
was VBD B-VP O
classified VBN I-VP O
as IN B-PP O
having VBG B-VP O
a DT B-NP O
rare JJ I-NP O
intermediate JJ I-NP O
type NN I-NP O
of IN B-PP O
adult JJ B-NP O
cerebral JJ I-NP O
and CC I-NP O
cerebello AFX I-NP O
- HYPH I-NP O
brain NN I-NP O
stem NN I-NP O
forms NNS I-NP O
, , O O
his PRP$ B-NP O
younger JJR I-NP O
brother NN I-NP O
( ( O O
patient NN B-NP O
2 CD I-NP O
) ) O O
and CC O O
nephew NN B-NP O
( ( O O
patient NN B-NP O
3 CD I-NP O
) ) O O
had VBD B-VP O
a DT B-NP O
childhood NN I-NP O
ALD NN I-NP B-Disease
type NN I-NP O
. . O O

Another DT B-NP O
nephew JJ I-NP O
( ( O O
patient NN B-NP O
4 CD I-NP O
) ) O O
of IN B-PP O
patient NN B-NP O
1 CD I-NP O
was VBD B-VP O
classified VBN I-VP O
as IN B-PP O
having VBG B-VP O
an DT B-NP O
adolescent JJ I-NP O
form NN I-NP O
. . O O

The DT B-NP O
tau SYM I-NP O
level NN I-NP O
in IN B-PP O
the DT B-NP O
cerebrospinal JJ I-NP O
fluid NN I-NP O
( ( O O
CSF NN B-NP O
) ) O O
in IN B-PP O
patient NN B-NP O
1 CD I-NP O
was VBD B-VP O
as RB B-ADJP O
high JJ I-ADJP O
as IN B-PP O
that DT B-NP O
of IN B-PP O
patients NNS B-NP O
with IN B-PP O
Alzheimers NNS B-NP B-Disease
disease NN B-NP I-Disease
( ( O O
AD NN B-NP B-Disease
) ) O O
. . O O

His PRP$ B-NP O
brain NN I-NP O
magnetic JJ I-NP O
resonance NN I-NP O
image NN I-NP O
( ( O O
MRI NN B-NP O
) ) O O
showed VBD B-VP O
abnormalities NNS B-NP B-Disease
in IN B-PP I-Disease
the DT B-NP I-Disease
bilateral JJ I-NP I-Disease
cerebellar JJ I-NP I-Disease
hemispheres NNS I-NP I-Disease
and CC O O
brain NN B-NP O
stem NN I-NP O
, , O O
but CC B-PP O
not RB B-PP O
in IN I-PP O
the DT B-NP O
cerebral JJ I-NP O
white JJ I-NP O
matter NN I-NP O
, , O O
where WRB B-ADVP O
marked JJ B-NP O
reductions NNS I-NP O
of IN B-PP O
the DT B-NP O
cerebral JJ I-NP O
blood NN I-NP O
flow NN I-NP O
and CC O O
oxygen NN B-NP O
metabolism NN I-NP O
were VBD B-VP O
clearly RB I-VP O
demonstrated VBN I-VP O
by IN B-PP O
positron NN B-NP O
emission NN I-NP O
tomography NN I-NP O
( ( O O
PET NN B-NP O
) ) O O
. . O O

In IN B-PP O
patients NNS B-NP O
2 CD B-NP O
and CC I-NP O
3 CD I-NP O
, , O O
the DT B-NP O
autopsy NN I-NP O
findings NNS I-NP O
showed VBD B-VP O
massive JJ B-NP O
demyelination NN I-NP B-Disease
of IN B-PP I-Disease
the DT B-NP I-Disease
cerebral JJ I-NP I-Disease
white JJ I-NP I-Disease
matter NN I-NP I-Disease
with IN B-PP O
sparing VBG B-NP O
of IN B-PP O
the DT B-NP O
U NN I-NP O
- HYPH B-NP O
fibers NNS I-NP O
, , O O
compatible JJ B-ADJP O
with IN B-PP O
the DT B-NP O
findings NNS I-NP O
of IN B-PP O
childhood NN B-NP O
ALD NN I-NP B-Disease
. . O O

Oleic JJ B-NP O
and CC I-NP O
erucic JJ I-NP O
acids NNS I-NP O
( ( O O
Lorenzos NNP B-NP O
Oil NNP I-NP O
) ) O O
were VBD B-VP O
administered VBN I-VP O
to TO B-PP O
patients NNS B-NP O
1 CD I-NP O
and CC I-NP O
4 CD I-NP O
, , O O
but CC O O
sufficient JJ B-NP O
effectiveness NN I-NP O
was VBD B-VP O
not RB I-VP O
obtained VBN I-VP O
. . O O

The DT B-NP O
findings NNS I-NP O
in IN B-PP O
this DT B-NP O
family NN I-NP O
suggest VBP B-VP O
that IN B-SBAR O
delGAG291 NN B-NP O
is VBZ B-VP O
part NN B-NP O
of IN B-PP O
the DT B-NP O
cause NN I-NP O
of IN B-PP O
Japanese JJ B-NP O
ALD NN I-NP B-Disease
with IN B-PP O
phenotypic JJ B-NP O
variations NNS I-NP O
. . O O

Moreover RB B-ADVP O
, , O O
although IN B-SBAR O
the DT B-NP O
scale NN I-NP O
of IN B-PP O
the DT B-NP O
study NN I-NP O
is VBZ B-VP O
limited VBN I-VP O
, , O O
there EX B-NP O
is VBZ B-VP O
a DT B-NP O
possibility NN I-NP O
that IN B-SBAR O
PET NN B-NP O
can MD B-VP O
detect VB I-VP O
an DT B-NP O
insidious JJ I-NP B-Disease
lesion NN I-NP I-Disease
which WDT B-NP O
is VBZ B-VP O
undetectable JJ B-ADJP O
by IN B-PP O
computed VBN B-NP O
tomogram NN I-NP O
( ( O O
CT NN B-NP O
) ) O O
or CC O O
MRI NN B-NP O
analysis NN I-NP O
, , O O
and CC O O
that IN B-SBAR O
the DT B-NP O
higher JJR I-NP O
level NN I-NP O
of IN B-PP O
tau SYM B-NP O
reflects VBZ B-VP O
the DT B-NP O
process NN I-NP O
of IN B-PP O
neuronal JJ B-NP B-Disease
degeneration NN I-NP I-Disease
in IN B-PP O
ALD NN B-NP B-Disease
. . O O

Lorenzos NNP B-NP O
Oil NNP I-NP O
should MD B-VP O
be VB I-VP O
given VBN I-VP O
in IN B-PP O
the DT B-NP O
early JJ I-NP O
stage NN I-NP O
. . O O

. . O O

Nonsense NN B-NP O
mutation NN I-NP O
in IN B-PP O
exon NN B-NP O
4 CD I-NP O
of IN B-PP O
human JJ B-NP O
complement NN I-NP O
C9 NN I-NP O
gene NN I-NP O
is VBZ B-VP O
the DT B-NP O
major JJ I-NP O
cause NN I-NP O
of IN B-PP O
Japanese JJ B-NP O
complement NN I-NP B-Disease
C9 NN I-NP I-Disease
deficiency NN I-NP I-Disease
. . O O

Deficiency NN B-NP B-Disease
of IN B-PP I-Disease
the DT B-NP I-Disease
ninth JJ I-NP I-Disease
component NN I-NP I-Disease
of IN B-PP I-Disease
human JJ B-NP I-Disease
complement NN I-NP I-Disease
( ( O O
C9 NN B-NP O
) ) O O
is VBZ B-VP O
the DT B-NP O
most RBS I-NP O
common JJ I-NP O
complement NN I-NP B-Disease
deficiency NN I-NP I-Disease
in IN B-PP O
Japan NNP B-NP O
but CC O O
is VBZ B-VP O
rare JJ B-ADJP O
in IN B-PP O
other JJ B-NP O
countries NNS I-NP O
. . O O

We PRP B-NP O
studied VBD B-VP O
the DT B-NP O
molecular JJ I-NP O
basis NN I-NP O
of IN B-PP O
C9 NN B-NP B-Disease
deficiency NN I-NP I-Disease
in IN B-PP O
four CD B-NP O
Japanese JJ I-NP O
C9 NN I-NP B-Disease
- HYPH O I-Disease
deficient JJ B-NP I-Disease
patients NNS I-NP O
who WP B-NP O
had VBD B-VP O
suffered VBN I-VP O
from IN B-PP O
meningococcal JJ B-NP B-Disease
meningitis NN I-NP I-Disease
. . O O

Direct JJ B-NP O
sequencing NN I-NP O
of IN B-PP O
amplified VBN B-NP O
C9 NN I-NP O
cDNA NN I-NP O
and CC I-NP O
DNA NN I-NP O
revealed VBD B-VP O
a DT B-NP O
nonsense JJ I-NP O
substitution NN I-NP O
( ( O O
CGA NN B-NP O
- SYM O O
- HYPH B-NP O
> SYM I-NP O
TGA NN I-NP O
) ) O O
at IN B-PP O
codon NN B-NP O
95 CD I-NP O
in IN B-PP O
exon NN B-NP O
4 CD I-NP O
in IN B-PP O
the DT B-NP O
four CD I-NP O
C9 NN I-NP B-Disease
- HYPH I-NP I-Disease
deficient JJ I-NP I-Disease
individuals NNS I-NP O
. . O O

An DT B-NP O
allele NN I-NP O
- HYPH B-NP O
specific JJ I-NP O
polymerase NN I-NP O
chain NN I-NP O
reaction NN I-NP O
system NN I-NP O
designed VBN B-VP O
to TO B-VP O
detect VB I-VP O
exclusively RB B-ADVP O
only RB B-NP O
one CD I-NP O
of IN B-PP O
the DT B-NP O
normal JJ I-NP O
and CC I-NP O
mutant JJ I-NP O
alleles NNS I-NP O
indicated VBD B-VP O
that IN B-SBAR O
all PDT B-NP O
the DT I-NP O
four CD I-NP O
patients NNS I-NP O
were VBD B-VP O
homozygous JJ B-ADJP O
for IN B-PP O
the DT B-NP O
mutation NN I-NP O
in IN B-PP O
exon NN B-NP O
4 CD I-NP O
and CC O O
that IN B-SBAR O
the DT B-NP O
parents NNS I-NP O
of IN B-PP O
patient NN B-NP O
2 CD I-NP O
were VBD B-VP O
heterozygous JJ B-ADJP O
. . O O

The DT B-NP O
common JJ I-NP O
mutation NN I-NP O
at IN B-PP O
codon NN B-NP O
95 CD I-NP O
in IN B-PP O
exon NN B-NP O
4 CD I-NP O
might MD B-VP O
be VB I-VP O
responsible JJ B-ADJP O
for IN B-PP O
most JJS B-NP O
Japanese JJ I-NP O
C9 NN I-NP B-Disease
deficiency NN I-NP I-Disease
. . O O

. . O O

BRCA1 NN B-NP O
required VBN B-VP O
for IN B-PP O
transcription NN B-NP O
- HYPH O O
coupled VBN B-NP O
repair NN I-NP O
of IN B-PP O
oxidative JJ B-NP O
DNA NN I-NP O
damage NN I-NP O
. . O O

The DT B-NP O
breast NN I-NP B-Disease
and CC I-NP I-Disease
ovarian JJ I-NP I-Disease
cancer NN I-NP I-Disease
susceptibility NN I-NP O
gene NN I-NP O
BRCA1 NN I-NP O
encodes VBZ B-VP O
a DT B-NP O
zinc NN I-NP O
finger NN I-NP O
protein NN I-NP O
of IN B-PP O
unknown JJ B-NP O
function NN I-NP O
. . O O

Association NN B-NP O
of IN B-PP O
the DT B-NP O
BRCA1 NN I-NP O
protein NN I-NP O
with IN B-PP O
the DT B-NP O
DNA NN I-NP O
repair NN I-NP O
protein NN I-NP O
Rad51 NN I-NP O
and CC O O
changes NNS B-NP O
in IN B-PP O
the DT B-NP O
phosphorylation NN I-NP O
and CC I-NP O
cellular JJ I-NP O
localization NN I-NP O
of IN B-PP O
the DT B-NP O
protein NN I-NP O
after IN B-PP O
exposure NN B-NP O
to TO B-PP O
DNA NN B-NP O
- HYPH O O
damaging VBG B-NP O
agents NNS I-NP O
are VBP B-VP O
consistent JJ B-ADJP O
with IN B-PP O
a DT B-NP O
role NN I-NP O
for IN B-PP O
BRCA1 NN B-NP O
in IN B-PP O
DNA NN B-NP O
repair NN I-NP O
. . O O

Here RB B-ADVP O
, , O O
it PRP B-NP O
is VBZ B-VP O
shown VBN I-VP O
that IN B-SBAR O
mouse NN B-NP O
embryonic JJ I-NP O
stem NN I-NP O
cells NNS I-NP O
deficient JJ B-ADJP B-Disease
in IN B-PP I-Disease
BRCA1 NN B-NP I-Disease
are VBP B-VP O
defective JJ B-ADJP O
in IN B-PP O
the DT B-NP O
ability NN I-NP O
to TO B-VP O
carry VB I-VP O
out RP B-PRT O
transcription NN B-NP O
- HYPH B-VP O
coupled VBN B-NP O
repair NN I-NP O
of IN B-PP O
oxidative JJ B-NP O
DNA NN I-NP O
damage NN I-NP O
, , O O
and CC O O
are VBP B-VP O
hypersensitive JJ B-ADJP O
to TO B-PP O
ionizing VBG B-VP O
radiation NN B-NP O
and CC I-NP O
hydrogen NN I-NP O
peroxide NN I-NP O
. . O O

These DT B-NP O
results NNS I-NP O
suggest VBP B-VP O
that IN B-SBAR O
BRCA1 NN B-NP O
participates VBZ B-VP O
, , O O
directly RB B-ADVP O
or CC I-ADVP O
indirectly RB I-ADVP O
, , O O
in IN B-PP O
transcription NN B-NP O
- HYPH O O
coupled VBN B-NP O
repair NN I-NP O
of IN B-PP O
oxidative JJ B-NP O
DNA NN I-NP O
damage NN I-NP O
. . O O

. . O O

Truncation NN B-NP O
mutations NNS I-NP O
in IN B-PP O
the DT B-NP O
transactivation NN I-NP O
region NN I-NP O
of IN B-PP O
PAX6 NN B-NP O
result VBP B-VP O
in IN B-PP O
dominant JJ B-NP O
- HYPH I-NP O
negative JJ I-NP O
mutants NNS I-NP O
. . O O

PAX6 NN B-NP O
is VBZ B-VP O
a DT B-NP O
transcription NN I-NP O
factor NN I-NP O
with IN B-PP O
two CD B-NP O
DNA NN I-NP O
- HYPH B-VP O
binding VBG B-NP O
domains NNS I-NP O
( ( O O
paired JJ B-NP O
box NN I-NP O
and CC O O
homeobox NN B-NP O
) ) O O
and CC O O
a DT B-NP O
proline NN I-NP O
- HYPH B-NP O
serine NN I-NP O
- HYPH O O
threonine NN B-NP O
( ( O O
PST NN B-NP O
) ) O O
- HYPH B-NP O
rich JJ I-NP O
transactivation NN I-NP O
domain NN I-NP O
. . O O

PAX6 NN B-NP O
regulates VBZ B-VP O
eye NN B-NP O
development NN I-NP O
in IN B-PP O
animals NNS B-NP O
ranging VBG B-VP O
from IN B-PP O
jellyfish NN B-NP O
to TO B-PP O
Drosophila FW B-NP O
to TO B-PP O
humans NNS B-NP O
. . O O

Heterozygous JJ B-NP O
mutations NNS I-NP O
in IN B-PP O
the DT B-NP O
human JJ I-NP O
PAX6 NN I-NP O
gene NN I-NP O
result VBP B-VP O
in IN B-PP O
various JJ B-NP O
phenotypes NNS I-NP O
, , O O
including VBG B-PP O
aniridia NN B-NP B-Disease
, , O O
Peters NNP B-NP B-Disease
anomaly RB B-ADVP I-Disease
, , O O
autosomal JJ B-NP B-Disease
dominant JJ I-NP I-Disease
keratitis NN I-NP I-Disease
, , O O
and CC O O
familial JJ B-NP B-Disease
foveal JJ I-NP I-Disease
dysplasia NN I-NP I-Disease
. . O O

It PRP B-NP O
is VBZ B-VP O
believed VBN I-VP O
that IN B-SBAR O
the DT B-NP O
mutated VBN I-NP O
allele NN I-NP O
of IN B-PP O
PAX6 NN B-NP O
produces VBZ B-VP O
an DT B-NP O
inactive JJ I-NP O
protein NN I-NP O
and CC I-NP O
aniridia NN I-NP B-Disease
is VBZ B-VP O
caused VBN I-VP O
due JJ B-ADJP O
to TO B-PP O
genetic JJ B-NP O
haploinsufficiency NN I-NP O
. . O O

However RB B-ADVP O
, , O O
several JJ B-NP O
truncation NN I-NP O
mutations NNS I-NP O
have VBP B-VP O
been VBN I-VP O
found VBN I-VP O
to TO I-VP O
occur VB I-VP O
in IN B-PP O
the DT B-NP O
C NN I-NP O
- HYPH B-NP O
terminal JJ I-NP O
half NN I-NP O
of IN B-PP O
PAX6 NN B-NP O
in IN B-PP O
patients NNS B-NP O
with IN B-PP O
Aniridia NNP B-NP B-Disease
resulting VBG B-VP O
in IN B-PP O
mutant JJ B-NP O
proteins NNS I-NP O
that WDT B-NP O
retain VBP B-VP O
the DT B-NP O
DNA NN I-NP O
- HYPH B-VP O
binding VBG B-NP O
domains NNS I-NP O
but CC O O
have VBP B-VP O
lost VBN I-VP O
most JJS B-NP O
of IN B-PP O
the DT B-NP O
transactivation NN I-NP O
domain NN I-NP O
. . O O

It PRP B-NP O
is VBZ B-VP O
not RB O O
clear JJ B-ADJP O
whether IN B-SBAR O
such JJ B-NP O
mutants NNS I-NP O
really RB B-ADVP O
behave VBP B-VP O
as IN B-PP O
loss NN B-NP O
- HYPH B-NP O
of IN B-PP O
- HYPH B-NP O
function NN I-NP O
mutants NNS I-NP O
as IN B-SBAR O
predicted VBN B-VP O
by IN B-PP O
haploinsufficiency NN B-NP O
. . O O

Contrary JJ B-ADJP O
to TO B-PP O
this DT B-NP O
theory NN I-NP O
, , O O
our PRP$ B-NP O
data NNS I-NP O
showed VBD B-VP O
that IN B-SBAR O
these DT B-NP O
mutants NNS I-NP O
are VBP B-VP O
dominant JJ B-ADJP O
- HYPH B-ADJP O
negative JJ I-ADJP O
in IN B-PP O
transient JJ B-NP O
transfection NN I-NP O
assays NNS I-NP O
when WRB B-ADVP O
they PRP B-NP O
are VBP B-VP O
coexpressed VBN I-VP O
with IN B-PP O
wild JJ B-NP O
- HYPH I-NP O
type NN I-NP O
PAX6 NN I-NP O
. . O O

We PRP B-NP O
found VBD B-VP O
that IN B-SBAR O
the DT B-NP O
dominant JJ I-NP O
- HYPH I-NP O
negative JJ I-NP O
effects NNS I-NP O
result VBP B-VP O
from IN B-PP O
the DT B-NP O
enhanced VBN I-NP O
DNA NN I-NP O
binding NN I-NP O
ability NN I-NP O
of IN B-PP O
these DT B-NP O
mutants NNS I-NP O
. . O O

Kinetic JJ B-NP O
studies NNS I-NP O
of IN B-PP O
binding NN B-NP O
and CC I-NP O
dissociation NN I-NP O
revealed VBD B-VP O
that IN B-SBAR O
various JJ B-NP O
truncation NN I-NP O
mutants NNS I-NP O
have VBP B-VP O
3 CD B-NP O
- HYPH I-NP O
5 CD I-NP O
- HYPH O O
fold RB B-NP O
higher JJR I-NP O
affinity NN I-NP O
to TO B-PP O
various JJ B-NP O
DNA NN I-NP O
- HYPH B-VP O
binding VBG B-NP O
sites NNS I-NP O
when WRB B-ADVP O
compared VBN B-PP O
with IN B-PP O
the DT B-NP O
wild JJ I-NP O
- HYPH I-NP O
type NN I-NP O
PAX6 NN I-NP O
. . O O

These DT B-NP O
results NNS I-NP O
provide VBP B-VP O
a DT B-NP O
new JJ I-NP O
insight NN I-NP O
into IN B-PP O
the DT B-NP O
role NN I-NP O
of IN B-PP O
mutant JJ B-NP O
PAX6 NN I-NP O
in IN B-PP O
causing VBG B-VP O
aniridia NN B-NP B-Disease
. . O O

. . O O

Reversal NN B-NP O
of IN B-PP O
severe JJ B-NP O
hypertrophic JJ I-NP B-Disease
cardiomyopathy NN I-NP I-Disease
and CC O O
excellent JJ B-NP O
neuropsychologic JJ I-NP O
outcome NN I-NP O
in IN B-PP O
very RB B-NP B-Disease
- HYPH I-NP I-Disease
long JJ I-NP I-Disease
- HYPH I-NP I-Disease
chain NN I-NP I-Disease
acyl NN I-NP I-Disease
- HYPH B-NP I-Disease
coenzyme NN I-NP I-Disease
A NN I-NP I-Disease
dehydrogenase NN I-NP I-Disease
deficiency NN I-NP I-Disease
. . O O

Very NN B-NP B-Disease
- HYPH B-NP I-Disease
long JJ I-NP I-Disease
- HYPH I-NP I-Disease
chain NN I-NP I-Disease
acyl NN I-NP I-Disease
- HYPH B-NP I-Disease
coenzyme NN I-NP I-Disease
A NN I-NP I-Disease
dehydrogenase NN I-NP I-Disease
( ( O I-Disease
VLCAD NN B-NP I-Disease
) ) O I-Disease
deficiency NN B-NP I-Disease
is VBZ B-VP O
a DT B-NP O
disorder NN I-NP O
of IN B-PP O
fatty JJ B-NP O
acid NN I-NP O
beta NN I-NP O
oxidation NN I-NP O
that WDT B-NP O
reportedly RB B-ADVP O
has VBZ B-VP O
high JJ B-NP O
rates NNS I-NP O
of IN B-PP O
morbidity NN B-NP O
and CC I-NP O
mortality NN I-NP O
. . O O

We PRP B-NP O
describe VBP B-VP O
the DT B-NP O
outcome NN I-NP O
of IN B-PP O
a DT B-NP O
5 CD I-NP O
- HYPH I-NP O
year NN I-NP O
- HYPH O O
old JJ B-NP O
girl NN I-NP O
with IN B-PP O
VLCAD NN B-NP B-Disease
deficiency NN I-NP I-Disease
who WP B-NP O
was VBD B-VP O
first RB I-VP O
seen VBN I-VP O
at IN B-PP O
5 CD B-NP O
months NNS I-NP O
of IN B-PP O
age NN B-NP O
with IN B-PP O
severe JJ B-NP O
hypertrophic JJ I-NP B-Disease
cardiomyopathy NN I-NP I-Disease
, , O O
hepatomegaly NN B-NP B-Disease
, , O O
encephalopathy NN B-NP B-Disease
, , O O
and CC O O
hypotonia NN B-NP B-Disease
. . O O

Biochemical JJ B-NP O
studies NNS I-NP O
indicated VBD B-VP O
VLCAD NN B-NP B-Disease
deficiency NN I-NP I-Disease
caused VBN B-VP O
by IN B-PP O
a DT B-NP O
stable JJ I-NP O
yet RB I-NP O
inactive JJ I-NP O
enzyme NN I-NP O
. . O O

Molecular JJ B-NP O
genetic JJ I-NP O
analysis NN I-NP O
of IN B-PP O
her PRP$ B-NP O
VLCAD NN I-NP O
gene NN I-NP O
revealed VBD B-VP O
a DT B-NP O
T1372C NN I-NP O
( ( O O
F458L NN B-NP O
) ) O O
missense JJ B-NP O
mutation NN I-NP O
and CC O O
a DT B-NP O
1668 CD I-NP O
ACAG NN I-NP O
1669 CD B-NP O
splice NN I-NP O
site NN I-NP O
mutation NN I-NP O
. . O O

After IN B-PP O
initial JJ B-NP O
treatment NN I-NP O
with IN B-PP O
intravenous JJ B-NP O
glucose NN I-NP O
and CC I-NP O
carnitine NN I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
has VBZ B-VP O
thrived VBN I-VP O
on IN B-PP O
a DT B-NP O
low JJ I-NP O
- HYPH I-NP O
fat NN I-NP O
diet NN I-NP O
supplemented VBN B-VP O
with IN B-PP O
medium JJ B-NP O
- HYPH I-NP O
chain NN I-NP O
triglyceride NN I-NP O
oil NN I-NP O
and CC I-NP O
carnitine NN I-NP O
and CC I-NP O
avoidance NN I-NP O
of IN B-PP O
fasting VBG B-NP O
. . O O

Her PRP$ B-NP O
ventricular JJ I-NP O
hypertrophy NN I-NP O
resolved VBN B-VP O
significantly RB B-NP O
over IN I-NP O
1 CD I-NP O
year NN I-NP O
, , O O
and CC O O
cognitively RB B-ADVP O
, , O O
she PRP B-NP O
is VBZ B-VP O
in IN B-PP O
the DT B-NP O
superior JJ I-NP O
range NN I-NP O
for IN B-PP O
age NN B-NP O
. . O O

Clinical JJ B-NP O
recognition NN I-NP O
of IN B-PP O
VLCAD NN B-NP B-Disease
deficiency NN I-NP I-Disease
is VBZ B-VP O
important JJ B-ADJP O
because IN B-SBAR O
it PRP B-NP O
is VBZ B-VP O
one CD B-NP O
of IN B-PP O
the DT B-NP O
few JJ I-NP O
directly RB I-NP O
treatable JJ I-NP O
causes NNS I-NP O
of IN B-PP O
cardiomyopathy NN B-NP B-Disease
in IN B-PP O
children NNS B-NP O
. . O O

. . O O

Cloning NN B-NP O
of IN B-PP O
a DT B-NP O
novel JJ I-NP O
member NN I-NP O
of IN B-PP O
the DT B-NP O
low JJ I-NP O
- HYPH I-NP O
density NN I-NP O
lipoprotein NN I-NP O
receptor NN I-NP O
family NN I-NP O
. . O O

A DT B-NP O
gene NN I-NP O
encoding VBG B-VP O
a DT B-NP O
novel JJ I-NP O
transmembrane JJ I-NP O
protein NN I-NP O
was VBD B-VP O
identified VBN I-VP O
by IN B-PP O
DNA NN B-NP O
sequence NN I-NP O
analysis NN I-NP O
within IN B-PP O
the DT B-NP O
insulin NN I-NP B-Disease
- HYPH B-NP I-Disease
dependent JJ I-NP I-Disease
diabetes NN I-NP I-Disease
mellitus NN I-NP I-Disease
( ( O O
IDDM NN B-NP B-Disease
) ) O O
locus NN B-NP O
IDDM4 NN I-NP O
on IN B-PP O
chromosome NN B-NP O
11q13 NN I-NP O
. . O O

Based VBN B-PP O
on IN B-PP O
its PRP$ B-NP O
chromosomal JJ I-NP O
position NN I-NP O
, , O O
this DT B-NP O
gene NN I-NP O
is VBZ B-VP O
a DT B-NP O
candidate NN I-NP O
for IN B-PP O
conferring VBG B-VP O
susceptibility NN B-NP O
to TO B-PP O
diabetes NNS B-NP B-Disease
. . O O

The DT B-NP O
gene NN I-NP O
, , O O
termed VBN B-VP O
low JJ B-NP O
- HYPH I-NP O
density NN I-NP O
lipoprotein NN I-NP O
receptor NN I-NP O
related JJ I-NP O
protein NN I-NP O
5 CD I-NP O
( ( O O
LRP5 NN B-NP O
) ) O O
, , O O
encodes VBZ B-VP O
a DT B-NP O
protein NN I-NP O
of IN B-PP O
1615 CD B-NP O
amino NN I-NP O
acids NNS I-NP O
that WDT B-NP O
contains VBZ B-VP O
conserved VBN B-NP O
modules NNS I-NP O
which WDT B-NP O
are VBP B-VP O
characteristic JJ B-ADJP O
of IN B-PP O
the DT B-NP O
low JJ I-NP O
- HYPH I-NP O
density NN I-NP O
lipoprotein NN I-NP O
( ( O O
LDL NN B-NP O
) ) O O
receptor NN B-NP O
family NN I-NP O
. . O O

These DT B-NP O
modules NNS I-NP O
include VBP B-VP O
a DT B-NP O
putative JJ I-NP O
signal NN I-NP O
peptide NN I-NP O
for IN B-PP O
protein NN B-NP O
export NN I-NP O
, , O O
four CD B-NP O
epidermal JJ I-NP O
growth NN I-NP O
factor NN I-NP O
( ( O O
EGF NN B-NP O
) ) O O
repeats NNS B-NP O
with IN B-PP O
associated VBN B-NP O
spacer NN I-NP O
domains NNS I-NP O
, , O O
three CD B-NP O
LDL NN I-NP O
- HYPH I-NP O
receptor NN I-NP O
( ( O O
LDLR NN B-NP O
) ) O O
repeats NNS B-NP O
, , O O
a DT B-NP O
single JJ I-NP O
transmembrane NN I-NP O
spanning VBG I-NP O
domain NN I-NP O
, , O O
and CC O O
a DT B-NP O
cytoplasmic JJ I-NP O
domain NN I-NP O
. . O O

The DT B-NP O
encoded VBN I-NP O
protein NN I-NP O
has VBZ B-VP O
a DT B-NP O
unique JJ I-NP O
organization NN I-NP O
of IN B-PP O
EGF NN B-NP O
and CC I-NP O
LDLR NN I-NP O
repeats NNS I-NP O
; : O O
therefore RB B-ADVP O
, , O O
LRP5 NN B-NP O
likely RB B-VP O
represents VBZ I-VP O
a DT B-NP O
new JJ I-NP O
category NN I-NP O
of IN B-PP O
the DT B-NP O
LDLR NN I-NP O
family NN I-NP O
. . O O

Both CC O O
human JJ O O
and CC O O
mouse NN B-NP O
LRP5 NN I-NP O
cDNAs NNS I-NP O
have VBP B-VP O
been VBN I-VP O
isolated VBN I-VP O
and CC O O
the DT B-NP O
encoded VBN I-NP O
mature JJ I-NP O
proteins NNS I-NP O
are VBP B-VP O
95 CD B-NP O
% NN I-NP O
identical JJ B-ADJP O
, , O O
indicating VBG B-VP O
a DT B-NP O
high JJ I-NP O
degree NN I-NP O
of IN B-PP O
evolutionary JJ B-NP O
conservation NN I-NP O
. . O O

. . O O

The DT B-NP O
APC NN I-NP B-Disease
variants NNS I-NP O
I1307K NN I-NP O
and CC I-NP O
E1317Q NN I-NP O
are VBP B-VP O
associated VBN I-VP O
with IN B-PP O
colorectal JJ B-NP B-Disease
tumors NNS I-NP I-Disease
, , O O
but CC O O
not RB B-ADVP O
always RB I-ADVP O
with IN B-PP O
a DT B-NP O
family NN I-NP O
history NN I-NP O
. . O O

Classical JJ B-NP O
familial JJ I-NP B-Disease
adenomatous JJ I-NP I-Disease
polyposis NN I-NP I-Disease
( ( O O
FAP NN B-NP B-Disease
) ) O O
is VBZ B-VP O
a DT B-NP O
high JJ I-NP O
- HYPH I-NP O
penetrance NN I-NP O
autosomal JJ I-NP B-Disease
dominant JJ I-NP I-Disease
disease NN I-NP I-Disease
that WDT B-NP O
predisposes VBZ B-VP O
to TO B-PP O
hundreds NNS B-NP O
or CC I-NP O
thousands NNS I-NP O
of IN B-PP O
colorectal JJ B-NP B-Disease
adenomas NNS I-NP I-Disease
and CC O I-Disease
carcinoma NN B-NP I-Disease
and CC O O
that DT B-NP O
results VBZ B-VP O
from IN B-PP O
truncating VBG B-VP O
mutations NNS B-NP O
in IN B-PP O
the DT B-NP O
APC NN I-NP B-Disease
gene NN I-NP O
. . O O

A DT B-NP O
variant NN I-NP O
of IN B-PP O
FAP NN B-NP B-Disease
is VBZ B-VP O
attenuated VBN I-VP B-Disease
adenomatous JJ B-NP I-Disease
polyposis NN I-NP I-Disease
coli NN I-NP I-Disease
, , O O
which WDT B-NP O
results VBZ B-VP O
from IN B-PP O
germ NN B-NP O
- HYPH B-NP O
line NN I-NP O
mutations NNS I-NP O
in IN B-PP O
the DT B-NP O
5 CD I-NP O
and CC I-NP O
3 CD I-NP O
regions NNS I-NP O
of IN B-PP O
the DT B-NP O
APC NN I-NP B-Disease
gene NN I-NP O
. . O O

Attenuated VBN B-NP B-Disease
adenomatous JJ I-NP I-Disease
polyposis NN I-NP I-Disease
coli NN I-NP I-Disease
patients NNS I-NP O
have VBP B-VP O
multiple JJ I-NP O
colorectal JJ I-NP B-Disease
adenomas NNS I-NP I-Disease
( ( O O
typically RB B-NP O
fewer JJR I-NP O
than IN I-NP O
100 CD I-NP O
) ) O O
without IN B-PP O
the DT B-NP O
florid JJ I-NP O
phenotype NN I-NP O
of IN B-PP O
classical JJ B-NP O
FAP NN I-NP B-Disease
. . O O

Another DT B-NP O
group NN I-NP O
of IN B-PP O
patients NNS B-NP O
with IN B-PP O
multiple JJ B-NP O
adenomas NNS I-NP B-Disease
has VBZ B-VP O
no DT B-NP O
mutations NNS I-NP O
in IN B-PP O
the DT B-NP O
APC NN I-NP B-Disease
gene NN I-NP O
, , O O
and CC O O
their PRP$ B-NP O
phenotype NN I-NP O
probably RB B-ADVP O
results VBZ B-VP O
from IN B-PP O
variation NN B-NP O
at IN B-PP O
a DT B-NP O
locus NN I-NP O
, , O O
or CC O O
loci NNS B-NP O
, , O O
elsewhere RB B-ADVP O
in IN B-PP O
the DT B-NP O
genome NN I-NP O
. . O O

Recently RB B-ADVP O
, , O O
however RB B-ADVP O
, , O O
a DT B-NP O
missense JJ I-NP O
variant NN I-NP O
of IN B-PP O
APC NN B-NP B-Disease
( ( O O
I1307K NN B-NP O
) ) O O
was VBD B-VP O
described VBN I-VP O
that WDT B-NP O
confers VBZ B-VP O
an DT B-NP O
increased VBN I-NP O
risk NN I-NP O
of IN B-PP O
colorectal JJ B-NP B-Disease
tumors NNS I-NP I-Disease
, , O O
including VBG B-PP O
multiple JJ B-NP O
adenomas NNS I-NP B-Disease
, , O O
in IN B-PP O
Ashkenazim NNP B-NP O
. . O O

We PRP B-NP O
have VBP B-VP O
studied VBN I-VP O
a DT B-NP O
set NN I-NP O
of IN B-PP O
164 CD B-NP O
patients NNS I-NP O
with IN B-PP O
multiple JJ B-NP O
colorectal JJ I-NP B-Disease
adenomas NNS I-NP I-Disease
and CC O I-Disease
/ SYM B-NP I-Disease
or CC O I-Disease
carcinoma NN B-NP I-Disease
and CC O O
analyzed VBN B-NP O
codons NNS I-NP O
1263 CD B-NP O
- HYPH I-NP O
1377 CD I-NP O
( ( O O
exon NN B-NP O
15G NN I-NP O
) ) O O
of IN B-PP O
the DT B-NP O
APC NN I-NP B-Disease
gene NN I-NP O
for IN B-PP O
germ NN B-NP O
- HYPH I-NP O
line NN I-NP O
variants NNS I-NP O
. . O O

Three CD B-NP O
patients NNS I-NP O
with IN B-PP O
the DT B-NP O
I1307K NN I-NP O
allele NN I-NP O
were VBD B-VP O
detected VBN I-VP O
, , O O
each DT B-NP O
of IN B-PP O
Ashkenazi NNP B-NP O
descent NNP I-NP O
. . O O

Four CD B-NP O
patients NNS I-NP O
had VBD B-VP O
a DT B-NP O
germ NN I-NP O
- HYPH I-NP O
line NN I-NP O
E1317Q NN I-NP O
missense JJ I-NP O
variant NN I-NP O
of IN B-PP O
APC NN B-NP O
that WDT B-NP O
was VBD B-VP O
not RB O O
present JJ B-ADJP O
in IN B-PP O
controls NNS B-NP O
; : O O
one CD B-NP O
of IN B-PP O
these DT B-NP O
individuals NNS I-NP O
had VBD B-VP O
an DT B-NP O
unusually RB I-NP O
large JJ I-NP O
number NN I-NP O
of IN B-PP O
metaplastic JJ B-NP B-Disease
polyps NNS I-NP I-Disease
of IN B-PP I-Disease
the DT B-NP I-Disease
colorectum NN I-NP I-Disease
. . O O

There EX B-NP O
is VBZ B-VP O
increasing VBG I-VP O
evidence NN B-NP O
that IN B-SBAR O
there EX B-NP O
exist VBP B-VP O
germ NN B-NP O
- HYPH B-NP O
line NN I-NP O
variants NNS I-NP O
of IN B-PP O
the DT B-NP O
APC NN I-NP B-Disease
gene NN I-NP O
that WDT B-NP O
predispose VBP B-VP O
to TO B-PP O
the DT B-NP O
development NN I-NP O
of IN B-PP O
multiple JJ B-NP O
colorectal JJ I-NP B-Disease
adenomas NNS I-NP I-Disease
and CC I-NP I-Disease
carcinoma NN I-NP I-Disease
, , O O
but CC O O
without IN B-PP O
the DT B-NP O
florid JJ I-NP O
phenotype NN I-NP O
of IN B-PP O
classical JJ B-NP O
FAP NN I-NP B-Disease
, , O O
and CC O O
possibly RB B-ADVP O
with IN B-PP O
importance NN B-NP O
for IN B-PP O
colorectal JJ B-NP B-Disease
cancer NN I-NP I-Disease
risk NN I-NP O
in IN B-PP O
the DT B-NP O
general JJ I-NP O
population NN I-NP O
. . O O

. . O O

Genomic JJ B-NP O
structure NN I-NP O
of IN B-PP O
the DT B-NP O
human JJ I-NP O
congenital JJ I-NP B-Disease
chloride NN I-NP I-Disease
diarrhea NN I-NP I-Disease
( ( O O
CLD NN B-NP B-Disease
) ) O O
gene NN B-NP O
. . O O

Congenital JJ B-NP B-Disease
chloride NN I-NP I-Disease
diarrhea NN I-NP I-Disease
( ( O O
CLD NN B-NP B-Disease
) ) O O
is VBZ B-VP O
caused VBN I-VP O
by IN B-PP O
mutations NNS B-NP O
in IN B-PP O
a DT B-NP O
gene NN I-NP O
which WDT B-NP O
encodes VBZ B-VP O
an DT B-NP O
intestinal JJ I-NP O
anion NN I-NP O
transporter NN I-NP O
. . O O

We PRP B-NP O
report VBP B-VP O
here RB B-ADVP O
the DT B-NP O
complete JJ I-NP O
genomic JJ I-NP O
organization NN I-NP O
of IN B-PP O
the DT B-NP O
human JJ I-NP O
CLD NN I-NP B-Disease
gene NN I-NP O
which WDT B-NP O
spans VBZ B-VP O
approximately RB B-ADJP O
39kb JJ I-ADJP O
, , O O
and CC O O
comprises VBZ B-VP O
21 CD B-NP O
exons NNS I-NP O
. . O O

All DT B-NP O
exon NN I-NP O
/ SYM B-VP O
intron NN B-NP O
boundaries NNS I-NP O
conform VBP B-VP O
to TO B-PP O
the DT B-NP O
GT NN I-NP O
/ SYM B-VP O
AG NN B-NP O
rule NN I-NP O
. . O O

An DT B-NP O
analysis NN I-NP O
of IN B-PP O
the DT B-NP O
putative JJ I-NP O
promoter NN I-NP O
region NN I-NP O
sequence NN I-NP O
shows VBZ B-VP O
a DT B-NP O
putative JJ I-NP O
TATA NN I-NP O
box NN I-NP O
and CC O O
predicts VBZ B-VP O
multiple JJ B-NP O
transcription NN I-NP O
factor NN I-NP O
binding NN I-NP O
sites NNS I-NP O
. . O O

The DT B-NP O
genomic JJ I-NP O
structure NN I-NP O
was VBD B-VP O
determined VBN I-VP O
using VBG B-VP O
DNA NN B-NP O
from IN B-PP O
several JJ B-NP O
sources NNS I-NP O
including VBG B-PP O
multiple JJ B-NP O
large JJ I-NP O
- HYPH I-NP O
insert NN I-NP O
libaries NNS I-NP O
and CC O O
genomic JJ B-NP O
DNA NN I-NP O
from IN B-PP O
Finnish JJ B-NP O
CLD NN I-NP B-Disease
patients NNS I-NP O
and CC I-NP O
controls NNS I-NP O
. . O O

Exon NN B-NP O
- HYPH I-NP O
specific JJ I-NP O
primers NNS I-NP O
developed VBN B-VP O
in IN B-PP O
this DT B-NP O
study NN I-NP O
will MD B-VP O
facilitate VB I-VP O
mutation NN B-NP O
screening NN I-NP O
studies NNS I-NP O
of IN B-PP O
patients NNS B-NP O
with IN B-PP O
the DT B-NP O
disease NN I-NP O
. . O O

Genomic JJ B-NP O
sequencing NN I-NP O
of IN B-PP O
a DT B-NP O
BAC NN I-NP O
clone NN I-NP O
H NN I-NP O
_ NN I-NP O
RG364P16 NN I-NP O
revealed VBD B-VP O
the DT B-NP O
presence NN I-NP O
of IN B-PP O
another DT B-NP O
, , O O
highly RB B-NP O
homologous JJ I-NP O
gene NN I-NP O
3 CD I-NP O
of IN B-PP O
the DT B-NP O
CLD NN I-NP B-Disease
gene NN I-NP O
, , O O
with IN B-PP O
a DT B-NP O
similar JJ I-NP O
genomic JJ I-NP O
structure NN I-NP O
, , O O
recently RB B-VP O
identified VBN I-VP O
as IN B-PP O
the DT B-NP O
Pendred NNP I-NP B-Disease
syndrome NN I-NP I-Disease
gene NN I-NP O
( ( O O
PDS NN B-NP B-Disease
) ) O O
. . O O

. . O O

The DT B-NP O
APCI1307K NN I-NP O
allele NN I-NP O
and CC O O
cancer NN B-NP B-Disease
risk NN I-NP O
in IN B-PP O
a DT B-NP O
community NN I-NP O
- HYPH O O
based VBN B-NP O
study NN I-NP O
of IN B-PP O
Ashkenazi NNP B-NP O
Jews NNP I-NP O
. . O O

Mutations NNS B-NP O
in IN B-PP O
APC NN B-NP O
are VBP B-VP O
classically RB I-VP O
associated VBN I-VP O
with IN B-PP O
familial JJ B-NP B-Disease
adenomatous JJ I-NP I-Disease
polyposis NN I-NP I-Disease
( ( O O
FAP NN B-NP B-Disease
) ) O O
, , O O
a DT B-NP O
highly RB I-NP O
penetrant JJ I-NP O
autosomal JJ I-NP B-Disease
dominant JJ I-NP I-Disease
disorder NN I-NP I-Disease
characterized VBN B-VP O
by IN B-PP O
multiple JJ B-NP O
intestinal JJ I-NP O
polyps NNS I-NP B-Disease
and CC O O
, , O O
without IN B-PP O
surgical JJ B-NP O
intervention NN I-NP O
, , O O
the DT B-NP O
development NN I-NP O
of IN B-PP O
colorectal JJ B-NP B-Disease
cancer NN I-NP I-Disease
( ( O O
CRC NN B-NP B-Disease
) ) O O
. . O O

APC NN B-NP B-Disease
is VBZ B-VP O
a DT B-NP O
tumour NN I-NP O
- HYPH I-NP O
suppressor NN I-NP O
gene NN I-NP O
, , O O
and CC O O
somatic JJ B-NP O
loss NN I-NP O
occurs VBZ B-VP O
in IN B-PP O
tumours NNS B-NP B-Disease
. . O O

The DT B-NP O
germline NN I-NP O
T NN I-NP O
- HYPH B-ADJP O
to TO B-PP O
- HYPH B-NP O
A NN I-NP O
transversion NN I-NP O
responsible JJ B-ADJP O
for IN B-PP O
the DT B-NP O
APC NN I-NP O
I1307K NN I-NP O
allele NN I-NP O
converts VBZ B-VP O
the DT B-NP O
wild JJ I-NP O
- HYPH I-NP O
type NN I-NP O
sequence NN I-NP O
to TO B-PP O
a DT B-NP O
homopolymer NN I-NP O
tract NN I-NP O
( ( O O
A8 NN B-NP O
) ) O O
that WDT B-NP O
is VBZ B-VP O
genetically RB B-ADJP O
unstable JJ I-ADJP O
and CC I-ADJP O
prone JJ I-ADJP O
to TO B-PP O
somatic JJ B-NP O
mutation NN I-NP O
. . O O

The DT B-NP O
I1307K NN I-NP O
allele NN I-NP O
was VBD B-VP O
found VBN I-VP O
in IN B-PP O
6 CD B-NP O
. . O O

1 CD B-NP O
% NN I-NP O
of IN B-PP O
unselected JJ B-NP O
Ashkenazi NNP I-NP O
Jews NNPS I-NP O
and CC O O
higher JJR B-NP O
proportions NNS I-NP O
of IN B-PP O
Ashkenazim NN B-NP O
with IN B-PP O
family NN B-NP O
or CC O O
personal JJ B-NP O
histories NNS I-NP O
of IN B-PP O
CRC NN B-NP B-Disease
( ( O O
ref NN B-NP O
. . O O

2 CD B-NP O
) ) O O
. . O O

To TO B-VP O
evaluate VB I-VP O
the DT B-NP O
role NN I-NP O
of IN B-PP O
I1307K NN B-NP O
in IN B-PP O
cancer NN B-NP B-Disease
, , O O
we PRP B-NP O
genotyped VBD B-VP O
5 CD B-NP O
, , O O
081 CD B-NP O
Ashkenazi NNP I-NP O
volunteers NNS I-NP O
in IN B-PP O
a DT B-NP O
community NN I-NP O
survey NN I-NP O
. . O O

Risk NN B-NP O
of IN B-PP O
developing VBG B-VP O
colorectal JJ B-NP B-Disease
, , I-NP I-Disease
breast NN I-NP I-Disease
and CC O I-Disease
other JJ B-NP I-Disease
cancers NNS I-NP I-Disease
were VBD B-VP O
compared VBN I-VP O
between IN B-PP O
genotyped VBN B-NP O
I1307K NN I-NP O
carriers NNS I-NP O
and CC O O
non AFX B-NP O
- HYPH I-NP O
carriers NNS I-NP O
and CC O O
their PRP$ B-NP O
first JJ I-NP O
- HYPH I-NP O
degree NN I-NP O
relatives NNS I-NP O
. . O O

Sperm NN B-NP O
DNA NN I-NP O
analysis NN I-NP O
in IN B-PP O
a DT B-NP O
Friedreich NNP I-NP B-Disease
ataxia NN I-NP I-Disease
premutation NN I-NP O
carrier NN I-NP O
suggests VBZ B-VP O
both CC O O
meiotic JJ B-NP O
and CC I-NP O
mitotic JJ I-NP O
expansion NN I-NP O
in IN B-PP O
the DT B-NP O
FRDA NN I-NP B-Disease
gene NN I-NP O
. . O O

Friedreich JJ B-NP B-Disease
ataxia NN I-NP I-Disease
is VBZ B-VP O
usually RB I-VP O
caused VBN I-VP O
by IN B-PP O
an DT B-NP O
expansion NN I-NP O
of IN B-PP O
a DT B-NP O
GAA NN I-NP O
trinucleotide NN I-NP O
repeat NN I-NP O
in IN B-PP O
intron NN B-NP O
1 CD I-NP O
of IN B-PP O
the DT B-NP O
FRDA NN I-NP B-Disease
gene NN I-NP O
. . O O

Occasionally RB B-ADVP O
, , O O
a DT B-NP O
fully RB I-NP O
expanded VBN I-NP O
allele NN I-NP O
has VBZ B-VP O
been VBN I-VP O
found VBN I-VP O
to TO I-VP O
arise VB I-VP O
from IN B-PP O
a DT B-NP O
premutation NN I-NP O
of IN B-PP O
100 CD B-NP O
or CC I-NP O
less JJR I-NP O
triplet JJ I-NP O
repeats NNS I-NP O
. . O O

We PRP B-NP O
have VBP B-VP O
examined VBN I-VP O
the DT B-NP O
sperm NN I-NP O
DNA NN I-NP O
of IN B-PP O
a DT B-NP O
premutation NN I-NP O
carrier NN I-NP O
. . O O

This DT B-NP O
mans VBZ B-VP O
leucocyte NN B-NP O
DNA NN I-NP O
showed VBD B-VP O
one CD B-NP O
normal JJ I-NP O
allele NN I-NP O
and CC O O
one CD B-NP O
allele NN I-NP O
of IN B-PP O
approximately RB B-NP O
100 CD I-NP O
repeats NNS I-NP O
. . O O

His PRP$ B-NP O
sperm NN I-NP O
showed VBD B-VP O
an DT B-NP O
expanded VBN I-NP O
allele NN I-NP O
in IN B-PP O
a DT B-NP O
tight JJ I-NP O
range NN I-NP O
centering NN I-NP O
on IN B-PP O
a DT B-NP O
size NN I-NP O
of IN B-PP O
approximately RB B-NP O
320 CD I-NP O
trinucleotide NN I-NP O
repeats NNS I-NP O
. . O O

His PRP$ B-NP O
affected JJ I-NP O
son NN I-NP O
has VBZ B-VP O
repeat NN B-NP O
sizes NNS I-NP O
of IN B-PP O
1040 CD B-NP O
and CC I-NP O
540 CD I-NP O
. . O O

These DT B-NP O
data NNS I-NP O
suggest VBP B-VP O
that IN B-SBAR O
expansion NN B-NP O
occurs VBZ B-VP O
in IN B-PP O
two CD B-NP O
stages NNS I-NP O
, , O O
the DT B-NP O
first JJ I-NP O
during IN B-PP O
meiosis NN B-NP O
followed VBN B-VP O
by IN B-PP O
a DT B-NP O
second JJ I-NP O
mitotic JJ I-NP O
expansion NN I-NP O
. . O O

We PRP B-NP O
also RB B-ADVP O
show VBP B-VP O
that IN B-SBAR O
in IN B-PP O
all DT B-NP O
informative JJ I-NP O
carrier NN I-NP O
father NN I-NP O
to TO B-PP O
affected VBN B-NP O
child NN I-NP O
transmissions NNS I-NP O
, , O O
with IN B-PP O
the DT B-NP O
notable JJ I-NP O
exception NN I-NP O
of IN B-PP O
the DT B-NP O
premutation NN I-NP O
carrier NN I-NP O
, , O O
the DT B-NP O
expansion NN I-NP O
size NN I-NP O
decreases VBZ B-VP O
. . O O

. . O O

The DT B-NP O
R496H NN I-NP O
mutation NN I-NP O
of IN B-PP O
arylsulfatase NN B-NP O
A NN I-NP O
does VBZ B-VP O
not RB I-VP O
cause VB I-VP O
metachromatic JJ B-NP B-Disease
leukodystrophy NN I-NP I-Disease
. . O O

Deficiency NN B-NP B-Disease
of IN B-PP I-Disease
arylsulfatase NN B-NP I-Disease
A NN I-NP I-Disease
( ( O O
ARSA NN B-NP O
) ) O O
enzyme NN B-NP O
activity NN I-NP O
causes VBZ B-VP O
metachromatic JJ B-NP B-Disease
leukodystrophy NN I-NP I-Disease
( ( O O
MLD NN B-NP B-Disease
) ) O O
. . O O

A DT B-NP O
number NN I-NP O
of IN B-PP O
ARSA NN B-NP O
gene NN I-NP O
mutations NNS I-NP O
responsible JJ B-ADJP O
for IN B-PP O
MLD NN B-NP B-Disease
have VBP B-VP O
been VBN I-VP O
identified VBN I-VP O
. . O O

Recently RB B-ADVP O
, , O O
the DT B-NP O
R496H NN I-NP O
mutation NN I-NP O
of IN B-PP O
ARSA NN B-NP O
was VBD B-VP O
proposed VBN I-VP O
to TO I-VP O
be VB I-VP O
a DT B-NP O
cause NN I-NP O
of IN B-PP O
MLD NN B-NP B-Disease
( ( O O
Draghia NNP B-NP O
et FW I-NP O
al FW I-NP O
. FW I-NP O

, , O O
1997 CD B-NP O
) ) O O
. . O O

We PRP B-NP O
have VBP B-VP O
investigated VBN I-VP O
the DT B-NP O
R496H NN I-NP O
mutation NN I-NP O
and CC O O
found VBD B-VP O
this DT B-NP O
mutation NN I-NP O
at IN B-PP O
a DT B-NP O
relatively RB I-NP O
high JJ I-NP O
frequency NN I-NP O
in IN B-PP O
an DT B-NP O
African JJ I-NP O
American JJ I-NP O
population NN I-NP O
( ( O O
f NN B-NP O
= SYM B-VP O
0 CD B-NP O
. SYM I-NP O

09 CD I-NP O
, , O O
n NN B-NP O
= SYM B-VP O
61 CD B-NP O
subjects NNS I-NP O
) ) O O
. . O O

The DT B-NP O
ARSA NN I-NP O
enzyme NN I-NP O
activity NN I-NP O
in IN B-PP O
subjects NNS B-NP O
with IN B-PP O
and CC I-PP O
without IN I-PP O
the DT B-NP O
R496H NN I-NP O
mutation NN I-NP O
was VBD B-VP O
determined VBN I-VP O
and CC O O
found VBN B-VP O
to TO I-VP O
be VB I-VP O
normal JJ B-ADJP O
. . O O

It PRP B-NP O
is VBZ B-VP O
therefore RB I-VP O
concluded VBN I-VP O
that IN B-SBAR O
the DT B-NP O
R496H NN I-NP O
mutation NN I-NP O
of IN B-PP O
ARSA NN B-NP O
does VBZ B-VP O
not RB I-VP O
negatively RB I-VP O
influence VB I-VP O
the DT B-NP O
activity NN I-NP O
of IN B-PP O
ARSA NN B-NP O
and CC O O
is VBZ B-VP O
not RB O O
a DT B-NP O
cause NN I-NP O
of IN B-PP O
MLD NN B-NP B-Disease
Down RB B-ADVP O
- HYPH O O
regulation NN B-NP O
of IN B-PP O
transmembrane NN B-NP O
carbonic JJ I-NP O
anhydrases NNS I-NP O
in IN B-PP O
renal JJ B-NP B-Disease
cell NN I-NP I-Disease
carcinoma NN I-NP I-Disease
cell NN I-NP O
lines NNS I-NP O
by IN B-PP O
wild JJ B-NP O
- HYPH I-NP O
type NN I-NP O
von NN I-NP B-Disease
Hippel NNP I-NP I-Disease
- HYPH I-NP I-Disease
Lindau NNP I-NP I-Disease
transgenes NNS I-NP O
. . O O

To TO B-VP O
discover VB I-VP O
genes NNS B-NP O
involved VBN B-VP O
in IN B-PP O
von NNP B-NP B-Disease
Hippel NNP I-NP I-Disease
- HYPH I-NP I-Disease
Lindau NNP I-NP I-Disease
( ( O O
VHL NNP B-NP B-Disease
) ) O O
- HYPH B-NP O
mediated VBN I-NP O
carcinogenesis NN I-NP O
, , O O
we PRP B-NP O
used VBD B-VP O
renal JJ B-NP B-Disease
cell NN I-NP I-Disease
carcinoma NN I-NP I-Disease
cell NN I-NP O
lines NNS I-NP O
stably RB B-VP O
transfected VBN I-VP O
with IN B-PP O
wild JJ B-NP O
- HYPH I-NP O
type NN I-NP O
VHL NN I-NP O
- HYPH O O
expressing VBG B-VP O
transgenes NNS B-NP O
. . O O

Large JJ B-NP O
- HYPH I-NP O
scale NN I-NP O
RNA NN I-NP O
differential JJ I-NP O
display NN I-NP O
technology NN I-NP O
applied VBN B-VP O
to TO B-PP O
these DT B-NP O
cell NN I-NP O
lines NNS I-NP O
identified VBD B-VP O
several JJ B-NP O
differentially RB I-NP O
expressed VBN I-NP O
genes NNS I-NP O
, , O O
including VBG B-PP O
an DT B-NP O
alpha NN I-NP O
carbonic JJ I-NP O
anhydrase NN I-NP O
gene NN I-NP O
, , O O
termed VBN B-NP O
CA12 NN I-NP O
. . O O

The DT B-NP O
deduced VBN I-NP O
protein NN I-NP O
sequence NN I-NP O
was VBD B-VP O
classified VBN I-VP O
as IN B-PP O
a DT B-NP O
one CD I-NP O
- HYPH I-NP O
pass NN I-NP O
transmembrane JJ I-NP O
CA NN I-NP O
possessing VBG B-VP O
an DT B-NP O
apparently RB I-NP O
intact JJ I-NP O
catalytic JJ I-NP O
domain NN I-NP O
in IN B-PP O
the DT B-NP O
extracellular JJ I-NP O
CA NN I-NP O
module NN I-NP O
. . O O

Reintroduced VBN B-NP O
wild JJ I-NP O
- HYPH I-NP O
type NN I-NP O
VHL NN I-NP B-Disease
strongly RB B-ADVP O
inhibited VBD B-VP O
the DT B-NP O
overexpression NN I-NP O
of IN B-PP O
the DT B-NP O
CA12 NN I-NP O
gene NN I-NP O
in IN B-PP O
the DT B-NP O
parental JJ I-NP O
renal JJ I-NP B-Disease
cell NN I-NP I-Disease
carcinoma NN I-NP I-Disease
cell NN I-NP O
lines NNS I-NP O
. . O O

Similar JJ B-NP O
results NNS I-NP O
were VBD B-VP O
obtained VBN I-VP O
with IN B-PP O
CA9 NN B-NP O
, , O O
encoding VBG B-VP O
another DT B-NP O
transmembrane JJ I-NP O
CA NN I-NP O
with IN B-PP O
an DT B-NP O
intact JJ I-NP O
catalytic JJ I-NP O
domain NN I-NP O
. . O O

Although IN B-SBAR O
both DT B-NP O
domains NNS I-NP O
of IN B-PP O
the DT B-NP O
VHL NN I-NP B-Disease
protein NN I-NP O
contribute VBP B-VP O
to TO B-PP O
regulation NN B-NP O
of IN B-PP O
CA12 NN B-NP O
expression NN I-NP O
, , O O
the DT B-NP O
elongin NN I-NP O
binding NN I-NP O
domain NN I-NP O
alone RB B-ADVP O
could MD B-VP O
effectively RB I-VP O
regulate VB I-VP O
CA9 NN B-NP O
expression NN I-NP O
. . O O

We PRP B-NP O
mapped VBD B-VP O
CA12 NN B-NP O
and CC I-NP O
CA9 NN I-NP O
loci NNS I-NP O
to TO B-PP O
chromosome NN B-NP O
bands NNS I-NP O
15q22 NN I-NP O
and CC I-NP O
17q21 NN I-NP O
. . O O

2 CD B-NP O
respectively RB I-NP O
, , O O
regions NNS B-NP O
prone JJ B-ADJP O
to TO B-PP O
amplification NN B-NP O
in IN B-PP O
some DT B-NP O
human JJ I-NP O
cancers NNS I-NP B-Disease
. . O O

Additional JJ B-NP O
experiments NNS I-NP O
are VBP B-VP O
needed VBN I-VP O
to TO B-VP O
define VB I-VP O
the DT B-NP O
role NN I-NP O
of IN B-PP O
CA NN B-NP O
IX CD I-NP O
and CC O O
CA NN B-NP O
XII NN I-NP O
enzymes NNS I-NP O
in IN B-PP O
the DT B-NP O
regulation NN I-NP O
of IN B-PP O
pH NN B-NP O
in IN B-PP O
the DT B-NP O
extracellular JJ I-NP O
microenvironment NN I-NP O
and CC O O
its PRP$ B-NP O
potential JJ I-NP O
impact NN I-NP O
on IN B-PP O
cancer NN B-NP B-Disease
cell NN I-NP O
growth NN I-NP O
. . O O

A DT B-NP O
gene NN I-NP O
encoding VBG B-VP O
a DT B-NP O
transmembrane JJ I-NP O
protein NN I-NP O
is VBZ B-VP O
mutated VBN I-VP O
in IN B-PP O
patients NNS B-NP O
with IN B-PP O
diabetes NN B-NP B-Disease
mellitus NN I-NP I-Disease
and CC O O
optic JJ B-NP B-Disease
atrophy NN I-NP I-Disease
( ( O O
Wolfram NN B-NP B-Disease
syndrome NN I-NP I-Disease
) ) O O
. . O O

Wolfram NN B-NP B-Disease
syndrome NN I-NP I-Disease
( ( O O
WFS NN B-NP B-Disease
; : O O
OMIM NN B-NP O
222300 CD I-NP O
) ) O O
is VBZ B-VP O
an DT B-NP O
autosomal JJ I-NP B-Disease
recessive JJ I-NP I-Disease
neurodegenerative JJ I-NP I-Disease
disorder NN I-NP I-Disease
defined VBN B-VP O
by IN B-PP O
young JJ B-NP O
- HYPH I-NP O
onset NN I-NP O
non AFX O O
- HYPH O O
immune JJ B-NP O
insulin NN I-NP B-Disease
- HYPH B-NP I-Disease
dependent JJ I-NP I-Disease
diabetes NNS I-NP I-Disease
mellitus NN I-NP I-Disease
and CC O O
progressive JJ B-NP O
optic JJ I-NP B-Disease
atrophy NN I-NP I-Disease
. . O O

Linkage NN B-NP O
to TO B-PP O
markers NNS B-NP O
on IN B-PP O
chromosome NN B-NP O
4p NN I-NP O
was VBD B-VP O
confirmed VBN I-VP O
in IN B-PP O
five CD B-NP O
families NNS I-NP O
. . O O

On IN B-PP O
the DT B-NP O
basis NN I-NP O
of IN B-PP O
meiotic JJ B-NP O
recombinants NNS I-NP O
and CC I-NP O
disease NN I-NP O
- HYPH B-NP O
associated VBN I-NP O
haplotypes NNS I-NP O
, , O O
the DT B-NP O
WFS NN I-NP B-Disease
gene NN I-NP O
was VBD B-VP O
localized JJ B-ADJP O
to TO B-PP O
a DT B-NP O
BAC NN I-NP O
/ SYM B-NP O
P1 NN I-NP O
contig NN I-NP O
of IN B-PP O
less JJR B-NP O
than IN I-NP O
250 CD I-NP O
kb NN I-NP O
. . O O

Mutations NNS B-NP O
in IN B-PP O
a DT B-NP O
novel JJ I-NP O
gene NN I-NP O
( ( O O
WFS1 NN B-NP O
) ) O O
encoding VBG B-VP O
a DT B-NP O
putative JJ I-NP O
transmembrane JJ I-NP O
protein NN I-NP O
were VBD B-VP O
found VBN I-VP O
in IN B-PP O
all DT B-NP O
affected VBN I-NP O
individuals NNS I-NP O
in IN B-PP O
six CD B-NP O
WFS NN I-NP B-Disease
families NNS I-NP O
, , O O
and CC O O
these DT B-NP O
mutations NNS I-NP O
were VBD B-VP O
associated VBN I-VP O
with IN B-PP O
the DT B-NP O
disease NN I-NP O
phenotype NN I-NP O
. . O O

WFS1 NN B-NP O
appears VBZ B-VP O
to TO I-VP O
function VB I-VP O
in IN B-PP O
survival NN B-NP O
of IN B-PP O
islet NN B-NP O
beta SYM B-NP O
- HYPH B-NP O
cells NNS I-NP O
and CC I-NP O
neurons NNS I-NP O
. . O O

. . O O

Stable JJ B-NP O
interaction NN I-NP O
between IN B-PP O
the DT B-NP O
products NNS I-NP O
of IN B-PP O
the DT B-NP O
BRCA1 NN I-NP O
and CC I-NP O
BRCA2 NN I-NP O
tumor NN I-NP B-Disease
suppressor NN I-NP O
genes NNS I-NP O
in IN B-PP O
mitotic JJ B-NP O
and CC I-NP O
meiotic JJ I-NP O
cells NNS I-NP O
. . O O

BRCA1 NN B-NP O
and CC I-NP O
BRCA2 NN I-NP O
account VBP B-VP O
for IN B-PP O
most JJS B-NP O
cases NNS I-NP O
of IN B-PP O
familial JJ B-NP O
, , I-NP O
early JJ I-NP O
onset NN I-NP O
breast NN I-NP B-Disease
and CC O I-Disease
/ SYM B-NP I-Disease
or CC O I-Disease
ovarian JJ B-NP I-Disease
cancer NN I-NP I-Disease
and CC O O
encode VBP B-VP O
products NNS B-NP O
that IN B-SBAR O
each DT B-NP O
interact NN I-NP O
with IN B-PP O
hRAD51 NN B-NP O
. . O O

Results NNS B-NP O
presented VBN B-VP O
here RB B-ADVP O
show VBP B-VP O
that IN B-SBAR O
BRCA1 NN B-NP O
and CC I-NP O
BRCA2 NN I-NP O
coexist NN I-NP O
in IN B-PP O
a DT B-NP O
biochemical JJ I-NP O
complex NN I-NP O
and CC I-NP O
colocalize NN I-NP O
in IN B-PP O
subnuclear JJ B-NP O
foci NNS I-NP O
in IN B-PP O
somatic JJ B-NP O
cells NNS I-NP O
and CC B-PP O
on IN B-PP O
the DT B-NP O
axial JJ I-NP O
elements NNS I-NP O
of IN B-PP O
developing VBG B-VP O
synaptonemal JJ B-NP O
complexes NNS I-NP O
. . O O

Like IN B-PP O
BRCA1 NN B-NP O
and CC I-NP O
RAD51 NN I-NP O
, , O O
BRCA2 NN B-NP O
relocates VBZ B-VP O
to TO B-PP O
PCNA NN B-NP O
+ SYM O O
replication NN B-NP O
sites NNS I-NP O
following VBG B-PP O
exposure NN B-NP O
of IN B-PP O
S NN B-NP O
phase NN I-NP O
cells NNS I-NP O
to TO B-PP O
hydroxyurea NN B-NP O
or CC I-NP O
UV NN I-NP O
irradiation NN I-NP O
. . O O

Thus RB B-ADVP O
, , O O
BRCA1 NN B-NP O
and CC I-NP O
BRCA2 NN I-NP O
participate VBP B-VP O
, , O O
together RB B-ADVP O
, , O O
in IN B-PP O
a DT B-NP O
pathway NN I-NP O
( ( I-NP O
s NNS I-NP O
) ) O O
associated VBN B-VP O
with IN B-PP O
the DT B-NP O
activation NN I-NP O
of IN B-PP O
double JJ B-NP O
- HYPH I-NP O
strand NN I-NP O
break NN I-NP O
repair NN I-NP O
and CC O O
/ SYM B-NP O
or CC O O
homologous JJ B-NP O
recombination NN I-NP O
. . O O

Dysfunction NN B-NP O
of IN B-PP O
this DT B-NP O
pathway NN I-NP O
may MD B-VP O
be VB I-VP O
a DT B-NP O
general JJ I-NP O
phenomenon NN I-NP O
in IN B-PP O
the DT B-NP O
majority NN I-NP O
of IN B-PP O
cases NNS B-NP O
of IN B-PP O
hereditary JJ B-NP B-Disease
breast NN I-NP I-Disease
and CC O I-Disease
/ SYM B-NP I-Disease
or CC O I-Disease
ovarian JJ B-NP I-Disease
cancer NN I-NP I-Disease
. . O O

. . O O

A DT B-NP O
novel JJ I-NP O
Arg362Ser NN I-NP O
mutation NN I-NP O
in IN B-PP O
the DT B-NP O
sterol NN I-NP O
27 CD I-NP O
- HYPH I-NP O
hydroxylase NN I-NP O
gene NN I-NP O
( ( O O
CYP27 NN B-NP O
) ) O O
: : O O
its PRP$ B-NP O
effects NNS I-NP O
on IN B-PP O
pre AFX B-NP O
- HYPH I-NP O
mRNA NN I-NP O
splicing NN I-NP O
and CC O O
enzyme NN B-NP O
activity NN I-NP O
. . O O

A DT B-NP O
novel JJ I-NP O
C NN I-NP O
to TO B-PP O
A NN B-NP O
mutation NN I-NP O
in IN B-PP O
the DT B-NP O
sterol NN I-NP O
27 CD I-NP O
- HYPH I-NP O
hydroxylase NN I-NP O
gene NN I-NP O
( ( O O
CYP27 NN B-NP O
) ) O O
was VBD B-VP O
identified VBN I-VP O
by IN B-PP O
sequencing VBG B-VP O
amplified VBN B-NP O
CYP27 NN I-NP O
gene NN I-NP O
products NNS I-NP O
from IN B-PP O
a DT B-NP O
patient NN I-NP O
with IN B-PP O
cerebrotendinous JJ B-NP B-Disease
xanthomatosis NN I-NP I-Disease
( ( O O
CTX NN B-NP B-Disease
) ) O O
. . O O

The DT B-NP O
mutation NN I-NP O
changed VBD B-VP O
the DT B-NP O
adrenodoxin NN I-NP O
cofactor NN I-NP O
binding NN I-NP O
residue NN I-NP O
362Arg NN I-NP O
to TO B-PP O
362Ser NN B-NP O
( ( O O
CGT NN B-NP O
362Arg NN I-NP O
to TO B-PP O
AGT NN B-NP O
362Ser NN I-NP O
) ) O O
, , O O
and CC O O
was VBD B-VP O
responsible JJ B-ADJP O
for IN B-PP O
deficiency NN B-NP O
in IN B-PP O
the DT B-NP O
sterol NN I-NP O
27 CD I-NP O
- HYPH I-NP O
hydroxylase NN I-NP O
activity NN I-NP O
, , O O
as IN B-SBAR O
confirmed VBN B-VP O
by IN B-PP O
expression NN B-NP O
of IN B-PP O
mutant JJ B-NP O
cDNA NN I-NP O
into IN B-PP O
COS NN B-NP O
- HYPH B-NP O
1 CD I-NP O
cells NNS I-NP O
. . O O

Quantitative JJ B-NP O
analysis NN I-NP O
showed VBD B-VP O
that IN B-SBAR O
the DT B-NP O
expression NN I-NP O
of IN B-PP O
CYP27 NN B-NP O
gene NN I-NP O
mRNA NN I-NP O
in IN B-PP O
the DT B-NP O
patient NN I-NP O
represented VBD B-VP O
52 CD B-NP O
. . O O

5 CD B-NP O
% NN I-NP O
of IN B-PP O
the DT B-NP O
normal JJ I-NP O
level NN I-NP O
. . O O

As IN B-SBAR O
the DT B-NP O
mutation NN I-NP O
occurred VBD B-VP O
at IN B-PP O
the DT B-NP O
penultimate JJ I-NP O
nucleotide NN I-NP O
of IN B-PP O
exon NN B-NP O
6 CD I-NP O
( ( O O
- SYM O O
2 CD B-NP O
position NN I-NP O
of IN B-PP O
exon NN B-NP O
6 CD I-NP O
- HYPH I-NP O
intron NN I-NP O
6 CD I-NP O
splice NN I-NP O
site NN I-NP O
) ) O O
of IN B-PP O
the DT B-NP O
gene NN I-NP O
, , O O
we PRP B-NP O
hypothesized VBD B-VP O
that IN B-SBAR O
the DT B-NP O
mutation NN I-NP O
may MD B-VP O
partially RB I-VP O
affect VB I-VP O
the DT B-NP O
normal JJ I-NP O
splicing NN I-NP O
efficiency NN I-NP O
in IN B-PP O
exon NN B-NP O
6 CD I-NP O
and CC O O
cause VB B-VP O
alternative JJ B-NP O
splicing NN I-NP O
elsewhere RB B-ADVP O
, , O O
which WDT B-NP O
resulted VBD B-VP O
in IN B-PP O
decreased VBN B-NP O
transcript NN I-NP O
in IN B-PP O
the DT B-NP O
patient NN I-NP O
. . O O

Transfection NN B-NP O
of IN B-PP O
constructed VBN B-NP O
minigenes NNS I-NP O
, , O O
with IN B-PP O
or CC B-PP O
without IN B-PP O
the DT B-NP O
mutation NN I-NP O
, , O O
into IN B-PP O
COS NN B-NP O
- HYPH B-NP O
1 CD I-NP O
cells NNS I-NP O
confirmed VBD B-VP O
that IN B-SBAR O
the DT B-NP O
mutant JJ I-NP O
minigene NN I-NP O
was VBD B-VP O
responsible JJ B-ADJP O
for IN B-PP O
a DT B-NP O
mRNA NN I-NP O
species NNS I-NP O
alternatively RB B-VP O
spliced VBN I-VP O
at IN B-PP O
an DT B-NP O
activated VBN I-NP O
cryptic JJ I-NP O
5 CD I-NP O
splice NN I-NP O
site NN I-NP O
88 CD I-NP O
bp NN I-NP O
upstream RB B-ADVP O
from IN B-PP O
the DT B-NP O
3 CD I-NP O
end NN I-NP O
of IN B-PP O
exon NN B-NP O
6 CD I-NP O
. . O O

Our PRP$ B-NP O
data NNS I-NP O
suggest VBP B-VP O
that IN B-SBAR O
the DT B-NP O
C NN I-NP O
to TO B-PP O
A NN B-NP O
mutation NN I-NP O
at IN B-PP O
the DT B-NP O
penultimate JJ I-NP O
nucleotide NN I-NP O
of IN B-PP O
exon NN B-NP O
6 CD I-NP O
of IN B-PP O
the DT B-NP O
CYP27 NN I-NP O
gene NN I-NP O
not RB B-CONJP O
only RB I-CONJP O
causes VBZ B-VP O
the DT B-NP O
deficiency NN I-NP B-Disease
in IN B-PP I-Disease
the DT B-NP I-Disease
sterol NN I-NP I-Disease
27 CD I-NP I-Disease
- HYPH I-NP I-Disease
hydroxylase NN I-NP I-Disease
activity NN I-NP I-Disease
, , O O
but CC O O
also RB B-ADVP O
partially RB B-ADVP O
leads VBZ B-VP O
to TO B-PP O
alternative JJ B-NP O
pre AFX I-NP O
- HYPH I-NP O
mRNA NN I-NP O
splicing NN I-NP O
of IN B-PP O
the DT B-NP O
gene NN I-NP O
. . O O

To TO B-PP O
our PRP$ B-NP O
knowledge NN I-NP O
, , O O
this DT B-NP O
is VBZ B-VP O
the DT B-NP O
first JJ I-NP O
report NN I-NP O
regarding VBG B-PP O
effects NNS B-NP O
on IN B-PP O
pre AFX B-NP O
- HYPH I-NP O
mRNA NN I-NP O
splicing NN I-NP O
of IN B-PP O
a DT B-NP O
mutation NN I-NP O
at IN B-PP O
the DT B-NP O
- SYM I-NP O
2 CD I-NP O
position NN I-NP O
of IN B-PP O
a DT B-NP O
5 CD I-NP O
splice NN I-NP O
site NN I-NP O
. . O O

ATM NN B-NP O
germline NN I-NP O
mutations NNS I-NP O
in IN B-PP O
classical JJ B-NP O
ataxia NN I-NP B-Disease
- HYPH B-NP I-Disease
telangiectasia NN I-NP I-Disease
patients NNS I-NP O
in IN B-PP O
the DT B-NP O
Dutch JJ I-NP O
population NN I-NP O
. . O O

Germline NN B-NP O
mutations NNS I-NP O
in IN B-PP O
the DT B-NP O
ATM NN I-NP O
gene NN I-NP O
are VBP B-VP O
responsible JJ B-ADJP O
for IN B-PP O
the DT B-NP O
autosomal JJ I-NP B-Disease
recessive JJ I-NP I-Disease
disorder NN I-NP I-Disease
ataxia NN I-NP B-Disease
- HYPH B-NP I-Disease
telangiectasia NN I-NP I-Disease
( ( O O
A NN B-NP B-Disease
- HYPH O I-Disease
T NN B-NP I-Disease
) ) O O
. . O O

In IN B-PP O
our PRP$ B-NP O
study NN I-NP O
, , O O
we PRP B-NP O
have VBP B-VP O
determined VBN I-VP O
the DT B-NP O
ATM NN I-NP O
mutation NN I-NP O
spectrum NN I-NP O
in IN B-PP O
19 CD B-NP O
classical JJ I-NP O
A NN I-NP B-Disease
- HYPH I-NP I-Disease
T NN I-NP I-Disease
patients NNS I-NP O
, , O O
including VBG B-PP O
some DT B-NP O
immigrant JJ I-NP O
populations NNS I-NP O
, , O O
as RB B-CONJP O
well RB I-CONJP O
as IN I-CONJP O
12 CD B-NP O
of IN B-PP O
Dutch JJ B-NP O
ethnic JJ I-NP O
origin NN I-NP O
. . O O

Both CC O O
the DT B-NP O
protein NN I-NP O
truncation NN I-NP O
test NN I-NP O
( ( O O
PTT NN B-NP O
) ) O O
and CC O O
the DT B-NP O
restriction NN I-NP O
endonuclease NN I-NP O
fingerprinting NN I-NP O
( ( O O
REF NN B-NP O
) ) O O
method NN B-NP O
were VBD B-VP O
used VBN I-VP O
and CC O O
compared VBN B-VP O
for IN B-PP O
their PRP$ B-NP O
detection NN I-NP O
efficiency NN I-NP O
, , O O
identifying VBG B-VP O
76 CD B-NP O
% NN I-NP O
and CC O O
60 CD B-NP O
% NN I-NP O
of IN B-PP O
the DT B-NP O
mutations NNS I-NP O
, , O O
respectively RB B-ADVP O
. . O O

Most JJS B-NP O
patients NNS I-NP O
were VBD B-VP O
found VBN I-VP O
to TO I-VP O
be VB I-VP O
compound JJ B-NP O
heterozygote NN I-NP O
. . O O

Seventeen CD B-NP O
mutations NNS I-NP O
were VBD B-VP O
distinct JJ B-ADJP O
, , O O
of IN B-PP O
which WDT B-NP O
10 CD B-NP O
were VBD B-VP O
not RB I-VP O
reported VBN I-VP O
previously RB B-ADVP O
. . O O

Mutations NNS B-NP O
are VBP B-VP O
small JJ B-NP O
deletions NNS I-NP O
or CC O O
point NN B-NP O
mutations NNS I-NP O
frequently RB B-VP O
affecting VBG I-VP O
splice NN B-NP O
sites NNS I-NP O
. . O O

Moreover RB B-ADVP O
, , O O
a DT B-NP O
16 CD I-NP O
. . O O

7 CD B-NP O
- HYPH I-NP O
kb NN I-NP O
genomic JJ I-NP O
deletion NN I-NP O
of IN B-PP O
the DT B-NP O
3 CD I-NP O
end NN I-NP O
of IN B-PP O
the DT B-NP O
gene NN I-NP O
, , O O
most RBS B-ADVP O
likely RB I-ADVP O
a DT B-NP O
result NN I-NP O
of IN B-PP O
recombination NN B-NP O
between IN B-PP O
two CD B-NP O
LINE NNP I-NP O
elements NNS I-NP O
, , O O
was VBD B-VP O
identified VBN I-VP O
. . O O

The DT B-NP O
most RBS I-NP O
frequently RB I-NP O
found VBN I-NP O
mutation NN I-NP O
, , O O
identified VBN B-VP O
in IN B-PP O
three CD B-NP O
unrelated JJ I-NP O
Turkish JJ I-NP O
A NN I-NP B-Disease
- HYPH I-NP I-Disease
T NN I-NP I-Disease
individuals NNS I-NP O
, , O O
was VBD B-VP O
previously RB I-VP O
described VBN I-VP O
to TO I-VP O
be VB I-VP O
a DT B-NP O
Turkish JJ I-NP O
A NN I-NP B-Disease
- HYPH I-NP I-Disease
T NN I-NP I-Disease
founder NN I-NP O
mutation NN I-NP O
. . O O

The DT B-NP O
presence NN I-NP O
of IN B-PP O
a DT B-NP O
founder NN I-NP O
mutation NN I-NP O
among IN B-PP O
relatively RB B-NP O
small JJ I-NP O
ethnic JJ I-NP O
population NN I-NP O
groups NNS I-NP O
in IN B-PP O
Western NNP B-NP O
Europe NNP I-NP O
could MD B-VP O
indicate VB I-VP O
a DT B-NP O
high JJ I-NP O
carrier NN I-NP O
frequency NN I-NP O
in IN B-PP O
such JJ B-NP O
communities NNS I-NP O
. . O O

In IN B-PP O
patients NNS B-NP O
of IN B-PP O
Dutch JJ B-NP O
ethnic JJ I-NP O
origin NN I-NP O
, , O O
however RB B-ADVP O
, , O O
no DT B-NP O
significant JJ I-NP O
founder NN I-NP O
effect NN I-NP O
could MD B-VP O
be VB I-VP O
identified VBN I-VP O
. . O O

The DT B-NP O
observed VBN I-NP O
genetic JJ I-NP O
heterogeneity NN I-NP O
including VBG B-PP O
the DT B-NP O
relative JJ I-NP O
high JJ I-NP O
percentage NN I-NP O
of IN B-PP O
splice NN B-NP O
- HYPH B-NP O
site NN I-NP O
mutations NNS I-NP O
had VBD B-VP O
no DT B-NP O
reflection NN I-NP O
on IN B-PP O
the DT B-NP O
phenotype NN I-NP O
. . O O

All DT B-NP O
patients NNS I-NP O
manifested VBD B-VP O
classical JJ B-NP O
A NN I-NP B-Disease
- HYPH I-NP I-Disease
T NN I-NP I-Disease
and CC O O
increased VBD B-VP O
cellular JJ B-NP O
radioresistant JJ I-NP O
DNA NN I-NP O
synthesis NN I-NP O
. . O O

Determination NN B-NP O
of IN B-PP O
the DT B-NP O
genomic JJ I-NP O
structure NN I-NP O
of IN B-PP O
the DT B-NP O
COL4A4 NN I-NP O
gene NN I-NP O
and CC B-PP O
of IN B-PP O
novel JJ B-NP O
mutations NNS I-NP O
causing VBG B-VP O
autosomal JJ B-NP B-Disease
recessive JJ I-NP I-Disease
Alport NN I-NP I-Disease
syndrome NN I-NP I-Disease
. . O O

Autosomal JJ B-NP B-Disease
recessive JJ I-NP I-Disease
Alport NNP I-NP I-Disease
syndrome NN I-NP I-Disease
is VBZ B-VP O
a DT B-NP O
progressive JJ I-NP O
hematuric JJ I-NP B-Disease
glomerulonephritis NN I-NP I-Disease
characterized VBN B-VP O
by IN B-PP O
glomerular JJ B-NP B-Disease
basement NN I-NP I-Disease
membrane NN I-NP I-Disease
abnormalities NNS I-NP I-Disease
and CC O O
associated VBN B-VP O
with IN B-PP O
mutations NNS B-NP O
in IN B-PP O
either CC O O
the DT B-NP O
COL4A3 NN I-NP O
or CC O O
the DT B-NP O
COL4A4 NN I-NP O
gene NN I-NP O
, , O O
which WDT B-NP O
encode VBP B-VP O
the DT B-NP O
alpha3 NN I-NP O
and CC I-NP O
alpha4 NN I-NP O
type NN I-NP O
IV CD I-NP O
collagen NN I-NP O
chains NNS I-NP O
, , O O
respectively RB B-ADVP O
. . O O

To TO B-PP O
date NN B-NP O
, , O O
mutation NN B-NP O
screening NN I-NP O
in IN B-PP O
the DT B-NP O
two CD I-NP O
genes NNS I-NP O
has VBZ B-VP O
been VBN I-VP O
hampered VBN I-VP O
by IN B-PP O
the DT B-NP O
lack NN I-NP O
of IN B-PP O
genomic JJ B-NP O
structure NN I-NP O
information NN I-NP O
. . O O

We PRP B-NP O
report VBP B-VP O
here RB B-ADVP O
the DT B-NP O
complete JJ I-NP O
characterization NN I-NP O
of IN B-PP O
the DT B-NP O
48 CD I-NP O
exons NNS I-NP O
of IN B-PP O
the DT B-NP O
COL4A4 NN I-NP O
gene NN I-NP O
, , O O
a DT B-NP O
comprehensive JJ I-NP O
gene NN I-NP O
screen NN I-NP O
, , O O
and CC O O
the DT B-NP O
subsequent JJ I-NP O
detection NN I-NP O
of IN B-PP O
10 CD B-NP O
novel JJ I-NP O
mutations NNS I-NP O
in IN B-PP O
eight CD B-NP O
patients NNS I-NP O
diagnosed VBN B-VP O
with IN B-PP O
autosomal JJ B-NP B-Disease
recessive JJ I-NP I-Disease
Alport NN I-NP I-Disease
syndrome NN I-NP I-Disease
. . O O

Furthermore RB B-ADVP O
, , O O
we PRP B-NP O
identified VBD B-VP O
a DT B-NP O
glycine NN I-NP O
to TO B-PP O
alanine NN B-NP O
substitution NN I-NP O
in IN B-PP O
the DT B-NP O
collagenous JJ I-NP O
domain NN I-NP O
that WDT B-NP O
is VBZ B-VP O
apparently RB B-ADJP O
silent JJ I-ADJP O
in IN B-PP O
the DT B-NP O
heterozygous JJ I-NP O
carriers NNS I-NP O
, , O O
in IN B-PP O
11 CD B-NP O
. . O O

5 CD B-NP O
% NN I-NP O
of IN B-PP O
all DT B-NP O
control NN I-NP O
individuals NNS I-NP O
, , O O
and CC O O
in IN B-PP O
one CD B-NP O
control NN I-NP O
individual JJ B-VP O
homozygous JJ B-ADJP O
for IN B-PP O
this DT B-NP O
glycine NN I-NP O
substitution NN I-NP O
. . O O

There EX B-NP O
has VBZ B-VP O
been VBN I-VP O
no DT B-NP O
previous JJ I-NP O
finding NN I-NP O
of IN B-PP O
a DT B-NP O
glycine NN I-NP O
substitution NN I-NP O
that WDT B-NP O
is VBZ B-VP O
not RB I-VP O
associated VBN I-VP O
with IN B-PP O
any DT B-NP O
obvious JJ I-NP O
phenotype NN I-NP O
in IN B-PP O
homozygous JJ B-NP O
individuals NNS I-NP O
. . O O

Founder NN B-NP O
BRCA1 NN I-NP O
and CC I-NP O
BRCA2 NN I-NP O
mutations NNS I-NP O
in IN B-PP O
French JJ B-NP O
Canadian JJ I-NP O
breast NN I-NP B-Disease
and CC O I-Disease
ovarian JJ B-NP I-Disease
cancer NN I-NP I-Disease
families NNS I-NP O
. . O O

We PRP B-NP O
have VBP B-VP O
identified VBN I-VP O
four CD B-NP O
mutations NNS I-NP O
in IN B-PP O
each DT B-NP O
of IN B-PP O
the DT B-NP O
breast NN I-NP B-Disease
cancer NN I-NP I-Disease
- HYPH B-NP O
susceptibility NN I-NP O
genes NNS I-NP O
, , O O
BRCA1 NN B-NP O
and CC O O
BRCA2 NN B-NP O
, , O O
in IN B-PP O
French JJ B-NP O
Canadian JJ I-NP O
breast NN I-NP B-Disease
cancer NN I-NP I-Disease
and CC I-NP O
breast NN I-NP B-Disease
/ SYM B-NP I-Disease
ovarian JJ B-NP I-Disease
cancer NN I-NP I-Disease
families NNS I-NP O
from IN B-PP O
Quebec NNP B-NP O
. . O O

To TO B-VP O
identify VB I-VP O
founder NN B-NP O
effects NNS I-NP O
, , O O
we PRP B-NP O
examined VBD B-VP O
independently RB I-VP O
ascertained VBN I-VP O
French JJ B-NP O
Canadian JJ I-NP O
cancer NN I-NP B-Disease
families NNS I-NP O
for IN B-PP O
the DT B-NP O
distribution NN I-NP O
of IN B-PP O
these DT B-NP O
eight CD I-NP O
mutations NNS I-NP O
. . O O

Mutations NNS B-NP O
were VBD B-VP O
found VBN I-VP O
in IN B-PP O
41 CD B-NP O
of IN B-PP O
97 CD B-NP O
families NNS I-NP O
. . O O

Six CD B-NP O
of IN B-PP O
eight CD B-NP O
mutations NNS I-NP O
were VBD B-VP O
observed VBN I-VP O
at IN B-ADVP O
least JJS I-ADVP O
twice RB B-ADVP O
. . O O

The DT B-NP O
BRCA1 NN I-NP O
C4446T NN I-NP O
mutation NN I-NP O
was VBD B-VP O
the DT B-NP O
most RBS I-NP O
common JJ I-NP O
mutation NN I-NP O
found VBN B-VP O
, , O O
followed VBN B-VP O
by IN B-PP O
the DT B-NP O
BRCA2 NN I-NP O
8765delAG NN I-NP O
mutation NN I-NP O
. . O O

Together RB B-ADVP O
, , O O
these DT B-NP O
mutations NNS I-NP O
were VBD B-VP O
found VBN I-VP O
in IN B-PP O
28 CD B-NP O
of IN B-PP O
41 CD B-NP O
families NNS I-NP O
identified VBN B-VP O
to TO I-VP O
have VB I-VP O
a DT B-NP O
mutation NN I-NP O
. . O O

The DT B-NP O
odds NNS I-NP O
of IN B-PP O
detection NN B-NP O
of IN B-PP O
any DT B-NP O
of IN B-PP O
the DT B-NP O
four CD I-NP O
BRCA1 NN I-NP O
mutations NNS I-NP O
was VBD B-VP O
18 CD B-NP O
. . O O

7x LS B-LST O
greater JJR B-NP O
if IN I-NP O
one CD I-NP O
or CC I-NP O
more JJR I-NP O
cases NNS I-NP O
of IN B-PP O
ovarian JJ B-NP B-Disease
cancer NN I-NP I-Disease
were VBD B-VP O
also RB B-ADVP O
present JJ B-ADJP O
in IN B-PP O
the DT B-NP O
family NN I-NP O
. . O O

The DT B-NP O
odds NNS I-NP O
of IN B-PP O
detection NN B-NP O
of IN B-PP O
any DT B-NP O
of IN B-PP O
the DT B-NP O
four CD I-NP O
BRCA2 NN I-NP O
mutations NNS I-NP O
was VBD B-VP O
5 CD B-NP O
. . O O

3x LS B-LST O
greater JJR B-ADVP O
if IN B-SBAR O
there EX B-NP O
were VBD B-VP O
at IN B-NP O
least JJS I-NP O
five CD I-NP O
cases NNS I-NP O
of IN B-PP O
breast NN B-NP B-Disease
cancer NN I-NP I-Disease
in IN B-PP O
the DT B-NP O
family NN I-NP O
. . O O

Interestingly RB B-ADVP O
, , O O
the DT B-NP O
presence NN I-NP O
of IN B-PP O
a DT B-NP O
breast NN I-NP B-Disease
cancer NN I-NP I-Disease
case NN I-NP O
< SYM O O
36 CD B-NP O
years NNS I-NP O
of IN B-PP O
age NN B-NP O
was VBD B-VP O
strongly RB B-ADJP O
predictive JJ I-ADJP O
of IN B-PP O
the DT B-NP O
presence NN I-NP O
of IN B-PP O
any DT B-NP O
of IN B-PP O
the DT B-NP O
eight CD I-NP O
mutations NNS I-NP O
screened VBN B-VP O
. . O O

Carriers NNS B-NP O
of IN B-PP O
the DT B-NP O
same JJ I-NP O
mutation NN I-NP O
, , O O
from IN B-PP O
different JJ B-NP O
families NNS I-NP O
, , O O
shared VBD B-VP O
similar JJ B-NP O
haplotypes NNS I-NP O
, , O O
indicating VBG B-VP O
that IN B-SBAR O
the DT B-NP O
mutant JJ I-NP O
alleles NNS I-NP O
were VBD B-VP O
likely JJ B-ADJP O
to TO B-VP O
be VB I-VP O
identical JJ B-ADJP O
by IN B-PP O
descent NN B-NP O
for IN B-PP O
a DT B-NP O
mutation NN I-NP O
in IN B-PP O
the DT B-NP O
founder NN I-NP O
population NN I-NP O
. . O O

The DT B-NP O
identification NN I-NP O
of IN B-PP O
common JJ B-NP O
BRCA1 NN I-NP O
and CC I-NP O
BRCA2 NN I-NP O
mutations NNS I-NP O
will MD B-VP O
facilitate VB I-VP O
carrier NN B-NP O
detection NN I-NP O
in IN B-PP O
French JJ B-NP O
Canadian JJ I-NP O
breast NN I-NP B-Disease
cancer NN I-NP I-Disease
and CC I-NP O
breast NN I-NP B-Disease
/ SYM B-NP I-Disease
ovarian JJ B-NP I-Disease
cancer NN I-NP I-Disease
families NNS I-NP O
. . O O

Are VBP O O
Dp71 NN B-NP O
and CC I-NP O
Dp140 NN I-NP O
brain NN I-NP O
dystrophin NN I-NP O
isoforms NNS I-NP O
related VBN B-VP O
to TO B-PP O
cognitive JJ B-NP B-Disease
impairment NN I-NP I-Disease
in IN B-PP O
Duchenne NNP B-NP B-Disease
muscular JJ I-NP I-Disease
dystrophy NN I-NP I-Disease
? . O O

Molecular JJ B-NP O
study NN I-NP O
and CC O O
neuropsychological JJ B-NP O
analysis NN I-NP O
were VBD B-VP O
performed VBN I-VP O
concurrently RB B-ADVP O
on IN B-PP O
49 CD B-NP O
patients NNS I-NP O
with IN B-PP O
Duchenne JJ B-NP B-Disease
muscular JJ I-NP I-Disease
dystrophy NN I-NP I-Disease
( ( O O
DMD NN B-NP B-Disease
) ) O O
in IN B-SBAR O
order NN O O
to TO B-VP O
find VB I-VP O
a DT B-NP O
molecular JJ I-NP O
explanation NN I-NP O
for IN B-PP O
the DT B-NP O
cognitive JJ I-NP B-Disease
impairment NN I-NP I-Disease
observed VBN B-VP O
in IN B-PP O
most JJS B-NP O
DMD NN I-NP B-Disease
patients NNS I-NP O
. . O O

Complete JJ B-NP O
analysis NN I-NP O
of IN B-PP O
the DT B-NP O
dystrophin NN I-NP O
gene NN I-NP O
was VBD B-VP O
performed VBN I-VP O
to TO I-VP O
define VB I-VP O
the DT B-NP O
localization NN I-NP O
of IN B-PP O
deletions NNS B-NP O
and CC I-NP O
duplications NNS I-NP O
in IN B-PP O
relation NN B-NP O
to TO B-PP O
the DT B-NP O
different JJ I-NP O
DMD NN I-NP B-Disease
promoters NNS I-NP O
. . O O

Qualitative JJ B-NP O
analysis NN I-NP O
of IN B-PP O
the DT B-NP O
Dp71 NN I-NP O
transcript NN I-NP O
and CC I-NP O
testing NN I-NP O
for IN B-PP O
the DT B-NP O
specific JJ I-NP O
first JJ I-NP O
exon NN I-NP O
of IN B-PP O
Dp140 NN B-NP O
were VBD B-VP O
also RB I-VP O
carried VBN I-VP O
out RP B-PRT O
. . O O

Neuropsychological JJ B-NP O
analysis NN I-NP O
assessed VBD B-VP O
verbal JJ B-NP O
and CC I-NP O
visuospatial JJ I-NP O
intelligence NN I-NP O
, , O O
verbal JJ B-NP O
memory NN I-NP O
, , O O
and CC O O
reading VBG B-VP O
skills NNS B-NP O
. . O O

Comparison NN B-NP O
of IN B-PP O
molecular JJ B-NP O
and CC I-NP O
psychometric JJ I-NP O
findings NNS I-NP O
demonstrated VBD B-VP O
that IN B-SBAR O
deletions NNS B-NP O
and CC I-NP O
duplications NNS I-NP O
that WDT B-NP O
were VBD B-VP O
localized JJ I-VP O
in IN B-PP O
the DT B-NP O
distal JJ I-NP O
part NN I-NP O
of IN B-PP O
the DT B-NP O
gene NN I-NP O
seemed VBD B-VP O
to TO I-VP O
be VB I-VP O
preferentially RB I-VP O
associated VBN I-VP O
with IN B-PP O
cognitive JJ B-NP B-Disease
impairment NN I-NP I-Disease
. . O O

Two CD B-NP O
altered JJ I-NP O
Dp71 NN I-NP O
transcripts NNS I-NP O
and CC O O
two CD B-NP O
deleted JJ I-NP O
Dp140 NN I-NP O
DNA NN I-NP O
sequences NNS I-NP O
were VBD B-VP O
found VBN I-VP O
in IN B-PP O
four CD B-NP O
patients NNS I-NP O
with IN B-PP O
severe JJ B-NP O
cerebral JJ I-NP B-Disease
dysfunction NN I-NP I-Disease
. . O O

These DT B-NP O
findings NNS I-NP O
suggest VBP B-VP O
that IN B-SBAR O
some DT B-NP O
sequences NNS I-NP O
located VBN B-VP O
in IN B-PP O
the DT B-NP O
distal JJ I-NP O
part NN I-NP O
of IN B-PP O
the DT B-NP O
gene NN I-NP O
and CC O O
, , O O
in IN B-PP O
particular JJ B-ADJP O
, , O O
some DT B-NP O
DMD NN I-NP B-Disease
isoforms NNS I-NP O
expressed VBN B-VP O
in IN B-PP O
the DT B-NP O
brain NN I-NP O
may MD B-VP O
be VB I-VP O
related JJ B-ADJP O
to TO B-PP O
the DT B-NP O
cognitive JJ I-NP B-Disease
impairment NN I-NP I-Disease
associated VBN B-VP O
with IN B-PP O
DMD NN B-NP B-Disease
. . O O

. . O O

I1307K NN B-NP O
APC NN I-NP O
and CC I-NP O
hMLH1 NN I-NP O
mutations NNS I-NP O
in IN B-PP O
a DT B-NP O
non AFX I-NP O
- HYPH I-NP O
Jewish JJ I-NP O
family NN I-NP O
with IN B-PP O
hereditary JJ B-NP B-Disease
non AFX I-NP I-Disease
- HYPH I-NP I-Disease
polyposis NN I-NP I-Disease
colorectal JJ I-NP I-Disease
cancer NN I-NP I-Disease
. . O O

We PRP B-NP O
describe VBP B-VP O
a DT B-NP O
French JJ I-NP O
Canadian JJ I-NP O
hereditary JJ I-NP B-Disease
non AFX I-NP I-Disease
- HYPH I-NP I-Disease
polyposis NN I-NP I-Disease
colorectal JJ I-NP I-Disease
cancer NN I-NP I-Disease
( ( O O
HNPCC NN B-NP B-Disease
) ) O O
kindred NN B-NP O
which WDT B-NP O
carries VBZ B-VP O
a DT B-NP O
novel JJ I-NP O
truncating VBG I-NP O
mutation NN I-NP O
in IN B-PP O
hMLH1 NN B-NP O
. . O O

Interestingly RB B-ADVP O
, , O O
the DT B-NP O
I1307K NN I-NP O
APC NN I-NP O
polymorphism NN I-NP O
, , O O
associated VBN B-VP O
with IN B-PP O
an DT B-NP O
increased VBN I-NP O
risk NN I-NP O
of IN B-PP O
colorectal JJ B-NP B-Disease
cancer NN I-NP I-Disease
, , O O
is VBZ B-VP O
also RB B-ADVP O
present JJ B-ADJP O
in IN B-PP O
this DT B-NP O
family NN I-NP O
. . O O

The DT B-NP O
I1307K NN I-NP O
polymorphism NN I-NP O
has VBZ B-VP O
previously RB I-VP O
only RB I-VP O
been VBN I-VP O
identified VBN I-VP O
in IN B-PP O
individuals NNS B-NP O
of IN B-PP O
self NN B-NP O
- HYPH B-NP O
reported VBN I-NP O
Ashkenazi NN I-NP O
Jewish JJ I-NP O
origins NNS I-NP O
. . O O

In IN B-PP O
addition NN B-NP O
, , O O
in IN B-PP O
this DT B-NP O
family NN I-NP O
, , O O
there EX B-NP O
appears VBZ B-VP O
to TO I-VP O
be VB I-VP O
no DT B-NP O
relationship NN I-NP O
between IN B-PP O
the DT B-NP O
I1307K NN I-NP O
polymorphism NN I-NP O
and CC O O
the DT B-NP O
presence NN I-NP O
or CC I-NP O
absence NN I-NP O
of IN B-PP O
cancer NN B-NP B-Disease
. . O O

. . O O

Identification NN B-NP O
of IN B-PP O
a DT B-NP O
novel JJ I-NP O
mutation NN I-NP O
of IN B-PP O
the DT B-NP O
CPO NN I-NP O
gene NN I-NP O
in IN B-PP O
a DT B-NP O
Japanese JJ I-NP O
hereditary JJ I-NP B-Disease
coproporphyria NN I-NP I-Disease
family NN I-NP O
. . O O

Hereditary JJ B-NP B-Disease
coproporphyria NN I-NP I-Disease
( ( O O
HCP NN B-NP B-Disease
) ) O O
is VBZ B-VP O
an DT B-NP O
autosomal JJ I-NP B-Disease
dominant JJ I-NP I-Disease
disease NN I-NP I-Disease
characterized VBN B-VP O
by IN B-PP O
a DT B-NP O
deficiency NN I-NP B-Disease
of IN B-PP I-Disease
coproporphyrinogen NN B-NP I-Disease
oxidase NN I-NP I-Disease
( ( O O
CPO NN B-NP O
) ) O O
caused VBN B-VP O
by IN B-PP O
a DT B-NP O
mutation NN I-NP O
in IN B-PP O
the DT B-NP O
CPO NN I-NP O
gene NN I-NP O
. . O O

Only RB B-NP O
11 CD I-NP O
mutations NNS I-NP O
of IN B-PP O
the DT B-NP O
gene NN I-NP O
have VBP B-VP O
been VBN I-VP O
reported VBN I-VP O
in IN B-PP O
HCP NN B-NP B-Disease
patients NNS I-NP O
. . O O

We PRP B-NP O
report VBP B-VP O
another DT B-NP O
mutation NN I-NP O
in IN B-PP O
a DT B-NP O
Japanese JJ I-NP O
family NN I-NP O
. . O O

Polymerase NN B-NP O
chain NN I-NP O
reaction NN I-NP O
- HYPH B-NP O
single JJ I-NP O
strand NN I-NP O
conformational JJ I-NP O
polymorphism NN I-NP O
and CC O O
direct JJ B-NP O
sequence NN I-NP O
analyses NNS I-NP O
demonstrated VBD B-VP O
a DT B-NP O
C NN I-NP O
to TO B-PP O
T NN B-NP O
substitution NN I-NP O
in IN B-PP O
exon NN B-NP O
1 CD I-NP O
of IN B-PP O
the DT B-NP O
CPO NN I-NP O
gene NN I-NP O
at IN B-PP O
nucleotide NN B-NP O
position NN I-NP O
85 CD I-NP O
, , O O
which WDT B-NP O
lies VBZ B-VP O
in IN B-PP O
the DT B-NP O
putative JJ I-NP O
presequence NN I-NP O
for IN B-PP O
targeting VBG B-VP O
to TO B-PP O
mitochondria NNS B-NP O
. . O O

This DT B-NP O
mutation NN I-NP O
changes VBZ B-VP O
the DT B-NP O
codon NN I-NP O
for IN B-PP O
glutamine NN B-NP O
to TO B-PP O
a DT B-NP O
termination NN I-NP O
codon NN I-NP O
at IN B-PP O
amino JJ B-NP O
acid NN I-NP O
position NN I-NP O
29 CD I-NP O
. . O O

MaeI NN B-NP O
restriction NN I-NP O
analysis NN I-NP O
showed VBD B-VP O
two CD B-NP O
other JJ I-NP O
carriers NNS I-NP O
in IN B-PP O
the DT B-NP O
family NN I-NP O
. . O O

The DT B-NP O
C NN I-NP O
- HYPH I-NP O
T NN I-NP O
mutation NN I-NP O
is VBZ B-VP O
located JJ B-ADJP O
within IN B-PP O
a DT B-NP O
recently RB I-NP O
proposed VBN I-NP O
putative JJ I-NP O
alternative JJ I-NP O
translation NN I-NP O
initiation NN I-NP O
codon NN I-NP O
( ( O O
TIC NN B-NP O
- HYPH B-NP O
1 CD I-NP O
) ) O O
, , O O
supporting VBG B-VP O
that IN B-SBAR O
TIC NN B-NP O
- HYPH B-NP O
1 CD I-NP O
is VBZ B-VP O
the DT B-NP O
real JJ I-NP O
TIC NN I-NP O
rather RB B-CONJP O
than IN I-CONJP O
TIC NN B-NP O
- HYPH O O
2 CD B-NP O
. . O O

. . O O

Human JJ B-NP B-Disease
complement NN I-NP I-Disease
factor NN I-NP I-Disease
H NN I-NP I-Disease
deficiency NN I-NP I-Disease
associated VBN B-VP O
with IN B-PP O
hemolytic JJ B-NP B-Disease
uremic JJ I-NP I-Disease
syndrome NN I-NP I-Disease
. . O O

This DT B-NP O
study NN I-NP O
reports VBZ B-VP O
on IN B-PP O
six CD B-NP O
cases NNS I-NP O
of IN B-PP O
deficiency NN B-NP B-Disease
in IN B-PP I-Disease
the DT B-NP I-Disease
human JJ I-NP I-Disease
complement NN I-NP I-Disease
regulatory JJ I-NP I-Disease
protein NN I-NP I-Disease
Factor NN I-NP I-Disease
H NN I-NP I-Disease
( ( O O
FH NN B-NP O
) ) O O
in IN B-PP O
the DT B-NP O
context NN I-NP O
of IN B-PP O
an DT B-NP O
acute JJ I-NP B-Disease
renal JJ I-NP I-Disease
disease NN I-NP I-Disease
. . O O

Five CD B-NP O
of IN B-PP O
the DT B-NP O
cases NNS I-NP O
were VBD B-VP O
observed VBN I-VP O
in IN B-PP O
children NNS B-NP O
presenting VBG B-VP O
with IN B-PP O
idiopathic JJ B-NP O
hemolytic JJ I-NP B-Disease
uremic JJ I-NP I-Disease
syndrome NN I-NP I-Disease
( ( O O
HUS NN B-NP B-Disease
) ) O O
. . O O

Two CD B-NP O
of IN B-PP O
the DT B-NP O
children NNS I-NP O
exhibited VBD B-VP O
a DT B-NP O
homozygous JJ I-NP O
deficiency NN I-NP O
characterized VBN B-VP O
by IN B-PP O
the DT B-NP O
absence NN I-NP O
of IN B-PP O
the DT B-NP O
150 CD I-NP O
- HYPH I-NP O
kD NN I-NP O
form NN I-NP O
of IN B-PP O
Factor NN B-NP O
H NN I-NP O
and CC O O
the DT B-NP O
presence NN I-NP O
, , O O
upon IN B-PP O
immunoblotting NN B-NP O
, , O O
of IN B-PP O
the DT B-NP O
42 CD I-NP O
- HYPH I-NP O
kD NN I-NP O
Factor NN I-NP O
H NN I-NP O
- HYPH B-NP O
like JJ I-NP O
protein NN I-NP O
1 CD I-NP O
( ( O O
FHL NN B-NP O
- HYPH B-NP O
1 CD I-NP O
) ) O O
and CC O O
other JJ B-NP O
FH NN I-NP O
- HYPH B-VP O
related VBN B-NP O
protein NN I-NP O
( ( O O
FHR NN B-NP O
) ) O O
bands NNS B-NP O
. . O O

Southern NN B-NP O
blot NN I-NP O
and CC O O
PCR NN B-NP O
analysis NN I-NP O
of IN B-PP O
DNA NN B-NP O
of IN B-PP O
one CD B-NP O
patient NN I-NP O
with IN B-PP O
homozygous JJ B-NP O
deficiency NN I-NP O
ruled VBD B-VP O
out RP B-PRT O
the DT B-NP O
presence NN I-NP O
of IN B-PP O
a DT B-NP O
large JJ I-NP O
deletion NN I-NP O
of IN B-PP O
the DT B-NP O
FH NN I-NP O
gene NN I-NP O
as IN B-PP O
the DT B-NP O
underlying VBG I-NP O
defect NN I-NP O
for IN B-PP O
the DT B-NP O
deficiency NN I-NP O
. . O O

The DT B-NP O
other JJ I-NP O
four CD I-NP O
children NNS I-NP O
presented VBD B-VP O
with IN B-PP O
heterozygous JJ B-NP O
deficiency NN I-NP O
and CC O O
exhibited VBD B-VP O
a DT B-NP O
normal JJ I-NP O
immunoblotting NN I-NP O
pattern NN I-NP O
of IN B-PP O
proteins NNS B-NP O
of IN B-PP O
the DT B-NP O
FH NN I-NP O
family NN I-NP O
. . O O

Factor NN B-NP B-Disease
H NN I-NP I-Disease
deficiency NN I-NP I-Disease
is VBZ B-VP O
the DT B-NP O
only JJ I-NP O
complement NN I-NP B-Disease
deficiency NN I-NP I-Disease
associated VBN B-VP O
with IN B-PP O
HUS NN B-NP B-Disease
. . O O

These DT B-NP O
observations NNS I-NP O
suggest VBP B-VP O
a DT B-NP O
role NN I-NP O
for IN B-PP O
FH NN B-NP O
and CC O O
/ SYM B-NP O
or CC O O
FH NN B-NP O
receptors NNS I-NP O
in IN B-PP O
the DT B-NP O
pathogenesis NN I-NP O
of IN B-PP O
idiopathic JJ B-NP O
HUS NN I-NP B-Disease
. . O O

. . O O

Further JJ B-NP O
evidence NN I-NP O
for IN B-PP O
a DT B-NP O
major JJ I-NP O
ancient JJ I-NP O
mutation NN I-NP O
underlying VBG B-VP O
myotonic JJ B-NP B-Disease
dystrophy NN I-NP I-Disease
from IN B-PP O
linkage NN B-NP O
disequilibrium NN I-NP O
studies NNS I-NP O
in IN B-PP O
the DT B-NP O
Japanese JJ I-NP O
population NN I-NP O
. . O O

The DT B-NP O
myotonic JJ I-NP B-Disease
dystrophy NN I-NP I-Disease
( ( O O
DM NN B-NP B-Disease
) ) O O
mutation NN B-NP O
is VBZ B-VP O
an DT B-NP O
unstable JJ I-NP O
( ( O O
CTG NN B-NP O
) ) O O
n NN B-NP O
repeat NN I-NP O
, , O O
present JJ B-ADJP O
at IN B-PP O
a DT B-NP O
copy NN I-NP O
number NN I-NP O
of IN B-PP O
5 CD B-NP O
- HYPH I-NP O
37 CD I-NP O
repeats NNS I-NP O
on IN B-PP O
normal JJ B-NP O
chromosomes NNS I-NP O
but CC O O
amplified VBN B-VP O
to TO B-PP O
50 CD B-NP O
- HYPH I-NP O
3000 CD I-NP O
copies NNS I-NP O
on IN B-PP O
DM NN B-NP B-Disease
chromosomes NNS I-NP O
. . O O

Previous JJ B-NP O
findings NNS I-NP O
in IN B-PP O
Caucasian JJ B-NP O
populations NNS I-NP O
of IN B-PP O
a DT B-NP O
DM NN I-NP B-Disease
founder NN I-NP O
chromosome NN I-NP O
raise VBP B-VP O
a DT B-NP O
question NN I-NP O
about IN B-PP O
the DT B-NP O
molecular JJ I-NP O
events NNS I-NP O
involved VBN B-VP O
in IN B-PP O
the DT B-NP O
expansion NN I-NP O
mutation NN I-NP O
. . O O

To TO B-VP O
investigate VB I-VP O
whether IN B-SBAR O
a DT B-NP O
founder NN I-NP O
chromosome NN I-NP O
for IN B-PP O
the DT B-NP O
DM NN I-NP B-Disease
mutation NN I-NP O
exists VBZ B-VP O
in IN B-PP O
the DT B-NP O
Japanese JJ I-NP O
population NN I-NP O
, , O O
we PRP B-NP O
genotyped VBD B-VP O
families NNS B-NP O
using VBG B-VP O
polymorphic JJ B-NP O
markers NNS I-NP O
near IN B-PP O
the DT B-NP O
( ( O O
CTG NN O O
) ) O O
n NN B-NP O
repeat NN I-NP O
region NN I-NP O
and CC O O
constructed VBN B-NP O
haplotypes NNS I-NP O
. . O O

Six CD B-NP O
different JJ I-NP O
haplotypes NNS I-NP O
were VBD B-VP O
found VBN I-VP O
and CC O O
DM NN B-NP B-Disease
alleles NNS I-NP O
were VBD B-VP O
always RB B-ADVP O
haplotype NN B-NP O
A NN I-NP O
. . O O

To TO B-VP O
find VB I-VP O
an DT B-NP O
origin NN I-NP O
of IN B-PP O
the DT B-NP O
( ( O O
CTG NN O O
) ) O O
n NN B-NP O
repeat NN I-NP O
mutation NN I-NP O
and CC O O
to TO B-VP O
investigate VB I-VP O
the DT B-NP O
mechanism NN I-NP O
of IN B-PP O
the DT B-NP O
expansion NN I-NP O
mutation NN I-NP O
in IN B-PP O
the DT B-NP O
Japanese JJ I-NP O
population NN I-NP O
we PRP B-NP O
have VBP B-VP O
studied VBN I-VP O
90 CD B-NP O
Japanese JJ I-NP O
DM NN I-NP B-Disease
families NNS I-NP O
comprising VBG B-VP O
190 CD B-NP O
affected VBN B-VP O
and CC O O
130 CD B-NP O
unaffected JJ I-NP O
members NNS I-NP O
. . O O

The DT B-NP O
results NNS I-NP O
suggest VBP B-VP O
that IN B-SBAR O
a DT B-NP O
few JJ I-NP O
common JJ I-NP O
ancestral JJ I-NP O
mutations NNS I-NP O
in IN B-PP O
both CC B-NP O
Caucasian JJ I-NP O
and CC I-NP O
Japanese JJ I-NP O
populations NNS I-NP O
have VBP B-VP O
originated VBN I-VP O
by IN B-PP O
expansion NN B-NP O
of IN B-PP O
an DT B-NP O
ancestral JJ I-NP O
n NN I-NP O
= SYM B-VP O
5 CD B-NP O
repeat NN I-NP O
to TO B-PP O
n NN B-NP O
= SYM B-VP O
19 CD B-NP O
- HYPH I-NP O
37 CD I-NP O
copies NNS I-NP O
. . O O

These DT B-NP O
data NNS I-NP O
support VBP B-VP O
multistep JJ B-NP O
models NNS I-NP O
of IN B-PP O
triplet JJ B-NP O
repeat NN I-NP O
expansion NN I-NP O
that WDT B-NP O
have VBP B-VP O
been VBN I-VP O
proposed VBN I-VP O
for IN B-PP O
both CC O O
DM NN B-NP B-Disease
and CC I-NP O
Friedreichs NNS I-NP B-Disease
ataxia NN I-NP I-Disease
. . O O

. . O O

The DT B-NP O
molecular JJ I-NP O
basis NN I-NP O
of IN B-PP O
C6 NN B-NP B-Disease
deficiency NN I-NP I-Disease
in IN B-PP O
the DT B-NP O
western JJ I-NP O
Cape NNP I-NP O
, , O O
South NNP B-NP O
Africa NNP I-NP O
. . O O

Deficiency NN B-NP B-Disease
of IN B-PP I-Disease
the DT B-NP I-Disease
sixth JJ I-NP I-Disease
component NN I-NP I-Disease
of IN B-PP I-Disease
human JJ B-NP I-Disease
complement NN I-NP I-Disease
( ( O O
C6 NN B-NP O
) ) O O
has VBZ B-VP O
been VBN I-VP O
reported VBN I-VP O
in IN B-PP O
a DT B-NP O
number NN I-NP O
of IN B-PP O
families NNS B-NP O
from IN B-PP O
the DT B-NP O
western JJ I-NP O
Cape NNP I-NP O
, , O O
South NNP B-NP O
Africa NNP I-NP O
. . O O

Meningococcal JJ B-NP B-Disease
disease NN I-NP I-Disease
is VBZ B-VP O
endemic JJ B-ADJP O
in IN B-PP O
the DT B-NP O
Cape NNP I-NP O
and CC O O
almost RB B-NP O
all DT I-NP O
pedigrees NNS I-NP O
of IN B-PP O
total JJ B-NP O
C6 NN I-NP B-Disease
deficiency NN I-NP I-Disease
( ( O O
C6Q0 NN B-NP O
) ) O O
have VBP B-VP O
been VBN I-VP O
ascertained VBN I-VP O
because IN B-PP O
of IN I-PP O
recurrent JJ B-NP O
disease NN I-NP O
. . O O

We PRP B-NP O
have VBP B-VP O
sequenced VBN I-VP O
the DT B-NP O
expressed VBN I-NP O
exons NNS I-NP O
of IN B-PP O
the DT B-NP O
C6 NN I-NP O
gene NN I-NP O
from IN B-PP O
selected VBN B-NP O
cases NNS I-NP O
and CC O O
have VBP B-VP O
found VBN I-VP O
three CD B-NP O
molecular JJ I-NP O
defects NNS I-NP O
leading VBG B-VP O
to TO B-PP O
total JJ B-NP O
deficiency NN I-NP O
879delG NN I-NP O
, , O O
which WDT B-NP O
is VBZ B-VP O
the DT B-NP O
common JJ I-NP O
defect NN I-NP O
in IN B-PP O
the DT B-NP O
Cape NNP I-NP O
and CC O O
hitherto RB B-ADJP O
unreported JJ I-ADJP O
, , O O
and CC O O
1195delC NN B-NP O
and CC I-NP O
1936delG NN I-NP O
, , O O
which WDT B-NP O
have VBP B-VP O
been VBN I-VP O
previously RB I-VP O
reported VBN I-VP O
in IN B-PP O
African JJ B-NP O
- HYPH I-NP O
Americans NNPS I-NP O
. . O O

We PRP B-NP O
also RB B-ADVP O
show VBP B-VP O
that IN B-SBAR O
the DT B-NP O
879delG NN I-NP O
and CC I-NP O
1195delC NN I-NP O
defects NNS I-NP O
are VBP B-VP O
associated VBN I-VP O
with IN B-PP O
characteristic JJ B-NP O
C6 NN I-NP O
/ SYM B-NP O
C7 NN I-NP O
region NN I-NP O
DNA NN I-NP O
marker NN I-NP O
haplotypes NNS I-NP O
, , O O
although IN B-SBAR O
small JJ B-NP O
variations NNS I-NP O
were VBD B-VP O
observed VBN I-VP O
. . O O

The DT B-NP O
1936delG NN I-NP O
defect NN I-NP O
was VBD B-VP O
observed VBN I-VP O
only RB B-ADVP O
once RB I-ADVP O
in IN B-PP O
the DT B-NP O
Cape NNP I-NP O
, , O O
but CC O O
its PRP$ B-NP O
associated VBN I-NP O
haplotype NN I-NP O
could MD B-VP O
be VB I-VP O
deduced VBN I-VP O
. . O O

The DT B-NP O
data NNS I-NP O
from IN B-PP O
the DT B-NP O
haplotypes NNS I-NP O
indicate VBP B-VP O
that IN B-SBAR O
these DT B-NP O
three CD I-NP O
molecular JJ I-NP O
defects NNS I-NP O
account VBP B-VP O
for IN B-PP O
the DT B-NP O
defects NNS I-NP O
in IN B-PP O
all PDT B-NP O
the DT I-NP O
38 CD I-NP O
unrelated JJ I-NP O
C6Q0 NN I-NP O
individuals NNS I-NP O
we PRP B-NP O
have VBP B-VP O
studied VBN I-VP O
from IN B-PP O
the DT B-NP O
Cape NNP I-NP O
. . O O

We PRP B-NP O
have VBP B-VP O
also RB I-VP O
observed VBN I-VP O
the DT B-NP O
879delG NN I-NP O
defect NN I-NP O
in IN B-PP O
two CD B-NP O
Dutch JJ I-NP O
C6 NN I-NP B-Disease
- HYPH B-NP I-Disease
deficient JJ I-NP I-Disease
kindreds NNS I-NP O
, , O O
but CC O O
the DT B-NP O
879delG NN I-NP O
defect NN I-NP O
in IN B-PP O
the DT B-NP O
Cape NNP I-NP O
probably RB B-ADVP O
did VBD B-VP O
not RB I-VP O
come VB I-VP O
from IN B-PP O
The DT B-NP O
Netherlands NNP I-NP O
. . O O

. . O O

Complement NN B-NP B-Disease
C7 NN I-NP I-Disease
deficiency NN I-NP I-Disease
: : O O
seven CD B-NP O
further JJ I-NP O
molecular JJ I-NP O
defects NNS I-NP O
and CC O O
their PRP$ B-NP O
associated VBN I-NP O
marker NN I-NP O
haplotypes NNS I-NP O
. . O O

Seven CD B-NP O
further JJ I-NP O
molecular JJ I-NP O
bases NNS I-NP O
of IN B-PP O
C7 NN B-NP B-Disease
deficiency NN I-NP I-Disease
are VBP B-VP O
described VBN I-VP O
. . O O

All PDT B-NP O
these DT I-NP O
new JJ I-NP O
molecular JJ I-NP O
defects NNS I-NP O
involve VBP B-VP O
single JJ B-NP O
- HYPH I-NP O
nucleotide NN I-NP O
events NNS I-NP O
, , I-NP O
deletions NNS I-NP O
and CC I-NP O
substitutions NNS I-NP O
, , O O
some DT B-NP O
of IN B-PP O
which WDT B-NP O
alter VBP B-VP O
splice NN B-NP O
sites NNS I-NP O
, , O O
and CC O O
others NNS B-NP O
codons NNS I-NP O
. . O O

They PRP B-NP O
are VBP B-VP O
distributed VBN I-VP O
along IN B-PP O
the DT B-NP O
C7 NN I-NP O
gene NN I-NP O
, , O O
but CC O O
predominantly RB B-ADVP O
towards IN B-PP O
the DT B-NP O
3 CD I-NP O
end NN I-NP O
. . O O

All DT B-NP O
were VBD B-VP O
found VBN I-VP O
in IN B-PP O
compound NN B-NP O
heterozygous JJ I-NP O
individuals NNS I-NP O
. . O O

The DT B-NP O
C6 NN I-NP O
/ SYM B-VP O
C7 NN B-NP O
marker NN I-NP O
haplotypes NNS I-NP O
associated VBN B-VP O
with IN B-PP O
most JJS B-NP O
C7 NN I-NP B-Disease
defects NNS I-NP I-Disease
are VBP B-VP O
tabulated VBN I-VP O
. . O O

. . O O

A DT B-NP O
genome NN I-NP O
- HYPH B-NP O
wide JJ I-NP O
search NN I-NP O
for IN B-PP O
chromosomal JJ B-NP O
loci NNS I-NP O
linked VBN B-VP O
to TO B-PP O
mental JJ B-NP O
health NN I-NP O
wellness NN I-NP O
in IN B-PP O
relatives NNS B-NP O
at IN B-PP O
high JJ B-NP O
risk NN I-NP O
for IN B-PP O
bipolar JJ B-NP B-Disease
affective JJ I-NP I-Disease
disorder NN I-NP I-Disease
among IN B-PP O
the DT B-NP O
Old NNP I-NP O
Order NNP I-NP O
Amish NNP I-NP O
. . O O

Bipolar JJ B-NP B-Disease
affective JJ I-NP I-Disease
disorder NN I-NP I-Disease
( ( O O
BPAD NN B-NP B-Disease
; : O O
manic JJ B-NP B-Disease
- HYPH I-NP I-Disease
depressive JJ I-NP I-Disease
illness NN I-NP I-Disease
) ) O O
is VBZ B-VP O
characterized VBN I-VP O
by IN B-PP O
episodes NNS B-NP O
of IN B-PP O
mania NN B-NP B-Disease
and CC O O
/ SYM B-NP O
or CC O O
hypomania NN B-NP B-Disease
interspersed VBN B-VP O
with IN B-PP O
periods NNS B-NP O
of IN B-PP O
depression NN B-NP B-Disease
. . O O

Compelling NN B-NP O
evidence NN I-NP O
supports VBZ B-VP O
a DT B-NP O
significant JJ I-NP O
genetic JJ I-NP O
component NN I-NP O
in IN B-PP O
the DT B-NP O
susceptibility NN I-NP O
to TO B-VP O
develop VB I-VP O
BPAD NN B-NP B-Disease
. . O O

To TO B-PP O
date NN B-NP O
, , O O
however RB B-ADVP O
, , O O
linkage NN B-NP O
studies NNS I-NP O
have VBP B-VP O
attempted VBN I-VP O
only RB B-ADVP O
to TO B-VP O
identify VB I-VP O
chromosomal JJ B-NP O
loci NNS I-NP O
that WDT B-NP O
cause VBP B-VP O
or CC I-VP O
increase VBP I-VP O
the DT B-NP O
risk NN I-NP O
of IN B-PP O
developing VBG B-VP O
BPAD NN B-NP B-Disease
. . O O

To TO B-VP O
determine VB I-VP O
whether IN B-SBAR O
there EX B-NP O
could MD B-VP O
be VB I-VP O
protective JJ B-NP O
alleles NNS I-NP O
that WDT B-NP O
prevent VBP B-VP O
or CC I-VP O
reduce VBP I-VP O
the DT B-NP O
risk NN I-NP O
of IN B-PP O
developing VBG B-VP O
BPAD NN B-NP B-Disease
, , O O
similar JJ B-ADJP O
to TO B-PP O
what WP B-NP O
is VBZ B-VP O
observed VBN I-VP O
in IN B-PP O
other JJ B-NP O
genetic JJ I-NP B-Disease
disorders NNS I-NP I-Disease
, , O O
we PRP B-NP O
used VBD B-VP O
mental JJ B-NP O
health NN I-NP O
wellness NN I-NP O
( ( O O
absence NN B-NP O
of IN B-PP O
any DT B-NP O
psychiatric JJ I-NP B-Disease
disorder NN I-NP I-Disease
) ) O O
as IN B-PP O
the DT B-NP O
phenotype NN I-NP O
in IN B-PP O
our PRP$ B-NP O
genome NN I-NP O
- HYPH B-NP O
wide JJ I-NP O
linkage NN I-NP O
scan NN I-NP O
of IN B-PP O
several JJ B-NP O
large JJ I-NP O
multigeneration NN I-NP O
Old NNP I-NP O
Order NNP I-NP O
Amish NNP I-NP O
pedigrees NNS I-NP O
exhibiting VBG B-VP O
an DT B-NP O
extremely RB I-NP O
high JJ I-NP O
incidence NN I-NP O
of IN B-PP O
BPAD NN B-NP B-Disease
. . O O

We PRP B-NP O
have VBP B-VP O
found VBN I-VP O
strong JJ B-NP O
evidence NN I-NP O
for IN B-PP O
a DT B-NP O
locus NN I-NP O
on IN B-PP O
chromosome NN B-NP O
4p NN I-NP O
at IN B-PP O
D4S2949 NN B-NP O
( ( O O
maximum NN B-NP O
GENEHUNTER NN I-NP O
- HYPH B-NP O
PLUS NN I-NP O
nonparametric JJ I-NP O
linkage NN I-NP O
score NN I-NP O
= SYM B-VP O
4 CD B-NP O
. SYM I-NP O

05 CD I-NP O
, , O O
P NN B-NP O
= SYM B-VP O
5 CD B-NP O
. SYM I-NP O

22 CD I-NP O
x SYM I-NP O
10 CD I-NP O
( ( O O
- SYM O O
4 CD B-NP O
) ) O O
; : O O
SIBPAL JJ B-NP O
Pempirical JJ I-NP O
value NN I-NP O
< SYM B-NP O
3 CD B-NP O
x SYM I-NP O
10 CD I-NP O
( ( O O
- SYM O O
5 CD B-NP O
) ) O O
) ) O O
and CC O O
suggestive JJ B-NP O
evidence NN I-NP O
for IN B-PP O
a DT B-NP O
locus NN I-NP O
on IN B-PP O
chromosome NN B-NP O
4q NN I-NP O
at IN B-PP O
D4S397 NN B-NP O
( ( O O
maximum NN B-NP O
GENEHUNTER NN I-NP O
- HYPH B-NP O
PLUS NN I-NP O
nonparametric JJ I-NP O
linkage NN I-NP O
score NN I-NP O
= SYM B-VP O
3 CD B-NP O
. SYM I-NP O

29 CD I-NP O
, , O O
P NN B-NP O
= SYM B-VP O
2 CD B-NP O
. . O O

57 CD B-NP O
x CC I-NP O
10 CD I-NP O
( ( O O
- SYM B-NP O
3 CD I-NP O
) ) O O
; : O O
SIBPAL JJ B-NP O
Pempirical JJ I-NP O
value NN I-NP O
< SYM B-NP O
1 CD I-NP O
x SYM I-NP O
10 CD I-NP O
( ( O O
- SYM B-NP O
3 CD I-NP O
) ) O O
) ) O O
that WDT B-NP O
are VBP B-VP O
linked VBN I-VP O
to TO B-PP O
mental JJ B-NP O
health NN I-NP O
wellness NN I-NP O
. . O O

These DT B-NP O
findings NNS I-NP O
are VBP B-VP O
consistent JJ B-ADJP O
with IN B-PP O
the DT B-NP O
hypothesis NN I-NP O
that IN B-SBAR O
certain JJ B-NP O
alleles NNS I-NP O
could MD B-VP O
prevent VB I-VP O
or CC I-VP O
modify VB I-VP O
the DT B-NP O
clinical JJ I-NP O
manifestations NNS I-NP O
of IN B-PP O
BPAD NN B-NP B-Disease
and CC O O
perhaps RB B-ADVP O
other JJ B-NP O
related JJ I-NP O
affective JJ I-NP B-Disease
disorders NNS I-NP I-Disease
. . O O

Segregation NN B-NP O
distortion NN I-NP O
in IN B-PP O
myotonic JJ B-NP B-Disease
dystrophy NN I-NP I-Disease
. . O O

Myotonic JJ B-NP B-Disease
dystrophy NN I-NP I-Disease
( ( O O
DM NN B-NP B-Disease
) ) O O
is VBZ B-VP O
an DT B-NP O
autosomal JJ I-NP B-Disease
dominant JJ I-NP I-Disease
disease NN I-NP I-Disease
which WDT B-NP O
, , O O
in IN B-PP O
the DT B-NP O
typical JJ I-NP O
pedigree NN I-NP O
, , O O
shows VBZ B-VP O
a DT B-NP O
three CD I-NP O
generation NN I-NP O
anticipation NN I-NP O
cascade NN I-NP O
. . O O

This DT B-NP O
results VBZ B-VP O
in IN B-PP O
infertility NN B-NP B-Disease
and CC O O
congenital JJ B-NP B-Disease
myotonic JJ I-NP I-Disease
dystrophy NN I-NP I-Disease
( ( O O
CDM NN B-NP B-Disease
) ) O O
with IN B-PP O
the DT B-NP O
disappearance NN I-NP O
of IN B-PP O
DM NN B-NP B-Disease
in IN B-PP O
that DT B-NP O
pedigree NN I-NP O
. . O O

The DT B-NP O
concept NN I-NP O
of IN B-PP O
segregation NN B-NP O
distortion NN I-NP O
, , O O
where WRB B-ADVP O
there EX B-NP O
is VBZ B-VP O
preferential JJ B-NP O
transmission NN I-NP O
of IN B-PP O
the DT B-NP O
larger JJR I-NP O
allele NN I-NP O
at IN B-PP O
the DT B-NP O
DM NN I-NP B-Disease
locus NN I-NP O
, , O O
has VBZ B-VP O
been VBN I-VP O
put VBN I-VP O
forward RB B-ADVP O
to TO B-VP O
explain VB I-VP O
partially RB B-ADVP O
the DT B-NP O
maintenance NN I-NP O
of IN B-PP O
DM NN B-NP B-Disease
in IN B-PP O
the DT B-NP O
population NN I-NP O
. . O O

In IN B-PP O
a DT B-NP O
survey NN I-NP O
of IN B-PP O
DM NN B-NP B-Disease
in IN B-PP O
Northern NNP B-NP O
Ireland NNP I-NP O
, , O O
59 CD B-NP O
pedigrees NNS I-NP O
were VBD B-VP O
ascertained VBN I-VP O
. . O O

Sibships NNS B-NP O
where WRB B-ADVP O
the DT B-NP O
status NN I-NP O
of IN B-PP O
all PDT B-NP O
the DT I-NP O
members NNS I-NP O
had VBD B-VP O
been VBN I-VP O
identified VBN I-VP O
were VBD B-VP O
examined VBN I-VP O
to TO B-VP O
determine VB I-VP O
the DT B-NP O
transmission NN I-NP O
of IN B-PP O
the DT B-NP O
DM NN I-NP B-Disease
expansion NN I-NP O
from IN B-PP O
affected VBN B-NP O
parents NNS I-NP O
to TO B-PP O
their PRP$ B-NP O
offspring NN I-NP O
. . O O

Where WRB B-ADVP O
the DT B-NP O
transmitting VBG I-NP O
parent NN I-NP O
was VBD B-VP O
male JJ B-ADJP O
, , O O
58 CD B-NP O
. . O O

3 CD B-NP O
% NN I-NP O
of IN B-PP O
the DT B-NP O
offspring NN I-NP O
were VBD B-VP O
affected VBN I-VP O
, , O O
and CC O O
in IN B-PP O
the DT B-NP O
case NN I-NP O
of IN B-PP O
a DT B-NP O
female JJ I-NP O
transmitting JJ I-NP O
parent NN I-NP O
, , O O
68 CD B-NP O
. . O O

7 CD B-NP O
% NN I-NP O
were VBD B-VP O
affected VBN I-VP O
. . O O

Studies NNS B-NP O
on IN B-PP O
meiotic JJ B-NP O
drive NN I-NP O
in IN B-PP O
DM NN B-NP B-Disease
have VBP B-VP O
shown VBN I-VP O
increased VBN B-NP O
transmission NN I-NP O
of IN B-PP O
the DT B-NP O
larger JJR I-NP O
allele NN I-NP O
at IN B-PP O
the DT B-NP O
DM NN I-NP B-Disease
locus NN I-NP O
in IN B-PP O
non AFX B-NP O
- HYPH I-NP O
DM NN I-NP O
heterozygotes NNS I-NP O
for IN B-PP O
CTGn NN B-NP O
. . O O

This DT B-NP O
study NN I-NP O
provides VBZ B-VP O
further JJ B-NP O
evidence NN I-NP O
that IN B-SBAR O
the DT B-NP O
DM NN I-NP B-Disease
expansion NN I-NP O
tends VBZ B-VP O
to TO I-VP O
be VB I-VP O
transmitted VBN I-VP O
preferentially RB B-ADVP O
. . O O

Diagnosis NN B-NP O
of IN B-PP O
hemochromatosis NN B-NP B-Disease
. . O O

If IN B-SBAR O
untreated JJ B-NP O
, , I-NP O
hemochromatosis NN I-NP B-Disease
can MD B-VP O
cause VB I-VP O
serious JJ B-NP O
illness NN I-NP O
and CC O O
early JJ B-NP B-Disease
death NN I-NP I-Disease
, , O O
but CC O O
the DT B-NP O
disease NN I-NP O
is VBZ B-VP O
still RB B-ADVP O
substantially RB B-ADVP O
under IN B-PP O
- HYPH B-NP O
diagnosed VBN B-VP O
. . O O

The DT B-NP O
cornerstone NN I-NP O
of IN B-PP O
screening NN B-NP O
and CC I-NP O
case NN I-NP O
detection NN I-NP O
is VBZ B-VP O
the DT B-NP O
measurement NN I-NP O
of IN B-PP O
serum NN B-NP O
transferrin NN I-NP O
saturation NN I-NP O
and CC O O
the DT B-NP O
serum NN I-NP O
ferritin NN I-NP O
level NN I-NP O
. . O O

Once RB O O
the DT B-NP O
diagnosis NN I-NP O
is VBZ B-VP O
suspected VBN I-VP O
, , O O
physicians NNS B-NP O
must MD B-VP O
use VB I-VP O
serum NN B-NP O
ferritin NN I-NP O
levels NNS I-NP O
and CC O O
hepatic JJ B-NP O
iron NN I-NP O
stores NNS I-NP O
on IN B-PP O
liver NN B-NP O
biopsy NN I-NP O
specimens NNS I-NP O
to TO B-VP O
assess VB I-VP O
patients NNS B-NP O
for IN B-PP O
the DT B-NP O
presence NN I-NP O
of IN B-PP O
iron NN B-NP B-Disease
overload NN I-NP I-Disease
. . O O

Liver NN B-NP O
biopsy NN I-NP O
is VBZ B-VP O
also RB I-VP O
used VBN I-VP O
to TO B-VP O
establish VB I-VP O
the DT B-NP O
presence NN I-NP O
or CC I-NP O
absence NN I-NP O
of IN B-PP O
cirrhosis NN B-NP B-Disease
, , O O
which WDT B-NP O
can MD B-VP O
affect VB I-VP O
prognosis NN B-NP O
and CC I-NP O
management NN I-NP O
. . O O

A DT B-NP O
DNA NN I-NP O
- HYPH B-VP O
based VBN I-VP O
test NN B-NP O
for IN B-PP O
the DT B-NP O
HFE NN I-NP O
gene NN I-NP O
is VBZ B-VP O
commercially RB B-ADJP O
available JJ I-ADJP O
, , O O
but CC O O
its PRP$ B-NP O
place NN I-NP O
in IN B-PP O
the DT B-NP O
diagnosis NN I-NP O
of IN B-PP O
hemochromatosis NN B-NP B-Disease
is VBZ B-VP O
still RB I-VP O
being VBG I-VP O
evaluated VBN I-VP O
. . O O

Currently RB B-ADVP O
, , O O
the DT B-NP O
most RBS I-NP O
useful JJ I-NP O
role NN I-NP O
for IN B-PP O
this DT B-NP O
test NN I-NP O
is VBZ B-VP O
in IN B-PP O
the DT B-NP O
detection NN I-NP O
of IN B-PP O
hemochromatosis NN B-NP B-Disease
in IN B-PP O
the DT B-NP O
family NN I-NP O
members NNS I-NP O
of IN B-PP O
patients NNS B-NP O
with IN B-PP O
a DT B-NP O
proven JJ I-NP O
case NN I-NP O
of IN B-PP O
the DT B-NP O
disease NN I-NP O
. . O O

It PRP B-NP O
is VBZ B-VP O
crucial JJ B-ADJP O
to TO B-PP O
diagnose NN B-NP O
hemochromatosis NN I-NP B-Disease
before IN B-PP O
hepatic JJ B-NP B-Disease
cirrhosis NN I-NP I-Disease
develops VBZ B-VP O
because IN B-SBAR O
phlebotomy NN B-NP O
therapy NN I-NP O
can MD B-VP O
avert VB I-VP O
serious JJ B-NP O
chronic JJ I-NP O
disease NN I-NP O
and CC O O
can MD B-VP O
even RB I-VP O
lead VB I-VP O
to TO B-PP O
normal JJ B-NP O
life NN I-NP O
expectancy NN I-NP O
. . O O

. . O O

Prevalence NN B-NP O
of IN B-PP O
the DT B-NP O
I1307K NN I-NP O
APC NN I-NP B-Disease
gene NN I-NP O
variant NN I-NP O
in IN B-PP O
Israeli JJ B-NP O
Jews NNS I-NP O
of IN B-PP O
differing VBG B-VP O
ethnic JJ B-NP O
origin NN I-NP O
and CC I-NP O
risk NN I-NP O
for IN B-PP O
colorectal JJ B-NP B-Disease
cancer NN I-NP I-Disease
. . O O

BACKGROUND NN B-NP O
& CC I-NP O
AIMS NNS I-NP O
Israeli JJ B-NP O
Jews NNS I-NP O
of IN B-PP O
European JJ B-NP O
birth NN I-NP O
, , O O
i NN B-NP O
. . I-NP O

e NN I-NP O
. . O O

, , O O
Ashkenazim NNP B-NP O
, , O O
have VBP B-VP O
the DT B-NP O
highest JJS I-NP O
colorectal JJ I-NP B-Disease
cancer NN I-NP I-Disease
incidence NN I-NP O
of IN B-PP O
any DT B-NP O
Israeli JJ I-NP O
ethnic JJ I-NP O
group NN I-NP O
. . O O

The DT B-NP O
I1307K NN I-NP O
APC NN I-NP B-Disease
gene NN I-NP O
variant NN I-NP O
was VBD B-VP O
found VBN I-VP O
in IN B-PP O
6 CD B-NP O
. . O O

1 CD B-NP O
% NN I-NP O
of IN B-PP O
American JJ B-NP O
Jews NNS I-NP O
, , O O
28 CD B-NP O
% NN I-NP O
of IN B-PP O
their PRP$ B-NP O
familial JJ I-NP O
colorectal JJ I-NP B-Disease
cancer NN I-NP I-Disease
cases NNS I-NP O
, , B-PP O
but CC I-PP O
not RB B-PP O
in IN I-PP O
non AFX O O
- HYPH O O
Jews NNPS B-NP O
. . O O

We PRP B-NP O
assessed VBD B-VP O
the DT B-NP O
I1307K NN I-NP O
prevalence NN I-NP O
in IN B-PP O
Israeli JJ B-NP O
Jews NNS I-NP O
of IN B-PP O
differing VBG B-VP O
ethnic JJ B-NP O
origin NN I-NP O
and CC I-NP O
risk NN I-NP O
for IN B-PP O
colorectal JJ B-NP B-Disease
cancer NN I-NP I-Disease
. . O O

METHODS NNS B-NP O
DNA NN I-NP O
samples NNS I-NP O
from IN B-PP O
500 CD B-NP O
unrelated JJ I-NP O
Jews NNS I-NP O
of IN B-PP O
European JJ B-NP O
or CC I-NP O
non AFX I-NP O
- HYPH I-NP O
European JJ I-NP O
origin NN I-NP O
, , O O
with IN B-PP O
or CC B-PP O
without IN B-PP O
a DT B-NP O
personal JJ I-NP O
and CC O O
/ SYM B-NP O
or CC O O
family NN B-NP O
history NN I-NP O
of IN B-PP O
neoplasia NN B-NP B-Disease
, , O O
were VBD B-VP O
examined VBN I-VP O
for IN B-PP O
the DT B-NP O
I1307K NN I-NP O
variant NN I-NP O
by IN B-PP O
the DT B-NP O
allele NN I-NP O
- HYPH B-NP O
specific JJ I-NP O
oligonucleotide NN I-NP O
( ( O O
ASO NN B-NP O
) ) O O
method NN B-NP O
. . O O

RESULTS NNS B-NP O
In IN B-PP O
persons NNS B-NP O
at IN B-PP O
average JJ B-NP O
risk NN I-NP O
for IN B-PP O
colorectal JJ B-NP B-Disease
cancer NN I-NP I-Disease
, , O O
I1307K NN B-NP O
was VBD B-VP O
found VBN I-VP O
in IN B-PP O
5 CD B-NP O
. . O O

0 CD B-NP O
% NN I-NP O
of IN B-PP O
120 CD B-NP O
European JJ I-NP O
and CC I-NP O
1 CD I-NP O
. . O O

6 CD B-NP O
% NN I-NP O
of IN B-PP O
188 CD B-NP O
non AFX O O
- HYPH O O
European JJ B-NP O
Jews NNS I-NP O
( ( O O
P NN B-NP O
= SYM B-VP O
0 CD B-NP O
. SYM I-NP O

08 CD I-NP O
) ) O O
. . O O

It PRP B-NP O
occurred VBD B-VP O
in IN B-PP O
15 CD B-NP O
. . O O

4 CD B-NP O
% NN I-NP O
of IN B-PP O
52 CD B-NP O
Ashkenazi NNP I-NP O
Israelis NNPS I-NP O
with IN B-PP O
familial JJ B-NP O
cancer NN I-NP B-Disease
( ( O O
P NN B-NP O
= SYM B-VP O
0 CD B-NP O
. . O O

02 CD B-NP O
) ) O O
and CC O O
was VBD B-VP O
not RB I-VP O
detected VBN I-VP O
in IN B-PP O
51 CD B-NP O
non AFX O O
- HYPH O O
European JJ B-NP O
Jews NNS I-NP O
at IN B-PP O
increased VBN B-NP O
cancer NN I-NP B-Disease
risk NN I-NP O
. . O O

Colorectal JJ B-NP B-Disease
neoplasia NN I-NP I-Disease
occurred VBD B-VP O
personally RB B-ADVP O
or CC O O
in IN B-PP O
the DT B-NP O
families NNS I-NP O
of IN B-PP O
13 CD B-NP O
of IN B-PP O
20 CD B-NP O
Ashkenazi NNP I-NP O
I1307K NN I-NP O
carriers NNS I-NP O
, , O O
8 CD B-NP O
of IN B-PP O
whom WP B-NP O
also RB B-ADVP O
had VBD B-VP O
a DT B-NP O
personal JJ I-NP O
or CC I-NP O
family NN I-NP O
history NN I-NP O
of IN B-PP O
noncolonic JJ B-NP O
neoplasia NN I-NP B-Disease
. . O O

CONCLUSIONS NNS B-NP O
The DT B-NP O
I1307K NN I-NP O
APC NN I-NP O
variant NN I-NP O
may MD B-VP O
represent VB I-VP O
a DT B-NP O
susceptibility NN I-NP O
gene NN I-NP O
for IN B-PP O
colorectal JJ B-ADJP B-Disease
, , O I-Disease
or CC O I-Disease
other JJ B-ADJP I-Disease
, , O I-Disease
cancers NNS B-NP I-Disease
in IN B-PP O
Ashkenazi NNP B-NP O
Jews NNP I-NP O
, , O O
and CC O O
partially RB B-VP O
explains VBZ I-VP O
the DT B-NP O
higher JJR I-NP O
incidence NN I-NP O
of IN B-PP O
colorectal JJ B-NP B-Disease
cancer NN I-NP I-Disease
in IN B-PP O
European JJ B-NP O
Israelis NNPS I-NP O
. . O O

Systematic JJ B-NP O
analysis NN I-NP O
of IN B-PP O
coproporphyrinogen NN B-NP O
oxidase NN I-NP O
gene NN I-NP O
defects NNS I-NP O
in IN B-PP O
hereditary JJ B-NP B-Disease
coproporphyria NN I-NP I-Disease
and CC I-NP O
mutation NN I-NP O
update NN I-NP O
. . O O

Hereditary JJ B-NP B-Disease
coproporphyria NN I-NP I-Disease
( ( O O
HC NN B-NP B-Disease
) ) O O
is VBZ B-VP O
an DT B-NP O
acute JJ I-NP O
hepatic JJ I-NP B-Disease
porphyria NN I-NP I-Disease
with IN B-PP O
autosomal JJ B-NP O
dominant JJ I-NP O
inheritance NN I-NP O
caused VBN B-VP O
by IN B-PP O
deficient JJ B-NP B-Disease
activity NN I-NP I-Disease
of IN B-PP I-Disease
coproporphyrinogen NN B-NP I-Disease
III CD I-NP I-Disease
oxidase NN I-NP I-Disease
( ( O O
CPO NN B-NP O
) ) O O
. . O O

Clinical JJ B-NP O
manifestations NNS I-NP O
of IN B-PP O
the DT B-NP O
disease NN I-NP O
are VBP B-VP O
characterized VBN I-VP O
by IN B-PP O
acute JJ B-NP O
attacks NNS I-NP O
of IN B-PP O
neurological JJ B-NP B-Disease
dysfunction NN I-NP I-Disease
often RB B-VP O
precipitated VBN I-VP O
by IN B-PP O
drugs NNS B-NP O
, , O O
fasting VBG B-VP O
, , O O
cyclical JJ B-NP O
hormonal JJ I-NP O
changes NNS I-NP O
, , O O
or CC O O
infectious JJ B-NP B-Disease
diseases NNS I-NP I-Disease
. . O O

Skin NN B-NP O
photosensitivity NN I-NP O
may MD B-VP O
also RB I-VP O
be VB I-VP O
present JJ B-ADJP O
. . O O

The DT B-NP O
seven CD I-NP O
exons NNS I-NP O
, , O O
the DT B-NP O
exon NN I-NP O
/ SYM B-VP O
intron NN B-NP O
boundaries NNS I-NP O
and CC O O
part NN B-NP O
of IN B-PP O
3 CD B-NP O
noncoding JJ I-NP O
sequence NN I-NP O
of IN B-PP O
the DT B-NP O
CPO NN I-NP O
gene NN I-NP O
were VBD B-VP O
systematically RB I-VP O
analyzed VBN I-VP O
by IN B-PP O
an DT B-NP O
exon NN I-NP O
- HYPH B-ADJP O
by IN B-PP O
- HYPH B-NP O
exon NN I-NP O
denaturing VBG B-VP O
gradient NN B-NP O
gel NN I-NP O
electrophoresis NN I-NP O
( ( O O
DGGE NN B-NP O
) ) O O
strategy NN B-NP O
followed VBN B-VP O
by IN B-PP O
direct JJ B-NP O
sequencing NN I-NP O
in IN B-PP O
seven CD B-NP O
unrelated JJ I-NP O
heterozygous JJ I-NP O
HC NN I-NP B-Disease
patients NNS I-NP O
from IN B-PP O
France NNP B-NP O
, , O O
Holland NNP B-NP O
, , O O
and CC O O
Czech NNP B-NP O
Republic NNP I-NP O
. . O O

Seven CD B-NP O
novel JJ I-NP O
mutations NNS I-NP O
and CC O O
two CD B-NP O
new JJ I-NP O
polymorphisms NNS I-NP O
were VBD B-VP O
detected VBN I-VP O
. . O O

Among IN B-PP O
these DT B-NP O
mutations NNS I-NP O
two CD B-NP O
are VBP B-VP O
missense JJ B-ADJP O
( ( O O
G197W NN B-NP O
, , O O
W427R NN B-NP O
) ) O O
, , O O
two CD B-NP O
are VBP B-VP O
nonsense JJ B-ADJP O
( ( O O
Q306X NN B-NP O
, , O O
Q385X NN B-NP O
) ) O O
, , O O
two CD B-NP O
are VBP B-VP O
small JJ B-NP O
deletions NNS I-NP O
( ( O O
662de14bp NN B-NP O
; : O O
1168del3bp NN B-NP O
removing VBG B-VP O
a DT B-NP O
glycine NN I-NP O
at IN B-PP O
position NN B-NP O
390 CD I-NP O
) ) O O
, , O O
and CC O O
one CD B-NP O
is VBZ B-VP O
a DT B-NP O
splicing NN I-NP O
mutation NN I-NP O
( ( O O
IVS1 NN B-NP O
- HYPH O O
15c SYM B-NP O
- SYM I-NP O
- SYM I-NP O
> SYM I-NP O
g NN I-NP O
) ) O O
which WDT B-NP O
creates VBZ B-VP O
a DT B-NP O
new JJ I-NP O
acceptor NN I-NP O
splice NN I-NP O
site NN I-NP O
. . O O

The DT B-NP O
pathological JJ I-NP O
significance NN I-NP O
of IN B-PP O
the DT B-NP O
point NN I-NP O
mutations NNS I-NP O
G197W NN I-NP O
, , O O
W427R NN B-NP O
, , O O
and CC O O
the DT B-NP O
in IN B-PP O
- HYPH B-NP O
frame NN I-NP O
deletion NN I-NP O
390delGly NN I-NP O
were VBD B-VP O
assessed VBN I-VP O
by IN B-PP O
their PRP$ B-NP O
respective JJ I-NP O
expression NN I-NP O
in IN B-PP O
a DT B-NP O
prokaryotic JJ I-NP O
system NN I-NP O
using VBG B-VP O
site NN B-NP O
- HYPH O O
directed VBN B-NP O
mutagenesis NN I-NP O
. . O O

These DT B-NP O
mutations NNS I-NP O
resulted VBD B-VP O
in IN B-PP O
the DT B-NP O
absence NN I-NP O
or CC O O
a DT B-NP O
dramatic JJ I-NP O
decrease NN I-NP O
of IN B-PP O
CPO NN B-NP O
activity NN I-NP O
. . O O

The DT B-NP O
two CD I-NP O
polymorphisms NNS I-NP O
were VBD B-VP O
localized VBN I-VP O
in IN B-PP O
noncoding JJ B-NP O
part NN I-NP O
of IN B-PP O
the DT B-NP O
gene NN I-NP O
1 CD I-NP O
) ) O O
a DT B-NP O
C NN I-NP O
/ SYM O O
G NN B-NP O
polymorphism NN I-NP O
in IN B-PP O
the DT B-NP O
promotor NN I-NP O
region NN I-NP O
, , O O
142 CD B-NP O
bp NN I-NP O
upstream RB B-ADVP O
from IN B-PP O
the DT B-NP O
transcriptional JJ I-NP O
initiation NN I-NP O
site NN I-NP O
( ( O O
- SYM B-NP O
142C NN I-NP O
/ SYM I-NP O
G NN I-NP O
) ) O O
, , O O
and CC O O
2 LS B-LST O
) ) O O
a DT B-NP O
6 CD I-NP O
bp NN I-NP O
deletion NN I-NP O
polymorphism NN I-NP O
in IN B-PP O
the DT B-NP O
3 CD I-NP O
noncoding JJ I-NP O
part NN I-NP O
of IN B-PP O
the DT B-NP O
CPO NN I-NP O
gene NN I-NP O
, , O O
574 CD B-NP O
bp NN I-NP O
downstream RB B-ADVP O
of IN B-PP O
the DT B-NP O
last JJ I-NP O
base NN I-NP O
of IN B-PP O
the DT B-NP O
normal JJ I-NP O
termination NN I-NP O
codon NN I-NP O
( ( O O
+ SYM B-NP O
574 CD B-NP O
delATTCTT NN I-NP O
) ) O O
. . O O

Five CD B-NP O
intragenic JJ I-NP O
dimorphisms NNS I-NP O
are VBP B-VP O
now RB I-VP O
well RB I-VP O
characterized VBN I-VP O
and CC O O
the DT B-NP O
high JJ I-NP O
degree NN I-NP O
of IN B-PP O
allelic JJ B-NP O
heterogeneity NN I-NP O
in IN B-PP O
HC NN B-NP B-Disease
is VBZ B-VP O
demonstrated VBN I-VP O
with IN B-PP O
seven CD B-NP O
new JJ I-NP O
different JJ I-NP O
mutations NNS I-NP O
making VBG B-VP O
a DT B-NP O
total NN I-NP O
of IN B-PP O
nineteen CD B-NP O
CPO NN I-NP O
gene NN I-NP B-Disease
defects NNS I-NP I-Disease
reported VBN B-VP O
so RB B-ADVP O
far RB I-ADVP O
. . O O

. . O O

Coincidence NN B-NP O
of IN B-PP O
two CD B-NP O
novel JJ I-NP O
arylsulfatase NN I-NP O
A NN I-NP O
alleles NNS I-NP O
and CC O O
mutation NN B-NP O
459 CD I-NP O
+ SYM I-NP O
1G NN I-NP O
> SYM I-NP O
A NN I-NP O
within IN B-PP O
a DT B-NP O
family NN I-NP O
with IN B-PP O
metachromatic JJ B-NP B-Disease
leukodystrophy NN I-NP I-Disease
: : O O
molecular JJ B-NP O
basis NN I-NP O
of IN B-PP O
phenotypic JJ B-NP O
heterogeneity NN I-NP O
. . O O

In IN B-PP O
a DT B-NP O
family NN I-NP O
with IN B-PP O
three CD B-NP O
siblings NNS I-NP O
, , O O
one CD B-NP O
developed VBD B-VP O
classical JJ B-NP O
late JJ I-NP O
infantile JJ I-NP O
metachromatic JJ I-NP B-Disease
leukodystrophy NN I-NP I-Disease
( ( O O
MLD NN B-NP B-Disease
) ) O O
, , O O
fatal JJ B-ADJP O
at IN B-PP O
age NN B-NP O
5 CD B-NP O
years NNS I-NP O
, , O O
with IN B-PP O
deficient JJ B-NP O
arylsulfatase NN I-NP O
A NN I-NP O
( ( O O
ARSA NN B-NP O
) ) O O
activity NN B-NP O
and CC O O
increased VBN B-NP O
galactosylsulfatide NN I-NP O
( ( I-NP O
GS NN I-NP O
) ) I-NP O
excretion NN I-NP O
. . O O

The DT B-NP O
two CD I-NP O
other JJ I-NP O
siblings NNS I-NP O
, , O O
apparently RB B-ADJP O
healthy JJ I-ADJP O
at IN B-PP O
12 CD B-NP O
( ( O O
1 CD B-NP O
/ SYM I-NP O
2 CD I-NP O
) ) O O
and CC O O
15 CD B-NP O
years NNS I-NP O
, , O O
respectively RB B-ADVP O
, , O O
and CC O O
their PRP$ B-NP O
father NN I-NP O
, , O O
apparently RB B-ADJP O
healthy JJ I-ADJP O
as IN B-ADVP O
well RB I-ADVP O
, , O O
presented VBN B-NP O
ARSA NN I-NP O
and CC I-NP O
GS NN I-NP O
values NNS I-NP O
within IN B-PP O
the DT B-NP O
range NN I-NP O
of IN B-PP O
MLD NN B-NP B-Disease
patients NNS I-NP O
. . O O

Mutation NN B-NP O
screening NN I-NP O
and CC O O
sequence NN B-NP O
analysis NN I-NP O
disclosed VBD B-VP O
the DT B-NP O
involvement NN I-NP O
of IN B-PP O
three CD B-NP O
different JJ I-NP O
ARSA NN I-NP O
mutations NNS I-NP O
being VBG B-VP O
the DT B-NP O
molecular JJ I-NP O
basis NN I-NP O
of IN B-PP O
intrafamilial JJ B-NP O
phenotypic JJ I-NP O
heterogeneity NN I-NP O
. . O O

The DT B-NP O
late JJ I-NP O
infantile JJ I-NP O
patient NN I-NP O
inherited VBN B-VP O
from IN B-PP O
his PRP$ B-NP O
mother NN I-NP O
the DT B-NP O
frequent JJ I-NP O
0 CD I-NP O
- HYPH I-NP O
type NN I-NP O
mutation NN I-NP O
459 CD I-NP O
+ SYM I-NP O
1G NN I-NP O
> SYM I-NP O
A NN I-NP O
, , B-PP O
and CC I-PP O
from IN B-PP O
his PRP$ B-NP O
father NN I-NP O
a DT B-NP O
novel JJ I-NP O
, , I-NP O
single JJ I-NP O
basepair NN I-NP O
microdeletion NN I-NP O
of IN B-PP O
guanine NN B-NP O
at IN B-PP O
nucleotide NN B-NP O
7 CD I-NP O
in IN B-PP O
exon NN B-NP O
1 CD I-NP O
( ( O O
7delG NN B-NP O
) ) O O
. . O O

The DT B-NP O
two CD I-NP O
clinically RB I-NP O
unaffected JJ I-NP O
siblings NNS I-NP O
carried VBD B-VP O
the DT B-NP O
maternal JJ I-NP O
mutation NN I-NP O
459 CD I-NP O
+ SYM I-NP O
1G NN I-NP O
> SYM B-NP O
A NN I-NP O
and CC O O
, , O O
on IN B-PP O
their PRP$ B-NP O
paternal JJ I-NP O
allele NN I-NP O
, , O O
a DT B-NP O
novel JJ I-NP O
cytosine NN I-NP O
to TO B-PP O
thymidine NN B-NP O
transition NN I-NP O
at IN B-PP O
nucleotide NN B-NP O
2435 CD I-NP O
in IN B-PP O
exon NN B-NP O
8 CD I-NP O
, , O O
resulting VBG B-VP O
in IN B-PP O
substitution NN B-NP O
of IN B-PP O
alanine NN B-NP O
464 CD I-NP O
by IN B-PP O
valine NN B-NP O
( ( O O
A464V NN B-NP O
) ) O O
. . O O

The DT B-NP O
fathers NNS I-NP O
genotype NN I-NP O
thus RB B-ADVP O
was VBD B-VP O
7delG NN B-NP O
/ SYM B-NP O
A464V NN I-NP O
. . O O

Mutation NN B-NP O
A464V NN I-NP O
was VBD B-VP O
not RB I-VP O
found VBN I-VP O
in IN B-PP O
18 CD B-NP O
unrelated JJ I-NP O
MLD NN I-NP B-Disease
patients NNS I-NP O
and CC O O
50 CD B-NP O
controls NNS I-NP O
. . O O

A464V NN B-NP O
, , O O
although IN B-SBAR O
clearly RB B-ADVP O
modifying VBG B-VP O
ARSA NN B-NP O
and CC I-NP O
GS NN I-NP O
levels NNS I-NP O
, , O O
apparently RB B-ADVP O
bears VBZ B-VP O
little JJ B-NP O
significance NN I-NP O
for IN B-PP O
clinical JJ B-NP O
manifestation NN I-NP O
of IN B-PP O
MLD NN B-NP B-Disease
, , O O
mimicking VBG B-VP O
the DT B-NP O
frequent JJ I-NP O
ARSA NN I-NP O
pseudodeficiency NN I-NP O
allele NN I-NP O
. . O O

Our PRP$ B-NP O
results NNS I-NP O
demonstrate VBP B-VP O
that IN B-SBAR O
in IN B-PP O
certain JJ B-NP O
genetic JJ I-NP O
conditions NNS I-NP O
MLD NN I-NP B-Disease
- HYPH B-NP O
like JJ I-NP O
ARSA NN I-NP O
and CC I-NP O
GS NN I-NP O
values NNS I-NP O
need VBP B-VP O
not RB I-VP O
be VB I-VP O
paralleled VBN I-VP O
by IN B-PP O
clinical JJ B-NP O
disease NN I-NP O
, , O O
a DT B-NP O
finding NN I-NP O
with IN B-PP O
serious JJ B-NP O
diagnostic JJ I-NP O
and CC I-NP O
prognostic JJ I-NP O
implications NNS I-NP O
. . O O

Moreover RB B-ADVP O
, , O O
further JJ B-NP O
ARSA NN I-NP O
alleles NNS I-NP O
functionally RB B-ADJP O
similar JJ I-ADJP O
to TO B-PP O
A464V NN B-NP O
might MD B-VP O
exist VB I-VP O
which WDT B-NP O
, , O O
together RB B-ADVP O
with IN B-PP O
0 CD B-NP O
- HYPH I-NP O
type NN I-NP O
mutations NNS I-NP O
, , O O
may MD B-VP O
cause VB I-VP O
pathological JJ B-NP O
ARSA NN I-NP O
and CC I-NP O
GS NN I-NP O
levels NNS I-NP O
, , O O
but CC B-CONJP O
not RB I-CONJP O
clinical JJ B-NP O
outbreak NN I-NP O
of IN B-PP O
the DT B-NP O
disease NN I-NP O
. . O O

. . O O

Human JJ B-NP O
MLH1 NN I-NP O
deficiency NN I-NP O
predisposes VBZ B-VP O
to TO B-PP O
hematological JJ B-NP B-Disease
malignancy NN I-NP I-Disease
and CC I-NP O
neurofibromatosis NN I-NP B-Disease
type NN I-NP I-Disease
1 CD I-NP I-Disease
. . O O

Heterozygous JJ B-NP O
germ NN I-NP O
- HYPH I-NP O
line NN I-NP O
mutations NNS I-NP O
in IN B-PP O
the DT B-NP O
DNA NN I-NP O
mismatch NN I-NP O
repair NN I-NP O
genes NNS I-NP O
lead VBP B-VP O
to TO B-PP O
hereditary JJ B-NP B-Disease
nonpolyposis JJ I-NP I-Disease
colorectal JJ I-NP I-Disease
cancer NN I-NP I-Disease
. . O O

The DT B-NP O
disease NN I-NP O
susceptibility NN I-NP O
of IN B-PP O
individuals NNS B-NP O
who WP B-NP O
constitutionally RB B-ADVP O
lack VBP B-VP O
both CC O O
wild JJ B-NP O
- HYPH I-NP O
type NN I-NP O
alleles NNS I-NP O
is VBZ B-VP O
unknown JJ B-ADJP O
. . O O

We PRP B-NP O
have VBP B-VP O
identified VBN I-VP O
three CD B-NP O
offspring NN I-NP O
in IN B-PP O
a DT B-NP O
hereditary JJ I-NP B-Disease
nonpolyposis NN I-NP I-Disease
colorectal JJ I-NP I-Disease
cancer NN I-NP I-Disease
family NN I-NP O
who WP B-NP O
developed VBD B-VP O
hematological JJ B-NP B-Disease
malignancy NN I-NP I-Disease
at IN B-PP O
a DT B-NP O
very RB I-NP O
early JJ I-NP O
age NN I-NP O
, , O O
and CC O O
at IN B-NP O
least JJS I-NP O
two CD I-NP O
of IN B-PP O
them PRP B-NP O
displayed VBD B-VP O
signs NNS B-NP O
of IN B-PP O
neurofibromatosis NN B-NP B-Disease
type NN I-NP I-Disease
1 CD I-NP I-Disease
( ( O O
NF1 NN B-NP B-Disease
) ) O O
. . O O

DNA NN B-NP O
sequence NN I-NP O
analysis NN I-NP O
and CC I-NP O
allele NN I-NP O
- HYPH B-NP O
specific JJ I-NP O
amplification NN I-NP O
in IN B-PP O
two CD B-NP O
siblings NNS I-NP O
revealed VBD B-VP O
a DT B-NP O
homozygous JJ I-NP O
MLH1 NN I-NP O
mutation NN I-NP O
( ( O O
C676T NN B-NP O
- SYM O O
- HYPH B-NP O
> SYM I-NP O
Arg226Stop NN I-NP O
) ) O O
. . O O

Thus RB B-ADVP O
, , O O
a DT B-NP O
homozygous JJ I-NP O
germ NN I-NP O
- HYPH I-NP O
line NN I-NP O
MLH1 NN I-NP O
mutation NN I-NP O
and CC O O
consequent JJ B-NP O
mismatch NN I-NP O
repair NN I-NP O
deficiency NN I-NP O
results VBZ B-VP O
in IN B-PP O
a DT B-NP O
mutator NN I-NP O
phenotype NN I-NP O
characterized VBN B-VP O
by IN B-PP O
leukemia NN B-NP B-Disease
and CC O O
/ SYM B-NP O
or CC O O
lymphoma NN B-NP B-Disease
associated VBN B-VP O
with IN B-PP O
neurofibromatosis NN B-NP B-Disease
type NN I-NP I-Disease
1 CD I-NP I-Disease
. . O O

. . O O

Missense JJ B-NP O
mutations NNS I-NP O
in IN B-PP O
the DT B-NP O
most RBS I-NP O
ancient JJ I-NP O
residues NNS I-NP O
of IN B-PP O
the DT B-NP O
PAX6 NN I-NP O
paired JJ I-NP O
domain NN I-NP O
underlie VBP B-VP O
a DT B-NP O
spectrum NN I-NP O
of IN B-PP O
human JJ B-NP O
congenital JJ I-NP B-Disease
eye NN I-NP I-Disease
malformations NNS I-NP I-Disease
. . O O

Mutations NNS B-NP O
of IN B-PP O
the DT B-NP O
human JJ I-NP O
PAX6 NN I-NP O
gene NN I-NP O
underlie VBP B-VP O
aniridia NN B-NP B-Disease
( ( O O
congenital JJ B-NP B-Disease
absence NN I-NP I-Disease
of IN B-PP I-Disease
the DT B-NP I-Disease
iris NN I-NP I-Disease
) ) O O
, , O O
a DT B-NP O
rare JJ I-NP O
dominant JJ I-NP O
malformation NN I-NP B-Disease
of IN B-PP I-Disease
the DT B-NP I-Disease
eye NN I-NP I-Disease
. . O O

The DT B-NP O
spectrum NN I-NP O
of IN B-PP O
PAX6 NN B-NP O
mutations NNS I-NP O
in IN B-PP O
aniridia NN B-NP B-Disease
patients NNS I-NP O
is VBZ B-VP O
highly RB I-VP O
biased VBN I-VP O
, , O O
with IN B-PP O
92 CD B-NP O
% NN I-NP O
of IN B-PP O
all DT B-NP O
reported VBN I-NP O
mutations NNS I-NP O
leading VBG B-VP O
to TO B-PP O
premature JJ B-NP O
truncation NN I-NP O
of IN B-PP O
the DT B-NP O
protein NN I-NP O
( ( O O
nonsense NN B-NP O
, , O O
splicing NN B-NP O
, , O O
insertions NNS B-NP O
and CC I-NP O
deletions NNS I-NP O
) ) O O
and CC O O
just RB B-NP O
2 CD I-NP O
% NN I-NP O
leading VBG B-VP O
to TO B-PP O
substitution NN B-NP O
of IN B-PP O
one CD B-NP O
amino NN I-NP O
acid NN I-NP O
by IN B-PP O
another DT B-NP O
( ( O O
missense JJ B-ADJP O
) ) O O
. . O O

The DT B-NP O
extraordinary JJ I-NP O
conservation NN I-NP O
of IN B-PP O
the DT B-NP O
PAX6 NN I-NP O
protein NN I-NP O
at IN B-PP O
the DT B-NP O
amino JJ I-NP O
acid NN I-NP O
level NN I-NP O
amongst IN B-PP O
vertebrates NNS B-NP O
predicts VBZ B-VP O
that IN B-SBAR O
pathological JJ B-NP O
missense JJ I-NP O
mutations NNS I-NP O
should MD B-VP O
in IN B-PP O
fact NN B-NP O
be VB B-VP O
common JJ B-ADJP O
even RB B-SBAR O
though IN I-SBAR O
they PRP B-NP O
are VBP B-VP O
hardly RB I-VP O
ever RB I-VP O
seen VBN I-VP O
in IN B-PP O
aniridia NN B-NP B-Disease
patients NNS I-NP O
. . O O

This DT B-NP O
indicates VBZ B-VP O
that IN B-SBAR O
there EX B-NP O
is VBZ B-VP O
a DT B-NP O
heavy JJ I-NP O
ascertainment NN I-NP O
bias NN I-NP O
in IN B-PP O
the DT B-NP O
selection NN I-NP O
of IN B-PP O
patients NNS B-NP O
for IN B-PP O
PAX6 NN B-NP O
mutation NN I-NP O
analysis NN I-NP O
and CC O O
that IN B-SBAR O
the DT B-NP O
missing VBG I-NP O
PAX6 NN I-NP O
missense JJ I-NP O
mutations NNS I-NP O
frequently RB B-ADVP O
may MD B-VP O
underlie VB I-VP O
phenotypes NNS B-NP O
distinct JJ B-ADJP O
from IN B-PP O
textbook NN B-NP O
aniridia NN I-NP B-Disease
. . O O

Here RB B-ADVP O
we PRP B-NP O
present VBP B-VP O
four CD B-NP O
novel JJ I-NP O
PAX6 NN I-NP O
missense JJ I-NP O
mutations NNS I-NP O
, , O O
two CD B-NP O
in IN B-PP O
association NN B-NP O
with IN B-PP O
atypical JJ B-NP O
phenotypes NNS I-NP O
ectopia NN I-NP B-Disease
pupillae NNS I-NP I-Disease
( ( O O
displaced VBN B-NP B-Disease
pupils NNS I-NP I-Disease
) ) O O
and CC O O
congenital JJ B-NP B-Disease
nystagmus NN I-NP I-Disease
( ( O O
searching VBG B-VP B-Disease
gaze NN B-NP I-Disease
) ) O O
, , O O
and CC O O
two CD B-NP O
in IN B-PP O
association NN B-NP O
with IN B-PP O
more RBR B-NP O
recognizable JJ I-NP O
aniridia NN I-NP B-Disease
phenotypes NNS I-NP O
. . O O

Strikingly RB B-ADVP O
, , O O
all DT B-NP O
four CD I-NP O
mutations NNS I-NP O
are VBP B-VP O
located JJ B-ADJP O
within IN B-PP O
the DT B-NP O
PAX6 NN I-NP O
paired JJ I-NP O
domain NN I-NP O
and CC O O
affect VB B-VP O
amino JJ B-NP O
acids NNS I-NP O
which WDT B-NP O
are VBP B-VP O
highly RB I-VP O
conserved VBN I-VP O
in IN B-PP O
all DT B-NP O
known VBN I-NP O
paired JJ I-NP O
domain NN I-NP O
proteins NNS I-NP O
. . O O

Our PRP$ B-NP O
results NNS I-NP O
support VBP B-VP O
the DT B-NP O
hypothesis NN I-NP O
that IN B-SBAR O
the DT B-NP O
under NN I-NP O
- HYPH I-NP O
representation NN I-NP O
of IN B-PP O
missense JJ B-NP O
mutations NNS I-NP O
is VBZ B-VP O
caused VBN I-VP O
by IN B-PP O
ascertainment NN B-NP O
bias NN I-NP O
and CC O O
suggest VBP B-VP O
that IN B-SBAR O
a DT B-NP O
substantial JJ I-NP O
burden NN I-NP O
of IN B-PP O
PAX6 NN B-NP B-Disease
- HYPH B-NP I-Disease
related VBN I-NP I-Disease
disease NN I-NP I-Disease
remains VBZ B-VP O
to TO I-VP O
be VB I-VP O
uncovered VBN I-VP O
. . O O

. . O O

The DT B-NP O
chromosomal JJ I-NP O
order NN I-NP O
of IN B-PP O
genes NNS B-NP O
controlling VBG B-VP O
the DT B-NP O
major JJ I-NP O
histocompatibility NN I-NP O
complex NN I-NP O
, , O O
properdin NN B-NP O
factor NN I-NP O
B NN I-NP O
, , O O
and CC O O
deficiency NN B-NP B-Disease
of IN B-PP I-Disease
the DT B-NP I-Disease
second JJ I-NP I-Disease
component NN I-NP I-Disease
of IN B-PP I-Disease
complement NN B-NP I-Disease
. . O O

The DT B-NP O
relationship NN I-NP O
of IN B-PP O
the DT B-NP O
genes NNS I-NP O
coding VBG B-VP O
for IN B-PP O
HLA NN B-NP O
to TO B-PP O
those DT B-NP O
coding VBG B-VP O
for IN B-PP O
properdin NN B-NP O
Factor NN I-NP O
B NN I-NP O
allotypes NNS I-NP O
and CC B-PP O
for IN B-PP O
deficiency NN B-NP B-Disease
of IN B-PP I-Disease
the DT B-NP I-Disease
second JJ I-NP I-Disease
component NN I-NP I-Disease
of IN B-PP I-Disease
complement NN B-NP I-Disease
( ( O O
C2 NN B-NP O
) ) O O
was VBD B-VP O
studied VBN I-VP O
in IN B-PP O
families NNS B-NP O
of IN B-PP O
patients NNS B-NP O
with IN B-PP O
connective JJ B-NP O
tissue NN I-NP O
disorders NNS I-NP O
. . O O

Patients NNS B-NP O
were VBD B-VP O
selected VBN I-VP O
because IN B-SBAR O
they PRP B-NP O
were VBD B-VP O
heterozygous JJ B-ADJP O
or CC I-ADJP O
homozygous JJ I-ADJP O
for IN B-PP O
C2 NN B-NP B-Disease
deficiency NN I-NP I-Disease
. . O O

12 CD B-NP O
families NNS I-NP O
with IN B-PP O
15 CD B-NP O
matings NNS I-NP O
informative JJ B-ADJP O
for IN B-PP O
C2 NN B-NP B-Disease
deficiency NN I-NP I-Disease
were VBD B-VP O
found VBN I-VP O
. . O O

Of IN B-PP O
57 CD B-NP O
informative JJ I-NP O
meioses NNS I-NP O
, , O O
two CD B-NP O
crossovers NNS I-NP O
were VBD B-VP O
noted VBN I-VP O
between IN B-PP O
the DT B-NP O
C2 NN I-NP B-Disease
deficiency NN I-NP I-Disease
gene NN I-NP O
and CC O O
the DT B-NP O
HLA NN I-NP O
- HYPH B-NP O
B NN I-NP O
gene NN I-NP O
, , O O
with IN B-PP O
a DT B-NP O
recombinant JJ I-NP O
fraction NN I-NP O
of IN B-PP O
0 CD B-NP O
. . O O

035 CD B-NP O
. . O O

A DT B-NP O
lod NN I-NP O
score NN I-NP O
of IN B-PP O
13 CD B-NP O
was VBD B-VP O
calculated VBN I-VP O
for IN B-PP O
linkage NN B-NP O
between IN B-PP O
C2 NN B-NP B-Disease
deficiency NN I-NP I-Disease
and CC I-NP O
HLA NN I-NP O
- HYPH O O
B NN B-NP O
at IN B-PP O
a DT B-NP O
maximum NN I-NP O
likelihood NN I-NP O
value NN I-NP O
of IN B-PP O
the DT B-NP O
recombinant JJ I-NP O
fraction NN I-NP O
of IN B-PP O
0 CD B-NP O
. . O O

04 CD B-NP O
. . O O

18 CD B-NP O
families NNS I-NP O
with IN B-PP O
21 CD B-NP O
informative JJ I-NP O
matings NNS I-NP O
for IN B-PP O
both CC O O
properdin NN B-NP O
Factor NN I-NP O
B NN I-NP O
allotype NN I-NP O
and CC I-NP O
HLA NN I-NP O
- HYPH O O
B NN B-NP O
were VBD B-VP O
found VBN I-VP O
. . O O

Of IN B-PP O
72 CD B-NP O
informative JJ I-NP O
meioses NNS I-NP O
, , O O
three CD B-NP O
recombinants NNS I-NP O
were VBD B-VP O
found VBN I-VP O
, , O O
giving VBG B-VP O
a DT B-NP O
recombinant JJ I-NP O
fraction NN I-NP O
of IN B-PP O
0 CD B-NP O
. . O O

042 CD B-NP O
. . O O

A DT B-NP O
lod NN I-NP O
score NN I-NP O
of IN B-PP O
16 CD B-NP O
between IN B-PP O
HLA NN B-NP O
- HYPH I-NP O
B NN I-NP O
and CC I-NP O
Factor NN I-NP O
B NN I-NP O
allotypes NNS I-NP O
was VBD B-VP O
calculated VBN I-VP O
at IN B-PP O
a DT B-NP O
maximum NN I-NP O
likelihood NN I-NP O
value NN I-NP O
of IN B-PP O
the DT B-NP O
recombinant JJ I-NP O
fraction NN I-NP O
of IN B-PP O
0 CD B-NP O
. . O O

04 CD B-NP O
. . O O

A DT B-NP O
crossover NN I-NP O
was VBD B-VP O
shown VBN I-VP O
to TO I-VP O
have VB I-VP O
occurred VBN I-VP O
between IN B-PP O
genes NNS B-NP O
for IN B-PP O
Factor NN B-NP O
B NN I-NP O
and CC O O
HLA NN B-NP O
- HYPH O O
D NN B-NP O
, , O O
in IN B-PP O
which WDT B-NP O
HLA NN B-NP O
- HYPH I-NP O
D NN I-NP O
segregared VBN B-VP O
with IN B-PP O
HLA NN B-NP O
- HYPH I-NP O
A NN I-NP O
and CC I-NP O
B NN I-NP O
. . O O

These DT B-NP O
studies NNS I-NP O
suggest VBP B-VP O
that IN B-SBAR O
the DT B-NP O
genes NNS I-NP O
for IN B-PP O
Factor NN B-NP O
B NN I-NP O
and CC O O
C2 NN B-NP B-Disease
deficiency NN I-NP I-Disease
are VBP B-VP O
located JJ B-ADJP O
outside IN B-PP O
those DT B-NP O
for IN B-PP O
HLA NN B-NP O
, , O O
that IN B-SBAR O
the DT B-NP O
order NN I-NP O
of IN B-PP O
genese NN B-NP O
is VBZ B-VP O
HLA NN B-NP O
- HYPH I-NP O
A NN I-NP O
, , O O
- HYPH B-NP O
B NN I-NP O
, , O O
- HYPH B-NP O
D NN I-NP O
, , O O
Factor NN B-NP O
B NN I-NP O
allotype NN I-NP O
, , O O
C2 NN B-NP B-Disease
deficiency NN I-NP I-Disease
, , O O
that IN B-SBAR O
the DT B-NP O
genes NNS I-NP O
coding VBG B-VP O
for IN B-PP O
C2 NN B-NP B-Disease
deficiency NN I-NP I-Disease
and CC O O
Factor NN B-NP O
B NN I-NP O
allotypes NNS I-NP O
are VBP B-VP O
approximately RB B-NP O
3 CD I-NP O
- HYPH I-NP O
- SYM I-NP O
5 CD I-NP O
centimorgans NNS I-NP O
from IN B-PP O
the DT B-NP O
HLA NN I-NP O
- HYPH I-NP O
A NN I-NP O
and CC I-NP O
HLA NN I-NP O
- HYPH B-NP O
B NN I-NP O
loci NNS I-NP O
, , O O
and CC O O
that IN B-SBAR O
the DT B-NP O
apparent JJ I-NP O
lack NN I-NP O
of IN B-PP O
recombinants NNS B-NP O
between IN B-PP O
the DT B-NP O
Factor NN I-NP O
B NN I-NP O
gene NN I-NP O
and CC O O
C2 NN B-NP B-Disease
deficiency NN I-NP I-Disease
gene NN I-NP O
suggests VBZ B-VP O
that IN B-SBAR O
these DT B-NP O
two CD I-NP O
genes NNS I-NP O
lie VBP B-VP O
in IN B-PP O
close JJ B-NP O
proximity NN I-NP O
to TO B-PP O
one CD B-NP O
another DT I-NP O
. . O O

Distribution NN B-NP O
of IN B-PP O
emerin NN B-NP O
and CC I-NP O
lamins NNS I-NP O
in IN B-PP O
the DT B-NP O
heart NN I-NP O
and CC I-NP O
implications NNS I-NP O
for IN B-PP O
Emery NNP B-NP B-Disease
- HYPH B-NP I-Disease
Dreifuss NNP I-NP I-Disease
muscular JJ I-NP I-Disease
dystrophy NN I-NP I-Disease
. . O O

Emerin NN B-NP O
is VBZ B-VP O
a DT B-NP O
nuclear JJ I-NP O
membrane NN I-NP O
protein NN I-NP O
which WDT B-NP O
is VBZ B-VP O
missing JJ B-ADJP O
or CC I-ADJP O
defective JJ I-ADJP O
in IN B-PP O
Emery NNP B-NP B-Disease
- HYPH B-NP I-Disease
Dreifuss NNP I-NP I-Disease
muscular JJ I-NP I-Disease
dystrophy NN I-NP I-Disease
( ( O O
EDMD NN B-NP B-Disease
) ) O O
. . O O

It PRP B-NP O
is VBZ B-VP O
one CD B-NP O
member NN I-NP O
of IN B-PP O
a DT B-NP O
family NN I-NP O
of IN B-PP O
lamina NN B-NP O
- HYPH B-NP O
associated VBN I-NP O
proteins NNS I-NP O
which WDT B-NP O
includes VBZ B-VP O
LAP1 NN B-NP O
, , I-NP O
LAP2 NN I-NP O
and CC I-NP O
lamin NN I-NP O
B NN I-NP O
receptor NN I-NP O
( ( O O
LBR NN B-NP O
) ) O O
. . O O

A DT B-NP O
panel NN I-NP O
of IN B-PP O
16 CD B-NP O
monoclonal JJ I-NP O
antibodies NNS I-NP O
( ( O O
mAbs NNS B-NP O
) ) O O
has VBZ B-VP O
been VBN I-VP O
mapped VBN I-VP O
to TO B-PP O
six CD B-NP O
specific JJ I-NP O
sites NNS I-NP O
throughout IN B-PP O
the DT B-NP O
emerin NN I-NP O
molecule NN I-NP O
using VBG B-VP O
phage NN B-NP O
- HYPH O O
displayed VBN B-NP O
peptide NN I-NP O
libraries NNS I-NP O
and CC O O
has VBZ B-VP O
been VBN I-VP O
used VBN I-VP O
to TO I-VP O
localize VB I-VP O
emerin NN B-NP O
in IN B-PP O
human JJ B-NP O
and CC I-NP O
rabbit NN I-NP O
heart NN I-NP O
. . O O

Several JJ B-NP O
mAbs NNS I-NP O
against IN B-PP O
different JJ B-NP O
emerin NN I-NP O
epitopes NNS I-NP O
did VBD B-VP O
not RB I-VP O
recognize VB I-VP O
intercalated VBN B-NP O
discs NNS I-NP O
in IN B-PP O
the DT B-NP O
heart NN I-NP O
, , O O
though IN B-SBAR O
they PRP B-NP O
recognized VBD B-VP O
cardiomyocyte NN B-NP O
nuclei NNS I-NP O
strongly RB B-ADVP O
, , O O
both DT B-NP O
at IN B-PP O
the DT B-NP O
rim NN I-NP O
and CC B-PP O
in IN B-PP O
intranuclear JJ B-NP O
spots NNS I-NP O
or CC I-NP O
channels NNS I-NP O
. . O O

A DT B-NP O
polyclonal JJ I-NP O
rabbit NN I-NP O
antiserum NN I-NP O
against IN B-PP O
emerin NN B-NP O
did VBD B-VP O
recognize VB I-VP O
both CC O O
nuclear JJ B-NP O
membrane NN I-NP O
and CC O O
intercalated JJ B-NP O
discs NNS I-NP O
but CC O O
, , O O
after IN B-PP O
affinity NN B-NP O
purification NN I-NP O
against IN B-PP O
a DT B-NP O
pure JJ I-NP O
- HYPH I-NP O
emerin NN I-NP O
band NN I-NP O
on IN B-PP O
a DT B-NP O
western JJ I-NP O
blot NN I-NP O
, , O O
it PRP B-NP O
stained VBD B-VP O
only RB B-NP O
the DT I-NP O
nuclear JJ I-NP O
membrane NN I-NP O
. . O O

These DT B-NP O
results NNS I-NP O
would MD B-VP O
not RB I-VP O
be VB I-VP O
expected VBN I-VP O
if IN B-SBAR O
immunostaining NN B-NP O
at IN B-PP O
intercalated JJ B-NP O
discs NNS I-NP O
were VBD B-VP O
due JJ B-ADJP O
to TO B-PP O
a DT B-NP O
product NN I-NP O
of IN B-PP O
the DT B-NP O
emerin NN I-NP O
gene NN I-NP O
and CC O O
, , O O
therefore RB B-ADVP O
, , O O
cast VBD B-VP O
some DT B-NP O
doubt NN I-NP O
upon IN B-PP O
the DT B-NP O
hypothesis NN I-NP O
that IN B-SBAR O
cardiac JJ B-NP B-Disease
defects NNS I-NP I-Disease
in IN B-PP O
EDMD NN B-NP B-Disease
are VBP B-VP O
caused VBN I-VP O
by IN B-PP O
absence NN B-NP O
of IN B-PP O
emerin NN B-NP O
from IN B-PP O
intercalated VBN B-NP O
discs NNS I-NP O
. . O O

Although IN B-SBAR O
emerin NN B-NP O
was VBD B-VP O
abundant JJ B-ADJP O
in IN B-PP O
the DT B-NP O
membranes NNS I-NP O
of IN B-PP O
cardiomyocyte NN B-NP O
nuclei NNS I-NP O
, , O O
it PRP B-NP O
was VBD B-VP O
absent JJ B-ADJP O
from IN B-PP O
many JJ B-NP O
non AFX I-NP O
- HYPH I-NP O
myocyte NN I-NP O
cells NNS I-NP O
in IN B-PP O
the DT B-NP O
heart NN I-NP O
. . O O

This DT B-NP O
distribution NN I-NP O
of IN B-PP O
emerin NN B-NP O
was VBD B-VP O
similar JJ B-ADJP O
to TO B-PP O
that DT B-NP O
of IN B-PP O
lamin NN B-NP O
A NN I-NP O
, , O O
a DT B-NP O
candidate NN I-NP O
gene NN I-NP O
for IN B-PP O
an DT B-NP O
autosomal JJ I-NP O
form NN I-NP O
of IN B-PP O
EDMD NN B-NP B-Disease
. . O O

In IN B-PP O
contrast NN B-NP O
, , O O
lamin NN B-NP O
B1 NN I-NP O
was VBD B-VP O
absent JJ B-ADJP O
from IN B-PP O
cardiomyocyte NN B-NP O
nuclei NNS I-NP O
, , O O
showing VBG B-VP O
that IN B-SBAR O
lamin NN B-NP O
B1 NN I-NP O
is VBZ B-VP O
not RB O O
essential JJ B-ADJP O
for IN B-PP O
localization NN B-NP O
of IN B-PP O
emerin NN B-NP O
to TO B-PP O
the DT B-NP O
nuclear JJ I-NP O
lamina NN I-NP O
. . O O

Lamin NN B-NP O
B1 NN I-NP O
is VBZ B-VP O
also RB B-ADVP O
almost RB B-ADJP O
completely RB I-ADJP O
absent JJ I-ADJP O
from IN B-PP O
skeletal JJ B-NP O
muscle NN I-NP O
nuclei NNS I-NP O
. . O O

In IN B-PP O
EDMD NNP B-NP B-Disease
, , O O
the DT B-NP O
additional JJ I-NP O
absence NN I-NP O
of IN B-PP O
lamin NN B-NP O
B1 NN I-NP O
from IN B-PP O
heart NN B-NP O
and CC O O
skeletal JJ B-NP O
muscle NN I-NP O
nuclei NNS I-NP O
which WDT B-NP O
already RB B-ADVP O
lack VBP B-VP O
emerin NN B-NP O
may MD B-VP O
offer VB I-VP O
an DT B-NP O
alternative JJ I-NP O
explanation NN I-NP O
of IN B-PP O
why WRB B-ADVP O
these DT B-NP O
tissues NNS I-NP O
are VBP B-VP O
particularly RB I-VP O
affected VBN I-VP O
. . O O

. . O O

Genetic JJ B-NP O
mapping NN I-NP O
of IN B-PP O
the DT B-NP O
copper NN I-NP B-Disease
toxicosis NN I-NP I-Disease
locus NN I-NP O
in IN B-PP O
Bedlington NNP B-NP O
terriers NNS I-NP O
to TO B-PP O
dog NN B-NP O
chromosome NN I-NP O
10 CD I-NP O
, , O O
in IN B-PP O
a DT B-NP O
region NN I-NP O
syntenic JJ B-ADJP O
to TO B-PP O
human JJ B-NP O
chromosome NN I-NP O
region NN I-NP O
2p13 NN I-NP O
- HYPH B-NP O
p16 NN I-NP O
. . O O

Abnormal JJ B-NP O
hepatic JJ I-NP B-Disease
copper NN I-NP I-Disease
accumulation NN I-NP I-Disease
is VBZ B-VP O
recognized VBN I-VP O
as IN B-PP O
an DT B-NP O
inherited VBN I-NP B-Disease
disorder NN I-NP I-Disease
in IN B-PP O
man NN B-NP O
, , O O
mouse NN B-NP O
, , O O
rat NN B-NP O
and CC I-NP O
dog NN I-NP O
. . O O

The DT B-NP O
major JJ I-NP O
cause NN I-NP O
of IN B-PP O
hepatic JJ B-NP B-Disease
copper NN I-NP I-Disease
accumulation NN I-NP I-Disease
in IN B-PP O
man NN B-NP O
is VBZ B-VP O
a DT B-NP O
dysfunctional JJ I-NP O
ATP7B NN I-NP O
gene NN I-NP O
, , O O
causing VBG B-VP O
Wilson NNP B-NP B-Disease
disease NN I-NP I-Disease
( ( O O
WD NN B-NP B-Disease
) ) O O
. . O O

Mutations NNS B-NP O
in IN B-PP O
the DT B-NP O
ATP7B NN I-NP O
genes NNS I-NP O
have VBP B-VP O
also RB I-VP O
been VBN I-VP O
demonstrated VBN I-VP O
in IN B-PP O
mouse NN B-NP O
and CC O O
rat NN B-NP O
. . O O

The DT B-NP O
ATP7B NN I-NP O
gene NN I-NP O
has VBZ B-VP O
been VBN I-VP O
excluded VBN I-VP O
in IN B-PP O
the DT B-NP O
much JJ I-NP O
rarer NN I-NP O
human JJ I-NP O
copper NN I-NP B-Disease
overload NN I-NP I-Disease
disease NN I-NP O
non AFX O B-Disease
- HYPH B-NP I-Disease
Indian JJ I-NP I-Disease
childhood NN I-NP I-Disease
cirrhosis NN I-NP I-Disease
, , O O
indicating VBG B-VP O
genetic JJ B-NP O
heterogeneity NN I-NP O
. . O O

By IN B-PP O
investigating VBG B-VP O
the DT B-NP O
common JJ I-NP O
autosomal JJ I-NP O
recessive JJ I-NP O
copper NN I-NP B-Disease
toxicosis NN I-NP I-Disease
( ( O O
CT NN B-NP B-Disease
) ) O O
in IN B-PP O
Bedlington NNP B-NP O
terriers NNS I-NP O
, , O O
we PRP B-NP O
have VBP B-VP O
identified VBN I-VP O
a DT B-NP O
new JJ I-NP O
locus NN I-NP O
involved VBN B-VP O
in IN B-PP O
progressive JJ B-NP O
liver NN I-NP B-Disease
disease NN I-NP I-Disease
. . O O

We PRP B-NP O
examined VBD B-VP O
whether IN B-SBAR O
the DT B-NP O
WD JJ I-NP B-Disease
gene NN I-NP O
ATP7B NN I-NP O
was VBD B-VP O
also RB B-ADVP O
causative JJ B-ADJP O
for IN B-PP O
CT NN B-NP B-Disease
by IN B-PP O
investigating VBG B-VP O
the DT B-NP O
chromosomal JJ I-NP O
co AFX I-NP O
- HYPH I-NP O
localization NN I-NP O
of IN B-PP O
ATP7B NN B-NP O
and CC I-NP O
C04107 NN I-NP O
, , O O
using VBG B-VP O
fluorescence NN B-NP O
in FW B-NP O
situ FW I-NP O
hybridization NN I-NP O
( ( O O
FISH NN B-NP O
) ) O O
. . O O

C04107 NN B-NP O
is VBZ B-VP O
an DT B-NP O
anonymous JJ I-NP O
microsatellite NN I-NP O
marker NN I-NP O
closely RB B-VP O
linked VBN I-VP O
to TO B-PP O
CT NN B-NP B-Disease
. . O O

However RB B-ADVP O
, , O O
BAC NN B-NP O
clones NNS I-NP O
containing VBG B-VP O
ATP7B NN B-NP O
and CC I-NP O
C04107 NN I-NP O
mapped VBD B-VP O
to TO B-PP O
the DT B-NP O
canine JJ I-NP O
chromosome NN I-NP O
regions NNS I-NP O
CFA22q11 NN I-NP O
and CC I-NP O
CFA10q26 NN I-NP O
, , O O
respectively RB B-ADVP O
, , O O
demonstrating VBG B-VP O
that IN B-SBAR O
WD NN B-NP B-Disease
cannot MD B-VP O
be VB I-VP O
homologous JJ B-ADJP O
to TO B-PP O
CT NN B-NP B-Disease
. . O O

The DT B-NP O
copper NN I-NP O
transport NN I-NP O
genes NNS I-NP O
CTR1 NN I-NP O
and CC I-NP O
CTR2 NN I-NP O
were VBD B-VP O
also RB I-VP O
excluded VBN I-VP O
as IN B-PP O
candidate NN B-NP O
genes NNS I-NP O
for IN B-PP O
CT NN B-NP B-Disease
since IN B-SBAR O
they PRP B-NP O
both DT B-NP O
mapped VBD B-VP O
to TO B-PP O
canine JJ B-NP O
chromosome NN I-NP O
region NN I-NP O
CFA11q22 NN I-NP O
. . O O

2 CD B-NP O
- HYPH I-NP O
22 CD I-NP O
. . O O

5 LS B-LST O
. . O O

A DT B-NP O
transcribed VBN I-NP O
sequence NN I-NP O
identified VBN B-VP O
from IN B-PP O
the DT B-NP O
C04107 NN I-NP O
- HYPH O O
containing VBG B-VP O
BAC NN B-NP O
was VBD B-VP O
found VBN I-VP O
to TO I-VP O
be VB I-VP O
homologous JJ B-ADJP O
to TO B-PP O
a DT B-NP O
gene NN I-NP O
expressed VBN B-VP O
from IN B-PP O
human JJ B-NP O
chromosome NN I-NP O
2p13 NN I-NP O
- HYPH B-NP O
p16 NN I-NP O
, , O O
a DT B-NP O
region NN I-NP O
devoid JJ B-ADJP O
of IN B-PP O
any DT B-NP O
positional JJ I-NP O
candidate NN I-NP O
genes NNS I-NP O
. . O O

Molecular JJ B-NP O
analysis NN I-NP O
of IN B-PP O
the DT B-NP O
APC NN I-NP B-Disease
gene NN I-NP O
in IN B-PP O
205 CD B-NP O
families NNS I-NP O
: : O O
extended VBN B-NP O
genotype NN I-NP O
- HYPH B-NP O
phenotype NN I-NP O
correlations NNS I-NP O
in IN B-PP O
FAP NN B-NP B-Disease
and CC I-NP O
evidence NN I-NP O
for IN B-PP O
the DT B-NP O
role NN I-NP O
of IN B-PP O
APC NN B-NP B-Disease
amino JJ I-NP O
acid NN I-NP O
changes NNS I-NP O
in IN B-PP O
colorectal JJ B-NP B-Disease
cancer NN I-NP I-Disease
predisposition NN I-NP O
. . O O

BACKGROUND NN B-NP O
/ SYM I-NP O
AIMS NNS I-NP O
The DT B-NP O
development NN I-NP O
of IN B-PP O
colorectal JJ B-NP B-Disease
cancer NN I-NP I-Disease
and CC O O
a DT B-NP O
variable JJ I-NP O
range NN I-NP O
of IN B-PP O
extracolonic JJ B-NP O
manifestations NNS I-NP O
in IN B-PP O
familial JJ B-NP B-Disease
adenomatous JJ I-NP I-Disease
polyposis NN I-NP I-Disease
( ( O O
FAP NN B-NP B-Disease
) ) O O
is VBZ B-VP O
the DT B-NP O
result NN I-NP O
of IN B-PP O
the DT B-NP O
dominant JJ I-NP O
inheritance NN I-NP O
of IN B-PP O
adenomatous JJ B-NP B-Disease
polyposis NN I-NP I-Disease
coli NN I-NP I-Disease
( ( O O
APC NN B-NP B-Disease
) ) O O
gene NN B-NP O
mutations NNS I-NP O
. . O O

In IN B-PP O
this DT B-NP O
study NN I-NP O
, , O O
direct JJ B-NP O
mutation NN I-NP O
analysis NN I-NP O
of IN B-PP O
the DT B-NP O
APC NN I-NP B-Disease
gene NN I-NP O
was VBD B-VP O
performed VBN I-VP O
to TO B-VP O
determine VB I-VP O
genotype NN B-NP O
- HYPH B-NP O
phenotype NN I-NP O
correlations NNS I-NP O
for IN B-PP O
nine CD B-NP O
extracolonic JJ I-NP O
manifestations NNS I-NP O
and CC O O
to TO B-VP O
investigate VB I-VP O
the DT B-NP O
incidence NN I-NP O
of IN B-PP O
APC NN B-NP B-Disease
mutations NNS I-NP O
in IN B-PP O
non AFX B-NP O
- HYPH I-NP O
FAP NN I-NP O
colorectal JJ I-NP B-Disease
cancer NN I-NP I-Disease
. . O O

METHODS NNS B-NP O
The DT B-NP O
APC NN I-NP B-Disease
gene NN I-NP O
was VBD B-VP O
analysed VBN I-VP O
in IN B-PP O
190 CD B-NP O
unrelated JJ I-NP O
FAP NN I-NP B-Disease
and CC O O
15 CD B-NP O
non AFX I-NP O
- HYPH I-NP O
FAP NN I-NP O
colorectal JJ I-NP B-Disease
cancer NN I-NP I-Disease
patients NNS I-NP O
using VBG B-VP O
denaturing VBG B-VP O
gradient NN B-NP O
gel NN I-NP O
electrophoresis NN I-NP O
, , O O
the DT B-NP O
protein NN I-NP O
truncation NN I-NP O
test NN I-NP O
, , O O
and CC O O
direct JJ B-NP O
sequencing NN I-NP O
. . O O

RESULTS NNS B-NP O
Chain VBP B-VP O
terminating VBG B-NP O
signals NNS I-NP O
were VBD B-VP O
only RB I-VP O
identified VBN I-VP O
in IN B-PP O
patients NNS B-NP O
belonging VBG B-VP O
to TO B-PP O
the DT B-NP O
FAP NN I-NP B-Disease
group NN I-NP O
( ( O O
105 CD B-NP O
patients NNS I-NP O
) ) O O
. . O O

Amino NN B-NP O
acid NN I-NP O
changes NNS I-NP O
were VBD B-VP O
identified VBN I-VP O
in IN B-PP O
four CD B-NP O
patients NNS I-NP O
, , O O
three CD B-NP O
of IN B-PP O
whom WP B-NP O
belonged VBD B-VP O
to TO B-PP O
the DT B-NP O
non AFX I-NP O
- HYPH I-NP O
FAP NN I-NP O
group NN I-NP O
of IN B-PP O
colorectal JJ B-NP B-Disease
cancer NN I-NP I-Disease
patients NNS I-NP O
. . O O

Genotype NN B-NP O
- HYPH I-NP O
phenotype NN I-NP O
correlations NNS I-NP O
identified VBD B-VP O
significant JJ B-NP O
differences NNS I-NP O
in IN B-PP O
the DT B-NP O
nature NN I-NP O
of IN B-PP O
certain JJ B-NP O
extracolonic JJ I-NP O
manifestations NNS I-NP O
in IN B-PP O
FAP NN B-NP B-Disease
patients NNS I-NP O
belonging VBG B-VP O
to TO B-PP O
three CD B-NP O
mutation NN I-NP O
subgroups NNS I-NP O
. . O O

CONCLUSIONS NNS B-NP O
Extended VBD B-VP O
genotype NN B-NP O
- HYPH O O
phenotype NN B-NP O
correlations NNS I-NP O
made VBN B-VP O
in IN B-PP O
this DT B-NP O
study NN I-NP O
may MD B-VP O
have VB I-VP O
the DT B-NP O
potential NN I-NP O
to TO B-VP O
determine VB I-VP O
the DT B-NP O
most RBS I-NP O
appropriate JJ I-NP O
surveillance NN I-NP O
and CC O O
prophylactic JJ B-NP O
treatment NN I-NP O
regimens NNS I-NP O
for IN B-PP O
those DT B-NP O
patients NNS I-NP O
with IN B-PP O
mutations NNS B-NP O
associated VBN B-VP O
with IN B-PP O
life NN B-NP O
threatening JJ I-NP O
conditions NNS I-NP O
. . O O

This DT B-NP O
study NN I-NP O
also RB B-ADVP O
provided VBD B-VP O
evidence NN B-NP O
for IN B-PP O
the DT B-NP O
pathological JJ I-NP O
nature NN I-NP O
of IN B-PP O
amino JJ B-NP O
acid NN I-NP O
changes NNS I-NP O
in IN B-PP O
APC NN B-NP O
associated VBN B-VP O
with IN B-PP O
both CC O O
FAP NN B-NP B-Disease
and CC O O
non AFX B-NP O
- HYPH I-NP O
FAP NN I-NP O
colorectal JJ I-NP B-Disease
cancer NN I-NP I-Disease
patients NNS I-NP O
. . O O

. . O O

Inherited VBN B-NP B-Disease
colorectal JJ I-NP I-Disease
polyposis NN I-NP I-Disease
and CC I-NP O
cancer NN I-NP B-Disease
risk NN I-NP O
of IN B-PP O
the DT B-NP O
APC NN I-NP O
I1307K NN I-NP O
polymorphism NN I-NP O
. . O O

Germ NN B-NP O
- HYPH I-NP O
line NN I-NP O
and CC O O
somatic JJ B-NP O
truncating NN I-NP O
mutations NNS I-NP O
of IN B-PP O
the DT B-NP O
APC NN I-NP B-Disease
gene NN I-NP O
are VBP B-VP O
thought VBN I-VP O
to TO I-VP O
initiate VB I-VP O
colorectal JJ B-NP B-Disease
tumor NN I-NP I-Disease
formation NN I-NP O
in IN B-PP O
familial JJ B-NP B-Disease
adenomatous JJ I-NP I-Disease
polyposis NN I-NP I-Disease
syndrome NN I-NP I-Disease
and CC O O
sporadic JJ B-NP O
colorectal JJ I-NP O
carcinogenesis NN I-NP O
, , O O
respectively RB B-ADVP O
. . O O

Recently RB B-ADVP O
, , O O
an DT B-NP O
isoleucine NN I-NP O
- SYM B-VP O
- SYM B-NP O
> SYM I-NP O
lysine NN I-NP O
polymorphism NN I-NP O
at IN B-PP O
codon NN B-NP O
1307 CD I-NP O
( ( O O
I1307K NN B-NP O
) ) O O
of IN B-PP O
the DT B-NP O
APC NN I-NP B-Disease
gene NN I-NP O
has VBZ B-VP O
been VBN I-VP O
identified VBN I-VP O
in IN B-PP O
6 CD B-NP O
% NN I-NP O
- HYPH I-NP O
7 CD I-NP O
% NN I-NP O
of IN B-PP O
the DT B-NP O
Ashkenazi NNP I-NP O
Jewish JJ I-NP O
population NN I-NP O
. . O O

To TO B-VP O
assess VB I-VP O
the DT B-NP O
risk NN I-NP O
of IN B-PP O
this DT B-NP O
common JJ I-NP O
APC NN I-NP B-Disease
allelic JJ I-NP O
variant NN I-NP O
in IN B-PP O
colorectal JJ B-NP O
carcinogenesis NN I-NP O
, , O O
we PRP B-NP O
have VBP B-VP O
analyzed VBN I-VP O
a DT B-NP O
large JJ I-NP O
cohort NN I-NP O
of IN B-PP O
unselected JJ B-NP O
Ashkenazi NNP I-NP O
Jewish JJ I-NP O
subjects NNS I-NP O
with IN B-PP O
adenomatous JJ B-NP B-Disease
polyps NNS I-NP I-Disease
and CC O O
. . O O

or CC O O
colorectal JJ B-NP B-Disease
cancer NN I-NP I-Disease
, , O I-Disease
for IN B-PP O
the DT B-NP O
APC NN I-NP O
I1307K NN I-NP O
polymorphism NN I-NP O
. . O O

The DT B-NP O
APC NN I-NP O
I1307K NN I-NP O
allele NN I-NP O
was VBD B-VP O
identified VBN I-VP O
in IN B-PP O
48 CD B-NP O
( ( O O
10 CD B-NP O
. . O O

1 CD B-NP O
% NN I-NP O
) ) O O
of IN B-PP O
476 CD B-NP O
patients NNS I-NP O
. . O O

Compared VBN B-PP O
with IN B-PP O
the DT B-NP O
frequency NN I-NP O
in IN B-PP O
two CD B-NP O
separate JJ I-NP O
population NN I-NP O
control NN I-NP O
groups NNS I-NP O
, , O O
the DT B-NP O
APC NN I-NP O
I1307K NN I-NP O
allele NN I-NP O
is VBZ B-VP O
associated VBN I-VP O
with IN B-PP O
an DT B-NP O
estimated VBN I-NP O
relative JJ I-NP O
risk NN I-NP O
of IN B-PP O
1 CD B-NP O
. . O O

5 CD B-NP O
- HYPH I-NP O
1 CD I-NP O
. . O O

7 CD B-NP O
for IN B-PP O
colorectal JJ B-NP B-Disease
neoplasia NN I-NP I-Disease
( ( O O
both DT B-NP O
P NN I-NP O
= JJ I-NP O
. . I-NP O

01 CD I-NP O
) ) O O
. . O O

Furthermore RB B-ADVP O
, , O O
compared VBN B-PP O
with IN B-PP O
noncarriers NNS B-NP O
, , O O
APC NN B-NP O
I1307K NN I-NP O
carriers NNS I-NP O
had VBD B-VP O
increased VBN I-VP O
numbers NNS B-NP O
of IN B-PP O
adenomas NNS B-NP B-Disease
and CC O O
colorectal JJ B-NP B-Disease
cancers NNS I-NP I-Disease
per IN B-PP O
patient NN B-NP O
( ( O O
P NN B-NP O
= SYM B-VP O
. . B-NP O

03 CD I-NP O
) ) O O
, , O O
as RB B-CONJP O
well RB I-CONJP O
as IN I-CONJP O
a DT B-NP O
younger JJR I-NP O
age NN I-NP O
at IN B-PP O
diagnosis NN B-NP O
. . O O

We PRP B-NP O
conclude VBP B-VP O
that IN B-SBAR O
the DT B-NP O
APC NN I-NP O
I1307K NN I-NP O
variant NN I-NP O
leads VBZ B-VP O
to TO B-PP O
increased VBN B-NP O
adenoma NN I-NP B-Disease
formation NN I-NP O
and CC O O
directly RB B-VP O
contributes VBZ I-VP O
to TO B-PP O
3 CD B-NP O
% NN I-NP O
- HYPH O O
4 CD B-NP O
% NN I-NP O
of IN B-PP O
all DT B-NP O
Ashkenazi NNP I-NP O
Jewish NNP I-NP O
colorectal JJ I-NP B-Disease
cancer NN I-NP I-Disease
. . O O

The DT B-NP O
estimated VBN I-NP O
relative JJ I-NP O
risk NN I-NP O
for IN B-PP O
carriers NNS B-NP O
may MD B-VP O
justify VB I-VP O
specific JJ B-NP O
clinical JJ I-NP O
screening NN I-NP O
for IN B-PP O
the DT B-NP O
360 CD I-NP O
, , I-NP O
000 CD I-NP O
Americans NNPS I-NP O
expected VBN B-VP O
to TO I-VP O
harbor VB I-VP O
this DT B-NP O
allele NN I-NP O
, , O O
and CC O O
genetic JJ B-NP O
testing NN I-NP O
in IN B-PP O
the DT B-NP O
setting NN I-NP O
of IN B-PP O
long JJ B-NP O
- HYPH I-NP O
term NN I-NP O
- HYPH I-NP O
outcome NN I-NP O
studies NNS I-NP O
may MD B-VP O
impact VB I-VP O
significantly RB B-ADVP O
on IN B-PP O
colorectal JJ B-NP B-Disease
cancer NN I-NP I-Disease
prevention NN I-NP O
in IN B-PP O
this DT B-NP O
population NN I-NP O
. . O O

Localization NN B-NP O
of IN B-PP O
human JJ B-NP O
BRCA1 NN I-NP O
and CC O O
its PRP$ B-NP O
loss NN I-NP O
in IN B-PP O
high JJ B-NP O
- HYPH I-NP O
grade NN I-NP O
, , O O
non AFX O B-Disease
- HYPH O I-Disease
inherited VBN B-NP I-Disease
breast NN I-NP I-Disease
carcinomas NNS I-NP I-Disease
. . O O

Although IN B-SBAR O
the DT B-NP O
link NN I-NP O
between IN B-PP O
the DT B-NP O
BRCA1 NN I-NP O
tumour NN I-NP B-Disease
- HYPH B-NP O
suppressor NN I-NP O
gene NN I-NP O
and CC O O
hereditary JJ B-NP B-Disease
breast NN I-NP I-Disease
and CC O I-Disease
ovarian JJ B-NP I-Disease
cancer NN I-NP I-Disease
is VBZ B-VP O
established VBN I-VP O
, , O O
the DT B-NP O
role NN I-NP O
, , O O
if IN B-SBAR O
any DT B-NP O
, , O O
of IN B-PP O
BRCA1 NN B-NP O
in IN B-PP O
non AFX B-NP B-Disease
- HYPH I-NP I-Disease
familial JJ I-NP I-Disease
cancers NNS I-NP I-Disease
is VBZ B-VP O
unclear JJ B-ADJP O
. . O O

BRCA1 NN B-NP O
mutations NNS I-NP O
are VBP B-VP O
rare JJ B-ADJP O
in IN B-PP O
sporadic JJ B-NP B-Disease
cancers NNS I-NP I-Disease
, , O O
but CC O O
loss NN B-NP O
of IN B-PP O
BRCA1 NN B-NP O
resulting VBG B-VP O
from IN B-PP O
reduced VBN B-NP O
expression NN I-NP O
or CC O O
incorrect JJ B-NP O
subcellular JJ I-NP O
localization NN I-NP O
is VBZ B-VP O
postulated VBN I-VP O
to TO I-VP O
be VB I-VP O
important JJ B-ADJP O
in IN B-PP O
non AFX B-NP B-Disease
- HYPH I-NP I-Disease
familial JJ I-NP I-Disease
breast NN I-NP I-Disease
and CC O I-Disease
ovarian JJ B-NP I-Disease
cancers NNS I-NP I-Disease
. . O O

Epigenetic JJ B-NP O
loss NN I-NP O
, , O O
however RB B-ADVP O
, , O O
has VBZ B-VP O
not RB I-VP O
received VBN I-VP O
general JJ B-NP O
acceptance NN I-NP O
due JJ B-ADJP O
to TO B-VP O
controversy VB I-VP O
regarding VBG I-VP O
the DT B-NP O
subcellular JJ I-NP O
localization NN I-NP O
of IN B-PP O
BRCA1 NN B-NP O
proteins NNS I-NP O
, , O O
reports NNS B-NP O
of IN B-PP O
which WDT B-NP O
have VBP B-VP O
ranged VBN I-VP O
from IN B-PP O
exclusively RB B-ADJP O
nuclear JJ I-ADJP O
, , O O
to TO B-PP O
conditionally RB B-NP O
nuclear JJ I-NP O
, , O O
to TO B-PP O
the DT B-NP O
ER NN I-NP O
/ SYM B-NP O
golgi NN I-NP O
, , O O
to TO B-PP O
cytoplasmic JJ B-NP O
invaginations NNS I-NP O
into IN B-PP O
the DT B-NP O
nucleus NN I-NP O
. . O O

In IN B-PP O
an DT B-NP O
attempt NN I-NP O
to TO B-VP O
resolve VB I-VP O
this DT B-NP O
issue NN I-NP O
, , O O
we PRP B-NP O
have VBP B-VP O
comprehensively RB I-VP O
characterized VBN I-VP O
19 CD B-NP O
anti AFX B-NP O
- HYPH I-NP O
BRCA1 NN I-NP O
antibodies NNS I-NP O
. . O O

These DT B-NP O
reagents NNS I-NP O
detect VBP B-VP O
a DT B-NP O
220 CD I-NP O
- HYPH I-NP O
kD NN I-NP O
protein NN I-NP O
localized VBN B-VP O
in IN B-PP O
discrete JJ B-NP O
nuclear JJ I-NP O
foci NNS I-NP O
in IN B-PP O
all DT B-NP O
epithelial JJ I-NP O
cell NN I-NP O
lines NNS I-NP O
, , O O
including VBG B-PP O
those DT B-NP O
derived VBN B-VP O
from IN B-PP O
breast NN B-NP B-Disease
malignancies NNS I-NP I-Disease
. . O O

Immunohistochemical JJ B-NP O
staining NN I-NP O
of IN B-PP O
human JJ B-NP O
breast NN I-NP O
specimens NNS I-NP O
also RB B-ADVP O
revealed VBD B-VP O
BRCA1 NN B-NP O
nuclear JJ I-NP O
foci NNS I-NP O
in IN B-PP O
benign JJ B-NP O
breast NN I-NP O
, , O O
invasive JJ B-NP B-Disease
lobular JJ I-NP I-Disease
cancers NNS I-NP I-Disease
and CC O O
low JJ B-NP B-Disease
- HYPH I-NP I-Disease
grade NN I-NP I-Disease
ductal JJ I-NP I-Disease
carcinomas NNS I-NP I-Disease
. . O O

Conversely RB B-ADVP O
, , O O
BRCA1 NN B-NP O
expression NN I-NP O
was VBD B-VP O
reduced VBN I-VP O
or CC O O
undetectable JJ B-ADJP O
in IN B-PP O
the DT B-NP O
majority NN I-NP O
of IN B-PP O
high JJ B-NP O
- HYPH I-NP O
grade NN I-NP O
, , O O
ductal JJ B-NP B-Disease
carcinomas NNS I-NP I-Disease
, , O O
suggesting VBG B-VP O
that IN B-SBAR O
absence NN B-NP O
of IN B-PP O
BRCA1 NN B-NP O
may MD B-VP O
contribute VB I-VP O
to TO B-PP O
the DT B-NP O
pathogenesis NN I-NP O
of IN B-PP O
a DT B-NP O
significant JJ I-NP O
percentage NN I-NP O
of IN B-PP O
sporadic JJ B-NP B-Disease
breast NN I-NP I-Disease
cancers NNS I-NP I-Disease
. . O O

. . O O

